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New chemical entities (NCE) are in continuous development in pharmaceutical 
companies across the globe, in a never-ending arms race of human ingenuity against 
human disease. Methods for the testing of NCEs in the past have relied on the widespread 
use of basic cellular epithelial equivalents, generally made by culturing a single epithelial 
cell line on a 2D permeable plastic membrane, and animal models for the validation of 
NCEs. These techniques are utilised before progression onto animal and human trials and 
eventual commercial availability after thorough efficacy and safety testing.  
 
The use of cell lines to create two-dimensional (2D) models of the intestinal epithelium 
have been the gold standard since the 1980’s. These models benefit as both a cost saving 
exercise due to their simplicity and in reducing the need to use animals in research. which 
then, as today, is both ethically important and physiologically justified because animal 
models are often unreliable models of human anatomy, tissue and function. However, 2D 
models are unable to recreate complex structural variations present in vivo, usually 
incorporating a single cell phenotype in a non-physiologically based system. Whilst these 
simple models are cheap and mass producible, their use for NCEs analysis leads to 
progression of poor clinical candidates to later phases of development which fail due to 
in vivo functional irrelevance, toxicity or poor pharmacokinetics. Newer methods have 
been developed which improve the in vivo characteristics of 2D models, often through 
inclusion of additional cells lineages, such as goblet cells to make use of their distinct 
functions. Likewise, paracrine effects of fibroblasts or immune cells are increasingly 
shown to have critical functions in directing epithelial homeostasis and development. 
Three-dimensional (3D) tissue equivalents, are an emerging technology able to model a 
number of systems in vitro, bridging the gap between 2D models and human tissues. 
Ultimately however, conventional 2D monoculture models such as Caco-2 remain the 
gold standard for pharmacokinetic and toxicity analysis of NCE.   
 
It was hypothesised that Caco-2 model phenotypes can be improved through the use of 
fibroblast conditioned medias and application of cell lines into a 3D model. The aim was 
to develop a more developed understanding of the effect of the paracrine 
microenvironment and 3D culture on epithelial, specifically Caco-2, phenotype.   
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Through utilisation of  the Caco-2 cell line along with fibroblast cells of varying origin 
(Colon carcinoma, normal small intestine and skin) this study was able to create both 2D 
Transwell paracrine cultures and 3D models of both the intestinal epithelium and mucosae 
respectively. Colon derived fibroblast cells were shown to secrete significant 
concentrations of Keratinocyte Growth Factor (KGF) into media under normal 2D culture 
conditions. Moreover, the addition of paracrine factors released by fibroblast cells into 
culture and direct 3D co-culture allows for the creation of models with enhanced 
structural characteristics over Caco-2 monolayers with distinct epithelial and sub-
epithelial compartmentalisation and similar structural morphologies as seen in in vivo 
tissues.  Functionally, models were tested for their pharmacokinetic capability to a 
number of model compounds. Comparison of model functional between models and 
reported literature values for tissues and Caco-2 controls suggests that paracrine fibroblast 
secretome and 3D cells culture has a significant effect on Caco-2 function. Significant 
variation between models was observed in this study suggesting further research into the 























First of all I’d like to thank my supervisor Professor Stefan Przyborski and Dr Mathilde 
Roger for all the advice and guidance over the last four years that has helped be grow into 
the scientist I am today. It has been a real pleasure to have completed my doctoral research 
within your lab. I’d also like to thank Jim Cooper and the staff at ECACC for their 
generous provision of cells, and for the valuable industrial perspective and training given 
to me. Your positive comments after lunchtime seminars were great encouragement. 
Thanks also to my thesis committee, Prof. Jahoda, Dr Djoko and Dr Hole for your 
periodic contributions and care for the project. Additionally, I’d like to thank the staff of  
Reprocell, particularly Fred Tholozan for your contributions in my first year of study, 
getting me on the right path early on. Immense gratitude belongs to the staff of Durham 
Biosciences in general and to the imaging team of Joanne, Tim, Christine and Helen. With 
a special mention to the late Ian Cummings for his excellent work on the analysis of study 
samples. He will be missed by a great many. 
 
As for the lab; Henry, your ideas make me realise I’m not the craziest person here. Ben, 
the morning crossword was possibly the most difficult part of this PhD. Lydia, housemate, 
friend and black-market peanut-puff supplier. Steve, for the trets (ughhh). Lucy and 
Nicole, the only people in lab 4 to have a reasonably sane conversation with. Claire, for 
funding the local taxi companies. Bek and Kirsty, for the laughs and guidance both in the 
lab and out. And to all others in the lab past and present, far too numerous to mention 




Caroline, thanks for putting up with me and guiding me through the years. Your steadying 
presence helped more than you could know. Here’s to future challenges faced together. 
 
Finally, Mum and Dad, thank you for all the encouragement throughout all my education, 
from a tiny 4 year old at his first day at school to now, without your  support this wouldn’t 





Table of contents 
 
List of Tables ................................................................................................................. 21 
List of Figures ................................................................................................................ 25 
Abbreviations ................................................................................................................ 40 
1. General Introduction ................................................................................................ 43 
1.1 Challenges of modern drug discovery ............................................................... 43 
1.2 The general anatomy of the gastro-intestinal tract .......................................... 48 
1.3 Epithelial anatomy, the relation of structure and function. ............................ 54 
1.4 Understanding the functional absorptive component of the intestine, the 
enterocyte. .................................................................................................................. 57 
1.5 Methods of epithelial permeability and epithelial junctional composition, 
development of a selective passive paracellular barrier. ....................................... 60 
1.5.1 Methods of permeability through epithelial barriers ...................................... 60 
1.5.2 Occluding junctions ........................................................................................ 60 
1.5.3 Anchoring junctions ........................................................................................ 62 
1.5.4 Gap Junctions .................................................................................................. 64 
1.6 Quantitative techniques for monolayer integrity and tight junction formation 
measurement. ............................................................................................................. 66 
1.7 Paracellular permeability, measuring membrane integrity ............................ 67 
1.8 Other cells of the intestinal epithelium and mucosa ........................................ 68 
1.8.1 Goblet cells ..................................................................................................... 68 
1.8.2 Enteroendocrine cells ...................................................................................... 69 
7 
 
1.8.3 Paneth cells ..................................................................................................... 69 
1.8.4 Fibroblasts and myofibroblasts ....................................................................... 70 
1.9 The Villus-crypt axis and the stem cell niche .................................................... 71 
1.10 In Vitro models of the intestinal epithelium .................................................... 72 
1.10.1 Caco-2 Transwell models of the intestinal epithelium ................................. 72 
1.10.2 Stem cells applied to the Transwell system .................................................. 75 
1.10.3 Utilising HT29-MTX as a goblet cell component of the epithelial layer ..... 76 
1.11 Understanding the growing use of CCD-18co cells in intestinal model cell 
culture. ..................................................................................................................... 78 
1.12 The growing use of advanced 2D and 3D models of the intestine over the 
current 2D standards. ............................................................................................... 79 
1.13 Regulatory alignment and the challenges of applying new, more complex 
models to the drug development process. ................................................................ 83 
1.12 Project Hypothesis ............................................................................................. 85 
1.13 Project Aims ....................................................................................................... 85 
1.14 Project Objectives .............................................................................................. 86 
2. Materials and methods ............................................................................................. 87 
2.1 Materials ............................................................................................................... 87 
2.1.1 Chemicals and miscellaneous lab reagents ..................................................... 87 
2.1.2 Cells and cell culture media components ....................................................... 87 
2.1.3 Plastic ware ..................................................................................................... 88 
2.1.4 Antibodies ....................................................................................................... 89 
2.1.5 qPCR primers and PCR reagents .................................................................... 90 
2.2 General methods .................................................................................................. 91 
8 
 
2.2.1 General cell culture ......................................................................................... 91 
2.2.2 Passaging ........................................................................................................ 92 
2.2.3 Trypan Blue cell counting............................................................................... 92 
2.2.4 Cryopreservation ............................................................................................. 93 
2.2.5 Cell revival ...................................................................................................... 93 
2.3 Embedding techniques for study samples ......................................................... 94 
2.3.1 Paraffin embedding ......................................................................................... 94 
2.3.2 OCT embedding .............................................................................................. 95 
2.4 Immunochemistry ............................................................................................... 95 
2.4.1 Paraffin embedded samples ............................................................................ 95 
2.4.2 OCT embedded samples ................................................................................. 96 
2.4.3 Wholemount cell coverslips, wells and Transwell inserts. ............................. 96 
2.5 Histological staining techniques of paraffin embedded samples. .................... 97 
2.5.1 Haematoxylin and eosin.................................................................................. 97 
2.5.2 Periodic acid Schiff stain ................................................................................ 97 
2.5.3 Masson trichrome stain with methyl blue ....................................................... 98 
2.6 Scanning electron microscopy (SEM) ................................................................ 98 
2.7 Transmission electron microscope (TEM) ........................................................ 99 
2.8 Drug permeability transport assays. ................................................................. 99 
2.9 qPCR analysis of cell models and tissues ........................................................ 100 
2.9.1 mRNA purification and extraction from whole cell and tissue lysates. ....... 100 
2.9.2 mRNA quantification of purified cell model lysates. ................................... 101 
2.9.3 mRNA reverse transcription into single strand complementary DNA ......... 101 
2.9.4 cDNA quantification and comparative analysis to controls. ........................ 102 
2.10 Bradford assay assessment of protein abundance ........................................ 103 
9 
 
2.11 Quantification of aminopeptidase activity .................................................... 103 
2.12 Standard Caco-2 Transwell experimental set up and conditioned media 
creation and application. ........................................................................................ 104 
2.13 Human tissue processing and staining ........................................................... 105 
2.14 Outgrowth of myofibroblast primary cell cultures from human tissue sections
 ................................................................................................................................... 106 
2.15 Generation of a 3D intestinal model .............................................................. 107 
2.16 Epithelial electrophysical resistance measurements of Transwell models of 
the intestine. ............................................................................................................. 108 
2.17 Statistical analysis of study data .................................................................... 108 
3. Development Transwell co-culture models ........................................................... 109 
3.1 Introduction ....................................................................................................... 109 
3.1.1 Caco-2 Transwell, the gold standard for intestinal pharmacokinetics. ......... 109 
3.1.2 Understanding the role of sub-epithelial fibroblasts on the homeostasis of the 
intestinal epithelium. .............................................................................................. 109 
3.1.3 Methods for the advancement of model in vivo relevancy. .......................... 110 
3.1.4 Understanding the importance of 3D architecture on model development. . 111 
3.2 Hypothesis, aims and objectives ....................................................................... 113 
3.2.1 Hypothesis .................................................................................................... 113 
3.2.2 Aims .............................................................................................................. 113 
3.2.3 Objectives ..................................................................................................... 114 
3.3 Methods .............................................................................................................. 115 
3.3.1 Immunohistochemical characterisation of intermediate filament expression in 
CCD-18co, HDFn and HIC cells. .......................................................................... 115 
10 
 
3.3.2 Characterisation of Caco-2 and HT29-MTX in pre and post confluency states 
through immunohistochemistry. ............................................................................ 115 
3.3.3 Co-culture model formation.......................................................................... 115 
3.3.4 Trans-Epithelial Electrical Resistance (TEER) measurement of epithelial 
layers ...................................................................................................................... 116 
3.3.5 MTT assay for the assessment of metabolic function................................... 116 
3.3.6 Assessment of conditioned media and KGF on the metabolic activity of Caco-
2 epithelial cells. .................................................................................................... 117 
3.3.7 Assessment of tight junction formation in conditioned media treated cellular 
layers through immunostaining of the tight junction protein Occludin. ................ 117 
3.2.8 Immunostaining of wholemount Transwell models ..................................... 118 
3.3.9 qPCR analysis of Transwell model lysates ................................................... 118 
3.3.10 Aminopeptidase quantification of Transwell models compared to 3D 
cultures. .................................................................................................................. 118 
3.3.11 Keratinocyte growth factor (KGF) conditioned media experiments in 
Snapwell format inserts. ........................................................................................ 119 
3.3.12 MTT assessment of KGF treated Caco-2 layers. ........................................ 119 
3.3.13 Assessment of tight junction formation in KGF treated cell layers through 
immunostaining of the tight junction protein Occludin. ........................................ 119 
3.3.14 ELISA quantification of KGF abundance in conditioned media samples. . 120 
3.3.15 DNA concentration quantification for KGF ELISA normalisation ............ 121 
3.3.16 Transport assays utilising the Ussing chamber system for Transwell and 
Alvetex Lucifer Yellow permeability assays ......................................................... 121 
3.3.17 qPCR analysis of conditioned media and KGF spiked Caco-2 2D layers. . 123 
3.4 Results ................................................................................................................. 125 
3.4.1 Morphological characterisation of stromal and epithelial cell lines. ............ 125 
3.4.2 Immunostaining characterisation of myofibroblasts for characteristic 
cytoskeletal markers. ............................................................................................. 125 
11 
 
3.4.3 Analysis of the changing characteristics of Caco-2 cells in pre and post 
confluency states. ................................................................................................... 130 
3.4.4 Understanding the effects of confluency on the differentiation of HT29-MTX 
cells in 2D culture. ................................................................................................. 133 
3.4.5 Paracrine conditioned media has differential effects on epithelium 
development dependant on the origin of the fibroblasts. ....................................... 137 
3.4.6 Trans-epithelial resistance is shown to decrease in the presence of conditioned 
media from all origins with a variable degree of response. ................................... 139 
3.4.7 MTT metabolic measurements of Caco-2 2D paracrine co-culture models 
shows CCD-18co conditioned media increases the metabolic activity of Caco-2 
cells at later timepoints be delaying lag phase onset. ............................................ 140 
3.4.8 Understanding the differential development of tight junction formation in 
Caco-2 cells treated with fibroblast conditioned media......................................... 143 
3.4.9 Immunostaining of cells grown in Snapwell Transwell and CCD-18co effects 
on functional differentiation of Caco-2 cells with regards to P-gp expression and 
brush border formation. ......................................................................................... 145 
3.4.10 qPCR analysis of the development of Caco-2 layers in relation to key targets 
of function and the effects of CCD-18co paracrine media on Caco-2 layer 
development. .......................................................................................................... 149 
3.4.11 Co-culture of Caco-2 cells increases the aminopeptidase activity within 
intestinal models. ................................................................................................... 153 
3.4.12 KGF changes the structural physiology of Caco-2 monolayers and decreases 
membrane TEER levels in a dose-dependent manner. .......................................... 155 
3.4.13 Immunostaining characterisation of KGF treated Caco-2 layers shows 
increased Villin expression with higher KGF concentrations. .............................. 159 
3.4.14 KGF in Caco-2 culture media increases the metabolic activity of Caco-2 
cells in a dose-dependent manner. ......................................................................... 160 
3.4.15 Understanding the development of tight junction expression in Caco-2 cells 
grown in control and KGF spiked media conditions. ............................................ 164 
3.4.16 Differential aminopeptidase activity of KGF conditioned layers. .............. 166 
12 
 
3.4.17 Quantification of the levels of KGF present in paracrine conditioned media 
samples................................................................................................................... 167 
3.4.18 The effects of conditioned and KGF spiked media on the passive 
paracellular transport of Lucifer yellow. ............................................................... 173 
3.4.19 qPCR analysis of conditioned and KGF spiked media samples for the 
relative abundance of mRNA for key tight junctional components. ..................... 174 
3.5.20 qPCR analysis of conditioned and KGF spiked media samples for the 
relative abundance of mRNA for efflux transporter protein important in the 
function of  Caco-2  cells. ...................................................................................... 176 
3.5 Discussion ........................................................................................................... 178 
3.5.1 Chapter overview .......................................................................................... 178 
3.5.2 Fibroblast characterisation through phase contrast and immunohistological 
microscopy. ............................................................................................................ 179 
3.5.3 Paracrine influences on structural morphology and Trans-Epithelial Electrical 
Resistance (TEER). ................................................................................................ 181 
3.5.4 Tight junctional formation in Caco-2 control and paracrine treated layers and 
its effect on epithelial layer TEER and permeability. ............................................ 184 
3.5.5 Understanding the effects of conditioned media and KGF spiked media on the 
relative expression of key junctional and transporter proteins as assessed through 
qPCR analysis of 2D Caco-2 layers. ...................................................................... 190 
3.6 Conclusion .......................................................................................................... 191 
4. Epithelial - Goblet cell co-culture and its effect on model function. .................. 193 
4.1 Introduction ....................................................................................................... 193 
4.1.1 Understanding the structure of the mucus layer and its importance on the 
functional aspects of the human intestine. ............................................................. 193 
4.1.2 Limitations of the Caco-2 system to model the effects of mucus on the drug 
pharmacokinetics and methods to more accurately mimic the intestinal epithelium.
 ............................................................................................................................... 194 
13 
 
4.2 Hypothesis, Aims and Objectives ..................................................................... 197 
4.2.1 Hypothesis .................................................................................................... 197 
4.2.2 Aims .............................................................................................................. 197 
4.2.3 Objectives ..................................................................................................... 197 
4.3 Materials and Methods ..................................................................................... 198 
4.3.1 Generation of epithelial co-culture models consisting of Caco-2 and HT29-
MTX cells. ............................................................................................................. 198 
4.3.2 H&E, PAS staining of sectioned and wholemount Caco-2/ HT29-MTX co-
culture models. ....................................................................................................... 199 
4.3.3 Toludine blue staining of epithelial co-culture models. ............................... 199 
4.3.4 TEM analysis of Caco-2/ HT29-MTX co-culture constructs. ...................... 200 
4.3.5 qPCR analysis of Snapwell Transwell epithelial co-culture constructs. ...... 200 
4.3.6 Rhodamine 123 transport analysis of epithelial co-culture constructs. ........ 200 
4.4 Results ................................................................................................................. 202 
4.4.1 Trans-epithelial resistance measurements of Caco-2:HT29-MTX co-cultures 
and the effects of CCD-18co conditioned media on resultant co-culture layers. .. 202 
4.4.2 Histological investigation of Caco-2:HT29-MTX 2D co-culture on Snapwell 
Transwell membranes. ........................................................................................... 207 
4.4.3 Understanding the effects of CCD-18co paracrine culture on the development 
of Caco-2/HT29-MTX co-culture Snapwell® membranes. .................................. 211 
4.4.4 Analysis of Co-culture model cellular phenotype under CCD-18co 
conditioned media by Toludine blue staining of resin embedded sections. .......... 215 
4.4.5 Analysis of Caco-2:HT29-MTX co-cultures structural phenotype through 
high resolution transmission electron microscopy (TEM). ................................... 217 
4.4.6 E-cadherin staining of Caco-2/ HT29-MTX layers highlights the changes in 
structural morphology when HT29-MTX cells are exposed to CCD-18co paracrine 
media. ..................................................................................................................... 221 
14 
 
4.4.7 qPCR analysis of the development of Caco-2:HT29-MTX co-culture layers in 
relation to key targets of function. ......................................................................... 223 
4.4.8 Functional characterisation of Caco-2/ HT29-MTX co-culture Rhodamine 
123 transport in Snapwell culture. ......................................................................... 226 
4.5 Discussion ........................................................................................................... 228 
4.5.1 Epithelial co-culture and the effects of differing seeding ratio on the Trans-
Epithelial Electrical Resistance (TEER) of the tissue construct. ........................... 228 
4.5.2 Functional transport characteristics of epithelial co-culture layers. ............. 230 
4.5.3 Understanding the effects of CCD-18co conditioned media on the 
development of the epithelial construct layers. ..................................................... 231 
4.6 Conclusion .......................................................................................................... 233 
5. Optimisation & characterisation of an in vitro model of the intestinal mucosa and 
development of associated technology. ...................................................................... 235 
5.1 Introduction ....................................................................................................... 235 
5.1.1 The biological relevance of 3D culture. ........................................................ 235 
5.1.2 Different applications of the Caco-2 cell line to 3D systems of the intestinal 
epithelium. ............................................................................................................. 236 
5.2 Hypothesis, Aims and Objectives ..................................................................... 241 
5.2.1 Hypothesis .................................................................................................... 241 
5.2.2 Aims .............................................................................................................. 241 
5.2.3 Objectives ..................................................................................................... 242 
5.3 Materials and methods ...................................................................................... 243 
5.3.1 Seeding Caco-2 cells onto Alvetex® of varying format. .............................. 243 
5.3.2 Basement membrane addition to Alvetex Scaffold®. .................................. 243 
5.3.3 Differential CCD-18co seeding density on model development. ................. 243 
5.3.4 The effect of culture time on model development. ....................................... 244 
15 
 
5.3.5 MTT assay analysis of CCD-18co cells grown in Alvetex® Scaffold. ........ 245 
5.3.6 SEM processing of differential seeded CCD-18co Alvetex® layers. .......... 245 
5.3.7 3D model processing for TEM analysis ....................................................... 246 
5.3.8 Toluene Blue stained samples....................................................................... 246 
5.3.9 Clearing of Alvetex Scaffold for high resolution lighsheet imaging of 3D 
intestinal models. ................................................................................................... 246 
5.3.10 Immunostaining of 3D models and human intestinal tissue. ...................... 247 
5.3.11 Developing a 24 and 96 well Ussing chamber design for the efficient 
functional analysis of Alvetex intestinal models. .................................................. 247 
5.4 Results ................................................................................................................. 248 
5.4.1 Caco-2 growth characteristics in different Alvetex® configurations. .......... 248 
5.4.2 Addition of a basement membrane protein to the surface of Alvetex 
Scaffold®. .............................................................................................................. 250 
5.4.3 CCD-18co conditioned media effects on Caco-2 development on Collagen I 
Basement membranes in Alvetex Scaffold®. ........................................................ 253 
5.4.5 Optimisation of CCD-18co cells seeding density within Alvetex Scaffold® to 
create a surface layer to support the culture of Caco-2 epithelial cells. ................ 255 
5.4.6 Metabolic activity assessment of CCD-18co seeding optimisation 
experiments. ........................................................................................................... 258 
5.4.7 SEM analysis of the surface topography of CCD-18co seeding density layers.
 ............................................................................................................................... 261 
5.4.8 The effects of extended culture time on the population of Alvetex Scaffold® 
with CCD-18co cells. ............................................................................................. 261 
5.4.9 SEM analysis of stromal fibroblast cell layers. ............................................ 263 
5.4.10 Structural analysis of optimised multiphasic seeded Caco-2/ CCD-18co 
Alvetex Scaffold® intestinal models. ..................................................................... 264 
5.4.11 Optimisation and structural analysis of Caco-2/ HDFn Alvetex Scaffold® 
intestinal models. ................................................................................................... 271 
16 
 
5.4.12 Histological analysis of the structure of Caco-2/ HIC Alvetex Scaffold® 
intestinal models. ................................................................................................... 277 
5.4.13 Human colonic and small intestinal characterisation for comparison to 3D 
co-culture models. .................................................................................................. 277 
5.4.14 Human small intestine characterisation for comparison to 3D co-culture 
intestinal models. ................................................................................................... 282 
5.4.15 3D CCD-18co intestinal model immunostaining characterisation. ............ 286 
5.4.16 3D HDFn intestinal model immunostaining characterisation..................... 288 
5.4.17 3D HIC intestinal model immunostaining characterisation. ....................... 290 
5.4.18 Lighsheet analysis of 3D model immunostaining morphology. ................. 292 
 ............................................................................................................................... 294 
5.4.19 Development of an Ussing chamber for the incorporation of the 24-well 
format Alvetex Scaffold®. .................................................................................... 295 
5.4.20 Creating a high throughput solution for the culture of 96-well format 3D 
Alvetex ®models. .................................................................................................. 298 
5.4.17 Development of an Ussing chamber suitable for the analysis of 3D cultured 
96 well format models. .......................................................................................... 301 
5.5 Discussion ........................................................................................................... 305 
5.5.1 The properties of Alvetex® and its potential uses as a substrate for 3D culture 
systems. .................................................................................................................. 305 
5.5.2 Optimisation of a 3D model of the intestinal epithelia utilising Alvetex 
Scaffold®. .............................................................................................................. 308 
5.5.3 What does 3D tissue engineering tell us about the biology of tissues, 
understanding the limitation of 3D models............................................................ 310 
5.5.3 Overcoming the technical limitation of 3D models by designing a method of 
high throughput culture and analysis. .................................................................... 311 
5.6 Conclusions ........................................................................................................ 313 
17 
 
6. 3D Alvetex® and paracrine Transwell model transport dynamics of CCD-18co, 
HDFn and HIC/ Caco-2 co-culture models. .............................................................. 315 
6.1 Introduction ....................................................................................................... 315 
6.1.1 Chapter goals ................................................................................................ 315 
6.1.2 Understanding the disadvantages of 2D culture and methods for improved 
model in vivo physiology. ..................................................................................... 315 
6.1.3 Model drugs, their mechanisms of action and relevance to this study. ........ 319 
6.1.3.1 Rhodamine 123 ................................................................................................. 319 
6.1.3.2 Atenolol ............................................................................................................. 322 
6.1.3.3 Propranolol ........................................................................................................ 324 
6.1.3.4 Etoposide ........................................................................................................... 326 
6.1.3.5 Methotrexate ..................................................................................................... 328 
6.1.3.6 Lucifer Yellow .................................................................................................. 330 
6.2 Hypothesis, Aims and Objectives ..................................................................... 332 
6.2.1 Hypothesis .................................................................................................... 332 
6.2.2 Aims .............................................................................................................. 332 
6.2.3 Objectives ..................................................................................................... 332 
6.3 Materials and methods ...................................................................................... 334 
6.3.1 Ussing chamber permeability assessment of Transwell and 3D intestinal 
tissue models. ......................................................................................................... 334 
6.3.2 Efflux Co-efficient calculation from Papp permeability values ................... 334 
6.3.3 Electrophysiological measurements of Transwell Snapwell and 96 well 
Alvetex models. ..................................................................................................... 335 
6.4 Results ................................................................................................................. 340 
6.4.1 Transepithelial resistance measurements of 3D models compared to 
conventional Caco-2 standards and Human small intestinal sections. .................. 340 
6.4.2 Rhodamine 123 transport and Verapamil Hydrochloride MDR1/P-gp 
inhibition in Caco-2 Snapwell conditioned media models. ................................... 343 
18 
 
6.4.3 Rhodamine 123 transport and Verapamil Hydrochloride MDR1/ P-gp 
inhibition in 3D Caco-2/ Fibroblast bioengineered intestinal equivalents. ........... 348 
6.4.4 Timecourse analysis of Rhodamine permeability across conventionally and 
conditioned cultured Transwell models and 3D bioengineered co-culture systems.
 ............................................................................................................................... 354 
6.4.5 Efflux co-efficient value calculation and analysis to show directional bias in 
Rhodamine 123 transport within 2D Transwell and 3D Alvetex ® intestinal models.
 ............................................................................................................................... 357 
6.4.6 KGF treatment of Caco-2 Transwell models reduces its models capability to 
actively transport Rhodamine 123. ........................................................................ 362 
6.4.7 Atenolol Transport in Co-culture Transwell model layers. .......................... 365 
6.4.8 Atenolol Transport in 3D bioengineered Alvetex models. ........................... 369 
6.4.9 Efflux co-efficient of Caco-2 Transwell and 3D bio-engineered Caco-2 
Alvetex models for Atenolol.................................................................................. 373 
6.4.10 Propranolol Transport of 2D Transwell co-cultures and 3D Alvetex based 
intestinal models. ................................................................................................... 376 
6.4.11 Efflux co-efficient analysis of Propranolol permeability in 2D Transwell 
Snapwell and 3D Alvetex models. ......................................................................... 381 
6.4.12 Etoposide transport of 2D Transwell co-cultures and 3D Alvetex based 
intestinal models. ................................................................................................... 382 
6.4.13 Efflux co-efficient analysis of Etoposide permeability in 2D Transwell 
Snapwell and 3D Alvetex models demonstrate the differential effects of 3D culture 
on the permeability of tissue constructs. ................................................................ 387 
6.4.14 Methotrexate Transport for 2D Transwell paracrine co-cultures. .............. 389 
6.4.15 Methotrexate Transport for 3D Alvetex based intestinal models. .............. 390 
6.4.16 Efflux co-efficient values for 2D paracrine Transwell and 3D Alvetex 
methotrexate model transport. ............................................................................... 395 
6.4.17 Lucifer yellow transport of 2D Transwell co-cultures and 3D Alvetex based 
intestinal models. ................................................................................................... 396 
19 
 
6.4.18 Efflux co-efficient of lucifer yellow in 2D and 3D models ........................ 401 
6.5 Discussion ........................................................................................................... 403 
6.5.1 Transport dynamics of model systems and the context for this chapter ....... 403 
6.5.2 2D paracrine Transwell and 3D intestinal equivalents both show significantly 
decreased membrane resistance compared to conventionally cultured Caco-2 
models. ................................................................................................................... 403 
6.5.3 Analysis of the functional capabilities of epithelial intestinal equivalents 
through the passive paracellular transport assessment of model drug compounds.
 ............................................................................................................................... 407 
6.5.4 Actively transported compound analysis ...................................................... 410 
6.6 Conclusion .......................................................................................................... 414 
7. General discussion, project conclusions and future directions ........................... 416 
7.1 Introduction ....................................................................................................... 416 
7.2 Understanding the needs for an improved in vitro model of the intestinal 
epithelium ................................................................................................................. 417 
7.3 Understanding the paracrine microenvironment is key to developing systems 
with improved in vivo mimicry. ............................................................................. 417 
7.4 Stromal epithelial interactions result in loss of function of HT29-MTX cells 
when co-cultured in vitro. ....................................................................................... 422 
7.5 3D fibroblast culture allows for the development of a complex ECM 
microenvironment within cell substrates. ............................................................. 424 
7.6 Functional analysis of paracrine and 3D models shows significant changes in 
the function of Caco-2 epithelial layers. ................................................................ 425 
7.7 Future work ...................................................................................................... 433 
7.8 Final remarks ..................................................................................................... 434 
20 
 
8. References ................................................................................................................ 435 
9. Appendix and supplementary information. .......................................................... 464 
9.1 Negative control images .................................................................................. 464 
9.1.1 Fibroblast negative controls for 2D immunostained samples ....................... 464 
9.1.2 Epithelial lineage negative controls for 2D immunostained samples. .......... 465 
9.1.3 Caco-2 Transwell negative controls ............................................................. 466 
9.1.4 Caco-2 and HT29-MTX Transwell controls ................................................. 467 
9.1.5 3D model negative controls .......................................................................... 468 
9.1.6 Human tissue negative controls .................................................................... 469 
9.2 Intrinsic permeability of different Alvetex formats ......................................... 470 
9.3 PCR Primer optimisation ................................................................................. 470 
9.4 Project poster presentations ............................................................................. 478 



















List of Tables 
 
Table 2.1: Summary of plastic materials consumed during the course of this project 
including cell culture grade and general lab reagents. .............................................. 89 
Table 2.2: List of antibodies used in this project including secondary Alexa Fluor 
conjugated secondaries. ................................................................................................ 90 
Table 2.3: qPCR primers including reference of origin. ........................................... 91 
Table 2.4: qPCR reagents for the isolation of RNA, reverse transcription into cDNA 
and expansion  SYBR based detection methods. ........................................................ 91 
Table 3.1 Statistical analysis of Transwell model TEER measurements ............... 138 
Table 3.2: Significances of conditioned media MTT data ....................................... 142 
Table 3.3: Significances for comparative Villin expression in time course samples
 ....................................................................................................................................... 151 
Table 3.4: Significances for comparative Occludin expression in time course samples
 ....................................................................................................................................... 151 
Table 3.5: Significances for comparative OATP-B expression in time course samples
 ....................................................................................................................................... 151 
Table 3.6: Significances for comparative MRP2 expression in time course samples
 ....................................................................................................................................... 152 
Table 3.7: Significances for comparative BCRP expression in time course samples
 ....................................................................................................................................... 152 
22 
 
Table 3.8: Significances for comparative MDR1 expression in time course samples
 ....................................................................................................................................... 152 
Table 3.9 Statistical analysis of Transwell model TEER measurements ............... 154 
Table 3.10: Time-point comparison of Conditioned media and KGF spiked 
conditions ..................................................................................................................... 163 
Table 3.11: KGF levels in conditioned media normalised to DNA concentration of 
2D cellular layers ......................................................................................................... 170 
Table 3.12: Absolute KGF levels in conditioned media statistical analysis ........... 171 
Table 3.13: DNA concentration of 2D fibroblast cellular layers statistical analysis
 ....................................................................................................................................... 172 
Table 4.1: Significancy calculation between TEER values measured in epithelial co-
culture Transwell models of the intestinal epithelium ............................................. 206 
Table 6.1: TEER expression comparison between Transwell and 3D intestinal 
models ........................................................................................................................... 342 
Table 6.2: Significancy values from Rhodamine 123 ±Verapamil Hydrochloride 
permeability studies of Transwell conditioned media models – B-A and A-B data 
sets were analysed for significancy separately.......................................................... 347 
Table 6.3: Significancy values from Rhodamine 123 ±Verapamil Hydrochloride 
permeability studies of Transwell control compared with Alvetex® based intestinal 
models – B-A and A-B data sets were analysed for significancy separately. ......... 353 
Table 6.4: Efflux co-efficient analysis of Rhodamine 123 in 2D and 3D intestinal 
models both with and without Verapamil Hydrochloride and at both 60 and 120 
minutes assay lengths .................................................................................................. 361 
23 
 
Table 6.5: Significancy values for Rhodamine 123 permeability between models of 
differing KGF concentration both with and without the addition of Verapamil 
Hydrochloride .............................................................................................................. 364 
Table 6.6: Significancy values for Atenolol permeability experiments .................. 369 
Table 6.7: Significancy values for Atenolol permeability in 3D intestinal models 373 
Table 6.8: Significancy values for Atenolol Efflux Co-efficient for both 2D and 3D 
intestinal models .......................................................................................................... 375 
Table 6.9: Significancy values for Propranolol in 2D conditioned media Transwell 
models ........................................................................................................................... 380 
Table 6.10: Significancy values for Propranolol in 3D Alvetex® models ............... 380 
Table 6.11: Significancy values for Etoposide in 2D conditioned media Transwell 
models ........................................................................................................................... 386 
Table 6.12: Significancy values for Etoposide in 3D Alvetex® models ................... 386 
Table 6.13: Significancy values for Etoposide efflux co-efficient for both 2D and 3D 
intestinal models .......................................................................................................... 388 
Table 6.15: Significancy values for Methotrexate permeability in 3D Alvetex® based 
intestinal models .......................................................................................................... 394 
Table 6.14: Significancy values for Methotrexate permeability in 2D Transwell 
based intestinal models ............................................................................................... 394 
Table 6.17: Significancy values for Lucifer yellow permeability in 3D intestinal 
models ........................................................................................................................... 400 
Table 6.16: Significancy values for Lucifer yellow permeability in 2D intestinal 
models ........................................................................................................................... 400 
24 
 
Table 6.18: Comparative Papp values of models created in this study compared to 
values gained from the literature for both Caco-2 standards and intestinal tissues 
























List of Figures 
 
Figure 1.1: Understanding the costs for the development and testing of novel drug 
compounds ..................................................................................................................... 47 
Figure 1.2: The gross anatomy of the digestive system with specific focus on the 
structure of the intestine – ............................................................................................ 50 
Figure 1.3: The structural layers of the intestine ....................................................... 52 
Figure 1.4: Structural characteristics of simple epithelial layers in the human body
 ......................................................................................................................................... 55 
Figure 1.5: Complex squamous epithelial show gradients of differentiation across 
the thickness of the epithelial layer ............................................................................. 56 
Figure 1.6: General methods of permeability through epithelial barriers .............. 59 
Figure 1.7: General organisation of a tight junction complex .................................. 62 
Figure 1.8: Basic structural anatomy of the adherens  junction complex ............... 63 
Figure 1.9: Basic anatomy of gap junction physiology .............................................. 64 
Figure 1.10: Basic anatomy of human small and large intestine - ............................ 65 
Figure 1.11: Transepithelial resistance chopstick equipment and calculations ...... 66 
Figure 1.12: Expression of key proteins by Caco-2 cells in Transwell ..................... 73 
Figure 2.1: Schematic representation of the embedding and sectioning process for 
both Transwell and Alvetex® based intestinal models – ............................................ 94 
Figure 2.2: Schematic representation of the process for setting up and culturing 
Transwell based intestinal models in control and conditioned media systems...... 105 
26 
 
Figure 2.3: Schematic representation of the process for setting up and culturing 
Alvetex® based intestinal models. .............................................................................. 107 
Figure 3.1: Fibroblasts from differing origins are indistinguishable morphologically 
by phase contrast microscopy – ................................................................................. 127 
Figure 3.2: Epithelial cells grow in densely packed “cobble stone” colony formations
 ....................................................................................................................................... 128 
Figure 3.3: Lineage specific intermediate filament expression analysis in 2D shows 
similar expression patterns between the three cell lineages. ................................... 129 
Figure 3.4: Post-confluent Caco-2 cells express heightened levels of junctional 
marker, Occludin and surface efflux protein, MDR1 .............................................. 131 
Figure 3.5: Caco-2 cells are negative for Vimentin and E-cadherin staining remains 
proportional in pre and post-confluency states ........................................................ 132 
Figure 3.6: Immunofluorescent characterisation of 2D epithelial cells Pre and Post-
confluency shows increasing differentiation expression with time in culture ....... 134 
Figure 3.7: Immunofluorescent characterisation of 2D epithelial cells Pre and Post-
confluency .................................................................................................................... 135 
Figure 3.8: H&E stained comparison of Caco-2 conditioned media co-culture models 
shows consistent monolayer formation in each of the model conditions. Cells are 
clearly able to differentiate and polarise in conditioned media at differential rates 
than in Control conditions .......................................................................................... 136 
Figure 3.9: 7, 14 & 21 day TEER measurements of Caco-2 cells on Transwell 
Snapwell in control and conditioned media experiments shows that addition of 
27 
 
conditioned media to the Caco-2 cellular layers results in a variable decrease in 
TEER values compared to control layers ................................................................. 138 
Figure 3.10: The effects of fibroblast conditioned media on the MTT values of 2D 
cultured Caco-2 cells shows that CCD-18co paracrine influences have the most effect 
on Caco-2 cells with a continuation of growth up to 10 days in culture ................ 141 
Figure 3.11: Time-point comparison of all conditioned media conditions ............ 142 
Figure 3.12: Tight junction expression between conditioned media conditions shows 
increased cellular packing in conditioned media samples ....................................... 144 
Figure 3.13: Caco-2 control models appear to be well differentiated through 
expression of key proteins for model differentiation and function ........................ 147 
Figure 3.14: Caco-2 cells grown in CCD-18co conditioned paracrine media shows 
differences in the cellular organisation as analysed through expression of key 
proteins for model function ........................................................................................ 148 
Figure 3.15: Transwell time course models PCR for Villin, Occludin and OATP-B
 ....................................................................................................................................... 151 
Figure 3.16: Transwell time course models qPCR of MRP2, BCRP and MDR1 .. 152 
Figure 3.17: Aminopeptidase activity levels increase in both paracrine and 3D CCD-
18co cultures ................................................................................................................ 153 
Figure 3.18: 7, 14 & 21 day TEER measurements of Caco-2 cells on Transwell 
Snapwell in control and KGF spiked media conditions shows that addition of KGF 
to the Caco-2 models results in highly significant decreases in epithelial construct 
TEER values ................................................................................................................ 154 
28 
 
Figure 3.19: H+E of KGF spiked media Caco-2 Transwell models shows similar 
histology to the addition of paracrine media with increased cellular height and 
cytoplasmic staining .................................................................................................... 156 
Figure 3.20: Immunofluorescence staining of Control Caco-2 Snapwell models . 157 
Figure 3.21: Immunofluorescence staining of 0.5ng/ml KGF spikes Caco-2 Snapwell 
models ........................................................................................................................... 157 
Figure 3.22: Immunofluorescence staining of 5ng/ml KGF spikes Caco-2 Snapwell 
models ........................................................................................................................... 158 
Figure 3.23: Immunofluorescence staining of 25ng/ml KGF spikes Caco-2 Snapwell 
models ........................................................................................................................... 158 
Figure 3.24: MTT assessment of  cellular viability over 10 days culture period (2D) 
with and without KGF spiked media. ....................................................................... 161 
Figure 3.25: Time-point comparison of all conditions ............................................. 162 
Figure 3.26: Tight junction expression of Caco-2 cells treated with different KGF 
concentrations over 10 days ....................................................................................... 165 
Figure 3.27: Aminopeptidase activity of KGF treated Caco-2 layers .................... 166 
Figure 3.28: DNA normalised KGF ELISA .............................................................. 169 
Figure 3.29: Total KGF concentration of conditioned media ................................. 171 
Figure 3.30: Total DNA abundance of fibroblasts utilised for the generation of 
conditioned media shows no significant differences between like-samples ........... 172 
Figure 3.31: Lucifer yellow paracrine transport across treated epithelial layers . 173 
Figure 3.32: qPCR analysis of relative tight junctional component expression in 2D 
conditioned media studies........................................................................................... 175 
29 
 
Figure 3.33: qPCR analysis of relative functional efflux protein component and 
Villin expression in 2D conditioned media studies ................................................... 177 
Figure 4.1: Schematic diagram of the process for the set up and culture of Caco-2/ 
HT29-MTX co-culture mucus models of the intestinal epithelium ........................ 198 
Figure 4.2: Schematic diagram of the process for the set-up of Caco-2 co-culture 
models within an Ussing chamber system ................................................................. 201 
Figure 4.3: Caco-2/ HT29-MTX co-culture decreases the TEER values of resultant 
epithelial constructs .................................................................................................... 204 
Figure 4.4: CCD-18co paracrine co-culture with Caco-2/ HT29-MTX epithelial 
constructs increases TEER values compared to non-treated controls ................... 205 
Figure 4.5: Caco-2:HT29-MTX epithelial co-cultures shows significant differences 
in cellular morphology between models .................................................................... 209 
Figure 4.6: Mucous staining in Caco-2:HT29-MTX epithelial co-cultures ........... 210 
Figure 4.7: CCD-18co effects on Caco-2:HT29-MTX epithelial co-cultures ......... 213 
Figure 4.8: Caco-2:HT29-MTX epithelial co-cultures with CCD-18co paracrine 
media ............................................................................................................................ 214 
Figure 4.9: Toluidine blue stained sections of Caco-2/ HT29-MTX co-cultures with 
and without CCD-18co conditioned media  on Transwell membranes .................. 216 
Figure 4.10: TEM images of Caco-2/ HT29-MTX co-cultures ............................... 219 
Figure 4.11: TEM images of Caco-2 and HT29-MTX cultures in the presence of 
CCD-18co conditioned media .................................................................................... 220 
Figure 4.12: E-cadherin stained Caco-2/ HT29-MTX co-cultures in the presence and 
absence of CCD-18co conditioned media .................................................................. 222 
30 
 
Figure 4.13: qPCR analysis of Caco-2/ HT29-MTX co-culture Transwell models 
shows differential expression between Caco-2 and HT29-MTX cells lines ........... 225 
Figure 4.14: B-A Rhodamine 123 transport dynamics of Caco-2/ HT29-MTX co-
cultures in control and CCD-18co paracrine treated Snapwell layers .................. 227 
Figure 5.1: Understanding the growth characteristics of Caco-2 cells in different 
formats of Alvetex® polystyrene supports................................................................ 249 
Figure 5.2: Application of basement membrane proteins to Alvetex Scaffold ...... 252 
Figure 5.3: Optimising the volume and concentration of Collagen I gels to add to the 
surface of the Scaffold to limit cellular invasion. ..................................................... 253 
Figure 5.4: CCD-18co paracrine treatment of Caco-2 cells cultured on 2mg/ml 
Collagen I gel layers shows an enhanced Caco-2 phenotype over control layers.. 254 
Figure 5.5: Optimisation of fibroblast seeding density to limit the invasive 
characteristics of Caco-2 cells .................................................................................... 256 
Figure 5.6: Creating a quantifiable technique for the analysis of model sections for 
the percentage invasion of Caco-2 cells within the Alvetex scaffold ...................... 257 
Figure 5.7: Metabolic activity of the models shows that seeding higher densities of 
CCD-18co cells at the beginning of model culture has little effect on the number of 
surviving fibroblasts at the time of analysis ............................................................. 259 
Figure 5.8: SEM topographical analysis of optimisation CCD-18co layers shows 
significant gaps in the surface support for the culture of Caco-2 cells .................. 260 
Figure 5.10: Understanding the effects of time on the growth of CCD-18co 
population in 3D Alvetex models ............................................................................... 262 
31 
 
Figure 5.9: The effects of time on the growth of CCD-18co population in 3D Alvetex 
models shows little active proliferation when cultured in 3D ................................. 262 
Figure 5.11: Caco-2 invasion characteristics show that CCD-18co culture time has 
no significant effects on reducing the levels of Caco-2 invasion in Alvetex models
 ....................................................................................................................................... 263 
Figure 5.12: SEM Images of CCD-18co cells cultured in Alvetex Scaffold for a period 
of 21 days ...................................................................................................................... 264 
Figure 5.13: 14 day multi-phasic culture design using young intestinal CCD-18co 
fibroblasts results in the formation of an intestinal model with little observable 
Caco-2 infiltration ....................................................................................................... 267 
Figure 5.14: Toludine blue stained samples provides enhanced resolution over H&E 
stained images allowing for closer analysis of the structural morphology of Caco-2 
layers on the surface of CCD-18co models ............................................................... 268 
Figure 5.15: High magnification analysis of Caco-2/ CCD-18co 3D models reveals 
differentiated enterocytes with clear microvilli formation and associated glycocalyx
 ....................................................................................................................................... 269 
Figure 5.16: TEM ultra-thin cross sections of CCD-18co 3D co-culture model 
showing microvilli, intercellular junctions and basement membrane formation . 270 
Figure 5.17: H+E staining of 7, 14 and 21 day cultures of Caco-2 on 28 day matured 
dermal equivalents show a changing fibroblast morphology over time................. 273 
Figure 5.18: Methyl Blue stained Collagen staining of the 7, 14 and 21 day cultured 
Caco-2 models shows how Collagen deposition decreases after 21 days in culture
 ....................................................................................................................................... 274 
32 
 
Figure 5.19: 14 day multi-phasic culture design using low passage HDFn  fibroblasts 
results in the formation of an intestinal model with little observable Caco-2 
infiltration .................................................................................................................... 275 
Figure 5.20: 14-day multi-phasic culture design using low passage HIC fibroblasts 
results in the formation of an intestinal model with poor Caco-2 structure when 
compared to CCD-18co and HDFn optimised models ............................................. 276 
Figure 5.21: Histological analysis of normal human colonic tissue sections .......... 279 
Figure 5.22: Immunofluorescence analysis of normal Human Colonic tissue sections 
shows significant Collagen I, III and IV staining located at the sub-epithelial 
compartment of the tissues ......................................................................................... 280 
Figure 5.23: Immunofluorescence analysis of normal human colonic tissue sections 
highlights the two distinct cellular populations between epithelial and stromal 
lineages ......................................................................................................................... 281 
Figure 5.24: Histological analysis of normal Human Small intestinal tissue sections
 ....................................................................................................................................... 283 
Figure 5.25: Immunofluorescence study of normal Human Small intestinal tissue 
sections for the analysis of ECM deposition in the stromal intestinal tissues........ 284 
Figure 5.26: immunofluorescence analysis of normal Human Small intestinal tissue 
sections shows distinct population of cells within the epithelial and stromal 
compartments .............................................................................................................. 285 
Figure 5.27: Immunofluorescence analysis of normal Human Small intestinal tissue 
sections ......................................................................................................................... 285 
33 
 
Figure 5.28: Immunofluorescence analysis of CCD-18co/ Caco-2 Alvetex 3D models 
shows significant ECM deposition within the substrate in addition to well defined 
epithelial layers ............................................................................................................ 287 
Figure 5.29: HDFn/ Caco-2 Alvetex models show well defined epithelial layers 
without the significant Collagen deposition within the substrate as seen in CCD-18co 
models ........................................................................................................................... 289 
Figure 5.30: HIC/ Caco-2 3D models are shown to secrete significant levels of 
Collagen IV with only minor amounts of other ECM components, epithelial layering 
is significantly diminished compared to other model systems ................................ 291 
Figure 5.31: 3D cellular organization of CCD-18co fibroblasts and Caco-2 cells . 293 
Figure 5.32: 3D cellular organization of CCD-18co fibroblasts and Caco-2 cells . 294 
Figure 5.33: Wireframe schematic diagram of the 24-well Alvetex Scaffold Ussing 
chamber design ............................................................................................................ 296 
Figure 5.34: Photographic images of the 24-Well format manufactured Ussing 
chamber ........................................................................................................................ 297 
Figure 5.35: Creating a Deep well culture dish for the maintenance of the ideal 
conditions to allow for 3D intestinal model growth in 96 well formats .................. 299 
Figure 5.36: Photographic analysis of 96 well deep well format ............................ 300 
Figure 5.37: Wireframe schematic of the 96 well Ussing chamber system, designed 
for the incorporation and functional testing of 96 well format Alvetex intestinal 
models ........................................................................................................................... 302 
Figure 5.38: Photographic images of the 96 well format Ussing chamber with added 
96 well Alvetex insert .................................................................................................. 303 
34 
 
Figure 5.39: Schematic diagram of the process require for addition of 96 well format 
inserts into the custom designed 96 well Ussing chamber ....................................... 304 
Figure 6.1: Theoretical Rhodamine 123 permeability routes – .............................. 321 
Figure 6.2: Theoretical Atenolol permeability routes .............................................. 323 
Figure 6.3: Theoretical Propranolol permeability routes ....................................... 325 
Figure 6.4: Theoretical Etoposide permeability routes ........................................... 327 
Figure 6.5: Theoretical Methotrexate permeability routes ..................................... 329 
Figure 6.6: Theoretical Lucifer yellow permeability routes .................................... 331 
Figure 6.7: Schematic representation of directional transport within the cells .... 334 
Figure 6.8: Representative images of Ag/Cl electrodes used in electrophysiological 
studies ........................................................................................................................... 336 
Figure 6.9: Representative images of Ussing equipment utilised in this study...... 339 
Figure 6.10: TEER Values of 3D intestinal models shows a significant physiological 
decrease in TEER compared to conventional 2D Caco-2 Transwell models ......... 341 
Figure 6.11: Schematic representation of the transport processes being studied in 
this experiment ............................................................................................................ 343 
Figure 6.12: Comparative analysis of Rhodamine 123 transport across Control and 
paracrine media treated Caco-2 membranes shows a significant increase in 
Rhodamine 123 transport in HDFn treated Caco-2 layers ..................................... 346 
Figure 6.13: Schematic representation of the transport processes of 3D Alvetex 
systems being studied in this experiment .................................................................. 350 
35 
 
Figure 6.14: Comparative analysis of Rhodamine 123 transport across Control and 
3D Alvetex Caco-2/ Fibroblast intestinal tissue equivalents shows a large increase in 
Rhodamine 123 membrane permeability in CCD-18co and HIC 3D models ........ 352 
Figure 6.15: Time course analysis of Rhodamine 123 permeability in paracrine 
Transwell models throughout the assay period shows a general rapid increase in 
permeability followed by a plateau phase whereby permeability values stop 
increasing ..................................................................................................................... 355 
Figure 6.16: Time course analysis of Rhodamine 123 permeability in 3D Alvetex 
tissue equivalent models throughout the assay period shows a general rapid increase 
in permeability followed by a plateau phase whereby permeability values stop 
increasing ..................................................................................................................... 356 
Figure 6.17: Efflux ratio permeability calculation of 2D Transwell paracrine models 
for Rhodamine 123  - .................................................................................................. 359 
Figure 6.18: Efflux ratio permeability calculation of 3D Alvetex Caco-2/ Fibroblast 
models for Rhodamine 123 ......................................................................................... 360 
Figure 6.19: B-A transport of Rhodamine 123 in KGF treated Caco-2 layers shows 
decreased transport in treated layers versus controls with addition of Verapamil 
Hydrochloride having a dose dependant increasing effect on membrane 
permeability ................................................................................................................. 363 
Figure 6.20: Schematic representation of the expected directional travel mechanisms 
for Atenolol in Transwell and 3D Alvetex® models.................................................. 365 
Figure 6.21: Apparent Caco-2 permeability of Atenolol in Transwell Snapwell model 
systems .......................................................................................................................... 367 
36 
 
Figure 6.22: Apparent Caco-2 Transwell permeability of Atenolol in Transwell Co-
culture systems ............................................................................................................ 368 
Figure 6.23: Apparent Caco-2 Transwell permeability of Atenolol in 3D Alvetex 
Scaffold models systems .............................................................................................. 371 
Figure 6.24: Apparent Caco-2 Transwell permeability of Atenolol in Alvetex 
Scaffold co-culture systems ........................................................................................ 372 
Figure 6.25: Efflux co-efficient calculations shows no significant directional bias in 
2D model atenolol transport ....................................................................................... 374 
Figure 6.26: Efflux co-efficient calculations shows significant differences in the 
transport bias of HDFn models to other 3D systems and Transwell co-cultures .. 374 
Figure 6.27: Schematic representation of the expected permeability routes of 
Propranolol across Transwell and Alvetex models .................................................. 376 
Figure 6.28: 2D comparison of Propranolol transport across Control and treated 
Transwell models shows HDFn and HIC treatments increase propranolol 
permeability. ................................................................................................................ 378 
Figure 6.29: 3D comparison of Propranolol transport across Control and 3D Alvetex 
models with both CCD-18co and HIC models displaying attenuated propranolol 
permeability compared to controls ............................................................................ 379 
Figure 6.30: Efflux co-efficient of Propranolol across 2D and 3D intestinal constructs 
suggests no bias in directional drug transport ......................................................... 381 
Figure 6.31: Schematic overview of the expected permeability routes of Etoposide 
through Caco-2 Transwell and 3D Alvetex intestinal models ................................. 382 
37 
 
Figure 6.32: Etoposide 2D paracrine media Transwell comparison shown large 
significant increases compared to control values in all culture conditions ............ 384 
Figure 6.33: 3D HIC and HDFn Alvetex models show significant Etoposide 
permeability increases over their 2D paracrine counterparts and 2D Caco-2 Control 
layers. 3D CCD-18co models similar to CCD-18co conditioned media models .... 385 
Figure 6.34: Efflux co-efficient values show significant bias toward B-A transport in 
all conditions, both 2D and 3D ................................................................................... 388 
Figure 6.35: Schematic diagram of the expected permeability routes of Methotrexate 
in both Transwell and 3D Alvetex intestinal models ............................................... 389 
Figure 6.36: Methotrexate membrane permeability analysis of 2D paracrine Caco-
2 co-cultures shows a trending increase in membrane permeability in CCD-18co, 
HIC and HDFn co-cultures ........................................................................................ 392 
Figure 6.37: Methotrexate membrane integrity analysis of 3D Alvetex/ Caco-2 co-
cultures shows significant increases in membrane permeability in HIC cultures 393 
Figure 6.38: Efflux co-efficient values of Methotrexate comparing controls with 
paracrine media and 3D Alvetex models .................................................................. 395 
Figure 6.39: Schematic diagram of expected lucifer yellow transportation routes 
through both Transwell and Alvetex scaffold intestinal models ............................. 396 
Figure 6.40: Lucifer yellow membrane integrity analysis of 2D paracrine Caco-2 co-
cultures ......................................................................................................................... 398 
Figure 6.41: Bi-directional transport of Lucifer Yellow shows significant increase in 
membrane permeability in 3D Alvetex based intestinal models compared to 2D 
Transwell alternatives ................................................................................................. 399 
38 
 
Figure 6.42: Efflux co-efficient of lucifer yellow analysis suggests Control and 2D 
CCD-18co layers have a B-A directional bias .......................................................... 401 
Figure 6.43: Summary of the complete analysis of 2D Caco-2 Transwell models with 
the model compounds tested in this study ................................................................ 412 
Figure 6.44: Summary of the complete analysis of 3D bioengineered models with the 
model compounds tested in this study ....................................................................... 413 
Figure 6.45: Reported human and animal tissue values compared to Caco-2 
Transwell controls ....................................................................................................... 414 
Figure S1: Negative control images for 2D fibroblast cell lines – ........................... 464 
Figure S2: Negative control images for 2D Epithelial – .......................................... 465 
Figure S3: Negative control images for wholemount and transverse Caco-2 
Transwell models – ...................................................................................................... 466 
Figure S4: Negative control images for Sectioned Transwell models – ................. 467 
Figure S5: Negative control images for Sectioned 3D models –.............................. 468 
Figure S6: Negative control images for human tissues – ......................................... 469 
Figure S7: Preliminary data for the intrinsic permeability of different Alvetex 
formats to Crystal Violet dye – .................................................................................. 470 
Figure S8: MDR1 primer optimisation and efficiency check.................................. 471 
Figure S9: MRP2 primer optimisation and efficiency check .................................. 472 
Figure S10: OATP-B primer optimisation and efficiency check ............................ 473 
Figure S11: Occludin primer optimisation and efficiency check ........................... 474 
Figure S12: Villin primer optimisation and efficiency check.................................. 475 
39 
 
Figure S13: BCRP primer optimisation and efficiency check ................................ 476 
Figure S14: GAPDH primer optimisation and efficiency check ............................. 477 
Figure S16: Green channel for Figure 3.4 ................................................................ 478 
Figure S15: Green channel for Figure 3.3 ................................................................ 478 
Figure S18: Green channel for Figure 3.6 ................................................................ 479 
Figure S17: Green channel for Figure 3.5 ................................................................ 479 
Figure S19: Green channel for Figure 3.7 ................................................................ 480 
Figure S20: Green channel for Figure 3.12 .............................................................. 481 
Figure S21: Green channel for Figure 3.26 .............................................................. 482 
Figure S23: Green channel for Figure 3.14 .............................................................. 483 
Figure S22: Green channel for Figure 3.13 .............................................................. 483 
Figure S24: Green channel for Figure 3.20-23 ......................................................... 484 
Figure S26: Green channel for Figure 5.22/23 ......................................................... 485 
Figure S25: Green channel for Figure 4.11 .............................................................. 485 
Figure S27: Green channel for Figure 5.25-27 ......................................................... 486 
Figure S28: Green channel for Figure 5.28 .............................................................. 486 
Figure S30: Green channel for Figure 5.30 .............................................................. 487 






GI    Gastro-intestinal 
Conventional culture Gold standard Caco-2 Transwell epithelial models 
ADME   Absorption, Distribution, Metabolism and excretion 
3D   Three Dimensional 
2D   Two Dimensional 
iPSC     Induced Pluripotent Stem cell 
Caco-2    Colon Adenocarcinoma cell line 
NCE    New chemical entities  
ZO-1/2   Zonula Occludens – 1/2 
CAM   Calcium dependant adhesion molecule 
LGR5   Leucine-rich repeat-containing G-protein coupled receptor 5 
MRP1,2,3  Multidrug resistance-associated protein 1,2,3 
BCRP   Breast cancer resistance protein 
MDR1   Multidrug resistance protein 
MHC   Major Histocompatibility Complex 
ECM   Extracellular Matrix 
αSMA   Alpha Smooth muscle actin 
CD4   Cluster of differentiation 4 
MUC   Mucin protein 
EC cells  Enterochromaffin cells 
CYP3A4  Cytochrome P450 3A4 
PTS domain  Phosphotransferase systems domain 
HT29-MTX  Colon Carcinoma Goblet “like” cell line 
CCD-18co  Colon carcinoma normal fibroblast cell line 
NHF   Normal Human Fibroblast 
Ki67   Antigen encoded by MK167 gene 
CEA   Carcinoembryonic antigen 
KGF   Keratinocyte growth factor  
HDF   Human Dermal Fibroblasts 
TEER   Transepithelial electrical resistance 
41 
 
LY   Lucifer yellow 
P-gp   P-glycoprotein 
Papp   Apparent permeability 
Poly HIPE  Polymers high internal phase emulsions 
HIC   Human intestinal cells 
MTT  MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
qPCR   Quantitative PCR 
OATP-B  Organic anion-transporting polypeptide B  
mRNA   Messenger RNA 
DAPI   4′,6-diamidino-2-phenylindole DNA stain 
ELISA   Enzyme Linked Immunosorbent Assay 
ECACC  European collection of authenticated cell cultures 
IBD   Irritable Bowel Disease 
hMSC   Human mesenchymal stem cells 
IGF-1   Insulin growth factor 1 
VEGFR-1  Vascular endothelial growth factor receptor-1 
MCP-1  Monocyte Chemoattractant Protein-1 
IL-6   Interleukin 6 
HUVEC  Human vascular endothelial cells 
MMP 9  Matrix metallopeptidase 9 
TGF-β   Transforming growth factor beta 
EGF   Epidermal growth factor 
PAS   Periodic acid Schiff  
TEM   Transmission electron microscopy 
SEM   Scanning electron microscopy 
DMEM  Dulbecco’s modified eagles medium 
PFA   Paraformaldehyde 
NHE8   Sodium/Hydrogen Exchanger 8 
TNF-α   Tumour necrosis factor alpha 
IEC   Intestinal epithelial cells 
MSC   Mesenchymal Stem cells 
FDA   Federal drug administration 
H&E   Haematoxylin and Eosin 
42 
 
ALI   Air liquid interface 
PBS   Phosphate buffered saline 
PBST   0.5% Tween in Phosphate buffered saline 
THF   Tetrahydrofuran 
DCM   Dichloromethane 
DBE   Dibenzyl ether 
PMN   Peripheral mononuclear cells 
PET   Polyethylene terephthalate 
HBSS   Hanks Buffered saline solution 
DMSO   Dimethyl sulfoxide 
HPLC   High Performance Liquid Chromatography 
AgCl   Silver Chloride 
KCl   Potassium Chloride 
mm   Millimetre 
μm   Micrometre 
nm   Nanometre 
mg   Milligram 
μg   Microgram 
ng   Nanogram 
pg   Picogram
 
Chapter 1 - General Introduction 
Page | 43 
 
1. General Introduction 
1.1 Challenges of modern drug discovery 
 
The gastro-intestinal (GI) tract is a major specialised organ. Its purpose during normal 
function is the breakdown of ingested substances into digestible molecules and the 
homeostatic removal of waste products produced within the body. Secondary functions, 
include protection against poisons, perceived or otherwise through expulsion mechanisms 
and as a major immunologically active area, again protecting the body against ingested 
pathogens (1) this time biological in nature. 
 
Ingested substances refer largely to food taken in for sustenance but in the modern world 
may often also refer to orally administered therapeutic drug compounds. Often the 
intestines natural defence mechanisms will detect and treat these ingested compounds as 
poisons, blocking them from absorption and as such significantly reducing compound 
uptake and bioavailability. Ultimately, this acts to limit therapeutic bioavailability and 
activity. Therefore, it goes without saying that a foundation of knowledge of the intestine, 
its structure, function, how the two relate and the likely interactions between compounds 
of interest and in vivo biology is of vast importance when understanding the bodies 
capability to absorb novel, pharmacokinetically untested compounds. 
 
Pharmaceutical development is as ancient as human history itself, however, with the 
scientific enlightenment, new methodologies were devised to understand the mechanistic 
action of medicines in the body. Early modern pharmaceutical pioneers such as Louis 
Pasteur et al would utilise animals, often in great numbers, to test their hypothesis. 
However, whilst animal usage can be effective, demonstrated by two of Pasteur’s more 
famous discoveries, vaccines for Anthrax (tested on Sheep and cattle) and Rabies (tested 
on rabbits, dogs and humans)(2) the ethical and moral use of animals as test subjects 
limits their use in modern science. Indeed, Pasteur himself had a reputation of  unethical 
practices, even in the mid 1800’s. Not only is animal use ethically challenging, more 
recent studies have begun to question their in vivo validity when comparing to human 




tissues. With issues ranging from differences in underlying animal disease mechanisms 
compared to humans, non-similar drug toxicities and pharmacokinetics (3,4) 
 
During the 20th century cell isolation and culture became a more time and cost-effective 
method to do biological research. Starting with the first continuously growing 
immortalised cell line, HeLa (5), cells of almost any tissue are now relatively readily 
available for use in in vitro tissue models. Some more modern approaches to cell culture 
focus on the culture and directed differentiation of stem cell lines to create more in vivo 
physiologically relevant cells for use in tissue models. As such, cellular models of human 
and animal tissues have slowly become one of the most prominent research tools in 
pharmaceutical biology, particularly in very early stage compound development where 
they can be used to efficiently screen large numbers of compounds in a single study. (6) 
New, models based on simple, familiar techniques such as the standard Caco-2 model 
have an improved likelihood of being adopted whilst occupying a significant niche in the 
early stages of drug discovery, lowering costs through improved predictability of NCEs’ 
in vivo. 
 
The current gold standard for the pharmacokinetic ADME (absorption, distribution, 
metabolism, and excretion) testing of novel compounds in the intestine is the Caco-2 
Transwell assay. This well-defined model consists of Caco-2 intestinal epithelial cells 
cultured on Transwell semi-permeable membranes.(7) Caco-2 cells were first isolated in 
the mid to late 1970s by Fogh et al (8) and have been utilised for a wide variety of 
purposes over the intervening decades, evolving from their original purpose as a cell to 
study cancer phenotypes (9) and understanding intestinal bacteriology (10,11) to their 
current gold standard use in drug permeability and toxicity. They are able to form 
confluent, differentiated monolayers with apically expressed, well-defined brush border 
formation and production of intestinal specific compound transporters. Additionally to 
this, Caco-2 cells bind to one another through the formation of tight junctional complexes  
to create a highly polarised cellular epithelium with quantifiable membranal resistance, a 
phenotype which will be discussed in detail later in this chapter. The value of the Caco-2 
cell line in intestinal research is hard to overstate with even a simple literature search 
demonstrating a large number of published applications.  
 




The Caco-2 intestinal model has been critical in the development and pharmacokinetic 
testing of numerous NCEs (new chemical entity) and their translation into clinical drug 
compounds. Other techniques such as PAMPA (parallel artificial membrane permeability 
assay), an artificial membrane able to be utilised in high throughput applications are able 
to model the passive para/ transcellular transport but do not incorporate the active 
movement of NCE compounds across the membrane by influx/ efflux protein pumps. 
PAMPA experiments are often ran co-currently with the Caco-2 Transwell model, 
together creating a strong predictive basis for NCEs in vitro, particularly those absorbed 
passively through the cell membrane. (12) 
 
A major issue with the Caco-2 system as a gold standard for intestinal research is its poor 
inter-lab reproducibility. It has been shown that, even at the earliest stages of Caco-2 
isolation and development, Caco-2 populations are highly heterogenous. Heterogenicity 
in itself isn’t necessarily a disadvantage, indeed the intestine itself is a highly 
heterogenous organ system with multiple cell types and functionalities in the epithelium 
alone. (13) However, differing culture techniques between labs in the intervening decades 
since initial isolation has caused large variations in Caco-2 cell phenotypes. Ultimately, 
unless comparable studies utilise the same master cell bank of Caco-2 cells, cellular 
phenotypes are unlikely to be directly comparable. Trans-epithelial electrical resistance 
(TEER) measurements are an obvious example of this with reported Caco-2 values 
ranging from 2-300 to 2-3000 Ohms.cm2 depending on the lab whilst in each case 
reported as normal Caco-2. (7,14–18) Even so, as before, variable phenotype is not 
necessarily a disadvantage so long as known cellular phenotypes are taken into 
consideration at the beginning of a study. The difficultly however is that differences in 
Caco-2 sub-clone phenotypes from multiple master cell banks are not often quantified, 
with no easy way to distinguish one sub-clone from another. Other inherent disadvantages 
of the Caco-2 system include no intrinsic CYP3A4 expression (a highly important cell 
surface enzyme molecule known to metabolise a number of drug classifications)(19), high 
TEER and  low P-gp (efflux protein with a wide substrate base important in drug 
absorption and availability) (19). There is growing concern that the Caco-2 model of the 
intestinal epithelium is insufficiently reproducible for accurate modelling the cell-drug 
interaction of the human intestine.(20)  
 




NCE clinical translation success rates generally lie in the low to mid-single figure 
percentages. (21) Figure 1.1 demonstrates how these extremely high attrition rates can 
lead to high development costs for new compounds to market, putting the average cost of 
development at almost 2.6 billion dollars per drug. With a capitalised cost in the mid 
2010s of over 1 billion dollars for the pre-human phases alone, over double the cost of 
the previous decade, an order of magnitude higher than costs in the 70s and 80s and 
accounting for nearly half the total cost to market. (22) Indeed recent figures show that 
more money is spent in the pre-clinical phases today than was spent getting a drug to 
market in the mid-2000s. (22) Increasing drug to market prices are always going to be a 
multifactorial process with inflation, new highly accurate but more expensive tests and 
improved testing and safety standards all contributing to developmental costs. When one 
considers some of the main reasons for compound attrition during the development 
process such as; clinical safety, efficacy and bioavailability (23) it clearly highlights how 
new systems for the large-scale testing of novel compounds which are more able to mimic 
the human intestine are required to reduce compound attrition in late stage clinical trials.  
 




Oral administration of drugs is the most common pathway by which pharmaceuticals are 
ingested.(24) This will likely continue to remain true due to oral administration being 
both the easiest for patients to correctly administer as well as being the least invasive 
method available when considered against intra-venous (IV) methods which bypass the 
intestine at the cost of being highly invasive. (25) As such improving the tools for 
pharmacological research will allow for more in vivo mimetic responses in tissue models 
which is key to future NCE development which rely on oral administration. The 
limitations of current intestinal models ultimately cause large levels of wasted time and 
effort on the validation of either toxic or non in vivo effective compounds (either by 
absorption or metabolism) that, with a more in vivo representative early stage model of 
the intestine, could have been removed as possibilities earlier in the process.  
 
Most current studies are focussed on the utilisation of the Caco-2 cell line in novel ways 
to adapt these well characterised cells to be more structurally and functionally relevant to 
in vivo tissue. This includes being utilised as an addition to a 3D model, growth upon 
tissue mimetic basement membrane proteins (26,27) or as a direct or paracrine co-culture 
with other cell types.(28) The use of iPSC, intestinal derived stem cells (29) or other 
Figure 1.1: Understanding the costs for the development and testing of novel drug 
compounds – The cost of bringing new drugs to market has shown a steady increase over the 
last 40 years with pre-clinical phase testing now costing over a billion dollars on average per 
new drug to market. Source DiMassi et al 2016 (21) 




existing cell lines in intestinal model construction is another way in which new research 
is creating more in vivo representative models. It is hypothesised that these new 
technologies (3D scaffold based models, hydrogels and organoids) will have a great 
impact on the methods utilised for pharmaceutical development in the future. 
 
1.2 The general anatomy of the gastro-intestinal tract 
 
The gastro-intestinal (GI) tract is an organ system of great diversity and complexity with 
each point tailored to a specific purpose and function. The upper tract consists of the 
mouth, responsible for the initial breakdown of ingested substances through mastication 
and secretion of salivary enzymes. The stomach contains a highly acidic environment 
with a complex array of digestive enzymes tailored for the breakdown of foods to small, 
absorbable component parts. (30) However, it is important to note that a significant part 
of digestion does take place within the intestine in addition to the stomach. (31) Gross 
digestive system structure is detailed in Figure 1.2. 
 
Intestinal biology begins at the pylorus, ending at the ileocecal valve. (32) Intestinal 
morphology is split into 2 major sections, the small intestine and the large, each of which 
can then be further broken down into distinct regions. The small intestine is the first of 
the two and is a major point in the body for compound digestion and the primary place of 
nutrient absorption, with 90% of useful compounds absorbed here. In total the intestine 




The duodenum is the smallest section of the small intestine at approximately 25cm 
long and is located immediately after the pyloric sphincter of the stomach. The 
function of this region of the small intestine is in the neutralisation of stomach 
acid and continued breakdown of proteins and fats into absorbable states through 
secretions from the liver, pancreas and the intestinal wall itself (bile, digestive 
enzymes and neutralisation agents respectively). Brunner’s glands are primarily 
localised in the proximal Duodenum. (33)Their role lies primarily in the secretion 




of bicarbonate containing mucous which has the dual role of neutralisation and 
lubrication through the intestine. Proteases and antimicrobial compounds are also 
seen within the Brunner’s glad secretome and are thought to protect the mucous 
layer against digestion by pancreatic enzymes. Another important distinction of 
the duodenum is its lack of mesentery support when compared to other regions of 
the small intestine. (31) 
 
2. Jejunum  
The jejunum is the middle and longest section of the small intestinal system at 
approximately 1.5 meters long and is primarily responsible for the absorption of 
digestive products; sugars, fatty and amino acids. The greatest levels of absorptive 
adaptation can be found here with large contiguous villus structures and circular 
(plical) folds to further increase absorptive surface area. Anatomically, there is no 
distinctive differences between the jejunum and the ileum. 
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Figure 1.2: The gross anatomy of the digestive system with specific focus on the structure of the intestine – The digestive tract is split into 4 distinct sections; 
mouth,  stomach, small inetstine and large intestine. The intestinal structures are further split into distinct regions, each with specific yet largley overlapping 
function.    
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3. Ileum 
The ileum is the final section of the small intestine and is generally considered to 
be the point whereby bile salts and vitamin B12 is absorbed alongside any left over, 
unabsorbed compounds from the jejunum. Additionally, the ileum is characterised 
by a highly developed gut associated lymphoid tissue (GALT).(34) Aggregations 
of lymphoid tissues known as Payer’s patches are located here primarily and span 
the lamina propria through to the submucosa. (35) Paneth cells in the ileum secrete 
antimicrobial peptides due to the increased bacterial load caused by proximity to 
the proximal large intestine. The ileal lumen diameter decreases compared to the 
jejunum and the circular folds decrease towards the terminal end of the ileum. The 
ileocecal valve is responsible for the controlled movement of matter from the 
small intestine to the large and is located at the terminal end of the ileum.  
 
Also known as the colon, the large intestine has three major functions in the absorption 
of water and electrolytes, producing and absorbing vitamins and movement of waste 
products towards the anus. Indeed, the colon is thought to reabsorb approximately 400-
1000ml of water per day from waste matter. Although this number varies drastically, it is 
important to remember that 80-90% of water is absorbed in the small intestine.  The large 
intestine in an average adult is approximately 1.5 meters long and has a significantly 
wider lumen diameter than the small intestine. A higher proportion of goblet cells can be 
found within the large intestine when compared to the small, due to the less absorptive 
functionality and the importance of lubrication as the faecal matter becomes more 
desiccated. Columnar cells of the intestine are the primary functional unit responsible for 
water and salt absorption in the large intestine as described above. They are the most 
numerous epithelial cell of the colon and are found sandwiched between the much larger 
goblet cells. (32) 
 
The large intestine can also be further split into 3 main sections however unlike the small 
intestine the function of the large intestine varies less significantly with distinctions 








1. Ascending colon 
This is the first section of the large intestine and, as the name suggests, ascends 
away from the rectum on the right side of the abdomen. 
2. Transverse colon 
This is the longest region of the colon. 
 
3. Descending Colon 
This is the final main stage of the colon and as the name suggests descends 
towards the sigmoid colon and the rectum 
 
It is in the large intestine where resident bacterial populations have a significant role in 
the breakdown of indigestible intestinal content into digestible forms to  be absorbed by 
the colonic epithelium such as vitamin B and K. (36) Additionally, bacteria are able to 
Figure 1.3: The structural layers of the intestine  – A simple schematic of the constituent 
layers of the intestine. The outer serosal layers provide a protective membrane around the entire 
organ. Muscularis layers support the peristaltic movement of digestive chyme. Submucosal 
layers are home to glands, muscularis and lamina propria layers support the functional 
epithelium.  




ferment non-absorbable carbohydrates such as cellulose and lipids. It is the digestion of 
these lipids in particular into short fatty chains which are readily absorbed into the colonic 
epithelium, catalysing the uptake of water and sodium ions at the same time. It is 
important to note that the colon itself is poorly organised for efficient nutrient absorption. 
Both villi and circular folds, critical for increasing the surface area of the absorptive 
epithelium in the small intestine are lost in the colon, significantly reducing absorptive 
efficiency. Smooth muscle banding around the outside of the colonic tissue is increased 
compared to the small intestine to reflect the function of the colon in the efficient removal 
of non-digestible waste matter. 
 
Whilst the detailed histology of intestinal epithelial tissues is highly variable dependant 
on the area of the intestine under study, the basic structure of the intestinal wall varies 
little through the length of the intestine. Figure 1.3 shows a simple schematic of the 
constituent layers of the intestine. 
 
The serosa is a protective layer covering the entire surface of the intestine consisting of 
connective tissues and a monolayer of squamous epithelium. Immediately below these 
serosa are the 2 muscle layers, longitudinal and circular, which together make up the 
muscularis externa. The purpose of these muscle layers is two-fold. 1. To mix up the 
intestinal contents to ensure optimal digestion, 2. Through peristaltic movement, force 
the intestinal contents through the intestinal lumen. Smooth muscle around the intestine 
forms sphincters at regular intervals, controlling the rate of intestinal content movement. 
The submucosa is a loose collection of fibroblasts, collagen and acellular connective 
tissues containing the majority of the intestinal lymphatics, blood vessels and nerves. 
Dependant on the part of the intestine under study, the submucosa may also be home to 
submucosal glands such as the Brunner’s glands mentioned earlier. The lamina propria 
and the epithelium are then supported by a thin layer of muscle tissues both longitudinal 
and circular. The lamina propria is home to resident fibroblast and myofibroblast 
populations whose function it is to support the development and maintenance of the 









1.3 Epithelial anatomy, the relation of structure and function. 
 
The epithelium is most generally described as a cellular layer which extensively covers 
the outermost surfaces of the body, both internally and externally.(38) Often the internal 
interface epithelial layers are covered with small cytoplasmic extensions known as either 
microvilli or cilia. The former being an adaption for improved cellular absorption through 
provision of larger surface area for substrate transport and the latter being an adaption for 
the transport of mucous. Alternatively, the epithelium on the “outer” interfaces of the 
body, namely the skin, are adapted to express a highly keratinised outer layers with 
several specialised functions such as defence against external pathogens and retention of 
moisture.(39)  The epithelium of the body are as diverse as the organs they support, 
deriving from all three germs layers with their function dependant on their location and 
structure. For example skin epithelium derives from the ectoderm, gastrointestinal  
epithelium from the endoderm and mesoderm creates blood vessel endothelium.  (40–43)  
 
Epithelia are structured differently throughout the body with their structure directly 
related to their function. Primarily the structures can be split into two broad categories, 1. 
Simple and 2. Squamous. A simple epithelium is described as a single layer of cells 
supported by a basement membrane (44) with primary functions as a selective interface 
for the absorption (Diffusion/ Active) and secretion at external body interfaces. Further 
subcategories of simple epithelium are based on the epithelial cell morphology. (38) 
Squamous cells are flattened cells whose lateral dimensions far exceed the cell height. 
These cells can be found in the blood vessel system as well as type I pneumocytes of the 
lung alveoli. (45) These cells are mostly involved in passive processes due to their cellular 
shape being unsuitable for complex differentiation and development. (Figure 1.4 A) 
Cuboidal cells are described as cells whose height and width are approximately equal and 
includes cells found in the kidney epithelium (46) and ciliary body of the eye. (47) (Figure 
1.4 B) Columnar cells are tall cells whose height exceeds their lateral dimensions. These 
cells are found in the intestine where they undergo complex differentiation into absorptive 
enterocytes or secretive goblet cells amongst others. (48) (Figure 1.4 C) Finally, 
pseudostratified epithelial layers are columnar cells whereby the arrangement appears to 




be organised into multicellular layers. However, all the cells into a pseudostratified 
epithelium are in contact with the basement membrane and hence only one cell thick. 
(Figure 1.4 D) 
 
Stratified epithelium (Figure 1.5) is composed of multiple layers of cells, with each layer 
consisting of cells at different stages of differentiation. Basel layer cells are often cuboidal 
and home to the self-replicating stem cell niche and the proliferating cells for the 
maintenance of the epithelial layer. E.g. the stratified epithelium of the skin. Cells of the 
basal layer migrate toward the apical surface of the epithelium over time, as cells move 





Figure 1.4: Structural characteristics of simple epithelial layers in the human body – 
Schematic showing the structures of different types of simple epithelium A) Squamous, B) 
Cuboidal, C) Columnar, D) Pseudostratified. Basement membrane (BM) is extremely 
important in the development and maintenance of the epithelial layer. A key feature lacking 









and lose proliferative capability. (49) Stratified epithelium can be described as keratinised 
(Skin) or non- keratinised (Buckle, Vagina) depending on their location and function.(50)  
 
The purpose of this thesis is the description of the intestinal epithelium, its adaption to its 
function and how it can mimic the human intestine in vivo. As such stratified epithelium 
will not be discussed in any more detail.  
 
The function of the epithelium of the body are diverse. Broadly speaking these functions 
can be categorised 3 ways; 1. Protection, 2. Absorption, 3. Secretion. Protective 
epithelium includes those such as the skin which is developed to include a denucleated 
highly keratinised external layer. (51–53) This acts as a physical barrier to external 
pathogens and desiccation of the underlying tissue through secretion of an outer oil layer. 
Other protective characteristics of epithelium include the creation and maintenance of a 
sterile mucous layer. These mucous layers are created and maintained through use of 
specialised epithelial cells known as goblet cells. This is most evident in tissues such as 
the colon or airway mucosa. Colon tissues in particular have complex bi-layer mucous 
structures including both secreted and membrane bound mucins. (54) These mucous 
layers, in much the same way as the skins keratinised outer layer, provide a physical 
barrier to the passage of outside pathogens such as bacteria. The mucous layer of the 
colon achieves this whilst maintaining some level of absorptive capability. Another 
primary function of the mucus layer of the colon is the provision of a niche for population 


























Figure 1.5: Complex squamous epithelial show gradients of differentiation across the 
thickness of the epithelial layer – Simple schematic of a classic stratified epithelium such as the 
skin. Notice the loss of nuclei as cells differentiate and the change in cell shape from a 
proliferative base layer to a non-proliferative differentiated surface barrier. 
 
BM 




components into useful compounds such as vitamin K which cannot be created by the 
body. (55–57) An important distinction for epithelial layers is their ability to form highly 
polarised cell layers, necessary for their proper function. The focus of this work is on the 
absorptive/ transportation capabilities of the intestinal simple epithelium and as such 
stratified epithelia will not be discussed further.  
 
1.4 Understanding the functional absorptive component of the 
intestine, the enterocyte. 
 
The intestinal mucosa is split into two main compartments, the epithelium and the lamina 
propria. The most abundant cell type of the epithelium is the absorptive enterocyte 
followed by mucous secreting goblet cells in addition to enteroendocrine and Paneth cells 
(small intestine) which are prevalent at a lesser rate. All cells in the epithelium arise from 
an intestinal LGR5+ve stem cell population located within the crypt of Lieberkühn. (58) 
Except for Paneth cells which reside in the small intestinal crypt and migrate downwards, 
all cells of the epithelium migrate from the crypts of Lieberkühn up to the villus tip. (59)  
The intestinal epithelium is one of the most highly turned over epithelia of the body with 
cell lifespan limited to a matter of 3-5 days for most mammals. (55) For example, in 
humans it is estimated that 1011 intestinal epithelial cells are lost daily. (60) As such the 
intestine exists in a carefully maintained homeostatic balance between cell renewal and 
apoptosis, with disruption to this homeostasis being the basis for many intestinal diseases.  
 
The enterocytes are the main absorptive cell in the intestinal epithelium. Their main role 
is in the selective absorption of nutrients and compounds through the epithelium, and 
ultimately into the blood stream. Phenotypically, enterocytes are organised into a single 
monolayer of columnar cells with an apically expressed brush border of microvilli and 
well-defined apical lateral tight junctional complexes. Nutrients in the intestinal lumen 
travel through the epithelium by two main routes, paracellularly and transcellularly. 
Transcellular transport can occur through a variety of mechanisms and is defined as the 
passive or active uptake of compounds by cellular mechanisms into the cell, creating 
concentration gradients which the cell must overcome to allow for continuous supply of 
nutrients.  





Paracellular absorption is characterised by the passive diffusion of compounds between 
the cells through the tight junctional complexes. Selective Paracellular absorption is 
primarily achieved through selection by compound size and charge. Additionally, 
enterocytes are bound by a thick membrane associated mucous layer and microvilli 
associated glycocalyx. The mucous layer is formed from variable length mucins made 
from carbohydrate side chains attached to a protein core whilst the glycocalyx is 
comprised of glycoproteins which are structurally similar to mucin proteins. (61) In both 
instances the main function of the glycocalyx and the mucous layer is as a diffusion 
barrier and filter of macromolecules in addition to pathogens such as viruses and bacteria. 
The glycocalyx also has an important function as a reservoir of glycoprotein enzymes 
responsible for the digestion of macromolecule prior to enterocytic absorption. 
 
In addition, to the enterocytes role in absorption they also have further protective roles in 
compound expulsion. Transporter protein complexes found on the basal and apical 
membranes of the enterocytes such as P-gp, MRP1,2,3 and BCRP are ABC transporter 
proteins implicated in drug and toxin clearance within the intestine. (62) These 
transporters are of particular interest as they are involved in drug resistance and poor 
pharmaco-availability within the blood stream. Creating intestinal models more able to 
recapitulate the drug resistance aspects of the intestinal epithelia will have major uses in 
the development and testing of new drug compounds. Enterocytes have also been shown 
to have active roles in the intestinal immune response as antigen presenting cells through 
















A) B) C) D) 
Figure 1.6: General methods of permeability through epithelial barriers – A) Passive 
transcellular. Compounds can readily pass through the lipid cell membrane to enter the cell. B) 
Passive Paracellular. Compounds do not readily cross the cell membrane but can pass through 
the intercellular junctional complexes. C) Carrier mediated, compounds cannot passively cross 
the epithelial barrier and must be transported through active carrier mediated mechanisms. D) 
Transcytosis, Compounds are captured inside membrane bound vesicles and move through the 
cytoplasm. 




1.5 Methods of epithelial permeability and epithelial junctional 
composition, development of a selective passive paracellular 
barrier.  
 
Epithelial cells are bound together with several junctional types, namely; Occluding 
junctions  which provide a tight bound barrier (63), Anchoring junctions (Macular 
Adherens/ Zonula Adherens/ Adhering junctions) which give the epithelial layer 
mechanical stability and communicating junctions (Gap junctions) which allow the 
passage of signalling molecules between cells. (64) Intestinal epithelial cells, primarily 
those of the small intestine, are relatively weakly bound to one another due to the 
absorptive adaptations of the intestinal mucosae. TEER values of intestinal tissue for 
example are well known to be in the low 100s ohms.cm2 at the most, compared to skin 
which is regularly in the 1000s of ohms.cm2. (65) 
 
1.5.1 Methods of permeability through epithelial barriers 
 
Figure 1.6 demonstrates the 4 main routes of transepithelial permeability, two passive 
(Trans– and Paracellular) and two active (Carrier mediated and Transcytosis).  Compound 
chemistry largely determines the method of permeability and can fall into one or multiple 
categories. For example, Lipophilic compounds generally move Transcellularly as they 
are readily able to pass through the lipid bilayer membrane of the cell. Propranolol is an 
example of a lipophilic compound thought to travel in this manner exclusively. (66) Other 
such as etoposide move in more complex manners with a combination of passive and 
active transport mechanisms such as through OCT 2, MDR1, BCRP and MRP2. (67–69) 
Compounds such as vitamin B12 are known to move through the cell via transcytosis 
whereby they attached to membrane receptors and are packaged into membrane bound 
vesicles to cross the cell membrane.(70) 
 
1.5.2 Occluding junctions 
 




Tight junctions (Zonula occludens/ Occluding junctions) are one of the main junctional 
complexes important to the intestinal epithelium. (71) These junctions, as the name would 
suggest, work to tightly bind cells together at their apical interface preventing passive 
paracellular movement of molecules between cells and entering the blood stream. This is 
highly important to the intestinal epithelia in particular as it functions as a gatekeeper to 
the body, selectively absorbing/ rejecting molecules it comes into contact with. Tight 
junctions are important for the setup and maintenance of concentration gradients and 
establishment of membrane polarity, a key factor for the correct functioning of many 
transporter systems found within the intestine. Furthermore preventing back diffusion of 
compounds into the intestinal lumen ensures absorbed compounds are efficiently 
translated into the blood stream and the wider body. (72) Some of the key proteins 
involved in the tight junction complex are Occludins, Claudins and ZO-1/ ZO-2. 
Occludins and Claudins are structured similarly and as such have similar functions. (73) 
Both protein systems have 4 transmembrane complexes with two extracellular loops and 
in internal protein domain which binds to the anchoring protein ZO-1. These proteins 
have the function of bridging the intercellular gap, creating tightly bound cross-cell 
complexes and maintaining the integrity of the tight junction, essentially locking the cells 
together in a band circumnavigating the cell, creating an impermeable barrier to luminal 
contents. (74)  Figure 1.7 outlines the general structure of tight junctional complexes.  





1.5.3 Anchoring junctions  
 
Whilst the tight junctions work to create an impermeable barrier, they do not provide 
membrane stability between cells to any great extent. The purpose of anchoring junctions 
is in forming strong protein complexes between the lipid bilayers of neighbouring cells, 
anchoring to the cells cytoskeleton and providing stability. Anchoring junctions are 
observed throughout the bodies tissues but are generally more prevalent in areas which 
are exposed to high levels of mechanical stress such as the epidermis layers of the body 
and the blood vessels. (75) 
 
In general, there are two main categories for anchoring junctions; 1. Adherens junctions 
and desmosomes which bind cells to one another (76), 2. Focal adhesions and 















Figure 1.7: General organisation of a tight junction complex – Diagram showing the 
arrangement of some of the key proteins involved in the function of a developed tight junction. 
Adapted from Schneeberger et al, 2004 
 




A zonula adherens is described as a continuous belt of Adheren junctions immediately 
beneath the tight junctions of the cells.(79) Adheren junctions work to connect the actin 
cytoskeleton of adjacent cells to one another. The Cadherins, members of the Calcium-
dependant cell adhesion molecules (CAMs) are the inter-membrane spanning proteins 
which attach to inner membrane protein complexes made from Alpha/ Beta Catenin and 
Vinculin. (63,80) The primary cadherin of epithelial tissue is E-Cadherin and as such is 
found throughout the intestine, (81,82) which along with N-cadherin is also thought to be 
highly important during development, driving correct cellular localisation and 
differentiation. As such, Cadherins, specifically the switch in expression from E to N 
cadherin, is thought to signify a change towards a less differentiated, more proliferated 
phenotype and as such is a key marker for the malignancy of cancer cells. (81) 
 
Desmosomes are similar in function to the Adheren junctions, consisting of a cytoplasmic 
protein plaque made of the anchor proteins desmoplakin and plakoglobin. The inter-
membrane adhesion proteins of these junctions, desmoglein and desmocollin, are also 
members of the Cadherin family of proteins. Unlike adherens junctions, desmosomes 
attach primarily to keratin filaments within the cytoplasm instead of actin, and as such 
are of significant importance in keratin rich cells such as those seen in the skin. (83,84) 
Figure 1.8 outlines the general structure of adherens junctions. 
Figure 1.8: Basic structural anatomy of the adherens  junction complex – Diagram showing 
the basic protein arrangement of a simple adherens junction. In this instance E-cadherin 
expression would likely indicate cells of an epithelial origin. Adapted from Neissen et al 2007 





1.5.4 Gap Junctions 
 
The function of gap junctions within the intestinal epithelium and indeed throughout the 
body is to allow direct communication between adjacent cells. They achieve this through 
the direct linkage of cell cytoplasm’s to one another through the formation of channels 
by the protein family connexins, 21 genes of which are known to exist in humans. (85) 
Connexin proteins form hexametric complexes called connexons which form together to 
create the mature gap junction channel. Interestingly, connexons can be formed from a 
heterogenous composition of the 14 different human connexin types, the function of the 
junction changing with the composition of its connexons. (86) In addition to chemical 
signalling, gap junctions are critical for the electrical excitability of cell layers. (87) As 
such, cells which are regularly innervated generally contain higher proportion of gap 
junctions than those that are not. Figure 1.9 shows the basic anatomy of the gap junction 
complex and demonstrated the orientation of the protein relative to the cellular membrane. 
(88)
Figure 1.9: Basic anatomy of gap junction physiology – Basic gap junction structure showing 
the capability of gap junctions to be made from a number of different connexin proteins in 
mixtures of hetero and homogenous combinations. Image taken from Meşe et al 2007 (82) 
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= Transit amplifying cells 










Figure 1.10: Basic anatomy of human small and large intestine -  Left, Small intestinal anatomy highlighting the importance of the paneth cells in the 
stem cell crypt nestled between the intestinal stem cells and transit amplifying cells. Large intestine (Colon), Right, Is generally characterised by deep crypt 
structures and a high proportion of goblet cells forming both a membrane bound and secreted mucous layer. 
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1.6 Quantitative techniques for monolayer integrity and tight 
junction formation measurement. 
 
Transwell model systems are valuable models of many epithelia throughout the body. 
Unfortunately, they often take multiple weeks to culture to maturation and as such a 
method of measuring the development of the model throughout the culture time is 
required as barrier integrity is crucial to the models function. Transepithelial electrical 
resistance (TEER) is one widely accepted method whereby the development of the 
epithelium can be non-directly and non-invasively quantitatively measured throughout 
the differentiation period. Additionally, TEER measurements are often used as basic 
acceptance criteria before a model is utilised to give functional data. For example, the 
widely accepted TEER criteria for a Caco-2 monolayer is 500 ohms/cm2. The resistance 
measurement deemed as acceptable will vary, often greatly, dependant on the cell types 
used (14) within the model and the type of epithelium created. E.g. simple cuboidal 
epithelium will have a different TEER from a keratinised stratified epithelium. 
Furthermore, temperature, media composition and cell passage can all have large effects 
on the TEER values. (17) Temperature for example is normally controlled through 
incubating the cells for a short time in pre-warmed media, with the measurement taken at 
approximately the same time within each well to limit temperature change. 
Figure 1.11: Transepithelial resistance chopstick equipment and calculations – Raw TEER values 
are a sum of the internal resistance of the equipment, Electrodes and the polycarbonate membrane. In 
order to accurately measure he TEER of the membrane along a blank measurement is taken of an 
acellular membrane which is then subtracted from the raw values. 
𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒   𝑅 =  
∆(𝑉) 𝑣𝑜𝑙𝑡𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 
∆(𝐼) 𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒
 
𝑇𝐸𝐸𝑅 𝑉𝑎𝑙𝑢𝑒 = (𝐶𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 − 𝐵𝑙𝑎𝑛𝑘 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒) 𝑥 𝐶𝑢𝑙𝑡𝑢𝑟𝑒 𝑎𝑟𝑒𝑎 




Alternatively, Blume et al worked on mathematically modelling the changes in TEER 
with the changes in temperature of the media. (15) Hypothetically, utilising their 
equations you could “correct” the TEER values gained back to 37oC so long as the 
temperature of the solution is known when the measurement is taken. As such, these 
conditions need to be carefully controlled in each instance in order to gain a reliable 
quantification of TEER levels. In addition to the use of TEER as a monitoring tool, 
quantitative TEER measurements can be used to assess membrane damage, either as a 
result of scratch healing or compound toxicity assays. 
 
TEER equipment works through the application of an alternating current across the 
cellular membrane. The change in voltage is measured and utilising Ohms law a 
resistance can be calculated. Chopstick electrodes are most commonly used when 
culturing Transwell systems. These electrodes have a long and a short leg which allows 
for the complete submersion of both silver-chloride electrode pellets into the media 
without risk of damaging the epithelium being measured. Whilst commonly used 
throughout the industry for routine analysis of model development, significant variation 
in TEER response can be induced through small changes in the application of the probes 
to the culture media. Newer, more accurate systems for TEER analysis have been 
developed to negate this issue through the application of the model to a sterile chamber, 
removing the human added error. The cell membranes are blanked in fresh medium and 
the measurement is taken before being area and blank well corrected.  The TEER 
equipment simply measures the conductive properties of the membrane. As such TEER 
is an indirect tool with some flaws and cannot be used as a predictor of membrane activity 
or functionality. For example, a membrane could have a low resistance value but still be 
highly impermeable to a compound and vice-versa. Even paracellular compounds whose 
transport across the membranes is governed by the abundance of tight junctional 
complexes is not always accurately modelled by quantification of TEER values alone. 
 
1.7 Paracellular permeability, measuring membrane integrity 
 
In addition to the use of TEER as a measurement of membrane barrier function the 
integrity of a cellular membrane can also be assessed through the addition of paracellular 




transported compounds to the system. These can include compounds such as inulin, 
mannitol or lucifer yellow. (89,90) These compounds are used in much the same way as 
a normal transport assay would be set up, namely the compound of known concentration 
is added into either the apical or basal compartment and then samples after a set amount 
of time, from which an apparent permeability can be calculated for the model. The 
downside to using this method to quantify barrier integrity is that it is significantly more 
time consuming and invasive when compared to the TEER system of measurement. As 
such, unless the model resistance is being continuously monitored by equipment such as 
Ussing chambers these compounds are often run alongside the compounds of interest and 
measured at the end of the assay to ensure that the models have remained intact 
throughout the assay time period.  
 
1.8 Other cells of the intestinal epithelium and mucosa 
1.8.1 Goblet cells 
 
The main function of the goblet cell in the intestine is in the secretion of mucins into the 
intestinal lumen to create a mucous barrier over the surface of the intestinal epithelium. 
This mucous layer has several functions and is split into one or two main layers depending 
on the position within the intestine (Small intestine does not have a secreted mucous 
layer). Figure 1.10 shows the overall histology of the colonic structure with deep crypts 
and a higher proportion of goblet cells when compared to other regions of the alimentary 
tract, namely the small intestine.  
 
The primary function of the mucous layer is as a barrier to pathogens and physical damage 
of the intestine in addition to be a selective barrier to macromolecules. The mucins that 
make up the mucous layer have distinct functions. (91) MUC 2 makes up the main 
secretory glycoprotein and is the backbone of the secreted mucous layer. It is here that 
the majority of commensal bacterial populations are within the intestinal lumen. (92) 
Additionally, bioactive molecules such as MUC 1, 3 and 17 are membrane bound mucins 
and form the membrane bound mucous layer which is present on most cells of the 
intestinal epithelium. Bacteria of the small intestine are usually only associated with the 
enterocytes at the villus tips whereas the presence of the secreted mucous layer in the 




colon renders the inner membrane mostly sterile with no regular bacterial contact with 
colonic epithelial cells. (93) 
 
The distribution of goblet cells through the intestine changes with the lowest frequency 
being in the duodenum with increasing frequency throughout the jejunum and ileum with 
the largest goblet cell populations being in the distal colon. It has been shown that the 
amount of mucous produced in the intestine is correlated with the bacterial load, with 
bacterial colonisation increasing in a proximal-distal direction. 
 
1.8.2 Enteroendocrine cells 
 
The enteroendocrine cells of the intestine are primarily located within the mucosa and 
only comprise of a small minority of intestinal epithelial cells (<1%) with the highest 
abundance in the proximal small intestine and the lowest in the distal colon. There are 
over 30 different hormones secreted asymmetrically throughout the intestine with highly 
variable functions such as stimulation of peristaltic movement, appetite and enterocyte 
proliferation. There are many diverse populations of enteroendocrine cells in the gut with 
the most abundant being the EC (Enterochromaffin) cells which have primary functions 
in the secretion of serotonin into the intestinal lumen. (94) 
 
1.8.3 Paneth cells 
 
Paneth cells are a secretory cell type like enteroendocrine cells which are located 
exclusively within the small intestine and appendix. The range of peptides secreted by 
Paneth cells is large and variable with some of the main secreted peptides being alpha 
defensins and lysozyme, antimicrobial peptides that when secreted within the crypt act as 
both as a response to pathogenic invasion and as a method for the homeostasis of 
commensal gut bacteria. Additionally, Paneth cells have been majorly implicated in the 
regulation of the stem cell niche itself. In such a high turnover organ such as the intestine 
careful regulation of the stem cell niche is imperative for the continued homeostasis and 
function of the intestinal epithelium. A recent study by Pentinmikko et al showed how 
Paneth cells potentially attribute to changes in the intestinal epithelium with age through 




the production of the Notum protein, an extracellular Wnt inhibitor, as such decreasing 
stemness maintaining Wnt signalling. (95) 
 
As mentioned previously, Paneth cells differ from the other epithelial cell types of the 
intestine in that instead of migrating to the villus tip they instead migrate downwards into 
the crypt. Furthermore, Paneth cells also have a significantly longer lifespan of around 60 
days in contrast to 2-6 days of other intestinal epithelial cells. (96) 
 
1.8.4 Fibroblasts and myofibroblasts 
 
The intestinal epithelium is supported by a stromal population of myofibroblasts 
immediately beneath the epithelial basement membrane. Myofibroblasts in this work and 
others are characterised phenotypically as being positive for Vimentin (mesenchymal 
fibroblast marker) and Alpha-smooth muscle actin (Smooth muscle maker) whilst being 
negative for Desmin (a muscle lineage marker). (97) The location of these cells in close 
proximity to the epithelial layer suggests a role in the maintaining and controlling the 
epithelial layer through paracrine and direct-action effects. Epithelial-mesenchymal cross 
talk has been shown in the past to be of critical importance in the development and 
maintenance of epithelia throughout the body with signalling breakdowns often resulting 
in the development of tissue pathologies such as cancers. (98–100) In regards to the 
effects of paracrine factors on continuous cell lines, Montesano et al showed how 
advanced cellular phenotypes could be observed in MDCK cells when co-cultured with 
3T3 fibroblasts. Cells suspended in a collagen gel were able to form a branching tubular 
morphology similar to that seen in vivo (101) which was not seen in cells which were not 
co-cultured with fibroblasts. Epithelial cells are also able to modulate the function of 
fibroblast populations. Lichenberger et al in their study of epithelial-mesenchymal cross 
talk in skin derived cells, showed that β-catenin produced by epithelial cells was able to 
modulate and remodel the underlying dermis. (102) Growing evidence is also been seen 
in the effects of 3D cultured stromal tissues on the development of epithelia, specifically 
in the modulation of membrane resistance through tight junction abundance. Matsusaki 
et al (103) showed how co-culture of Caco-2 intestinal epithelial cells with normal human 
dermal fibroblasts significantly affected the epithelial resistance of the resultant model, 




decreasing it in comparison to conventionally cultured control models with further 
significant decreases in relative mRNA for tight junction proteins (Occludin, Claudin 1,2, 
ZO-1). Biologically, Caco-2 cells are known to produce heightened non-physiologically 
relevant epithelial resistance values when cultured by conventional mechanisms. This 
study highlights the effects of increased model complexity in regards to in vivo relevancy 
and how said conditions drive relevant changes in functional phenotype. 
 
1.9 The Villus-crypt axis and the stem cell niche 
 
To facilitate the rapid turnover of intestinal tissues a constant supply of new proliferating 
and differentiating epithelial cells are required to replace cellular attrition at the villus tip. 
A resident stem cell population of adult intestinal stem cells is found at the base of the 
crypt structures found within the intestine. Holistically, the stem cell populations and 
differentiating epithelium is known as the villus crypt axis and can be considered the 
single individual functional unit of the intestine. Figure 1.10 shows a simple schematic 
representation of the villus-crypt axis within the small intestine with the basally located 
stem cells maintained within their pluripotent states by paneth cell populations located 
adjacently. Transit amplifying cells are intermediaries between stem cell populations and 
differentiated enterocytes, undergoing 4 to 5 divisions as they move up the crypt axis. 
(104) Careful maintenance of stem and transit amplifying cells allows the functional unit 
of the crypt niche to be functional immortal through a human lifespan. Age related 
disfunction in intestinal stem cells is a large contributor to age related intestinal disease 
such as impaired intestinal barrier function (105) , impaired nutrient absorption (106) and 
an increase in the risk of GI cancers. (107,108) Cells at the base of the crypt can be 
considered to be less differentiated than the apical surface with increasing differentiation 
towards the villus tip. Cellular lineage differentiation is controlled by a complex 
environment of interacting cytokines and secreted factors, Notch, Wnt and BMP playing 
significant roles. (41,109,110) 
 
 




1.10 In Vitro models of the intestinal epithelium 
 
The Ussing chamber developed by Hans Ussing in the mid-20th century is a critical piece 
of equipment for the measurement of transport kinetics in vitro. The first methods utilised 
to test intestinal function in the human body primarily utilised animal systems to assess 
pharmacological properties of NCE in vitro. (111)Essentially, animal tissues would be 
excised and prepared before addition into the chamber system in which electrophysical 
and transport kinetic properties of tissue epithelia could be measured through addition of 
model compounds designed to stimulate specific responses. The use of these model 
substrates alongside inhibitory and stimulatory substances could build up a picture of 
intestinal function over time. MDR1 for example can be inhibited by a number of highly 
specific compounds, both competitively and non-competitively. Comparison of control 
and inhibited transport rates of NCE in in vitro animal intestinal models can build a 
picture of NCE MDR1 specificity. Following this logic you can build a picture of the 
NCE pharmacokinetic properties in a number of transport specific mechanisms.  
 
There is a huge variety of methods for the culture and creation of intestinal models 
throughout the literature, with many having specific advantages and disadvantages 
compared to one another such as improved in vivo relevancy or expression of a protein 
absent in the standard model such as CYP3A4 in Caco-2 cells.(18)  Most new emerging 
models of the intestine have moved away from the simplistic monocultures of the past 
and focus more on the incorporation of multiple cell lines/ types together in a single 
culture or in a 3D matrix through use of scaffolds and hydrogels. Additionally, new organ 
on chip approaches to tissue development promise the complexity of 3D co-cultures with 
the simplicity of high throughput design. 
 
1.10.1 Caco-2 Transwell models of the intestinal epithelium 
 
The Caco-2 cell line as previously described was first isolated by Fogh et al (112) during 
the 1970s with its early uses as a generic colorectal carcinoma cell line. The cell line as 
the name would suggest was originally isolated from a colon carcinoma but has a 
functional protein expression profile able to more closely mimic the small intestines 




absorptive properties.  Caco-2, since the pioneering papers in 1980s by Pino et al (113) 
and Hidalgo et al (114) among others, has been the main workhorse for intestinal research 
and model construction throughout the pharmaceutical and biological communities. 
Caco-2 cells are characterised by their capability to maturely differentiate over a culture 
period of 15-21 days into mature enterocytic cells with defined brush border expression, 
good cellular polarisation as shown by apical lateral tight junction formation and 
functional transport capabilities through the cells into the underlying “lumen”. Indeed, in 
2D cell culture these cells can form heterogenous layers of cells with characteristic 
monolayer doming upon reaching maturity and are particularly good at modelling the 
passive absorption of compounds like that of the jejunum. 
 
The Caco-2 cell line is also known to express proteins such as P-gp, MRP1/2 and BCRP 
which, as efflux ABC transporters, act to pump compounds from the cell back into the 
intestinal lumen. (115) Naturally, this efflux is an intrinsic way of removing waste 
compounds from the cell or as a defence mechanism against exogenous ingested toxins. 
Figure 1.12: Expression of key proteins by Caco-2 cells in Transwell – A small selection 
of the important transporter proteins and cell surface enzymes present in the caco-2 system. 
Figure modified from Sun et al (144) 
 




The result is that the Caco-2 cell line shows a natural resistance to the absorption of 
compounds which are the substrates of these efflux proteins in a way similar to the in vivo 
intestine (jejunum). Often however, the expression levels of these critical efflux proteins 
do not mimic that of the intestine, with some under expressed such as P-gp (especially if 
not allowed to fully differentiate) (116) and others overexpressed in comparison to in vivo 
tissues. As such the Caco-2 Transwell assay is limited in its capabilities to completely 
model the intestine especially for efflux substrate compounds.(115) Additionally, whilst 
these cells are positive for the expression of many critical markers of the intestine it is 
generally known that the Caco-2 cell line is lacking in the correct expression of many 
important proteins such as CYP3A4, a surface bound enzyme known to be expressed in 
the intestine at the apical surface of enterocytes, but absent in the Caco-2 cells line. 
Interestingly, it has been shown that CYP3A4 can be induced through the addition of 
1α,25-dihydroxyvitamin D3.(115) Whilst CYP3A4 is not directly involved in the 
absorption of compounds in the intestinal lumen it is a major contributor to 
pharmacological metabolism in the intestinal lumen. The consequence of a lack of 
CYP3A4 expression in Caco-2 models can artificially increase relative permeability due 
to a lack of substrate metabolism. 
 
The Caco-2 model has been key to the development of new drug compounds over the past 
three decades and has a number of significant advantages over other systems such as: 
 
1. Rapid assessment of drug permeability. 
2. Useful for testing how drugs are transported (Pathway analysis). 
3. Shows biologically relevant efflux transporter, apical enzymes and brush border 
proteins of a differentiated small intestine epithelium.  
4. Useful for toxicity in addition to permeability studies. 
5. Large scale screening application due to easy high throughput culture. 
6. Is a well characterised reference model with which to compare NCEs to model 
drugs in a highly controlled manner.  
 
However, Caco-2 models are well known to be both under representative in some aspects 
(P-gp expression) whilst over representative in others (heightened TEER values) and as 
such are not a perfect model for the intestinal epithelium. Indeed, whist enterocytes are 




the most abundant cell type in the small intestine, they are by no means the only cell 
represented in vivo. Transwell Caco-2 models can be modified in a number of 
physiologically relevant ways such as addition of goblet cells which will be discussed in 
detail later in this chapter. 
 
1.10.2 Stem cells applied to the Transwell system 
 
Other new methods based on the high throughput Transwell system are able to recreate 
the entire range of epithelial heterogenicity are being developed through the application 
of stem cells to the culture system. (117) Wang et al (118) showed how ground state 
intestinal stem cells in their model displayed positive immunofluorescence staining for 
enterocytic markers such as E-cadherin and Villin whilst also demonstrating a significant 
mucous component of the model through positive staining of MUC 5ac and MUC 2 mucin 
proteins. Additionally, cells were shown to multilayer and form villus like structure, 
drastically increasing the available surface are of the model for functional 
experimentation such as drug permeability not unlike that seen in in vivo  tissues. 
Unfortunately, the functional aspects of this model were not tested in this study but one 
could see the potential benefits of this model over Caco-2 monolayers. It was 
hypothesised that with increasing complexity, variation will increase at a similar rate. 
Therefore, there will always be a place for highly simplistic models such as the Caco-2 
systems when high degrees of reproducibility are preferred over in vivo replicability.  
 
Intestinal epithelial cells are known to be particularly challenging to culture in vivo from 
primary tissue sources unless highly complex/ expensive media compositions are used. 
Hence, this is one of the primary reasons why the Caco-2 cell line is still commonly 
utilised 30 years after its initial isolation. Primary cells are always preferred over cells of 
carcinoma origin if possible due to phenotypical changes caused during the 
transformation process. Stem cell culture and application to current in vivo model systems 
is thought to be one method by which the limitations of intestinal epithelial cell culture 
can be bypassed whilst concurrently creating greater in vivo relevancy. Another 
interesting application of stem cells in model systems generally comes in the creation of 
either disease state or patient specific models. Cystic fibrosis, cancer, ulcerative colitis 
and crohns disease are all genetic based examples of where stem cells have been utilised 




to create disease state models of the intestine. (119–121) More in vivo-like models of the 
intestine allow a more refined understanding of the basic biological principles underlying 
the formation of these disease phenotypes. Bio-banks of patient derived stem cells are an 
exciting direction for future development potentially allowing for, among a great many 
other applications, a more refined study of drug interactions in people of differing genetic 
backgrounds or ethnicity, allowing for more tailored personalised medicines. (122) 
However, as yet intestinal models based on stem cell cultures are limited in their 
characterisation and adoption in industry compared to older Caco-2 based systems. 
Essentially, the same issues apply to stem cell based models as does to complex 3D 
cultures in that they are expensive and technically challenging to culture. The justification 
for using Caco-2 cells in this project is as such in addition to allowing for easy adoption 
into an industrial setting. Creating a more in vivo relevant model, whilst still relying on 
the Caco-2 cell line is designed to bridge the gap towards even more in vivo mimetic 
model systems such as stem cell based cultures in the future.  
 
1.10.3 Utilising HT29-MTX as a goblet cell component of the 
epithelial layer 
 
The HT29 cell line was originally derived from a colorectal adenocarcinoma of a 44 year 
old Caucasian female (123) and, much like the Caco-2 cell line, was isolated in the 60/70s 
by Fogh et al (8). Most of the cells within the small intestinal epithelium are of enterocytic 
origin. However, the intestine is also resident to a significant population of mucous 
producing goblet cells which have important physiological applications on the function 
of the intestine. Mucous secreted by these goblet cells has a variety of functions such as, 
aiding the passage of material through the intestine, the creation of a protective barrier 
effect to exogenous compounds and promoting the  sterility effect of mucous on the small 
intestinal epithelium. (124,125)  
 
The mucous environment within the human body is quite variable dependant on the 
epithelium in question with over 20 mucin genes identified and tissue specific mucin 
expression. (92,126–128) Structurally, mucins are built of a protein core consisting 
mainly of Proline, Threonine and Serine. These so-called PTS domains are then highly 




glycosylated to form the mature mucin glycoprotein.   Mucins can vary quite drastically 
in size, structure and function with the smallest being on the scale of hundreds of amino 
acids and the largest multiple thousands.(124,129) For example MUC2, one of the most 
abundant mucins in the intestine is thought to be approximately 2200/2300 amino acids 
long.(125,129) Generally, mucins are split into two categories; the secretive gel forming 
and the transmembrane mucins. 
 
Differential expression of mucins and mucous layer formation is seen within the intestine; 
For example, the small intestine has only a single, transmembrane mucous layer whereas 
in contrast the Colon has a mucous bi-layer containing both transmembrane and secretory 
components.(125) The inner mucous layer of both the small intestine and the colon 
generally acts as a sterile environment so as to limit the direct exposure of the surface 
enterocyte cells to the intestinal bacteria. (126,127,130) It does this by organising into a 
dense layer, acting as a rudimentary filter. Commensal bacterial population survive in the 
gut in the secreted outer layers of the colon whose mucous layers are significantly less 
dense, providing a home for bacterial colonisation. These mucous layers are then slowly 
digested by the bacteria as an energy source. 
 
Most of the cell lines of the intestine reflect the relative abundance of enterocytes and as 
such very few goblet cell lineages exist for researchers to utilise. The HT29 line is one of 
the few which has been shown to, at least partially, mimic the function of a goblet cell; 
with enhanced mucous secretion over other, terminally differentiated enterocytic cell 
lines. The HT29 line of cells has can be further split into sub-populations which have 
been stimulated for a specific phenotype. For example, the HT29-MTX sub clone is 
created by treatment of HT29 cells with the drug Methotrexate. This treatment and the 
resultant cell line have been shown to have improved mucous secreting phenotypes over 
the parental HT29 populations. Attempts at incorporating the HT29-MTX line into 
cellular models of the intestine have been trailed with variable success, with the majority 
of Caco-2/ HT29-MTX co-cultures being utilised for model: bacterial interactions rather 
than pharmacological assessment. (131–134) 
 




1.11 Understanding the growing use of CCD-18co cells in 
intestinal model cell culture.  
 
The CCD-18co cell line is a normal colon cell line utilised through intestinal cell research 
as a myofibroblast lineage. It has been noted through the literature that the CCD-18co 
cells are able to secrete paracrine factors which are able to affect the co-cultured 
epithelium.(135,136) 
 
For example Visco et al (137) highlighted in their 2009 paper the effects of secreted KGF 
on the development of a co-cultured Caco-2 cells layer. They showed that KGF, both in 
a pure added form and as a result of CCD-18co or NHF (normal human fibroblasts) co-
culture, resulted in the increased expression of Ki67 and carcinoembryonic antigen 
(CEA). These markers correlate with increased Caco-2 cell proliferation and 
differentiation respectively. In addition to showing the effects of secreted factors on 
epithelial cell proteome expression they were also able to show differences between 
intestinal and skin fibroblast KGF expression. This additional information works to 
highlight the importance of choosing tissue specific fibroblasts which match the 
phenotypical characteristics of the model being created. In this instance the CCD-18co 
cell line was shown to express approximately 3 times the expression of KGF when 
compared to NHF.(137) 
 
Pereira et al (138) created a simple 3D co-culture model of the intestine utilising the CCD-
18co and Caco-2 cells for the purpose of creating a new method to test the in vitro 
permeability of the intestine to new compounds, similar to that done in this study. They 
found that direct co-culture of the cells together on a permeable membrane, created a 
model with significantly lower TEER values than the conventionally cultured Caco-2 
intestinal equivalent. Additionally, the authors tested the functionality of the model, 
specifically transcellular integrity, by loading the models with insulin and calculating the 
Papp over time. They showed that the membrane which had been co-cultured with 
intestinal fibroblasts were more permeable to insulin than the standard Caco-2 membrane 
layers. The authors in this case attribute the increase in permeability to a decrease in tight 
junction abundance and “tightness”, although they did not directly test this hypothesis in 




their study and they do acknowledge that the changes in insulin permeability could be 
due to other processes such as in increase in transporter expression of which insulin is a 
substrate.  
 
There is significant evidence that the co-culture of Caco-2 epithelial cells with fibroblasts 
has significant effects on the expression of several key transporters such as MDR1, 
MRP2, BCRP etc. Matsusaki et al (103) showed this in their paper creating a 3D model 
of Caco-2 cells with neonatal HDF (HDFn). Relative mRNA expression of these key 
transporters was shown to change significantly over controls when co-cultured with 
HDFn cells. This has the potential to have large repercussions on the activity of the overall 
model and as such the importance of the stromal component of any intestinal model 
shouldn’t be underestimated. Changes in transporter expression and relative changes in 
model functionality in co-culture and 3D systems will be discussed further in chapter 7. 
 
1.12 The growing use of advanced 2D and 3D models of the 
intestine over the current 2D standards.  
 
The 2D culture of cell lines for use as pharmacologically reliable markers of drug 
bioavailability and metabolism has been a common practice within the pharmaceutical 
industry for decades. These model cell lines have significant advantages in that they are; 
readily available, cheap to use and expand, highly reproducible and quick to culture. The 
advantages allow for the mass production and use of cheap in vitro models, allowing for 
the high throughput screening of novel drug compounds in early clinical testing. This is 
especially valuable in the first phases of compound discovery whereby hundreds of 
compounds with high structural homogeny may be tested for their pharmacological 
effects, toxicity and bioavailability. Additionally, most model cell lines when cultured in 
this method produce highly reproducible cellular models allowing for easy cross-
comparison of data between labs, as such increasing the reliability of data from these 
methods.  The disadvantages to utilising simply cultured cells in isolation are many. One 
of the most significant shortcomings is that they lack the in vivo ques, both direct and 
paracrine, that they would normally be exposed to in the body allowing for a level of 
genetic drift overtime. 




New intestinal models developed to replace the 2D monoculture assays have focussed 
more on the incorporation of in vivo like conditions such as three-dimensionality and 
through the culture of multiple complementary cell types together. One of the main 
focusses is in the addition of enterocytes with goblet like cells which can include the 
parental line HT29 but more often work with induced sub-clones such as HT29-MTX. 
An example of this can be seen in the work by Beduneau et al (139), in which they aim 
to create a tuneable co-culture model with the enterocytic cell line Caco-2 and the goblet-
like properties of the transformed cell line HT29-MTX. They created a simplistic co-
culture model which demonstrates a change in the functional characteristics of their 
model compared to simple control monocultures. They demonstrated changes in P-gp 
mediated transporter action through measurement of the permeability of the compound 
Rhodamine 123 to control Caco-2 and their own tuneable Caco-2/ HT29-MTX model. 
When HT29-MTX cells are added early in the culture period the apparent permeability 
of the membrane to Rhodamine 123 decreases. A decrease in permeability, e.g. A 
decrease in the movement of compound from the basal to apical compartments, would 
suggest a decrease in the active transport incurred by the P-gp present in the model, a 
non-physiological change compared to human intestinal P-gp levels. The aim of their 
project is to create a model which can begin to mimic not only the absorption 
characteristics of the enterocytes but also model the effects of mucous secretion on drug 
bioavailability. Indeed, the mucous layer of the intestine has been shown to be incredibly 
important in gut homeostasis and has significant effects on drug availability in vivo 
primarily through the creation of an unstirred water layer on the surface of the intestinal 
epithelium.(140) In this instance the bio-availability of the drug will rely primarily on the 
drugs hydrophobicity and its capability to diffuse through this unstirred layer to reach the 
cells beneath. Additionally, compounds have been shown to be able to bind to mucin 
molecules such as tetracycline hydrochloride (140), further limiting their availability as 
mucous is continuously produced and shed from the GI tract. (140,141)  
 
Ferraretto et al have also created a simple co-culture model utilising the Caco-2 and HT29 
cell lines.(142) Contrastingly, they showed that incorporating the HT29 cell line and 
mucous layer actually increased the levels of Lucifer yellow apparent permeability (Papp) 
in their models. As such this highlight the complexity that is added to the model through 
co-culture, with the mucous layer blocking some compounds but aiding the absorption of 




others. Another explanation for the apparent increase in lucifer yellow availability could 
also be deduced by looking at TEER values. Lucifer yellow is a marker of membrane 
integrity, moving exclusively through the paracellular absorption pathway. The TEER 
values of the 70/30 Caco-2/ HT29 layers that the authors created in this paper were 
markedly reduced compared to Caco-2 controls. As such one might expect an increase in 
LY movement through the membrane regardless of the presence of a mucous layer. Co-
culture Caco-2/ HT29-MTX models in general still suffer from a number of significant 
drawbacks such as even lower P-gp expression due to the addition of HT29-MTX cells 
and a lower, but yet not physiological TEER values. (139,142) Goblet cells are specialised 
secretory cells with little active function in the transport of compounds across the 
epithelial membrane. Therefore, logically one might expect that adding a higher 
proportion of non-transport capable goblet cells to the epithelial barrier would correlate 
with the decrease in the transport capabilities of the epithelial membrane as shown here. 
This paper can show how simple changes to the culture of cellular models can result in 
significant changes in the function of the resultant models. However, this paper doesn’t 
look at how the co-culture of the epithelial linages is affecting the gene and protein 
expression of the cells themselves, a key consideration when adding cells to a co-culture 
which don’t have intrinsic “functional” epithelial characteristics such as fibroblasts or 
immune cells.  
 
Recent work has highlighted the effects of the fibroblasts of the underlying supportive 
mucosae and the ECM microenvironment on the development and maintenance of an 
epithelial layer of high functionality. Schweinlin et al  demonstrated this approach in their 
intestinal model made from decellularised porcine intestinal tissues. They showed that 
the addition of fibroblasts to the models had significant effects on both the TEER of the 
organoid model and its permeability to dextran-4000, a commonly utilised measurement 
of membrane integrity similar to Lucifer yellow.(143) Additionally to the addition of 
fibroblasts to the model culture they also demonstrated the effects of fluid flow mechanics 
on the development of the epithelial layer. They described how perfused cultures with 
physiological sheer stresses were able to influence model functionality, changing its 
permeability to model drug compounds such as Rhodamine 123, Propranolol and 
Fluorescein.  The underlying mesenchymal layer of the intestinal crypt has also been 
shown to be critical in the maintenance of the intestinal stem cell niche, allowing for long 




term homeostasis of the stem cell population and the rapid turnover of stem cells into new 
epithelium seen in the intestine. (144,145)Additionally, the paracrine effects of 
myofibroblasts have been shown to induce differentiation and proliferation of epithelia. 
For example, Visco et al showed that the myofibroblast cell line CCD-18co was able to 
have effects on Caco-2 monolayers through the paracrine actions of keratinocyte growth 
factor (KGF), increasing the expression of the proliferation marker Ki-67 and the 
differentiation marker carcinoembryonic antigen (CEA). (137) 
 
Compound absorption studies are commonly done utilising the Transwell system, 
whereby a population of cells are cultured on one side of the permeable transport insert 
to create a polarised epithelial tissue model. Whilst widely accepted as the standard for 
compound screening, the Transwell system suffers from the same negatives as mentioned 
above in addition to lacking morphological similarity to the tissue being modelled. One 
of the main research directions being explored is the replacement of the Transwell 
systems with more physiological systems which incorporate multiple cell types, in 3D 
matrices and with tissue specific ECM deposition. There are multiple ways in which this 
is being achieved with one of the main being the utilisation of tissue specific stem cells 
to create organoid models. These organoid models often contain the most complexity of 
the advanced in vitro tissue models with multiple differentiated cell types and complex 
tissue specific 3D architecture. The work on intestinal organoids was first driven by the 
lab of  Hans Clevers et al.(146) Their work demonstrates the value of utilising intestinal 
organoids as models for human physiology in a number of ways; through their work in 
the identification of the function of paneth cells in the intestinal crypt,(96) understanding 
the roles of cancer mutation in intestinal cancers (147) or in disease states such as cystic 
fibrosis (148) to name a few. One major drawback to the use of organoid cultures for 
routine drug testing is the inability to control the macro structure of the model. Organoids 
naturally develop in suspension and as such are naturally shaped as a mass of cells with 
the functional epithelial layers orientated to the inside of the macro-structure. In order for 
application to a drug validation platform a single, layered epithelium with consistent 
directional polarity is necessary for Papp studies, something organoid cultures, as yet 
cannot recapitulate.  
 




Other promising methods for the creation of 3D models with physiological function rely 
on the use of scaffolds, both biological and synthetic, for the 3D culture of cells. 
Biological scaffold generally encompass extracellular matrix constituents such as 
collagen matrigel gels in their simplest form all the way up to decellularised tissues for 
the most complex models. (143,149–151) Decellularised tissues in particular have clinical 
applications in organ transplant/ regeneration research with the idea being that 
decellularised scaffold could be recellularised with patient derived stem cells, forming a 
new, functional tissue that could be transplanted with reduced fears of rejection. (152,153) 
Synthetic scaffold encompass any material of non-biological origin. For example, work 
discussed in this study primarily focusses on the use of Alvetex®, a polystyrene polyHIPE 
scaffold  treated to allow the routine culture of human and animal cells. Other examples 
could include electrospun scaffolds which can be constructed from a wide range of 
available materials with properties fine tines to the use of the model.  The advantages and 
disadvantages of each system will be discussed later in detail in chapter 5.  
 
1.13 Regulatory alignment and the challenges of applying new, 
more complex models to the drug development process.   
 
Studies involving humans suffer from a number of key challenges. Experiments using in 
vitro tissue segments and Ussing chamber devices are extremely expensive, technically 
challenging and low throughput. Whereas, in vivo human clinical trials are all of the 
aforementioned plus ethical considerations regarding screening of potentially toxic 
compounds in human subjects. As such, the FDA and other bodies have accepted model 
systems such as Caco-2 as surrogates for human intestines, albeit primarily for assessment 
of passive paracellular transport. (154)  
 
The Biopharmaceutics classification system (BCS) was originally developed as a tool to 
assess the correlation between jejunum permeability rates and drug absorption to facilitate 
the approval of Class I drugs known to be highly permeable and dissolvable within the 
intestine, important for an orally administered compound. BCS is used to classify 
compounds and is widely accepted in both academia and industry. Classifications fall into 
4 categories; Class 1, are highly soluble and permeable, Class 2 have low solubility but 




high intestinal permeability, Class 3 are highly soluble but have a low permeability and 
Class 4 are both poorly soluble and have low permeability.  
 
The code of federal regulations forms the basis of regulatory approval of new, innovative 
cellular products. These regulations cover a huge range of considerations such as 
biological evaluation, safety, manufacturing processed (GMP) etc. (155) 
 
What is clear is that current research pharmacokinetic practices do not function at close 
to tissue relevant levels in many instances. The development of new and more advanced 
research tools for the study of drug dynamics in the intestine is key to optimising the drug 
discovery and validation process. Regulatory approval for bodies such as the FDA 
required multidisciplinary expertise and must include those with experience in fields such 
as medicine, pharmacology/toxicology, cellular therapies, and cell biology, as such 
compounding the complexity for regulatory approval.(156) In silico modelling is one new 
area within which new regulatory models are being approved for use.(157) It is hoped 
that these models can accurately predict the permeability characteristics of certain 
compounds trough simple model layers such as Caco-2 without the requirement for “wet 
work” in the lab. These models would have a clear advantage over current practices 
however validating their efficacy is complex, primarily due to the inherent heterogeneity 
of Caco-2 populations dependant on origin and culture conditions. Any in silico model 
would need to pool data sets of Caco-2 of varying origins to assess for any variability.  
Other methods such as 3D models are more able to mimic the structural complexity of in 
vivo tissues and, as such, can help to bridge the gap between current standards and animal 
models. However, increasing model complexity through the addition of additional cell 
lines compounds on the already inherent variability in Caco-2 cells. Regulatory approval 
would require extensive characterisation and validation to assess for any changes in 
cellular phenotype. The challenge for new systems lay in the demonstration of significant 
improvement over current standards sufficient to justify the complex process which is 









1.12 Project Hypothesis 
 
The main hypothesis of this project was that, through use of either paracrine influences 
or 3D culture, the Caco-2 Transwell system could be improved to better recapitulate both 
the gross anatomy of the human intestine and its functional characteristics. Furthermore, 
it was hypothesised that simple Caco-2 3D models could be adapted for use in a 96 well 
system to better allow for adoption and use throughout industry as a direct replacement 
for the current Caco-2 Transwell gold standard. Additionally, the base architecture of the 
3D model could be further developed to include additional cell lines such as goblet cells 
to expand the functionality of the resultant model.  
1.13 Project Aims 
 
This project aims to create both advanced Transwell model variants of the Caco-2 
standard through the co-culture of Caco-2 membranes with conditioned media from 
fibroblasts of varying origins and to create a 3D model of the intestine, again using Caco-
2 cells in order to demonstrate how increased complexity allows for tissue models with 
more in vivo like properties.  
 
Additionally, work undergone in this project will include the analysis of such models 
including structural assessments through a range of techniques such as histological and 
immunological stains in addition to TEM and SEM.  Assessment of model function will 
be achieved through the use of an Ussing type chamber measuring the apparent 
permeability of model drug compounds within each model system. Values gained in this 
work will be cross referenced against both internal and literature derived values for 
standard Caco-2 models in addition to assessment against human tissue values, again 
gained form the literature where possible. It was hypothesised that the advanced co-
culture Transwell models and the full mucosal 3D models of the intestine will improve 
the structure and function of models, as such improving the in vivo  reliability of these 
models compared to data with human tissues.  
 




 1.14 Project Objectives 
 
1. Develop and optimise a novel 3D mucosal intestine equivalent utilising Alvetex 
Scaffold and multiple cell types including; Caco-2,CCD-18co, HDFn and HIC 
fibroblast lineages.  
 
2. Develop and optimise the culture of advanced paracrine Transwell models 
utilising conditioned media gained from 2D cultured CCD-18co, HDFn and HIC 
cell lines.  
 
3. Structurally characterise all models through the use of techniques such as 
histological staining of paraffin embedded samples in addition to immunostaining 
from key protein elements of cellular function and SEM/ TEM analysis of cellular 
ultrastructure. 
 
4. Utilising model drug compounds functionally characterise the models created 
during this study to assess their comparability to Caco-2 controls and human 
tissues. Another aim was to design and create novel tools for the culture and 
functional analysis of intestinal equivalents.  
 
5. Introduce HT29-MTX cells into the paracrine Transwell models to assess the 
effect of the mucous layer on the function of the epithelial models. 
 
6. Postulate and test a potential mechanism for any differences in structural and 
functional phenotypes observed in the characterisation of the models.
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2. Materials and methods 
2.1 Materials 
2.1.1 Chemicals and miscellaneous lab reagents 
 
Kits for periodic acid Schiff (PAS) ( RRSK15-100) and Massions Trichrome with Methyl 
blue (RRSK20-100) were both obtained from Atom scientific (UK). Rhodamine 123, 
Verapamil Hydrochloride, Etoposide, Methotrexate, Atenolol, Propranolol, Lucifer 
yellow, L-alanine-4-nitroanilide hydrochloride, 4-Nitroanaline, Hanks Buffered salt 
solutions (HBSS) and DPX (#06522-100ml) were obtained from Sigma Aldrich, UK. 3-
(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (#158990050) used for 
MTT studies of metabolic activity was obtained from Fisher Scientific along with 
embedding wax (#12624077), Methanol (#11976961), Acetone (#11453483), 
Isopropanol (#10588630) and microscope slides (#10149870). Vectorshield plus DAPI 
was obtained from Vector labs (#H1500) 
 
2.1.2 Cells and cell culture media components 
 
Caco-2 (#86010202) and HT29-MTX (#12040401) cells were obtained from the 
European Collection of Authenticated Cell Cultures (ECACC) (Porton Down, UK) and 
were used between passages 44-50 and 55-60 respectively. CCD-18co (CRL-1459) 
fibroblasts were obtained from ATCC (UK) and used between PDL 10 and 15.  HDFn 
cells (#C0045C) were obtained from Thermo Fisher Scientific (UK) and were used up to 
passage 4. HIC cells were isolated in lab as described later. HIC cells were used up to 
passage 5.  
 
High glucose containing DMEM with Pyruvate (#21969-035) cell culture media and 
supplements (L-glutamine (#25030-081), penicillin and streptomycin (#15140-122 
10,000 U/ml), FBS and 0.25% Trypsin (#25200-056)) were obtained from Thermo Fisher 
Scientific. DMSO (#D8418) and Trypan Blue (#T8154-100ml) were obtained from 




Sigma. KGF (#100-19) recombinant protein was obtained from PeproTech. KGF ELISA 
kit (#DKG00) was purchased from R&D systems. Cryovials for the long term storage of 
cell populations were purchased from Greiner (#121263) 
 
2.1.3 Plastic ware 
 
Cell culture grade polyester Snapwell inserts 12 mm diameter with 0.4μm pore size were 
purchased from Sigma Aldrich (CLS3407-24EA). 12 and 24-well Alvetex® Scaffolds (12 
(AVP005-12), 24 (AVP012-48)) and 96 (Prototype) well sized Alvetex Scaffold inserts 
were purchased from Reprocell, UK. Alvetex® Scaffolds were purchased at 200μm 
thickness. 
 
Supplier Item Catalogue # 
Greiner Bio-one 6 well plates 657160 
 12 well plates 665180 
 24 well plates 662160 
 T25 cell culture flask 658175 
 T75 cell culture flask 660175 
 T175 cell culture flask 690175 
 50ml Falcon centrifuge tube 227261 
 15ml Falcon centrifuge tube 188271 
 50ml syringe SYR5-L5 
 Cell storage cryovials  121263 
Sarstedt  50ml cell culture stripettes 86.1689.001 
 25ml cell culture stripettes 86.1685.001 
 10ml cell culture stripettes 86.1254.001 
 5ml cell culture stripettes 86.1253.001 
 P1000 pipette tips 70.762 
 P200 pipette tips 70.760.002 
 P10 pipette tips 70.153 




Fisher Scientific 0.2μm Syringe filter 15181499 
 96 well plate 10334791 






Antibodies were purchased from a number of sources dependant on price, availability and 
efficacy for a given use. Dilutions shown here were determined based on manufacturer 
recommendations. Antibodies used in this study are detailed below: 
 
Supplier Target protein Catalogue # Use & Dilution 
Abcam Collagen I ab34710 Immunofluorescence 
(1/100 Dilution)  
Abcam Fibronectin ab23750 Immunofluorescence 
(1/500 Dilution) 
Abcam Villin ab130751 Immunofluorescence 
(1/200 Dilution) 
Abcam E-cadherin ab1416 Immunofluorescence 
(1/200 Dilution) 
Abcam Collagen IV ab6586 Immunofluorescence 
(1/100 Dilution) 
Abcam αSMA ab7817 Immunofluorescence 
(1/100 Dilution) 
Abcam Elastin ab9519 Immunofluorescence 
(1/100 Dilution) 
Abcam Tubulin ab176560 Immunofluorescence 
(1/100 Dilution) 
Abcam Cyto-Keratin ab118817 Immunofluorescence 
(1/200 Dilution) 
Table 2.1: Summary of plastic materials consumed during the course of this project 
including cell culture grade and general lab reagents.  




Protein Tech Collagen III 22734-1-AP Immunofluorescence 
(1/100 Dilution) 
Santa Cruz Biotechnologies Vimentin sc-6260 Immunofluorescence 
(1/ 50 Dilution) 
Santa Cruz Biotechnologies Occludin sc-133256 Immunofluorescence 
(1/ 50 Dilution) 
Santa Cruz Biotechnologies MDR1 sc-55510 Immunofluorescence 
(1/ 50 Dilution) 
Santa Cruz Biotechnologies Desmin sc-23879 Immunofluorescence 
(1/ 50 Dilution) 
Santa Cruz Biotechnologies MRP2 sc-71603 Immunofluorescence 
(1/ 50 Dilution) 
Thermo Fisher Scientific Donkey anti 
rabbit (488) 
A21206 Secondary antibody 
(1/ 500 Dilution) 
Thermo Fisher Scientific Donkey anti 
mouse (488) 
A21202 Secondary antibody 




2.1.5 qPCR primers and PCR reagents 
 
qPCR primers used in this study were taken directly from literature resources prior to 















BCRP (S) TGCAACATGTACTGGCGAAGA (159) 
Table 2.2: List of antibodies used in this project including secondary Alexa Fluor 
conjugated secondaries. 


























Supplier Item Catalogue # 
Bio-Rad Hard-shell PCR plates HSP9601 
 Quick start SYBR 1725271 
Thermo Fisher PCR plate seals AB0558 
Qiagen RNeasy Plus mini kit 74134 
Promega GoScript reverse 
transcriptase 
A2791 
Sigma RNase ZAP R2020 
 
 
2.2 General methods 
2.2.1 General cell culture 
 
Cells were routinely cultured in T75 or T175 cell culture flasks maintained in a humid 
environment at 37oC, 5% CO2 in air. In 2D culture, cells were fed with their respective 
media, prewarmed to 37oC in a temperature-controlled water bath, at a rate of every other 
day unless otherwise stated. Cells were deemed ready for passage at 80% confluency. 
Cell lines were visually checked for contaminants daily and checked by phase microscopy 
immediately prior to media change. 
 
Table 2.3: qPCR primers including reference of origin.  
Table 2.4: qPCR reagents for the isolation of RNA, reverse transcription into cDNA and 
expansion  SYBR based detection methods. 






Cells were removed from the incubator and washed twice in sterilised PBS prior to 
incubation with 0.25% Trypsin/EDTA (2500mg/L) containing phenol red (2ml T75, 4ml 
T175). Cells were incubated in a humidified environment at 37oC, 5% CO2 for 3 minutes 
or until cells had detached for the tissue culture surface. For strongly adherent cell lines 
such as Caco-2 this could take up to a maximum of 10 minutes. If after 10 minutes cells 
were still attached to culture plastic flasks were gently tapped to liberate cells into 
solution. Cells were liberated and collected by gentle washing on the cell surface with 
10% FBS containing culture media. This also acts as the trypsin neutralisation step. The 
media volume was then topped up to 15ml in a Falcon tube. To remove trypsin containing 
media, cells were centrifuged for 3 minutes at 500g unless otherwise stated. Media was 
then removed being careful not to disturb the cell pellet which was then subsequently 
carefully resuspended in an appropriate volume of fresh prewarmed culture media 
(usually 1ml). Cells were re-seeded into new sterile cell culture flasks at the appropriate 
density as per the manufacturer’s instructions or were counted for use in experimental 
procedures. 
 
2.2.3 Trypan Blue cell counting 
 
To allow for the accurate seeding density within Transwell and 3D models or when 
manufacturers guidelines specified cell seeding numbers per flask, total cell number must 
be quantified prior to use. Cells were passaged as above and resuspended in an appropriate 
volume  of fresh cell culture medium (usually 1ml but more if large quantities of cells 
were being counted so as to ensure accurate sampling of cell numbers) A 9:1 dilution of 
trypan blue: cell suspension was created in a separate Eppendorf tube. This cell 
suspension is carefully pipette mixed (gently to avoid unnecessary cell damage) before 
being added to a haemocytometer. Live/dead cell counts can be made microscopically by 
counting the ratio of dyed (Blue) cells to dye excluded (White) cells, with dye exclusion 
indicating cellular viability. A total of 3 quadrants on a standard haemocytometer were 




counted to create an average of one quadrant with a known volume of 0.1μl. Raw cell 




= 𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 
 
𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑥 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 = 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 
 
𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 
𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 𝑣𝑜𝑙𝑢𝑚𝑒  𝑚𝑙 




Cells were passaged as previously described. Cells were resuspended in an appropriate 
volume of 10% FBS containing complete culture medium and counted with a 
haemocytometer. The volume for the correct number of cells to be frozen per vial (usually 
1-2 million) was calculated and added to a 1ml cryovial. DMSO and 10% complete cell 
culture medium was added to each tube to create a final volume of 1ml and a final DMSO 
concentration of 5%. Cell vials were then added to a Mr FrostyTM (Thermo-Fisher) for a 
minimum of 24 hours at -80oC. Cells were then placed at -150oC or in liquid nitrogen 
vapour phase for long term storage until required for use.  
 
2.2.5 Cell revival 
 
Cells vials were quickly warmed in a 37oC water bath until only small ice crystals 
remained floating in suspension. Cells were gently resuspended and added to an 
appropriate volume of 10% FBS cell culture medium. Cells were allowed to attach for 24 
hours in an appropriately sized flask ( <1,000,000 = T25, 1,000,000-2,000,000 = T75) 
before DMSO containing medium was removed and replaced with fresh pre-warmed 




culture media. Any unattached cells after 24 hours were carefully removed and pelleted 
before resuspension and addition back into the culture flask. Unattached cells after this 
point were discarded with media changes. 
2.3 Embedding techniques for study samples 
2.3.1 Paraffin embedding 
 
Samples to be processed for paraffin embedding were first washed in PBS before being 
fixed in 4% Formalin for a minimum of 30 minutes at room temperature but more 
generally overnight at 4oC. Actual fixation length was determined by the sample type 
with tissue samples preferably being fixed for longer at cooler temperatures to ensure 
complete tissue fixation. Samples were removed from fixative and washed twice in PBS 
before being dehydrated through a series of ethanol concentrations 30-100% (v/v) for a 
minimum of 10 minutes per concentration with an extended incubation time of 30 minutes 
for 100% ethanol solutions. Samples were then incubated for 30 minutes in Histoclear II 
(National diagnostics) at room temperature. Paraffin wax is added to Histoclear II samples 
to make a final ratio of 50:50 Histoclear: Paraffin for 30 minutes at 65oC. Finally, samples 
Cut from hanging insert and 
split into appropriately sized 
sections 
Samples were embedded in 
wax orientated so that the cut 










Figure 2.1: Schematic representation of the embedding and sectioning process for both 
Transwell and Alvetex® based intestinal models – Samples are cut in half and embedded 
with the cut end to the bottom of the block (first to be trimmed). Blocks are sectioned at 5μm. 




were washed twice in 100% Paraffin at 65oC for a minimum of 20 minutes per wash 
(longer for larger tissues before embedding in cassette moulds and allowing to cool.  
 
2.3.2 OCT embedding 
 
Samples to be processed for OCT embedding were first gently washed in PBS to remove 
all culture media. Samples were then fixed for 10 minutes in an ice cold mixture of 50:50 
methanol: acetone. OCT freezing moulds were made from aluminium foil and clearly 
labelled with the sample name before samples were added. OCT freezing solution was 
added to the foil moulds. Samples were cut to size and completely submerged in OCT for 
a period of 15 minutes before freezing. Liquid nitrogen was added to a polystyrene 
freezing box below a metal plate. Liquid nitrogen was not allowed to touch the surface of 
the metal plate as freezing will occur at vapour phase. Samples were added to the pre-
chilled plate and left to fully freeze for a period of 30 minutes. Samples were stored at -
80oc for long term storage.  
 
2.4 Immunochemistry 
2.4.1 Paraffin embedded samples 
 
Paraffin embedded 4% PFA fixed sections (7μm) were dewaxed for 15 minutes in 
Histoclear I and brought to water through a series of alcohol solutions (90, 70% ethanol). 
Samples were antigen retrieved by incubation for 30 minutes at 95oC in citrate buffer.  
Should permeabilisation be required samples were incubated for 5 minutes in a 0.5% 
Triton/ PBS solution. Samples were washed in PBS before being blocked to limit non-
specific protein binding in a 10% Normal Goat Serum (NGS)/ PBS solution for 30 
minutes at room temperature. Primary antibodies were incubated in a 1%NGS, 0.1% 
PBST solution at an antibody specific concentration for a minimum of 1 hour at room 
temperature or overnight at 4oC. Following primary antibody incubation samples were 
washed 3 x 5 minutes in 0.1% PBST to remove any unbound and non-specific primary 
antibody. Fluorescently tagged secondary antibodies were diluted at an antibody specific 




concentration in PBS and incubated with the samples for a minimum of 30 minutes at 
room temperature. Samples were protected from light at this stage onwards in order to 
protect the samples from photobleaching. Samples are then washed 2x in 0.1% PBST. 
Nuclei were stained using either DAPI or Hoechst which were added at an active 
concentration to the final wash step post-secondary antibody incubation. Excess nuclei 
stain was removed by one final wash in PBS followed by mounting with soft set 
Vectorshield fluorescent mounting media. Slides were sealed before imaging through the 
minimal application of clear nail varnish to the edges of the coverslip. 
 
2.4.2 OCT embedded samples 
 
Samples were allowed to warm to -20oC prior to sectioning. Sections were allowed to air 
dry for 10-20 minutes before being washed gently in PBS to remove excess freezing 
media. Samples were then fixed in ice cold 50:50 methanol: acetone before being brought 
back to water. OCT embedded methanol: acetone sections do not require antigen retrieval 
or permeabilisation steps. All other steps in this protocol are the same as Section 2.4.1 
Step 4 onwards.  
 
2.4.3 Wholemount cell coverslips, wells and Transwell inserts. 
 
Cells were fixed in ice cold methanol: acetone for 10 minutes at -20oC. Methanol: acetone 
fixed cells do not require antigen retrieval or permeabilisation steps. All other steps in 
this protocol are the same as Section 2.4.1 Step 4 onwards.  
For all immunochemistry negative controls were used routinely (Samples processed 
without primary antibody incubation). Where possible positive controls of either human 
tissues or specific cell lines were used.  
 




2.5 Histological staining techniques of paraffin embedded 
samples. 
2.5.1 Haematoxylin and eosin 
 
Paraffin embedded samples were sectioned at 7μm and heat dried to glass slides. Slides 
were de-paraffinised in Histoclear for 15 minutes. De-parrafinisation was followed by 
rehydration through ethanol to water (100, 95, 70%) for 1 minute per ethanol 
concentration. Samples were then placed in haematoxylin for 5 minutes in order to stain 
the cellular nuclei. Excess stain was washed off in water followed by a 30 second wash 
in alkaline ethanol to blue the stained nuclei. Samples were dehydrated in ethanol (70, 
95%) once more and incubated in eosin solution for 30 seconds. Finally, samples were 
rapidly washed in 95 and 100% (v/v) ethanol and cleared in Histoclear for 10 minutes. 
Slides were then mounted with a coverslip and left to dry before viewing under a 
microscope.  
 
2.5.2 Periodic acid Schiff stain 
 
Paraffin embedded samples were sectioned at 7μm and heat dried to glass slides. Slides 
were de-paraffinised in Histoclear for 15 minutes followed by rehydration through 
ethanol (100, 95, 70%) to water for 1 minute per ethanol concentration. Deparaffinised 
sections were oxidised in periodic acid solution for 5 minutes. Samples were then gently 
washed in distilled water and stained with Schiff reagent for 20 minutes at ambient 
temperature. Slides were then washed in running tap water until appearing pink 
macroscopically followed by staining of the cellular nuclei with Mayer’s Haematoxylin 
for 1 minute. Finally, samples were differentiated in 0.5% (v/v) acid alcohol and blued in 
running tap water. Samples were then dehydrated through an ethanol series, mounted and 
allowed to dry before viewing and imaging. 
  
 




2.5.3 Masson trichrome stain with methyl blue 
 
Paraffin embedded samples were sectioned at 7μm and heat dried to glass slides. Slides 
were de-paraffinised in Histoclear for 15 minutes followed by rehydration through 
ethanol (100, 95, 70%)  to water for 1 minute per ethanol concentration. Wiegert 
haematoxylin was prepared by mixing part A and B solutions in a 50:50 ratio immediately 
prior to use. Samples were incubated with Weigert haematoxylin for 20 minutes at room 
temperature. This was followed by quickly washing with water and differentiating in 1% 
acid alcohol. Nuclei were blued by rinsing in water. Next slides were stained with 
Ponceau Fuchsin solution for a period of 5 minutes then rinsed in water. Slides are then 
differentiated in phosphotungstic acid for 15 minutes and stained with methyl blue for 1 
minute without rinsing. Finally, samples were rinsed in distilled water, dehydrated 
through alcohols, cleared and mounted. Slides were allowed to dry before viewing and 
imaging.  
 
2.6 Scanning electron microscopy (SEM) 
 
Biological samples were fixed for SEM for 1 hour in Karnovsky fixative. Samples are 
washed 3x with 0.1M Cacodylate Buffer at pH 7.6. Karnovsky fixed samples were further 
fixed for a period of one hour in a 1:1 ratio of 2% (v/v) Osmium Tetroxide and 0.2M 
Cacodylate buffer at pH 7.4. Samples were then dehydrated through ethanol gradients 
(30-100% v/v ethanol) for 3 x 5 minutes per ethanol solution. The dehydration process 
was completed through use of critical point drying equipment. Critically dried samples 
were orientated on chips and sputter coated with platinum. Critically dried and coated 
samples were stored under vacuum. Images were taken on an S5200 Field emission 








2.7 Transmission electron microscope (TEM) 
 
Samples were fixed in Karnovsky fixative followed by osmium tetroxide treatment and 
dehydration in the same way as detailed for samples which were processed for SEM. Post 
dehydration samples were infiltrated with a 1:1 mixture of Ethanol (100% v/v) and 
propylene oxide for 15 minutes. This was followed by a further infiltration step of 
propylene oxide alone for 15 minutes. The resin used for embedding biological samples 
was the epoxy resin Agar 100 (Agar scientific, UK). Resin was pre-prepared at 37oC 
following kit instructions prior to use. Samples were infiltrated with 1x wash of 1:1 
propylene oxide and Epon resin for 15 minutes followed by 3x 1 hour infiltrations with 
Epon resin at room temperature on a rotating incubator. Samples were added to setting 
moulds and left to set at 37oC for at least 24 hours prior to sectioning. Ultra-thin sections 
were created using either a glass or diamond knife before being stained with uranyl 
acetate and lead citrate. Sections were then viewed under the H7600 Transmission 
electron microscope 
 
2.8 Drug permeability transport assays. 
 
Transport studies were conducted utilising a standard Ussing chamber set up (WPI, UK) 
with the chamber insert determined by the model/ tissue being tested. The general 
protocol for the experiments follows routinely utilised procedures. Transport buffer 
consisted on HBSS pH 7.4 with 2mM supplementary glucose. Stock solutions of all drug 
compounds were dissolved in a substance specific vehicle (DMSO/ Ethanol) before being 
added to the HBSS.  
Models to be tested were carefully removed from culture, washed twice in PBS and added 
into the Ussing chamber system. TEER measurements were taken both immediately 
before addition to the chamber and at the end of the experiment. 15ml of 37oC prewarmed 
HBSS was carefully added to both the apical and basal sides of the chamber system 
simultaneously, media was kept at 37oC throughout the experimental period through use 
of a circulating heated water jacket. Transport media was mixed and oxygenated utilising 
a bubble lift of 95% Oxygen and 5% CO2. Drug compounds were spiked into the Ussing 




chamber at T=0. Timepoints were taken every 30 minutes by removal and replacement 
of transport media directly from the test chamber, either the apical or basal side. Lucifer 
yellow was run alongside test compounds as an additional measure of barrier integrity 
throughout the experimental procedure where possible. Compound concentration within 
the transport medium was assessed through use of either the compounds fluorescent 
properties or through detection with HPLC equipment.  
Papp was calculated utilising the following equation; 
 
𝑃𝑎𝑝𝑝 =  
𝑉𝑅 ∗  𝑑𝐶𝑅
𝑑𝑡 ∗ 𝐴 ∗ 𝐶𝐷0
 
 
Whereby VR is the volume of the receiver compartment dCR/dt is the change in the analyte 
concentration of the receiver compartment over time, A is the area of the transport 
interface and CD0 is the concentration of the donor compartment at time zero. 
 
2.9 qPCR analysis of cell models and tissues 
2.9.1 mRNA purification and extraction from whole cell and 
tissue lysates. 
 
Firstly, mRNA was extracted from biological samples through use of the RNeasy RNA 
extraction kit (Qiagen, USA).  
Cells were lysed through addition of buffer RLT and mechanical disruption of the cell 
layer with either a cell scraping device or a pipette tip. Cell homogenate was then further 
homogenised through passing through a blunt 20-guage needle tip at least 5 times An 
equal amount of alcohol was added to the cell lysate. The alcohol/ lysate mix was then 
added to an RNeasy spin column and span for 15 seconds at 10,000 RPM. Pass through 
was discarded and DNase digestion was performed on column. Cell lysate was then 
washed one with RW1 buffer before being span for 15 seconds at 10,000 RPM. Samples 
were then washed twice with RPE buffer before being span for 15 seconds and 2 minutes 




respectively at 10,000 RPM. Pass through was discarded each time. Finally, the spin 
column was added to a fresh collection tube and 30μl of RNase free water was added. 
This was then span for 1 minute at 10,000 RPM to collect the purified RNA.  
Purified RNA was either stored at -80oC or was quantified using a Nanodrop and reverse 
transcribed immediately.  
 
2.9.2 mRNA quantification of purified cell model lysates. 
 
mRNA isolated from cell models through RNA easy extraction kits was quantified 
through the use of a Nanodrop spectrophotometer device. 
 
Briefly, 2μl of RNA free H2O was added to the Nanodrop and to allow for a blank to be 
read. 2μl of purified mRNA is then added to the reading pedestal and the top level 
carefully lowered. The droplet is visually checked to be in contact with both the top and 
bottom reading points before mRNA quantification. mRNA levels are read and 
concentration is automatically quantified by the software provided by the manufacturer. 
In addition to mRNA concentrations, 260/280 and 260/230nm reading ratios are 
calculated. Samples were deemed sufficiently contaminant free when 260/280 and 
260/230 ratios were  ≥ 1.8 and ≤ 2.2.  
 
Samples were quantified only immediately prior to reverse transcription and were re-
evaluated after a freeze-thaw cycle. 
 
2.9.3 mRNA reverse transcription into single strand 
complementary DNA 
 
Reverse transcription of known amounts of mRNA was done using the GoScriptTM 
Reverse Transcriptase  Kit from Promega. 500-2000ng of mRNA was added to a single 
reverse transcription reaction. Kit specific amounts of random primer mixes and reverse 
transcriptase were added to the mRNA sample. The mixture was gently mixed and then 




ran on a thermocycler utilising manufacturer stated temperature and time settings using  
the following protocol: 
Reaction buffer is made from constituent kit components by adding 4μl of GoScript™ 
Reaction Buffer, Oligo(dT) to 2μl of GoScript™ Enzyme Mix. Up to 5μg of RNA was 
added to a reaction vessel containing premixed reaction buffer and volume is made up to 
a total of 20μl using Nuclease-Free water. Pipette mix the reaction buffer/ RNA solution. 
Add reaction tubes containing Buffer/ RNA mix into a thermocycler set to the following 
settings: 
 
Step Temperature (oc) Time (Min) No# of cycles 
Anneal Primer 25 5 1 
Extension 42 60 1 
Inactivation 70 15 1 
Hold 4 ∞ 1 
 
2.9.4 cDNA quantification and comparative analysis to 
controls. 
 
cDNA was quantified utilising an SYBR based detection method. For initial optimisation 
of primers (list below) multiple concentrations of cDNA were tested with the most 
appropriate carried forward into testing. Primer efficiency was determined through 
analysis of melt curve dynamics and by plotting concentration curves onto a graph and 
calculating the R2 value. Primer specificity was tested by running qPCR end products 








2.10 Bradford assay assessment of protein abundance 
 
Samples were  lysed directly with MPER lysis buffer (Sigma, UK), scraped and added to 
a 1.5 ml Eppendorf tube before being mechanically homogenised every 5 minutes for 30 
minute using a vortex mixer. Samples were then sonicated for 30 minutes and centrifuged 
for 20 minutes to pellet cell debris. Cell lysates not used immediately were stored at -
80oC until further processing. Total protein concentration of the cell lysates was 
quantified by Bradford assay. Briefly, 5μl of cell lysate was added to a standard clear 
bottom 96 well plate. 195μl of Bradford reagent (Bio-Rad) was added to the wells 
containing the lysed samples. Colour was allowed to develop for at least 10 minutes at 
room temperature on an orbital shaker set to 100rpm. Colour change was assessed on a 
plate reader at 595nm wavelength. Protein levels were quantified against a standard curve 
of known BSA concentrations.  
 
2.11 Quantification of aminopeptidase activity  
 
Aminopeptidase activity was quantified through the catalysation of the cleavage of the 
substrate L-alanine-4-nitroanilide hydrochloride into the breakdown product 4-
nitroaniline. Briefly, 0.5ml of prewarmed 1.5mM of L-alanine-4-nitroanilide 
hydrochloride solution was added to the apical compartment of both Transwell and 3D 
models. These models were then incubated for a period of 1 hour under standard cell 
culture conditions on an orbital shaker set at 100rpm. After 1 hour 100μl of the cleavage 
product was transferred to a well of a clear 96-well plate. All samples were analysed in 
duplicate replicate to assess for intraassay variation and pipetting errors. A standard curve 
was created from a stock solution on 4-nitroanaline to allow for cleavage product 
quantification. Wells were quantified at 405nm using a plate reader and blank values were 
used for sample correction. End data was expressed as activity per cm2/ minute using the 
following equation:  
𝑅𝑎𝑤 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 − 𝐵𝑙𝑎𝑛𝑘 = 𝐵𝑙𝑎𝑛𝑘 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑣𝑎𝑙𝑢𝑒 




Blank reduced value is then used to find the concentration of 4-nitroanaline utilising the 
equation of the standard curve line. 
 
𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 4 − 𝑛𝑖𝑡𝑟𝑜𝑎𝑛𝑎𝑙𝑖𝑛𝑒 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑜𝑑𝑒𝑙
= 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦/𝐶𝑚2 
 
2.12 Standard Caco-2 Transwell experimental set up and 
conditioned media creation and application. 
 
For the creation of Caco-2 Snapwell® (Corning) cultures, 80% confluent flasks of 2D 
grown Caco-2 cells were passaged utilising the standard passaging technique mentioned 
earlier. Caco-2 cells are counted utilising a haemocytometer and Trypan Blue staining 
before being diluted in a 15ml falcon tube (Corning) to a concentration of 250,000 cells 
per 500μl of complete growth medium. 500μl of the cell mixture is added to the apical 
compartment of the Snapwell insert, resulting in a seeding density of 250,000 cells per 
insert or 223,000 cells/cm2. Caco-2 cells were allowed to settle and attach overnight (at 
least 12 hours) before experimental conditions were changed. 
 
Conditioned media was created by incubating complete Caco-2 medium with fibroblast 
cells for a period of 24 hours. 25ml of media was added to a confluent T175 flask of 
fibroblasts at a medium density of 0.143 ml/cm2. After 24 hours of fibroblast media 
conditioning, media was removed from the cells and sterile filtered through a 0.4μm pore 
syringe filter. Before addition to Transwell models, conditioned media was diluted at a 
1:1 ratio with fresh complete DMEM to ensure the media was sufficiently nutritious for 
continued Caco-2 growth and development. Conditioned media was added to Snapwell 
Transwell experiments on day 2 at the first media change post Caco-2 seeding. 
Conditioned media was stored at 2oC for a maximum of 7 days before use. 
 




Caco-2 Transwell models were media changed by careful aspiration of both apical and 
basal compartments before addition of 500μl and 3 ml of fresh media apically and basally 
respectfully. Caco-2 Transwell models were cultured for a minimum period of 21 days 
with media changed on alternative days. Caco-2 Transwell models were used in 
experiments between 21 and 25 days. 
 
2.13 Human tissue processing and staining 
 
Human tissues were obtained both pre-fixed and fresh from Biopta (Glasgow, UK). All 
tissue samples were cut into pieces no larger than 5mm3. Pre-fixed tissue samples were 
processed for paraffin wax embedding following the standard protocol mentioned in 
section 2.3.1 of alcohol dehydration followed by Histoclear and paraffin incubation and 




Culture with conditioned media 
Caco-2 500,000 cells seeded in 500μl suspension 
Overnight to 
attach 
Figure 2.2: Schematic representation of the process for setting up and culturing Transwell 
based intestinal models in control and conditioned media systems 




number of ways. Paraffin, OCT and resin embedding were done following the previously 
mentioned protocols (Sections 2.3.1, 2.3.2 & 2.7). All human tissues were used and 
processed under HTA licence following HTA guidelines.  
 
2.14 Outgrowth of myofibroblast primary cell cultures from 
human tissue sections 
 
Myofibroblast outgrowth was achieved from the culture of human tissue slices in the 
following method. Firstly, Human intestinal tissue was received from Biopta and washed 
twice in sterile PBS containing 3% P/S. The muscular layers of the tissues were carefully 
dissected from the tissue leaving only the epithelium and underlying mucosa. A 6 well 
plate was scored in a grid pattern with a sterile scalpel. The dissected tissue was placed 
onto the scored grid mucosa side down and incubated overnight in FBS containing 
concentrations of 4% Penicillin and Streptomycin (P/S) and gentamycin and amphotericin 
(G/A). After incubation overnight tissue sections were confirmed to be attached to the 
plate through gentle rocking. Tissue sections were incubated in FBS for up to 48 hours to 
allow for attachment. When confirmed to be attached tissue sections were carefully 
submerged in Hams F12 media (Fisher) containing 10% FBS, 4%P/S and 2%G/A. 
Submerged tissues were carefully media changed daily and microscopically checked for 
contaminants (early contamination was generally by bacteria whereby later 
contamination was usually fungal). Cell outgrowth was usually first seen 7-10 days after 
initiation of cell culture.  
 
Cells were passaged by carefully removing tissue sections from the plate and then 
following standard trypsinisation and seeding procedure as described previously. Tissues 
were added back into culture in fresh plates and cultured as described above. Passaged 
cells were cultured in standard DMEM conditions (10%FBS with supplemented L-
glutamine and P/S). Once tissues were no longer viable for cell culture they were disposed 
of through standard human tissue disposal practices as described by the HTA. 
 




2.15 Generation of a 3D intestinal model 
 
The generation of the intestinal model has been optimised for both the 24-well and 96-
well formats of Alvetex Scaffold®. This methods section will detail the process for both 
of the Alvetex® system although it is important to note that the functional model analysis 
was undertaken in the 96 well system. 
 
Firstly, Alvetex® Scaffold® is prepared for the seeding of cells through the submergence 
into 70% ethanol for a period of at least 15 minutes. Scaffold are then wash twice in PBS 
to remove the ethanol prior to the addition of the cells. Fibroblast cells are seeded into the 
Scaffold at the air liquid interface at a density of 250,000 cm2 (192,000 for 24 well, 
~50,000 cells for 96 well model). Fibroblasts are seeded in a volume of prewarmed media 
which is appropriate for the Scaffold size in use ( 24-well = 200μl, 96-well = 25μl). Once 
seeded these cells are left at the air liquid interface (base compartment filled with media) 
for 12 hours (overnight) to allow for complete surface attachment before being submerged 
and cultured submerged for a period of 7 days within the scaffold in an 12-well standard 
culture plate (24-well model) or an Alvetex® Deep well plate (ADW) (96 well model). 
Media is changed every 48 hours for optimal cell feeding (4.5ml in the 24 well format 
and 1.5 ml in the 96 deep well format). After 7 days of initial fibroblast culture further 
seeding of fibroblasts into the models is done twice more at 2 day intervals (day 7 and 9) 
at the same seeding density per cm2 as previously described. At 14 days of total cell 
1. Establish sub-epithelial compartment 
(variable media composition) 
CCD-18co, Multi-seeded, 14 days 
HIC, Multi-seeded, 14 days 
HDFn, Single seeding, 14 days 
14-Days 
2. Caco-2 epithelial culture for 21 days  
(DMEM, 10%FBS, 2mM L-glutamine) 
21-Days 
Figure 2.3: Schematic representation of the process for setting up and culturing Alvetex® 
based intestinal models.  




culture the fibroblast models are seeded with the cellular epithelium of Caco-2 colon 
adenocarcinoma cells (ECACC) at a density of 220,000 cells per cm2. After epithelium 
seeding models are cultured submerged in standard Caco-2 DMEM based media 
(described previously) for a further period of 21-25 days before use in downstream 
analysis. 
 
2.16 Epithelial electrophysical resistance measurements of 
Transwell models of the intestine. 
 
Samples are first washed in pre-warmed sterile PBS before fresh pre-warmed media is 
added to the models. Models are placed into a 37oC incubator and allowed to normalise 
for a period of at least 30 minutes. During this time TEER electrode probes (WPI) were 
first sterilised in 70% ethanol for a period of 5 minutes before being placed in sterile PBS 
to allow for electrode normalisation for 30 minutes before readings are taken by placing 
the electrodes into the model media  (longer probe to the outside of the model) and reading 
the values from the attached EVOM TEER equipment. Models were removed from the 
incubator immediately prior to taking a measurement and were taken as quickly as 
possible in order to limit any variations due to temperature fluctuations. Raw TEER 
measurements are processed to remove blank values which are taken at the same time as 
the non-blank wells through the culture of an insert without cells alongside experimental 
cultures, and then normalised to culture area to give the final value. It is important to 
remember that raw TEER measurements are inversely proportional to the culture area so 
normalisation is achieved through multiplication of culture areas rather than division. 
 
2.17 Statistical analysis of study data 
 
All data analysis achieved in this study was done utilising Prism5 software (GraphPad). 
A standard unpaired students T-test was used where statistical significance was required 
between 2 data sets. Study sets containing greater than 2  data sets were analysed by one-
way ANOVA with Tukeys post-test analysis. ***=p <0.0005, **=p<0.005, *=p<0.05.
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3. Development Transwell co-culture models 
3.1 Introduction 
3.1.1 Caco-2 Transwell, the gold standard for intestinal 
pharmacokinetics. 
The intestine is a highly complex 3D architecture consisting of multiple populations of 
distinct, functionally niche cells with the capability to cross talk with one another, existing 
together in a complex 3D architecture to maintain intestinal homeostasis and function. It 
is well understood that current Caco-2 Transwell models do not recapitulate the 
complexity of the intestinal mucosae; indeed they were never designed too with current 
models only supporting a single cell type within a basic 2D architecture. For the most part 
however, Caco-2 monocultures remain the primary model used within industry due to a 
number of reasons, the most important of which are: 
 
1. Simplicity allows for mass production, 
2. Simplicity allows for highly reproducible data with low inter/intra-assay 
variability. 
3. Less likely for human error in model construction 
 
That isn’t to say that attempts haven’t been made in the past to improve this model. HT29 
and HT29-MTX cell lines were one of the first to be used and have been cultured within 
Caco-2 Transwell models in order to attempt to create a mucous barrier which is present 
in in vivo intestine.(161) Addition of these cells has had some success and is discussd 
further in the following chapter. 
 
3.1.2 Understanding the role of sub-epithelial fibroblasts on the 
homeostasis of the intestinal epithelium.  
The role of the sub-epithelial cell populations in the intestine and similarly the addition 
of myofibroblast cell cultures into the Caco-2 models was, until recently, a poorly 




understood method in which to improve Caco-2 models’ phenotypes. Conventional, 
thinking placed fibroblasts as having limited function in the development and 
maintenance of the epithelium, serving a simple role in ECM secretion and tissue 
structure. Advances in the understanding of stromal-epithelial dynamics indicates the 
sub-epithelial cell layers have significant effects on epithelial growth, barrier integrity, 
repair and cellular differentiation. (162–165) 
 
Sub-epithelial mucosal fibroblasts in the intestine have also been implicated in a number 
of disease phenotypes. Crohn’s disease for example is an inflammatory condition of the 
bowel which ultimately leads to tissue fibrosis with excessive ECM deposition and 
fibroblast activation protein (FAP) expression.(166) inflammatory bowel disease (IBD) 
and ulcerative colitis are similarly related conditions involving excessive tissue fibrosis. 
(167)  
 
3.1.3 Methods for the advancement of model in vivo relevancy. 
In recent decades there has been an increase in the general focus towards tissue 
engineering more complex, tissue mimetic models and the culture of multiple cell lines 
together in both 2D and 3D environments. This has resulted in significant advances in the 
creation of biological tissue models representative of many tissue types within the body, 
such as; Skin, Bone, eye, brain, muscle etc. Skin models, for example, are one of the most 
thoroughly developed and routinely created models of tissue encompassing the full range 
of technologies available. (168–170) Indeed, establishment of continuous keratinocyte 
cultures in vitro and the creation of simple keratinocyte layers for clinical use within 
human patients go as far back as 1975 with the work by Rheinwald and Green (169,171). 
These first Keratinocyte constructs were simple monolayers and were reasonably 
effective for their simplicity. To use skin as another example, epidermis of structurally 
relevant composition can be created utilising modern techniques by simply growing a 
monoculture of keratinocytes on a semi-permeable 2D membrane such as Transwell or 
Millicell. (168) The uses of these models often go beyond simple in vitro models utilised 
within the lab and can be applied to in vivo applications as tissue implants or devices.  
 




In Vitro intestinal models have undergone significant changes and advancement over the 
past decade in order to more accurately recapitulate the full intestinal mucosae rather than 
the simple mono-cell type epithelium of current gold standard industrial models. 
Primarily, work has focussed on the creation of improved intestinal mucosae models 
encapsulating not only the epithelial layer, but also the sub-epithelial fibroblasts 
populations. These have the most relevance in the pharmaceutical industry as test pads 
for the pharmacokinetic and pharmacodynamic properties of novel and pre-clinical drug 
compounds. Whilst the purpose of this study is to improve upon the conventional Caco-
2 system, current simple cellular models of the intestine are already able to drastically 
reduce the reliance of animal models which in the past have been shown to be quite often 
non-physiologically aligned with human ADME phenotypes. (172) Even simple changes 
to current mono-culture models such as the inclusion of goblet cells to create the mucous 
layer (142)or co-culture with myofibroblasts to provide the tissue specific paracrine 
microenvironment (173) could have significant effects on the reliability of simple models.  
 
3.1.4 Understanding the importance of 3D architecture on 
model development.   
In a stepwise increase in model complexity, the provision of a 3D scaffold for the culture 
of cells could provide a more physiological platform of 3D mechano-transduction, 
resulting in improved cellular phenotypes. Even extremely small changes in substrate 
composition such as matrix stiffness can lead to large effects in cellular phenotype such 
as driving EMT in tumour cells (174) and regulating ECM deposition. (175) Dependent 
upon the model created the applications of complex 2D or 3D models are not necessarily 
limited to drug ADME and can range from potential tissue transplants to simple models 
for understanding the cancer dynamics.  
 
A very recent study by Castano et al (176) demonstrated how 3D scaffolds can be 
designed to more accurately mimic the tissue being modelled. Utilising a UV setting 
polymer hydrogel they were able to reliably create villi structures in their 3D scaffold. 
Scaffolds could then be functionalised and cultured with Caco-2 cells. These cells were 
shown to create confluent layers across the full length of the scaffolds 3D architecture. 




Actin viewed by immunofluorescence staining demonstrated a well formed monolayer 
structure with clear apical polarisation of cells. ZO-1 staining was also utilise to display 
the presence of tight junctions between adjacent cells. Interestingly TEER measurement 
of models showed a highly significant reduction in the epithelial resistance of 3D models 
which correlated well with an increase in FITC-dextran 4kDa, a commonly utilised 
marker for trans-cellular passive permeability. This system demonstrates a physiological 
change based on substrate morphology alone. It was hypothesised that this model could 
be further improved by either establishing fibroblast populations within the polymer 
scaffold or through paracrine conditioned media of physiologically important cell lines 
as achieved in this chapter.  
 
It is hoped that the creation of more tissue mimetic models will have the effects of 
lowering the time and cost taken to identify and test potential compounds, savings which 
can be passed onto consumers and allow for greater funding to be allocated to compound 
discovery. This chapter will focus first on the simple modification of conventionally 
cultured Caco-2 models through their culture with the released paracrine factors of human 
















3.2 Hypothesis, aims and objectives 
3.2.1 Hypothesis 
The hypothesis for this chapter was that the co-culture of Caco-2 cells with the paracrine 
influences of fibroblast conditioned media would have significant effects on the 
development and function of the Caco-2 epithelial layer. Furthermore, it is hypothesised 
that fibroblasts from differing origins, (CCD-18co - Intestinal Carcinoma, HIC – Normal 
Intestine, HDFn – Normal skin) would have different mechanistic effects on the Caco-2 
layer and work through a variety of morphogenic pathways. Finally, it is hypothesised 
that KGF is one of the main signalling molecules present in the fibroblast conditioned 
media based on similar experiments in the literature. (137,177) 
 
3.2.2 Aims  
The aims of this chapter were to develop simple co-culture alternatives to the 2D Caco-2 
Transwell cell model, currently the gold standard in the industrial pharmacokinetic testing 
of drugs and novel drug compounds. 
 
Initially, the aim was that Caco-2 models were to be modified through culture of Caco-2 
cells in conditioned media from a variety of sources. Namely, these were: HDFn (Human 
Dermal fibroblasts from neonatal foreskin biopsies), CCD-18co (Non-transformed 
colonic adenocarcinoma cell line) and HIC (Human intestinal cells isolated from normal 
Human small intestine biopsies). All of the above cell lines have been shown to possess 
myofibroblast like properties either in the literature or from in-house testing and as such 
were deemed suitable for conditioned media testing.  
 
The project aimed to characterise 2D Caco-2 models through a number of techniques such 
as immunofluorescence staining and qPCR analysis of key proteins of interest.  
 
The final aim of this chapter is to provide a mechanism of action for some/ all of the 
paracrine medias utilised in the creation of advanced Transwell models. 
 




3.2.3 Objectives  
The objectives of this chapter are summarised below; 
• Characterise the structural and protein expression phenotype of HDFn, CCD-18co 
and HIC cells. 
• Investigate the effects of conditioned media on the structure of Caco-2 cells grown 
on Transwell inserts. 
• Investigate the effects of conditioned media on epithelial resistance and cell 
metabolic rate. 
• Understand the development of tight junctional complexes overtime both in 
control and paracrine fibroblast conditions.  
• Characterise key protein expression in Transwell CCD-18co conditioned media 
through immunofluorescence.  
• Understand the relative abundance of mRNA of key proteins in different media 
conditions 
• Provide evidence of a mechanism of action for the changes seen in Caco-2 






















3.3.1 Immunohistochemical characterisation of intermediate 
filament expression in CCD-18co, HDFn and HIC cells. 
HIC cells were isolated from Human Small intestinal biopsies as previously described 
(Section 2.14). CCD-18co, HDFn and HIC cells were seeded onto the base of 12-well 
plates at a density of 25,000 cells per well. Cells were cultured in standard DMEM 
composition for a period of 5 days before being fixed and stained as described previously 
(Section 2.4.3). Cells were stained for Vimentin, aSMA, Desmin, Actin, Elastin and alpha 
tubulin. Stained cells were imaged on a Zeiss 880 confocal microscope and images 
processed utilising Zen Blue software.  
 
3.3.2 Characterisation of Caco-2 and HT29-MTX in pre and 
post confluency states through immunohistochemistry. 
Caco-2 and HT29-MTX were seeded on the base of 24-well cell culture plates at a density 
of 12,500 cells per well and cultured in a standard DMEM composition for a period of 5 
days for pre-confluency samples and 10 days for post-confluency samples. Samples were 
fixed as described previously (Section 2.4.3) and processed using the standard 
immunostaining protocol (Section 2.4.1). cells were stained for Pan-cytokeratin, 
Occludin, MDR1, MRP2, Actin, vimentin and E-cadherin. After staining samples were 
all imaged on a Zeiss 880 confocal microscope and images processed utilising Zen Blue 
software.  
 
3.3.3 Co-culture model formation 
Caco-2 Transwell models were formed as described in Section 2.12. Briefly, 80% 
confluent flasks of Caco-2 cells were passaged and counted with a haemocytometer. 
Cellular viability was assessed with Trypan blue. 250,000 Caco-2 cells were diluted in 
500μl of pre-warmed DMEM before addition to each Snapwell insert. Caco-2 cells were 
allowed to attached overnight before addition of conditioned media.  





Conditioned media was created as previously described (Section 2.12) with media 
changed ever two days for a minimum of 21 days total culture time. TEER measurements 
were taken every 7 days as described previously (Section 2.16).  
 
After 21 days models were processed for histological characterisation by both 4% PFA 
fixation for paraffin embedding (Section 2.3.1) and methanol: Acetone fixed for OCT 
embedding (Section 2.3.2). 
 
3.3.4 Trans-Epithelial Electrical Resistance (TEER) 
measurement of epithelial layers 
Cell cultures were removed from the incubators and media changed as per normal 
procedure using 37oC prewarmed 10% FBS containing complete medium. Cell cultures 
were returned to the incubator and allowed to equilibrate for at least 30 minutes prior to 
TEER measurement. Measurements of Transwell models were done using the EVOM2 
Voltohmeter with STX2 Chopstick probes. Chopsticks were completely submerged in 
media and allow 5-10 seconds to equilibrate before a measurement was taken. Raw TEER 
measurements were normalised to cell culture area utilising the following equation. 
 
RTISSUE (Ω) = RRAW – RBLANK 
RTISSUE (Ω) α 1/MAREA (cm
2) 
TEERMODEL = RTISSUE (Ω) x MAREA 
[1] TEER measurement techniques for in vitro barrier model systems 
 
3.3.5 MTT assay for the assessment of metabolic function 
Cell layers to be assessed by MTT assay were first washed in sterile PBS twice to remove 
all phenol containing medium and moved to a clean cell culture plate . Thiazolyl Blue 
Tetrazolium Bromide salt was dissolved at a concentration of 1mg/ml into sterile PBS 




and allowed to reach 37oC in a thermostatically controlled water bath for at least 30 
minutes before use. 1ml of Thiazolyl Blue Tetrazolium Bromide solution was added to 
cell layers and incubated in the dark at 37oC in standard cell culture conditions for 1 hour.  
 
After 1-hour cell layers were washed twice in PBS to remove excess Thiazolyl Blue 
Tetrazolium Bromide solution. Cells were lysed and the developed dye was liberated in 
an appropriate amount of acidified isopropanol. Liberation volume was the same for all 
experiments where a direct comparison between conditions was made. Solution intensity 
was then quantified on a plate reader at 450nm. 
 
3.3.6 Assessment of conditioned media and KGF on the 
metabolic activity of Caco-2 epithelial cells.  
For conditioned media and KGF spiked media assays, Caco-2 cells were seeded into 12-
well plates at a density of 2.86x103 cells per cm2 (~10,000 cells/ well) and allowed to 
attach in complete Caco-2 DMEM culture media for a period of 2 days before the addition 
of conditioned/ spiked media. MTT assays were performed as described in section 3.2.5 
on wells every 48 hours to assess for changes in cellular metabolism up to a maximum of 
14 days. MTT values were normalised to the protein concentration of a sister well, set up 
at the same time as the analysis well and assessed through use of a Bradford assay 
(protocol as previously described in Section 2.10). 
 
3.3.7 Assessment of tight junction formation in conditioned 
media treated cellular layers through immunostaining of the 
tight junction protein Occludin.  
Control and conditioned media wells were set up at a density of 10,000 cells per well as 
previously described in 12-well plates (Section 3.2.6). Samples were fixed by Methanol: 
Acetone fixation (Section 2.3.2) every 2 days for a total of 10 days (5 samples). Occludin 
was stained utilising normal immunostaining techniques (Section 2.4.3) with Occludin 




diluted at manufacturer recommended levels. Samples were imaged utilising a Zeiss 880 
confocal microscope and images were processed utilising Zen Blue software.  
 
3.2.8 Immunostaining of wholemount Transwell models 
Transwell models were set up as described in section 2.12 and cultured for a minimum of 
21 days. Transwell models were fixed and immunostained following the previously 
described protocol (Section 2.4.3) 
 
3.3.9 qPCR analysis of Transwell model lysates 
Transwell models were set up and cultured as previously described (Section 2.12) for a 
total of 7, 14 and 21 days to understand the development of Caco-2 Transwell layers over 
time in culture. Section 2.9 describes the basic protocol for the isolation of mRNA from 
cell and tissue samples. Specifically, Transwell Snapwell models were removed from 
culture and washed twice gently in room temperature PBS. Snapwell models were 
removed from the outer support and placed into clean 6 well plates. 500μl of ice cold RLT 
buffer was added to the apical side of the cells model. A pipette tip was used to scrape 
the surface of the Transwell to remove all of the cellular material. Scraped material was 
them placed into 500μl Eppendorf vials and placed on ice for further processing. The 
remaining protocol is identical as to what is described in Section 2.9. 
 
3.3.10 Aminopeptidase quantification of Transwell models 
compared to 3D cultures. 
Conditioned media, KGF spiked Snapwell Transwell models and 3D Alvetex models 
were created as specified in sections 2.12 and 2.15 respectively. Aminopeptidase activity 
quantification assay was performed as described in section 2.11. 




3.3.11 Keratinocyte growth factor (KGF) conditioned media 
experiments in Snapwell format inserts. 
Snapwell Caco-2 models are set up as previously describes (Section 2.12) and allowed to 
grow under normal conditions for a period of 48 hours in order to allow for normal 
cellular attachment to the Snapwell surface. KGF (PeproTech) is reconstituted in sterile 
PBS and nominally stored at -20oC before use. KGF is spiked into freshly prepared, 
prewarmed complete DMEM medium at an experimental dependant concentration. 
Snapwell cultures are then grown normally up to a total culture time of 21-25 days with 
KFG spiked medium changed every 48 hours.  
 
Processing of Transwell Snapwell layers for histological structural analysis was done as 
described in sections 2.3.1 and 2.3.2 for paraffin and OCT embedding procedures 
respectively. Wholemount Immunostaining of KGF spiked samples was processed as 
previously described (Section 2.4.3) 
 
3.3.12 MTT assessment of KGF treated Caco-2 layers. 
Caco-2 layers were set up as described in Section 3.2.6. KGF treatment was started 48 
hours after initial seeding with variable concentration of KGF added to different cellular 
conditions. MTT assay assessment of metabolic activity of treated cell layers was 
achieved as previously described (Section 3.2.5). 
 
3.3.13 Assessment of tight junction formation in KGF treated 
cell layers through immunostaining of the tight junction 
protein Occludin. 
Control and KGF treated wells were set up at a density of 10,000 cells per well as 
previously described in 12-well plates (Section 3.2.6 and 3.2.7). Samples were fixed by 
Methanol: Acetone fixation (Section 2.3.2) every 2 days for a total of 10 days (5 samples). 




Occludin was stained utilising normal immunostaining techniques (Section 2.4.3) with 
Occludin diluted at manufacturer recommended levels. Samples were imaged utilising a 
Zeiss 880 confocal microscope and images were processed utilising Zen Blue software.  
 
3.3.14 ELISA quantification of KGF abundance in conditioned 
media samples. 
CCD-18co, HDFn and HIC fibroblasts were seeded at a density of 50,000 cells per either 
6-well plate or 96-well (deep dish) format Alvetex Scaffold® insert. Cells were allowed 
to grow for a period of one week before the addition of Caco-2 conditioned media (As 
described previously) to “treated” wells or fresh DMEM to control wells. Media was 
changed every 2 days throughout the culture time. After a further 7 days of culture (14 
days culture total) 1.5 ml of fresh DMEM was added to all samples and cultured under 
normal conditions for 24 hours. After 24 hours 1 ml of media was removed from each 
condition and placed in a sterile deep dish plate following the preestablished assay plate 
map. Conditioned media samples were places at 2-8oC for no longer than one hour before 
being used in the ELISA assay.  
 
2D cell layers and 3D models were placed in RLT DNA/RNA lysis buffer (Qiagen). 3D 
models were fully lysed, with lysate stored at -80oC before analysis. 
 
ELISA kit for KGF quantification was purchased from R&D systems. The assay was run 
following the manufacturers guidelines.  
 
Briefly; 
Standards curve was created and 100μl Assay diluent added to each well of the plate. 
100μl of standard, sample or control was added to each well (200μl well volume total). 
Plate was incubated at room temperature for 3 hours. Plate was taped dry and washed 4 
times in assay wash buffer.n200μl of KGF conjugate was added to each well and 
incubated for a total of 1.75 hours. Repeat step 3. 200μl of substrate solution was added 
and incubated in the dark for 30 minutes. 50ul of stop solution was added and the plate 




was gently mixed (100rpm rotating plate) for 5 minutes in the dark. Plate was read at 
450nm with 570nm correction. 
 
3.3.15 DNA concentration quantification for KGF ELISA 
normalisation 
DNA lysates stored at -80oC (Section 3.2.12) were thawed and vortexed 5 x 30 seconds 
to ensure complete cell lysis and DNA dissolution. 
 
DNA quantification was performed utilising a DNA quantitation kit (Sigma).  
Briefly: 
Contents were thawed and DNA standard was incubated at 50oC for 30 minutes. 100μg 
DNA stock was created in MG H2O.  2μg/ml bisBenzimide H 33258 solution was created 
in MG H2O and 190μl of solution added to each assay well of a flat bottom 96 well 
plate.10μl of standard, sample and blank was pipetted in to relative wells in duplicate. 
Plate was read at 360nm excitation and 460nm emission at room temperature.  
 
3.3.16 Transport assays utilising the Ussing chamber system 
for Transwell and Alvetex Lucifer Yellow permeability assays 
Transport studies were conducted utilising a standard Ussing chamber set up (WPI, UK) 
with the chamber insert determined by the model/ tissue being tested. The general 
protocol for the experiments follows routinely utilised procedures. Transport buffer 
consisted on Hanks buffered saline solutions, (HBSS) (Sigma , UK) pH 7.4 with 2mM 
supplementary glucose. Stock solutions of all drug compounds were dissolved in a 
substance specific vehicle, usually DMSO, Ethanol or dH2O, before being added to the 
HBSS.  
 
2D Transwell conditioned media models to be tested were carefully removed from 
culture, washed twice in PBS and added into the Ussing chamber system. A CHM5 
chamber from WPI was used for all Snapwell culture experiments.  
 




3D models were all cultured in the 96 well format for Ussing chamber analysis (detailed 
further in chapter 7). Models were carefully snipped from the strip holder after washing 
before being added to the custom made Ussing chamber systems. A small amount of 
plastic supports were left attached to the model to allow for a snug fit within the chamber 
when the opposite ends are sandwiched together.  TEER measurements were taken both 
immediately before addition to the chamber and at the end of the experiment. 
  
15ml of 37oC prewarmed HBSS was carefully added to both the apical and basal sides of 
the chamber system simultaneously utilising 50ml syringes fitted with 2mm capillary 
tubing. Transport media was kept at 37oC throughout the experimental period through use 
of a circulating heated water jacket. Transport media was mixed and oxygenated utilising 
a bubble lift of 95% Oxygen and 5% CO2 (BOC, UK). Models were allowed to 
acclimatise to the assay system for a minimum of 30 minutes before t=0.  
 
Drug compounds were spiked into the Ussing chamber at T=0. Timepoints were taken 
every 30 or 60 minutes by removal and replacement of transport media directly from the 
test chamber, either the apical or basal side. Lucifer yellow was run alongside test 
compounds when pertinent as an additional measure of barrier integrity throughout the 
experimental procedure. Compound concentration within the transport medium was 
assessed through use of either the compounds fluorescent properties and a 
spectrophotometer or through detection with HPLC equipment. 
 
The apparent permeability (Papp) of the models was calculated utilising the following 
equation; 
𝑃𝑎𝑝𝑝 =  
𝑉𝑅 ∗  𝑑𝐶𝑅
𝑑𝑡 ∗ 𝐴 ∗ 𝐶𝐷0
 
 
Whereby VR is the volume of the receiver compartment dCR/dt is the change in the analyte 
concentration of the receiver compartment over time, A is the area of the transport 
interface and CD0 is the concentration of the donor compartment at time zero. Papp values 
show in this thesis are converted into reasonable number for comparison by amplifying 




the Papp value by 1x106. This amplification step is not technically necessary but is 
standard procedure for the reporting of Papp values throughout the literature.  
 
3.3.17 qPCR analysis of conditioned media and KGF spiked 
Caco-2 2D layers. 
Caco-2 cells were passaged and counted utilising the normal protocol as described 
previously (Section 2.2.1). Cells were then seeded into T25 flasks at a density of 50,000 
cells per flask. n=1 of each condition was set up with replicates cultured at weekly 
intervals from a separate bank of parental Caco-2 cells. Cell layers were cultured for a 
period of 21 days to allow for full differentiation prior to lysing and analysis.  Cells were 
lysed and processed utilising the standard Qiagen miniRNA kit, as described previously 
(Sections 2.9). Analysis was achieved with a SYBR based detection system, as described 
previously (Section 2.9.4) along with complementary primers to sequences of interest.  
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3.4 Results  
3.4.1 Morphological characterisation of stromal and epithelial 
cell lines. 
All cell lines utilised within this study were first cultured in conventional 2D cell culture 
techniques on cell treated culture plates and flasks. Figure 3.1 & 3.2 shows the 
morphological characteristics of the cell lines utilised within this study, The commercially 
available stromal cell lines namely the CCD-18co and HDFn (Figure 3.1 A-B, E-F) lines 
exhibit a stellate morphology without defined cellular junctions, classical of fibroblast 
and myofibroblast phenotypes. Cellular size at low passage is similar between the two 
cell lines with similar growth patterns in conventional 2D culture. The HIC (Human 
intestinal cells) cells (Figure 3.1 C-D) utilised here were isolated from human small 
intestine tissue explants (Biopta, Glasgow, UK as detailed in section 2.14). These cells 
have the same structural similarities to the commercially available cells with a noticeable 
stellate morphology and lack of cellular junctions. 
Contrastingly, the epithelial cell lines utilised here, Caco-2 and HT29-MTX (Figure 3.2 
A-D) exhibit a flattened continuous monolayer of cells with clear cellular junctions and 
a “cobblestone” morphology of growth. When cultured at low confluency these cells grow 
in colonies, staying in contact with each other rather than growing independently as seen 
in fibroblast cell populations. The HT29-MTX cells grow similarly to Caco-2 cells in 
culture with close cellular positioning, forming confluent monolayers of cobblestone 
patterned cells. Structurally, when grown in 2D HT29-MTX cells are smaller than Caco-
2 cells and form more densely packed formations. 
 
3.4.2 Immunostaining characterisation of myofibroblasts for 
characteristic cytoskeletal markers.  
CCD-18co, HDFn and HIC cells were all shown to be positive for the type II intermediate 
filament protein Vimentin (Figure 3.3 A, G & M). This cytoskeletal protein is found 
throughout all mesenchymal cells and as such is used as a positive control and as a 




determiner of cellular structure. All fibroblasts cell types show similar stellate formations 
and strong staining throughout the cellular cytoplasm. Alpha smooth muscle actin 
(αSMA) is used as a designator of myofibroblast morphology (Figure 3.3 B, H & N). As 
with Vimentin, CCD-18co, HDFn and HIC cells all were shown to positively express this 
protein. The intestinal cell lines CCD-18co and HIC both appear to express α-SMA at a 
significantly higher rate than HDFn cells which stained with a much lesser intensity. 
Desmin is a muscle specific type II intermediate protein, of which none of the cell lines 
tested were positive for this muscle lineage marker (Figure 3.3 C, I & O). Additionally, 
all cells were shown to be weakly positive for actin, a key component of the cellular 
cytoskeleton (Figure 3.3 D, J & P).  No significant elastin staining was seen in any of the 
cell lines tested (Figure 3.3 E, K & Q). All cell lines were positively stained for 
microtubule protein Tubulin (Figure 3.3 F, L & R). HDFn cells were stained 
homogenously with strong expression seen throughout all of the cells. CCD-18co and 
HIC cells were all positively stained for tubulin however staining was seen to be less 
homogenous. All staining was done in the presence of a negative control (not shown)














Figure 3.1: Fibroblasts from differing origins are indistinguishable morphologically by phase contrast microscopy – Representative phase 
contrast images of stromal cells utilised within this thesis. Stromal lines, CCD-18co, colonic fibroblast, Primary human small intestinal cells (HIC), 
HDFn, Human dermal fibroblasts. All cells exhibit a classical fibroblast morphology under phase contrast microscopy with a large stellate phenotype.  
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Figure 3.2: Epithelial cells grow in densely packed “cobble stone” colony formations – 
Representative phase contrast imaged of epithelial cells utilised within this thesis. Epithelial 
lines, Caco-2, colonic epithelial, HT29-MTX, a colonic HT29 cell lineage treated with 
methotrexate. Panel D is a magnified image of panel C. Panels A and B are unrelated. Images 































Figure 3.3: Lineage specific intermediate filament expression analysis in 2D shows similar expression patterns between the three cell lineages.  – A-F) CCD-
18co colonic carcinoma cells, G-L) HDFn dermal skin fibroblasts, M-R) HIC primary small intestinal cell. Blue staining represents cellular nuclei (DAPI), Green colour 
represents positive staining. All cells are positive for the general fibroblast lineage markers such a Vimentin, Alpha-SMA and Pan-Tubulin. Desmin is a stain specific 
to muscle lineages, as such no staining expression is expected. All staining was done alongside a negative control (See appendix). Images are representative of N=3 
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3.4.3 Analysis of the changing characteristics of Caco-2 cells in 
pre and post confluency states. 
The Caco-2 cell lines was characterised by immunofluorescence for key proteins of 
interest in both pre-confluency and post confluency 2D cultured samples. 
 
Pan-cytokeratin (Figure 3.4 A&E) is an intermediate filament protein found specifically 
within cells of epithelial origin. Pan-cytokeratin was used as both a marker of cellular 
structure and as a positive control.  Caco-2 cells were shown to be strongly positive of 
pan-cytokeratin in both pre and post-confluency states with no obvious difference in 
staining intensity noticed between samples.  Occludin (Figure 3.4 B & F) was used as a 
marker of tight junction expression within the cell populations. Caco-2 cells were shown 
to be weakly positive for Occludin when in pre-confluency and strongly positive when 
post confluence.  MRP2 and MDR1 (Figure 3.4 C&G, D & H respectively) are both ATP-
binding cassette proteins belonging to sub-families C and B respectively. These proteins 
are expressed at a low rate when cells are pre-confluent with increasing expression as the 
cells differentiate when they reach confluency.  Low levels of Actin (Figure 3.5 A, D) 
expression was seen in both pre and post-confluency Caco-2 samples.  Vimentin (Figure 
3.5 B, E) was used as the negative control to show that cells were not of mesenchymal 
origin.  Both pre and post-confluency states were negative for Vimentin.  Finally, E-
cadherin (Figure 3.5 C, F) was used as a marker of Adherens junctions. E-cadherin was 
shown to be expressed similarly to Occludin whereby low levels of  non- homogenous E-
cadherin staining was observed in the pre-confluency state whereby when post-confluent 
the cells express E-cadherin significantly more strongly throughout the sample. 

















Figure 3.4: Post-confluent Caco-2 cells express heightened levels of junctional marker, Occludin and surface efflux protein, MDR1 – Characterisation of Pre-
confluency Caco-2 stained images, A) Cyto-Keratin, B) Occludin, C) MRP2, D) MDR1. Post-confluency Caco-2 stained images E) Cytokeratin, F) Occludin, G) MRP2, 
H) MDR1. Post confluency cells express all markers at significant levels. MDR1 specifically is an efflux transporter protein important in the efflux of drug compounds 
from the cell back into the intestinal lumen. MDR1 is known to be over expressed in Caco-2 cells All staining was done alongside a negative control (See appendix). 
Images are representative of N=3 staining Scale: 200μm 
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Figure 3.5: Caco-2 cells are negative for Vimentin and E-cadherin staining remains proportional in pre and post-confluency states – 
Characterisation of Pre-confluency Caco-2 stained images, A) Actin, B) Vimentin, C) E-cadherin. Post-confluency Caco-2 stained images D) Actin, 
E) Vimentin, F) E-cadherin. Lack of Vimentin expression shows these cells are not of mesenchymal origin All staining was done alongside a negative 
control (See appendix). Images are representative of N=3 staining Scale: 200μm 
 Scale bar: 200μm 




3.4.4 Understanding the effects of confluency on the 
differentiation of HT29-MTX cells in 2D culture. 
HT29-MTX cells were cultured on standard tissue plastic and immunostained as 
described previously (Section 2.4.3). HT29-MTX cells were stained for key proteins of 
interest in both pre and post confluency states.  
 
Cyto-keratin (Figure 3.6  A, E) was expressed throughout both pre and post-confluency 
states as a marker of epithelial intermediate filaments. Occludin (Figure 3.6 B, F) shows 
a very low expression rate in the pre-confluency state with very little non-homogenous 
positive staining seen in the sample. The post-confluency state shows a significantly 
higher rate of staining throughout the samples however expression of Occludin was non-
homogenous between the cells.  HT29-MTX was negative for MRP2 (Figure 3.6 C, G) 
with no positive staining seen in either the pre or post-confluency samples. MDR1 (Figure 
3.6 D, H) staining was seen at a high rate in both pre and post-confluency states with no 
noticeable difference in expression in confluent samples. This is out of character for 
HT29-MTX cells as they are generally through to lack most enterocyte properties. 
Additionally, the staining seen in these samples compared to Caco-2 (Figure 3.4) is far 
less defined. It was hypothesised that positive staining seen here is most probably a 
consequence of membrane bound mucins sequestering the primary antibody. Actin 
(Figure 3.7 A, C) was not expressed at high rates in either of the samples. Vimentin 
(Figure 3.7 B, D) was not expressed in the pre-confluency state but some weak staining 
was seen when the cells were post-confluence. E-cadherin staining (Figure 3.7 C, F) was 
seen in both pre and post confluency states. Strong staining indicates continuous 
expression of adherens junctions between the cells, a hall mark of differentiated epithelial 
cells. 








Figure 3.6: Immunofluorescent characterisation of 2D epithelial cells Pre and Post-confluency shows increasing differentiation expression with time in culture – 
Characterisation of Pre-confluency HT29-MTX stained images, A) Cyto-Keratin, B) Occludin, C) MRP2, D) MDR1. Post-confluency HT29-MTX stained images E) 
Cytokeratin, F) Occludin, G) MRP2, H) MDR1. Interestingly, HT29-MTX cells appear to also highly express MDR1. This is unusual due to HT29-MTX supposed function as 
a goblet cell lineage. However, due to HT29-MTX’s epithelial origins some left over epithelial characteristics could be possible All staining was done alongside a negative 
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Figure 3.7: Immunofluorescent characterisation of 2D epithelial cells Pre and Post-confluency – Characterisation of Pre-
confluency HT29-MTX stained images, A) Actin, B) Vimentin, C) E-cadherin. Post-confluency HT29-MTX stained images 
D) Actin, E) Vimentin, F) E-cadherin. All staining was done alongside a negative control (See appendix). Images are 
representative of N=3 staining Scale: 200μm 
Scale bar: 200μm 




 A) Control B) CCD-18co 
C) HDFn D) HIC 
Figure 3.8: H&E stained comparison of Caco-2 conditioned media co-culture models shows consistent monolayer formation in each of the model conditions. Cells 
are clearly able to differentiate and polarise in conditioned media at differential rates than in Control conditions – Snapwell Transwell samples were fixed in 4% PFA 
and embedded into wax before being sectioned at 7μm and stained with Haematoxylin and Eosin to differentiate between nuclei and cytoplasm. A) Caco-2 control, B) Caco-
2/ CCD-18co, C) Caco-2/ HDFn, D) Caco-2/ HIC. Addition of conditioned media to the Caco-2 epithelial equivalents appears to induce significant changes in cellular 
morphology when compared to control layers. HIC conditioned media specifically shows a highly regular structure with basally located nuclei, suggesting enhanced cellular 
differentiation. E) Shows a schematic of the process for the creation and culture of conditioned media Transwell models. Media is conditioned in 2D flasks on top of fibroblast 
cells for a period of 24 hours before being filtered and mixed in a 50:50 ratio with fresh culture medium before application to Transwell models. Images are representative 
of a minimum of 3 repeats. Scale = 100μm 
Fibroblasts 
E) Schematic of 
conditioned media set up  
Filter 
Conditioned media 




3.4.5 Paracrine conditioned media has differential effects on 
epithelium development dependant on the origin of the 
fibroblasts. 
Caco-2 cells were cultured on Snapwell Transwell for a period of 21 days in the presence 
of conditioned media from the CCD-18co, HDFn and HIC fibroblast cell lines. 
Histologically it could be observed that samples were homogenous along their entire 
length. Caco-2 control (Figure 3.8 A) samples showed a polarised yet flattened 
morphology similar to that seen in cells grown in similar 2D culture systems.  
 
CCD-18co conditioned media (Figure 3.8 B) resulted in a slightly improved structural 
morphology over Caco-2 controls with increased cell height and basally located nuclei. 
Cells under high magnification could be seen to develop microvilli structures indicating 
cellular differentiation within the models. HDFn conditioned media (Figure 3.8 C) 
showed a drastically different morphology than that seen in the control samples. Cells 
were significantly taller with some cellular multilayering across the samples. HIC 
conditioned media (Figure 3.8 D) models were similar in histology to those gained in 
CCD-18co conditioned media experiments with a heightened cellular morphology and 
basally located nuclei with continuous brush border development apparent when viewed 
under light microscopy.  





Figure 3.9: 7, 14 & 21 day TEER measurements of Caco-2 cells on Transwell Snapwell in control 
and conditioned media experiments shows that addition of conditioned media to the Caco-2 cellular 
layers results in a variable decrease in TEER values compared to control layers – Caco-2 cells were 
grown on Snapwell Transwell inserts and were co-cultured in conditioned media from CCD-18co, HIC or 
HDFn cells. A) 7 Day, B) 14 Day, C) 21 Day comparative TEER measurement between culture conditions. 
D) 21 day line graph showing the development of the Caco-2 layers over the course of the experiment. All 
cellular layers showed increased TEER values over time with the highest TEER values per model being 




7 Days 14 Days 21 Days 
Caco-2 vs CCD-18co *** Caco-2 vs CCD-18co *** Caco-2 vs CCD-18co *** 
Caco-2 vs HIC ns Caco-2 vs HIC * Caco-2 vs HIC ** 
Caco-2 vs HDFn *** Caco-2 vs HDFn *** Caco-2 vs HDFn *** 
CCD-18co vs HIC ns CCD-18co vs HIC ** CCD-18co vs HIC *** 
CCD-18co vs HDFn ns CCD-18co vs HDFn ns CCD-18co vs HDFn ns 
HIC vs HDFn ns HIC vs HDFn ** HIC vs HDFn *** 
Table 3.1 Statistical analysis of Transwell model TEER measurements: One way ANOVA with 
Tukeys post-test analysis was used to calculate significacy between v n=3, N=3 
 
 




3.4.6 Trans-epithelial resistance is shown to decrease in the 
presence of conditioned media from all origins with a variable 
degree of response. 
The effects of paracrine media culture on the membrane integrity of Caco-2 monolayers 
was assessed utilising the commonly used TEER measurement system. All tested cultures 
demonstrate an increase in epithelial resistance values over the course of the 21 day 
culture period. Control models show the sharpest increases between Day 0 and 7 up to a 
resistance of approximately 1000-1500 ohms (Figure 3.9 D). This initial sharp rise in 
resistance measurements is followed by an increasingly slower rise in TEER values up to 
day 21 when resistance values are shown to have plateaued, with maximum TEER values 
seen of up to 2000 Ohms. 
 
In contrast to this in all instances the co-culture of Caco-2 cells with the paracrine media 
of CCD-18co, HDFn and HIC fibroblasts results in the decrease in the TEER values of 
the epithelial monolayer compared to control epithelial resistance values. HIC co-culture 
epithelial models show the smallest, yet still significant, attenuation of TEER values 
compared to control models. In contrast to control samples which showed an initial rapid 
increase in TEER values, HIC conditioned media treated Caco-2 cells show a shallow, 
almost linear increase in TEER values between the 0 and 14 day timepoints.  Around day 
14 a small attenuation in the gradient of the TEER curve indicated the beginnings of a 
plateau up to day 21. Statistical analysis of the Caco-2/ HIC cultures shows that the lines 
are non-significantly different  (Figure 3.9 A,B) until the 14 days timepoint (Figure 3.9 
C) whereby a significant decrease in the maximum TEER value of the epithelial 
membrane is seen with a maximum value at 21 days of around 1700 ohms.  
 
CCD-18co and HDFn co-culture epithelial layers are almost indistinguishable  from one 
another over the course of the 21 day co-culture (Figure 3.9 D). Statistically, CCD-18co 
and HDFn co-cultures are significantly lower than the control samples from the day 7 
timepoint onwards until the terminal 21 day values of around 500 Ohms. Similarly to HIC 
co-culture layers, HDFn cells show an almost constant linear increase in TEER values up 
to 21 days. CCD-18co co-cultures show an initial sharp increase in TEER between the 0 




and 7 day timepoints. This increase is shown to plateau after day 7 with a shallower linear 
increase up to day 21.   
 
3.4.7 MTT metabolic measurements of Caco-2 2D paracrine 
co-culture models shows CCD-18co conditioned media 
increases the metabolic activity of Caco-2 cells at later 
timepoints be delaying lag phase onset. 
Due to the significant changes seen in the epithelial TEER values when co-cultured with 
fibroblast conditioned media the logical next question was to assess whether these 
changes in barrier resistance were due to physiological changes in membrane phenotype 
rather than due to induced necrosis or apoptosis.  
 
Figure 3.10 A-D shows the comparative MTT values of 2D Caco-2 cells grown in control 
and conditioned media environments. HIC and HDFn (Figure 3.10 B,C) MTT curves 
follow the same approximate trend with an initial lag phase followed by an exponential 
phase of growth , ending with a plateau of MTT values by day 10. Contrastingly, control 
samples reach a maximal MTT value at day 8 which decreases at day 10. In HDFn and 
HIC instances there is no significant differences seen in MTT value at the day 10 
timepoint when compared to the control samples (Table 3.2).  CCD-18co conditioned 
media (Figure 3.10 A) samples show a similar increase in MTT values as the control up 
until day 6 whereby the rate of increase is lower than that of the control until day 8. 
Whereas, by day 10 the control, HDFn and HIC samples have reached plateau the CCD-
18co samples show a linear rate of growth past the day 10 timepoint.













Figure 3.10: The effects of fibroblast conditioned media on the MTT values of 2D cultured Caco-2 cells shows that CCD-18co 
paracrine influences have the most effect on Caco-2 cells with a continuation of growth up to 10 days in culture – Cell viability was 
assessed by MTT assay of 2D cells at set time points. All cell lines were shown to have effects on the metabolic activity of the Caco-2 cells, 
shifting the classical growth curve to the right, delaying the onset of the lag and death phases. CCD-18co conditioned media appears to delay 
the onset of the lag phase significantly more in comparison to other conditions.  Data is from at least 3 different experiments,  n=3. N=3 Scale 
bars represent ±SEM. 
A) B) 
C) D) 












4 ns ns ns 
6 ns * ns 
8 * ns ns 
10 ** ns ns 
A) Day 4 B) Day 6 C) Day 8 D) Day 10 
Figure 3.11: Time-point comparison of all conditioned media conditions – Control and 
conditioned media Caco-2 cells were assessed for metabolic activity by MTT assay. A) Day 4, 
B ) Day 6, C) Day 8, D) Day 10. Values represent means + SEM. All experiments n=3 N=3.  
 
Table 3.2: Significances of conditioned media MTT data – 
All comparative significances were tested by one way 
ANOVA with Tukeys post-test analysis of variance ***=p 
<0.0005, **=p<0.005, *=p<0.05 
 




3.4.8 Understanding the differential development of tight 
junction formation in Caco-2 cells treated with fibroblast 
conditioned media.  
The formation of tight junctions in Caco-2 monolayers was assessed through the staining 
of Occludin, a tight junctional component protein found in the membrane and inter-
membranal space between epithelial cells.  
 
Figure 3.12 shows that regardless of cellular confluency Occludin was expressed as early 
as day 2, weakly in cells with no other cellular contacts and more strongly in cells 
localised into small groups or colonies in all conditions tested. Initially, the staining 
appears to be patchy with non-continuous staining along the apical surface of the cellular 
membranes when cells are adjacent to the membranes of other cells. Furthermore, earlier 
timepoint samples appear to have significantly more intracellular/ cytoplasmic staining 
of the occludin than in later samples where the occludin appears to be more localised to 
the membranes. The cells in the immunostained samples appear to be larger in apparent 
size when at lower confluency and pack together more tightly as the cells mature and 
begin to differentiate. Immunologically there are no significant differences seen in the 
Occludin staining either in localisation or strength between the different paracrine models 
up to day 6. After day 6 the intensity of the stained samples seemingly increases in the 
conditioned media examples compared to the control although this observation was not 
quantified. Additionally, control cells show a homogenous cell size phenotype up to day 
8 in culture with a classic cobblestone pattern seen throughout the samples. Conditioned 
media stained samples appear to be more heterogenous in morphology earlier in the 










































Figure 3.12: Tight junction expression between conditioned media conditions shows increased cellular 
packing in conditioned media samples – Control and conditioned media treated Caco-2 cells were cultured 
on 2D plastic for a varying number of days before fixation and staining for the tight junction protein Occludin. 
Staining intensity appears to increase in conditioned media models at day 10, especially in HIC models which 
appear to be more consistently, strongly stained with more cells packed into the same area. Images are 
representative of N=3. Scale = 200μm 































3.4.9 Immunostaining of cells grown in Snapwell Transwell and 
CCD-18co effects on functional differentiation of Caco-2 cells 
with regards to P-gp expression and brush border formation. 
Figure 3.13 A & E, shows the staining of E-cadherin of Caco-2 cells grown on the 
permeable membrane Snapwell Transwell. Positive E-cadherin staining is localised to the 
membranes of the cells with homogeneity throughout the samples (Figure 3.13 A). The 
transverse sectioned sections (Figure 3.13 E) of E-cadherin shows primary baso and 
lateral staining localisation. Contrastingly, Figure 3.14 (A & E) shows the comparative 
E-cadherin staining of Caco-2 Snapwell Transwell cultures grown in the paracrine CCD-
18co conditioned media. Staining for E-cadherins shows significant changes in both 
staining intensity and in cellular structure with a far more heterogenous cell morphology 
throughout the samples. Transverse sections of these samples (Figure 3.14 E) shows 
significantly less cellular organisation with positive staining seen apically in addition to 
laterally and basally.  
 
Similarly, Occludin staining of control (Figure 3.13 B & F) and CCD-18co conditioned 
media (3.14 B & F) samples shows much the same pattern with less structural 
homogeneity seen in the conditioned media samples. 
 
P-gp/ MDR1 staining of Control samples (3.13 C & G) shows a heterogenic pattern of 
expression with areas of high intensity and low intensity staining observed. Transverse 
sections of high density areas of staining (Figure 3.13 G) shows localisation of primary 
staining to the apical boundary of the cells. P-gp/MDR1 staining of CCD-18co 
conditioned media treated samples (Figure 3.14 C & G) shows significantly less positive 
staining of P-gp throughout the sample. Transverse sections of high intensity stained areas 
(Figure 3.14 G) shows a similar pattern to that seen in other stained targets with 
significantly different structural organisation of the positive staining. However, the CCD-
18co conditioned samples still maintain the strong apical expression expected of this 
protein.  
 




Control samples stained for actin expression (Figure 3.13 D & H) show clear positive 
staining throughout the surface of the sample (Figure 3.13 D) with clear microvilli 
staining seen under high magnification. Figure 3.13 H shows the transverse section of the 
control sample showing staining primarily located to the actin rich brush border layer and 
to the junctional complexes in the lateral membranes of the cells. Similarly, CCD-18co 
conditioned media treated samples show consistent staining across the entire surface layer 
of the models (Figure 3.14 D). Transverse sections (3.14, H) of the models show strong 
positive staining at the actin rich brush border layer but significantly less staining across 
the lateral membrane when compared to the control samples.  
 





A) B) C) D) 
E) F) G) H) 
A) B) C) D) 
Figure 3.13: Caco-2 control models appear to be well differentiated through expression of key proteins for model differentiation and function – 
Representative stained images of Methanol: Acetone fixed Caco-2 cells for A&E) E-cadherin, B&F) Occludin, C&G) P-gp, D&H) Actin. Scale = 50μm for 
wholemount and sectioned images. Images are representative of N=3. 






Figure 3.14: Caco-2 cells grown in CCD-18co conditioned paracrine media shows differences in the cellular organisation as analysed through expression 
of key proteins for model function – Representative stained images of Methanol:Acetone fixed Caco-2 cells co-cultured with CCD-18co conditioned media for 
A&E ) E-cadherin, B&F) Occludin, C&G) P-gp, D&H) Actin. Both A and B show junctional proteins outlining the periphery of cells. Compared to control layers 
significant differences can be seen in cellular organisation with less homogenous structures seen in conditioned media treated epithelial constructs. Scale = 50μm 
for wholemount and sectioned images. Images are representative of N=3. 
 
 
A) B) C) D) 
E) F) G) H) 




3.4.10 qPCR analysis of the development of Caco-2 layers in 
relation to key targets of function and the effects of CCD-18co 
paracrine media on Caco-2 layer development.  
Figure 3.15 shows the qPCR results of Caco-2 monolayers cultured on Snapwell 
Transwell taken at 7 ,14 and 21 day time intervals with and without the addition of CCD-
18co conditioned media. Figure 3.15 A shows the results for the expression of Villin 
mRNA. Villin mRNA expression is shown to slowly increase in control samples between 
7 and 14 days in culture before a rapid increase in mRNA levels up to 21 days. Addition 
of CCD-18co conditioned media to the Transwell layers results in a gradual increase in 
levels over the full 21 day period, with terminal levels in CCD-18co conditioned media 
samples approximately 50% that of the control. Significance values for comparative 
Villin expression reflect these observation with significances in control samples only 
between the 21 day timepoints. No significant change is seen between 7 and 21 day 
samples treated with CCD-18co conditioned media although as mentioned an upwards 
trend can be observed. Interestingly, 21 day timepoints of CCD-18co treated Caco-2 
layers are not significantly different from 7 day non treated controls when comparing 
relative expression of Villin, OATP-B or  BCRP. Although, in each case the 21 day 
timepoint of CCD-18co treated layers tends to be higher than 7 day controls.  
 
Occludin, OATP-B and MRP2 levels (Figure 3.15 B, C & Figure 3.16 A respectively) 
shows a similar expression profile to that of Villin. CCD-18co conditioned media results 
in a decrease in mRNA expression of these genes at the 21 day period timepoint when 
compared to the control 21 day samples. With levels dropping to between 50 and 60% 
that of the control. Whilst a downwards trend in relative expression rates of samples 
cultured in CCD-18co conditioned media can be observed in each of the three samples 
mentioned above only OATP-B and MRP2 21 day +/- CCD-18co comparisons results in 
a significant decrease in relative expression. No significant differences can be seen when 
comparing Control and CCD-18co treated epithelial layers at 7 and 14 day timepoints. 
 
Figure 3.16 B shows the expression levels of BCRP. Control layers show a steady 
increase in mRNA levels until the 14 day timepoint whereby the levels plateau and remain 




at the same approximate level until 21 days. Conversely, CCD-18co conditioned media 
Caco-2 layers show an initial rapid rise in mRNA levels up until 7 days at which point 
levels rise steadily until the 21 day experimental endpoint. The mRNA levels of the 
conditioned media models 7 day time point is approximately equal to that of the 21 day 
matured non-treated Caco-2 layers with BCRP mRNA expression of the 21 day timepoint 
being approximately twice that of the control. Interestingly however, no significant 
differences can be seen between any combination of samples in this experiment. 
Although, as before, general increasing trends over time can be observed.  
  
Finally, MDR1 (Figure 3.16 C) shows a similar pattern to that of BCRP but to a lesser 
extent with conditioned media Caco-2 models being approximately 1.5x the levels of 
control layers. In the case of MDR1 however increases mediated by CCD-18co paracrine 
media culture can be shown to be significantly different from control Caco-2 epithelial 
model layers. 
  






 7D + 14D - 14D + 21D - 21D + 
7D -  ns ns *** ns 
7D +      
14D -   ns *** *** 
14D +    *** ns 
21D -     * 
 
 7D + 14D - 14D + 21D - 21D + 
7D -  ns ns *** * 
7D +      
14D -   ns ** ns 
14D +    *** * 
21D -     ns 
 
 7D + 14D - 14D + 21D - 21D + 
7D -  ns ns *** ns 
7D +      
14D -   ns ** ns 
14D +    *** ns 
21D -     * 
 
A) Villin B) Occludin C) OATP-B 
Figure 3.15: Transwell time course models PCR for Villin, Occludin and OATP-B - Graph shows the relative expression of 3 different markers of cellular 
differentiation at different timepoints of monolayer maturation and in the presence of CCD-18co compared to the 21D Caco-2 standard. A) Villin, B) Occludin, C) OATP-
B. Relative expression rates of Villin and OATP-B are significantly lower in CCD-18co treated epithelial layers at 21 days than in controls. Occludin levels do not 
significantly change over the 21 day culture period suggesting something else is responsible for the significant changes in TEER observed in conditioned media cultures 
n=3 N=3 in all cases except 7D + where n=2 N=2. Significancy calculations are omitted for N=2 data points. Scale bars represent +SEM. 
 
Table 3.3: Significances for comparative Villin 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
 
Table 3.4: Significances for comparative Occludin 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
 
Table 3.5: Significances for comparative OATP-B 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
 







 7D + 14D - 14D + 21D - 21D + 
7D -  ns ns *** * 
7D +      
14D -   ns *** ns 
14D +    ** ns 
21D -     * 
 
 7D + 14D - 14D + 21D - 21D + 
7D -  ns ns ns ns 
7D +      
14D -   ns ns ns 
14D +    ns ns 
21D -     ns 
 
 7D + 14D - 14D + 21D - 21D + 
7D -  ns ** ** ** 
7D +      
14D -   * *** ** 
14D +    ns ns 
21D -     * 
 
A) MRP2 B) BCRP C) MDR1 
Figure 3.16: Transwell time course models qPCR of MRP2, BCRP and MDR1- Graph shows the relative expression of 3 different markers of cellular differentiation 
at different timepoints of monolayer maturation and in the presence of CCD-18co compared to the 21D Caco-2 standard. A) MRP2, B) BCRP, C) MDR1. MDR1 is the 
only marker to show significant differences over the control with a significant increase in relative MRNA abundance. n=3, N=3 in all cases except 7D + where n=2, N=2. 
Significancy calculations are omitted for N=2 data points. Scale bars represent +SEM. 
 
Table 3.6: Significances for comparative MRP2 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis. *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
 
Table 3.7: Significances for comparative BCRP 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
 
Table 3.8: Significances for comparative MDR1 
expression in time course samples – Comparative 
sample analysis was achieved utilising One way 
ANOVA with Tukeys post-test analysis *** = 
P<0.0001, ** = P<0.001, * = P< 0.01 
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3.4.11 Co-culture of Caco-2 cells increases the aminopeptidase 
activity within intestinal models. 
Aminopeptidases are expressed in the intestine as a surface enzyme of enterocytes for the 
cataclysm of the breakdown of  amino acids through breakage of the N-terminus of 
proteins. Caco-2 monolayers were tested in comparison to both 2D and 3D CCD-18co 
models. 3D CCD-18co models in this instance refers to the Alvetex®  based 3D model 
discussed further in chapter 5. In both cases aminopeptidase activity was seen to increase 
by approximately 50% compared to control levels. There was no significant differences 
between the effect of 2D and 3D culture systems on the stimulation of Caco-2 layers. 
  
Figure 3.17: Aminopeptidase activity levels increase in both paracrine and 3D CCD-18co 
cultures – Aminopeptidase enzyme activity assessed at 21 days of Caco-2 culture in control, 
Paracrine treated and 3D CCD-18co models. When corrected to culture area both CCD-18co 
paracrine and 3D models resulted in a modest yet significant increase in aminopeptidase activity, 
suggesting improvements in cellular differentiation.  n=6 N=3. Significance compared to control 
was assessed by students unpaired T-test. ***=p <0.0005, **=p<0.005, *=p<0.05 Scale bars 
represent +SEM. 
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7 Days 14 Days 21 Days 
Control vs 0.5 ng/ml KGF ns Control vs 0.5 ng/ml KGF * Control vs 0.5 ng/ml KGF *** 
Control vs 5 ng/ml KGF *** Control vs 5 ng/ml KGF *** Control vs 5 ng/ml KGF *** 
Control vs 25 ng/ml KGF *** Control vs 25 ng/ml KGF *** Control vs 25 ng/ml KGF *** 
0.5 ng/ml KGF vs 5 ng/ml 
KGF *** 
0.5 ng/ml KGF vs 5 ng/ml 
KGF * 
0.5 ng/ml KGF vs 5 ng/ml 
KGF *** 
0.5 ng/ml KGF vs 25 
ng/ml KGF *** 
0.5 ng/ml KGF vs 25 
ng/ml KGF * 
0.5 ng/ml KGF vs 25 
ng/ml KGF *** 
5 ng/ml KGF vs 25 ng/ml 
KGF *** 
5 ng/ml KGF vs 25 ng/ml 
KGF ns 





Figure 3.18: 7, 14 & 21 day TEER measurements of Caco-2 cells on Transwell Snapwell in 
control and KGF spiked media conditions shows that addition of KGF to the Caco-2 models 
results in highly significant decreases in epithelial construct TEER values – KGF was spiked into 
Caco-2 culture media at a concentration of 0.5, 5 and 25ng/ml. TEER assessment was made to quantify 
changes in barrier integrity mediated by KGF. A) 7 Day Caco-2 culture, B) 14 days, C) 21 days, D) 
Comparative TEER measurements of spiked media cultures. n=3, N= a minimum of 3 independent 
experiments.. Scale bars represent +SEM. 
Table 3.9 Statistical analysis of Transwell model TEER measurements: One way ANOVA with 




A) 7 Days B) 14 Days 
C) 21 Days 
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3.4.12 KGF changes the structural physiology of Caco-2 
monolayers and decreases membrane TEER levels in a dose-
dependent manner.  
The addition of KGF to the media of Caco-2 Transwell models and its effects on the 
TEER measurement of the membrane over time were assessed using the same methods 
as measured previously. 
 
Figure 3.18 D shows the relative TEER curves of all variable concentration conditions 
together. The Caco-2 non-spiked media controls show a rapid increase in TEER values 
between 0 and 14 days. This is followed by a plateau of any further increase in membrane 
resistance until 21 days in culture, with maximum TEER values of around 3200 ohms. 
When 0.5 ng/ml of KGF is added to the culture media the initial increase in TEER values 
between 0 and 7 days is indistinguishable over the control values. 0.5 ng/ml values differ 
from control samples in that the beginning of the plateau phase of culture begins at day 7 
onwards, with TEER values increasing as a significantly reduced rate until day 21 
whereby 0.5 ng/ml cultures have a significantly reduced maximal TEER values over the 
controls (Figure 3.18 C). 5 ng/ml KGF spiked into the Caco-2 culture media is shown to 
have highly significant effects on the TEER values of the resultant models throughout the 
entire 21 days of culture (Figure 3.18, A-C). Initial expansion TEER measurement phase 
between 0 and 7 days is at a significantly decreased level over both control and 0.5 ng/ml 
models. Post day 7 this reduced rate of increase reduces further into a plateau phase which 
lasts until 21 days in culture (Figure 3.18 D). Similarly, 25 ng/ml has an overall culture 
TEER curve of the same general shape as 5 ng/ml KGF. 25 ng/ml culture results in a 
significantly decreased model TEER value throughout the course of the culture when 
compared against the Control models, with an end TEER values of approximately 500 
ohms, significantly closer to the TEER values of Human intestinal tissue. 
 
Histologically, Transwell models are shown in Figure 3.19 to change depending on the 
levels of KGF supplemented to the culture media. Figure 3.19 A, shows Caco-2 control 
models. Figure 3.19 B-D shows the addition of 0.5, 5 and 25 ng/ml of KGF respectively. 
0.5 ng/ml (Figure 3.19 B) shows the least amount of change as expected with cells being 
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mostly flattened albeit more strongly stained than the control samples. Models which 
contain higher levels of KGF can be observed to show a heightened cellular phenotype 
with more cuboidal like cells which are densely packed together to create a continuous 
layer. Additionally, cells appear to stain more strongly than controls with eosin and appear 
more polarised. 
 
Figure 3.19: H+E of KGF spiked media Caco-2 Transwell models shows similar histology to the 
addition of paracrine media with increased cellular height and cytoplasmic staining – H&E 
histology of 7μm sectioned, PFA fixed, Caco-2/KGF models cultured on Transwell Snapwell ®. A) 
Control, B) 0.5ng/ml, C) 5ng/ml, D) 25ng/ml. Images are representative of a minimum of 3 
independent repeats. Scale= 200μm 
A B 
C D 
Chapter 3 – Development of Transwell Co-culture models of the intestinal epithelium 
     














Figure 3.20: Immunofluorescence staining of Control Caco-2 Snapwell models – Representative images of wholemount 
immunostained Caco-2 Transwell Snapwell® intestinal models cultured for a period of 21 days in culture.  A) E-cadherin, B) Occludin, 
C) MDR1, D) Actin. Images are representative of a minimum of 3 independent repeats. Scale = 200μm 
Figure 3.21: Immunofluorescence staining of 0.5ng/ml KGF spikes Caco-2 Snapwell models – Representative images of wholemount 
immunostained Caco-2 Transwell Snapwell® intestinal models cultured with 0.5ng/ml of human recombinant KGF for a period of 21 days in 
culture.  A) E-cadherin, B) Occludin, C) MDR1, D) Actin. Images are representative of a minimum of 3 independent repeats Scale = 200μm 
A) E-cadherin B) Occludin C) MDR1 D) Actin 
A) E-cadherin B) Occludin C) MDR1 D) Actin 
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Figure 3.22: Immunofluorescence staining of 5ng/ml KGF spikes Caco-2 Snapwell models – Representative images of wholemount 
immunostained Caco-2 Transwell Snapwell® intestinal models cultured with 5ng/ml of human recombinant KGF for a period of 21 days in 
culture.  A) E-cadherin, B) Occludin, C) MDR1, D) Actin. Images are representative of a minimum of 3 independent repeats Scale = 200μm 
A) E-cadherin B) Occludin D) Actin C) MDR1 
Figure 3.23: Immunofluorescence staining of 25ng/ml KGF spikes Caco-2 Snapwell models – Representative images of wholemount 
immunostained Caco-2 Transwell Snapwell® intestinal models cultured with 25ng/ml of human recombinant KGF for a period of 21 days in 
culture.  A) E-cadherin, B) Occludin, C) MDR1, D) Actin. Images are representative of a minimum of 3 independent repeats Scale = 200μm 
A) E-cadherin B) Occludin D) Actin C) MDR1 
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3.4.13 Immunostaining characterisation of KGF treated Caco-
2 layers shows increased Villin expression with higher KGF 
concentrations. 
Figure 3.20 shows the wholemount expression profile of key protein markers, E-cadherin, 
Occludin, MDR1, Pan-Actin and Villin. E-cadherin of control layers shows consistent 
homogenous staining across the entire model layer. Orthogonal view of E-cadherin shows 
staining, apical to base, along the full length of the cell indicating consistent lateral 
membrane staining. Comparatively, in KGF treated layers E-cadherin shows a similar 
pattern of staining throughout all of the models. Occludin (Figure 3.20 B) staining of the 
same control models shows a similar wholemount pattern as E-cadherin with cell-cell 
junctional tracing. In contrast, the orthogonal view of Occludin shows localisation to the 
apical surface of the cells indicating apical lateral tight junction staining. Figure 3.20 C, 
shows MDR1 (p-gp) staining across control layers. Sample shows inconsistent staining 
across the surface of the model. Staining, where positive,  is located apically to the DAPI 
stained nuclei, indicating apical microvilli expression as is expected for MDR1. Pan-actin 
is utilised here (Figure 3.20 D) as a marker for both the surface brush border and actin 
dense junctional complexes. Control layers are inconsistently stained for actin with some 
junctional and surface staining seen. However, whilst inconsistent, control layers are 
shown to have significantly higher staining abundance and intensity when compared to 
0.5, 5 and 25 ng/ml KGF conditioned layers (Figure 3.21, 22 & 23, D). Indeed, the 
25ng/ml KGF (Figure 3.23 D) conditioned media sample shows extremely inconsistent 
pan-actin staining with only sporadic junctional staining seen and very little/no surface 
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3.4.14 KGF in Caco-2 culture media increases the metabolic 
activity of Caco-2 cells in a dose-dependent manner. 
In addition to analysis of the TEER of KGF spiked culture epithelial models, Figure 3.24 
shows the effects of the same spiked media concentration on the metabolic activity as 
measured by the MTT assay. In control wells (Figure 3.24 A-D) it can be observed that 
the cells undergo an initial lag phase of growth followed by an exponential growth phase 
and a plateau/ death phase after day 8 whereby the cells have become full confluent. 
  
The addition of 0.5 ng/ml of KGF to the media (Figure 24 A) results in no significantly 
different changes in the metabolism measured at any point during the culture of the cells. 
In contrast, both 5 and 25 ng/ml KGF supplementations (Figure 3.24 B, C) to the growth 
media results in significant increases in Caco-2 metabolic rates by day 20 of culture. 
Indeed, with regards to the 25ng/ml media concentration the increase in metabolic rate 
shown by the Caco-2 cells was significantly higher than the controls from day 6 onwards. 
Generally speaking, the curve shape is the same in ns tested up until day 8 whereby 
changes can be seen in the shape of the 5 and 25 ng/ml curved. Whereas the Control and 
0.5 ng/ml conditions both show a clear decrease in metabolic activity between days 8 and 
10, 5 and 25 ng/ml conditions show a more plateau like shape with 25 ng/ml continuing 
to rise but at a less steep gradient.  
 
When compared together (Figure 3.24 D) the data shows a stepwise increase in Caco-2 
metabolism and a less pronounced plateau/ death phase with increasing concentration of 













Figure 3.24: MTT assessment of  cellular viability over 10 days culture period (2D) with and without KGF spiked media. – Cell viability was 
assessed by MTT assay of 2D cells at set time points. Significant changes in model metabolic activity can be seen in a dose dependant manner with 
increasing KGF levels resulting in an increase in metabolic activity. Very similar to the effects of CCD-18co conditioned media. All experiments 
n=3 N=3. Statistical significance is summarised in Table 3.10. Error bars represent ±SEM. 
A) B) 
C) D) 




Figure 3.25: Time-point comparison of all conditions – A) Day 4, B ) Day 6, C) Day 8, D) Day 









4 Days 6 Days 8 Days 10 Days 
Control vs 0.5ng/ml KGF ns Control vs 0.5ng/ml KGF ns Control vs 0.5ng/ml KGF ns Control vs 0.5ng/ml KGF ns 
Control vs 5ng/ml KGF ns Control vs 5ng/ml KGF ns Control vs 5ng/ml KGF ns Control vs 5ng/ml KGF * 
Control vs 25 ng/ml KGF ns Control vs 25 ng/ml KGF ns Control vs 25 ng/ml KGF ** Control vs 25 ng/ml KGF *** 
Control vs CCD-18co ns Control vs CCD-18co ns Control vs CCD-18co * Control vs CCD-18co *** 
Control vs HDFn ns Control vs HDFn ns Control vs HDFn ns Control vs HDFn ns 
Control vs HIC ns Control vs HIC ns Control vs HIC * Control vs HIC ns 
0.5ng/ml KGF vs 5ng/ml KGF ns 0.5ng/ml KGF vs 5ng/ml KGF ns 0.5ng/ml KGF vs 5ng/ml KGF ns 0.5ng/ml KGF vs 5ng/ml KGF ns 
0.5ng/ml KGF vs 25 ng/ml KGF ns 0.5ng/ml KGF vs 25 ng/ml KGF ns 
0.5ng/ml KGF vs 25 ng/ml 
KGF * 
0.5ng/ml KGF vs 25 ng/ml 
KGF *** 
0.5ng/ml KGF vs CCD-18co ns 0.5ng/ml KGF vs CCD-18co ns 0.5ng/ml KGF vs CCD-18co ** 0.5ng/ml KGF vs CCD-18co *** 
0.5ng/ml KGF vs HDFn ns 0.5ng/ml KGF vs HDFn ns 0.5ng/ml KGF vs HDFn ns 0.5ng/ml KGF vs HDFn ns 
0.5ng/ml KGF vs HIC ns 0.5ng/ml KGF vs HIC ns 0.5ng/ml KGF vs HIC ** 0.5ng/ml KGF vs HIC ns 
5ng/ml KGF vs 25 ng/ml KGF ns 5ng/ml KGF vs 25 ng/ml KGF ns 5ng/ml KGF vs 25 ng/ml KGF ns 5ng/ml KGF vs 25 ng/ml KGF *** 
5ng/ml KGF vs CCD-18co ns 5ng/ml KGF vs CCD-18co ns 5ng/ml KGF vs CCD-18co *** 5ng/ml KGF vs CCD-18co ns 
5ng/ml KGF vs HDFn ns 5ng/ml KGF vs HDFn ns 5ng/ml KGF vs HDFn ** 5ng/ml KGF vs HDFn ns 
5ng/ml KGF vs HIC ns 5ng/ml KGF vs HIC ns 5ng/ml KGF vs HIC *** 5ng/ml KGF vs HIC ns 
25 ng/ml KGF vs CCD-18co ns 25 ng/ml KGF vs CCD-18co ns 25 ng/ml KGF vs CCD-18co *** 25 ng/ml KGF vs CCD-18co *** 
25 ng/ml KGF vs HDFn ns 25 ng/ml KGF vs HDFn ns 25 ng/ml KGF vs HDFn *** 25 ng/ml KGF vs HDFn *** 
25 ng/ml KGF vs HIC ns 25 ng/ml KGF vs HIC ns 25 ng/ml KGF vs HIC *** 25 ng/ml KGF vs HIC *** 
CCD-18co vs HDFn ns CCD-18co vs HDFn ns CCD-18co vs HDFn ns CCD-18co vs HDFn ** 
CCD-18co vs HIC ns CCD-18co vs HIC ns CCD-18co vs HIC ns CCD-18co vs HIC ** 
HDFn vs HIC ns HDFn vs HIC ns HDFn vs HIC ns HDFn vs HIC ns 
Table 3.10: Time-point comparison of Conditioned media and KGF spiked conditions – Summary of comparative significances between data sets.  Standard 
one way ANOVA with Tukeys post-test analysis was performed between data sets. *** = P<0.0005, ** = P<0.005, * = P< 0.05, n=3, N=3 
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3.4.15 Understanding the development of tight junction 
expression in Caco-2 cells grown in control and KGF spiked 
media conditions. 
As described previously in section 3.4.8, tight junctional abundance was assessed through 
the staining of epithelial layers with Occludin, an intermembrane component of the tight 
junctional complex. 
 
Figure 3.20 shows the expression of Occludin in each of the samples with timepoint taken 
2 days apart for 10 days. As before it can be seen that Occludin expression is abundant 
even in very low confluency cells and even as cytoplasmic staining of single cells without 
cell-cell contacts. This expression gets gradually stronger and more abundant over time 
in each of the spiked media conditions. By day 10 there is a clear difference in cellular 
confluency between the spiked media samples and the control, with an increasing level 
of cellular packing with increasing KGF concentration. This results in smaller more 
tightly packed cellular layers in models exposed to higher concentrations of KGF (5 and 
25 ng/ml) than the control. Additionally, cell layers appear to be more homogenous at 
higher KGF concentrations with little heterogenicity in cell size seen in the layers, 






















Figure 3.26: Tight junction expression of Caco-2 cells treated with different KGF 
concentrations over 10 days – Control and KGF media treated Caco-2 cells were cultured on 2D 
plastic for a varying number of days before fixation and staining for the tight junction protein, 
Occludin. Images are representative of 3 independent repeats Scale = 200μm 














































3.4.16 Differential aminopeptidase activity of KGF conditioned 
layers. 
Figure 3.27 shows the relative aminopeptidase activity of Caco-2 membranes treated with 
0.5, 5 and 25 ng/ml of KGF. What can be seen is that a small amount of KGF added to 
the Caco-2 layers, namely 0.5 and 5 ng/ml, results in a significant drop in aminopeptidase 
activity after 21 days of total culture time. Interestingly, this decrease in enzyme activity 
is recovered with the addition of further KGF, with 25ng/ml showing no significant 
decrease over the control samples. 
 
Figure 3.27: Aminopeptidase activity of KGF treated Caco-2 layers – Caco-2 treated layers 
were tested for their Aminopeptidase activity through their ability to convert L-alanine-4-
nitroanilide hydrochloride into 4-Nitroanaline. Significances calculated through Student T-test. 
n=3 N=3. Scale bars represent +SEM. 
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3.4.17 Quantification of the levels of KGF present in paracrine 
conditioned media samples. 
Figure 3.28 shows the relative amounts of KGF secreted into the conditioned media by 
CCD-18co , HIC and HDFn fibroblasts both cultured in standard DMEM and in Caco-2 
paracrine media. KGF levels within the media were normalised to total DNA levels within 
the samples. 
 
Figure 3.28 A shows the conditioned media gained from 2D cultured fibroblast cells 
compared with 2D fibroblasts cultured for a period of 7 days in Caco-2 DMEM 
conditioned media. CCD-18co conditioned media is shown to contain significantly higher 
levels of KGF than both HDFn and HIC conditioned medias, with an approximate 14-
fold increase in KGF abundance per ng of DNA. HDFn and HIC fibroblasts are not shown 
to have significantly different KGF abundance in cultured in standard DMEM. The 
application of Caco-2 conditioned media to the CCD-18co cells appears to induce a 
significant reduction in KGF abundance per ng of DNA over the untreated samples. 
Conversely, HDFn and HIC Caco-2 conditioned media treated layers do not appear to 
significantly change from their respective non-treated controls. However, 2D HDFn  KGF 
levels are shown to be significantly different from 2D HIC Caco-2 conditioned media 
KGF levels. Significances for Figure 3.28 A are summarised in Table 3.11. 
 
The KGF levels of cells cultured in 3D (Figure 3.28 B) shows a similar trend to the 
comparison in 2D with CCD-18co cells secreting the highest levels of KGF per ng of 
DNA albeit the difference in KGF secretion between CCD-18co and other fibroblasts is 
less than in 2D conditions. Similarly to 2D conditions, the addition of Caco-2 conditioned 
media to the CCD-18co cell layers results in a significant decrease in the KGF abundance 
overall with this change not reflected in the HDFn of the HIC samples. Significances for 
Figure 3.28 A are summarised in Table 3.11. 
 
Figure 3.28 C shows the comparative KGF levels between 2D and 3D cultures cells 
normalised to ng of DNA. As in other comparisons 2D CCD-18co results in the highest 
levels of KGF per ng of DNA than any other condition. Growth of cells within a 3D 
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scaffold results in a significant decrease in the levels of KGF over the 2D condition. 
Indeed, KGF levels of CCD-18co conditioned media grown in 3D reduce down to levels 
similar to that seen in HDFn and HIC samples. Significant reductions in KGF abundance 
are also observed in HDFn and HIC cultures although the amount of change is less than 
that seen in CCD-18co conditioned media experiments. Significances for Figure 3.28 C 
are summarised in Table 3.11. 
 
Figure 3.28 D shows the comparative KGF abundance between 2D and 3D cells grown 
in Caco-2 conditioned media. The trends are similar to that seen in Figure 2.20 C with a 
significant reduction of KGF in 3D cultures compared to 2D grown cells. Significances 
for Figure 3.28 C are summarised in Table 3.11. 
 
Figure 3.29 shows the total KGF levels of the conditioned media without the 
normalisation to cellular DNA concentration. Essentially, this graph shows the abundance 
of KGF in the paracrine conditioned media which would be effecting the Caco-2 
epithelium when added to the growing epithelial constructs. Similar to that seen in Figure 
3.28, 2D CCD-18co conditioned media has highest levels of KGF at approximately 700-
800 pg/ml. These levels are a whole order of magnitude higher than other 2D paracrine 
media conditions which generally express KGF in the mid to high tens of picogram.  
 
Treatment of fibroblast cultures with Caco-2 conditioned media prior to sampling of 
fibroblasts conditioned media resulted in a modest decrease in the levels of KGF within 
the CCD-18co samples with no significant differences in the others. Additionally, as seen 
in the DNA concentration corrected layers, culture of fibroblasts in 3D resulted in the 
significant decrease in secreted KGF. In the case of CCD-18co cells, this decrease brought 
the KGF expression rates in line with levels seen in Hic and HDFn fibroblast conditions. 
Figure 3.30 shows the relative abundance of DNA isolated from each of the fibroblast 
conditions. The graph shows that very little variation in DNA abundance can be seen 
between conditions. This suggests that the controlled seeding amounts at the beginning 
of the experiment were maintained throughout the culture period in both 2D and 3D. 
Additionally, treatment of fibroblast layers with Caco-2 conditioned media did not have 
any meaningful effects on fibroblast growth with Caco-2 conditioned DNA content non-
significantly different from the 2D counterparts.  








Figure 3.28: DNA normalised KGF ELISA – Conditioned media from 2D and 3D fibroblast cultures were 
assessed for levels of secreted KGF. KGF levels were quantified and normalised with total DNA concentration 
of 2D and 3D cell lysates. A) 2D vs 2D + Caco-2 conditioned media, B) 3D vs 3D + Caco-2 conditioned 
media, C) 2D vs 3D, D) 2D + Caco-2 conditioned media vs 3D + Caco-2 conditioned media. n=3 N=3 Error 
bars represent + SEM 
A) B) 
C) D) 
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2D CCD-18co vs 2D HDFn *** 2D HIC vs 2D CCD-18co + 
Caco-2 
*** 
2D CCD-18co vs 2D HIC *** 2D CCD-18co + Caco-2 vs 2D 
HDFn + Caco-2 
*** 
2D CCD-18co vs 2D CCD-
18co + Caco-2 
*** 2D CCD-18co + Caco-2 vs 2D 
HIC + Caco-2 
*** 
2D CCD-18co vs 2D HDFn + 
Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D 
CCD-18co 
*** 
2D CCD-18co vs 2D HIC + 
Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D 
HDFn 
*** 
2D CCD-18co vs 3D CCD-
18co 
*** 2D CCD-18co + Caco-2 vs 3D 
HIC 
*** 
2D CCD-18co vs 3D HDFn *** 2D CCD-18co + Caco-2 vs 3D 
CCD-18co + Caco-2 
*** 
2D CCD-18co vs 3D HIC *** 2D CCD-18co + Caco-2 vs 3D 
HDFn + Caco-2 
*** 
2D CCD-18co vs 3D CCD-
18co + Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D 
HIC + Caco-2 
*** 
2D CCD-18co vs 3D HDFn + 
Caco-2 
*** 3D CCD-18co vs 3D HDFn * 
2D CCD-18co vs 3D HIC + 
Caco-2 
*** 3D CCD-18co vs 3D HDFn + 
Caco-2 
* 





















Table 3.11: KGF levels in conditioned media normalised to DNA concentration of 2D 
cellular layers – Summary of comparative significances between data sets.  Standard one 
way ANOVA with Tukeys post-test analysis was performed between data sets. *** = 
P<0.0005, ** = P<0.005, * = P< 0.05, n=3, N=3 




Figure 3.29: Total KGF concentration of conditioned media – Total KGF concentration of the 
different conditions without the DNA concentration corrected. 2D CCD-18co cells can be seen 
secrete the most KGF of all conditions tested by approximately an order of magnitude. Culture of 
CCD-18co in 3D attenuates the high KGF secretion rates to levels much more similar to those seen 
in other conditions.  n=3, N=3. Scale bars represent +SEM. 
2D CCD-18co vs 2D HDFn *** 2D HIC vs 2D CCD-18co + Caco-2 *** 
2D CCD-18co vs 2D HIC *** 2D CCD-18co + Caco-2 vs 2D HDFn + 
Caco-2 
*** 
2D CCD-18co vs 2D HDFn + 
Caco-2 
*** 2D CCD-18co + Caco-2 vs 2D HIC + 
Caco-2 
*** 
2D CCD-18co vs 2D HIC + 
Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D CCD-
18co 
*** 
2D CCD-18co vs 3D CCD-18co *** 2D CCD-18co + Caco-2 vs 3D HDFn *** 
2D CCD-18co vs 3D HDFn *** 2D CCD-18co + Caco-2 vs 3D HIC *** 
2D CCD-18co vs 3D HIC *** 2D CCD-18co + Caco-2 vs 3D CCD-
18co + Caco-2 
*** 
2D CCD-18co vs 3D CCD-18co 
+ Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D HDFn + 
Caco-2 
*** 
2D CCD-18co vs 3D HDFn + 
Caco-2 
*** 2D CCD-18co + Caco-2 vs 3D HIC + 
Caco-2 
*** 
2D CCD-18co vs 3D HIC + 
Caco-2 
*** 3D CCD-18co vs 3D HDFn * 
2D HDFn vs 2D CCD-18co + 
Caco-2 
*** 3D CCD-18co vs 3D HDFn + Caco-2 ** 
2D HDFn vs 3D HDFn * 3D CCD-18co vs 3D HIC + Caco-2 * 




 Table 3.12: Absolute KGF levels in conditioned media statistical analysis – Summary of 
comparative significances between data sets.  Standard one way ANOVA with Tukeys post-test 
analysis was performed between data sets. *** = P<0.0005, ** = P<0.005, * = P< 0.05, n=3, 
N=3 




2D CCD-18co + Caco-2 vs 3D 
HDFn 
* 
2D CCD-18co + Caco-2 vs 3D 
HDFn + Caco-2 
* 
  
Figure 3.30: Total DNA abundance of fibroblasts utilised for the generation of conditioned 
media shows no significant differences between like-samples– Total DNA abundance in 
fibroblasts utilised to create the conditioned media utilised in the KGF concentration analysis 
experiment. Very little variation is seen between conditions suggesting that cell numbers in each 
conditions are approximately equal. Small variation in the DNA levels explains why similar trends 
are seen in corrected and total KGF graphs. n=3, N=3. Scale bars represent +SEM. 
Table 3.13: DNA concentration of 2D fibroblast cellular layers statistical analysis – Summary 
of comparative significances between data sets.  Standard one way ANOVA with Tukeys post-test 
analysis was performed between data sets. *** = P<0.0005, ** = P<0.005, * = P< 0.05, n=3, N=3 
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3.4.18 The effects of conditioned and KGF spiked media on the 
passive paracellular transport of Lucifer yellow. 
Figure 3.31 shows the passive paracellular transport of the fluorescent compound Lucifer 
Yellow. Caco-2 control layers show a Papp value of around 1x10-6 cms-1, a normal value 
for Caco-2 layers when compared to the literature. A small non-significant increasing 
trend is seen when Caco-2 cells are cultured in the paracrine media of CCD-18co 
fibroblasts. This increasing trend continues when comparing Caco-2 controls to 3D CCD-
18co Alvetex® models. A trend which is also shown to be non-significant when analysed 
by unpaired student T-test.  
 
2D HIC and HDFn layers show a decrease in the levels of permeability to Lucifer yellow 
compared to control to a similar level of that seen in KGF spiked conditions. 3D HIC and 
HDFn models however have an increased permeability, similar to the levels of 3D CCD-
18co. This increase could be attributed to the change in culture system rather than a 
physiological change in the cells. Addition, of KGF to the Caco-2 media results in a 
decrease in overall membrane permeability, albeit as before, in a non-significant manner 
when compared to control layers.  
 
 
Figure 3.31: Lucifer yellow 
paracrine transport across 
treated epithelial layers - 
Lucifer Yellow is utilised as 
a marker of membrane 
integrity by acting as a 
passive, paracellular 
transported compound. 
Membranes with low 
integrity would show higher 
Papp values. n=3 , N=3. 
Significancy was assessed by 
one way ANOVA with 
Tukeys post-test analysis. No 
significant difference was 
observed between samples. 
Scale bars represent +SEM. 
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3.4.19 qPCR analysis of conditioned and KGF spiked media 
samples for the relative abundance of mRNA for key tight 
junctional components. 
Figure 3.32 shows the relative junctional mRNA expression rates of conditioned and KGF 
spiked media samples. Figure 3.32 A, shows relative Occludin mRNA abundance. 
Generally, there is either no significant changes in mRNA levels (CCD-18co and HDFn 
conditioned media) or there is a small decrease in relative abundance (HIC conditioned 
media along with all KGF spiked media samples).  
 
A similar pattern of expression rates is seen in Figure 3.32 B, for the expression of mRNA 
encoding the protein Claudin 2 with HIC and KGF samples showing a small decrease in 
relative expression and CCD-18co and HDFn samples showing little relative change.  
 
Conversely, Figure 3.32 C shows the relative expression of ZO-1. Interestingly, CCD-
18co and HDFn conditioned media see large increased in relative expression compared 
to control Caco-2 layers. HIC conditioned and KGF spiked media samples also show 
significant increases in relative mRNA expression albeit to a lesser extent than CCD-18co 
and HDFn samples. Interestingly, whist compared to the control all ZO-1 samples are 











Figure 3.32: qPCR analysis of relative tight junctional component expression in 2D 
conditioned media studies – A) Occludin, B) Claudin 2, C) ZO-1.  Changes in expression patterns 
can be seen between different conditioned media samples. Generally, CCD-18co and HDFn models 
show increases in junctional proteins compared to HIC conditions which generally decrease 
compared to other conditions. KGF samples show decreases in Occludin and Claudin-2 whilst ZO-
1 levels generally increase. n=3 (HIC n=2) N=3 (HIC N=2). Significancy test were performed 
utilising one way ANOVA with Tukeys post-test analysis. No significancy between data points was 
observed. Scale bars represent mean +SEM. 
A) Occludin 
B) Claudin 2 
Chapter 3 – Development of Transwell Co-culture models of the intestinal epithelium 
176 
 
3.5.20 qPCR analysis of conditioned and KGF spiked media 
samples for the relative abundance of mRNA for efflux 
transporter protein important in the function of  Caco-2  cells.  
Figure 3.33 shows the relative mRNA abundance of key efflux proteins involved in the 
functionality of Caco-2 cells when utilised as models of drug permeability. Figure 3.33 
A shows the relative expression rate of MDR1, commonly known as P-glycoprotein (P-
gp) between different conditions. P-gp is thought to be under/ normally expressed in 
control Caco-2 layers. Addition of CCD-18o and HIC conditioned media to Caco-2 
monolayers results in a significant decrease in the relative levels of MDR1 mRNA. 
Conversely, addition of HDFn and KGF spiked media samples resulted in a significant 
increase in MDR1 levels compared to control sample expression rates.  
 
In contrast, Figure 3.33 B shows the relative expression rates of MRP1 between all 
samples. CCD-18co conditioned media is shown to increase mRNA levels significantly 
with all other conditions having no significant effects on the overall relative expression. 
KGF spiked media samples do not appear to be significantly changed compared to the 
control layers however, a trend in expression rates between KGF spiked samples can be 
observed here which is also seen in other mRNA targets whereby 5ng/ml KGF causes a 
relative decrease in mRNA expression levels compared to 0.5ng/ml which is then 
corrected through an increase in relative expression when samples are cultured in 25ng/ml 
KGF. This could suggest some kind of KGF regulation whereby 5ng/ml KGF addition 
into the media is being suppressed by some unknown mechanism which, when cultured 
with 25ng/ml KGF is overwhelmed, resulting in further changes, usually increases, in 
relative mRNA abundance.   
 
Figure 3.33 C shows the relative expression rates of mRNA encoding for MRP2. As can 
be seen by looking at Figure 3.33 B & C, very different expression changes are seen 
between the both MRP1 and 2, both of which are highly related and have many 
overlapping functions. HIC conditioned media along with all of the KGF spiked media 
conditions saw a decrease in the relative mRNA levels compared to the control. Whereas 
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CCD-18co and HDFn were both non-significantly different from Control levels with a 
trend towards a slight increase.  
 
Finally, relative Villin expression rates are shown in Figure 3.33 D. All conditions except 
5ng/ml KGF spiked media were non-significantly different from Control layers. CCD-
18co did show a trend to increased relative levels however the variability was too high 
for significancy. 5ng/ml KGF spiked levels showed a decrease in relative Villin mRNA 
expression compared to controls. Interestingly, this decreases in reverted in 25ng/ml KGF 























Figure 3.33: qPCR analysis of relative functional efflux protein component and Villin 
expression in 2D conditioned media studies – A) MDR1, B) MRP1, C) MRP2 D) Villin. Variable 
differences can be seen between different conditioned media samples. KGF spiked samples show 
increases MDR1 and MRP1 (A & B) expression over controls. Especially at 25 ng/ml levels. 
Conversely MRP1 and Villin levels are seen to decrease compared to controls. Significancy values 
were not calculated for this data set due to low replicate number of n=2-3 N=2-3. Scale bars 
represent mean +SEM. 
A) MDR1 B) MRP1 
C) MRP2 D) Villin 




3.5.1 Chapter overview 
The aims of this chapter were to evaluate the suitability of a number of prospective cell 
lines for co-culture with Caco-2 cells in a Transwell Snapwell epithelial model and to 
postulate a potential mechanism by which said cell lines were having physiological 
action. The commercially available cells lines utilised were CCD-18co (Colon 
Carcinoma) & HDFn (neonatal Human dermal fibroblasts), along with primary human 
intestinal cells (HIC) isolated from tissue in the lab. Fibroblast cell lines were 
characterised for their structural and protein morphology before being applied to Caco-2 
models through the use of conditioned media containing paracrine released factors 
released by the fibroblasts. The effects of said conditioned media on Caco-2 Snapwell® 
cell layer development was assessed by a number of techniques, namely, TEER, MTT 
assay and drug transport (discussed later). 
 
The barrier integrity of Caco-2 membranes is critically important to their function as 
pharmacokinetically useful models within the lab. As such barrier integrity of Caco-2 
layers was assessed through the immunostaining of Occludin (Tight junction marker) 
alongside TEER measurements of control and conditioned models and MTT assessment 
of model metabolism. The metabolic activity of Caco-2 cells within Snapwell model is 
also a good indicator of the transport capabilities of the developed epithelium. Cell layer 
metabolic activity was assessed both in 2D over time and at 21 days in culture in 
Snapwell® models by use of MTT assay. 
 
Changes in the functional components of the Caco-2 epithelial layers such as surface 
aminopeptidase and efflux protein expression was assessed by N-nitroaniline assay and 
qPCR for transporter mRNA abundance respectively. Finally, a potential mechanism for 
the change in Caco-2 layers seen to be induced by paracrine conditioned medium, was 
investigated through quantification of KGF and comparison of KGF spiked media layers 
to conditioned media values. 
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3.5.2 Fibroblast characterisation through phase contrast and 
immunohistological microscopy. 
ATCC (American Type Culture Collections) describes CCD-18co cells as normal 
neonatal colon fibroblast cells. Phase contrast analysis of these cells shows a classical 
fibroblast like morphology with long protruding, spindle-like extensions and small 
cellular bodies. (178) There is some evidence to suggest that fibroblasts differentiate 
along the villi-crypt axis in much the same way that epithelial cells do, going from a 
discoid shape in the crypt to a spindle shape at the villus tip. As such the fibroblast 
morphology seen in 2D culture here is more reminiscent of the “differentiated” fibroblasts 
of the villus tip rather than those of the crypt. (179) Fibroblast cell layers are motile, 
spacing equidistantly from on another before replicating to confluency, at which point 
cells become contact inhibited and further replication stops after a period of cellular 
packing. 
 
When immunostained for cell lineage specific markers positive staining of the major 
mesenchymal intermediate filament protein Vimentin alongside alpha smooth muscle 
actin (αSMA) were shown. No positive staining is seen for Desmin (a smooth muscle 
lineage marker), which along with positive Vimentin staining suggests cells are not of a 
smooth muscle origin.  αSMA staining is often used as a marker for myofibroblast 
identification (180) but is also seen to be expressed in many other cell types within the 
intestinal mucosae, some of which are dependent on the location within the intestine. E.g. 
Smooth muscle of the small intestine or in lymphatic pericytes found within the colon. 
(180) 
 
Past literature shows that myofibroblast populations exist throughout the intestine, 
primarily located beneath epithelial layers and are responsible for the development, 
maintenance of the epithelial layer (179,180), principally through the secretion of 
paracrine factors. (179) Indeed, they are thought to not only support the development of 
the mature epithelium at the villus tip but also be important regulators of the stem cell 
niche in the crypt base. (173) Lei et al, worked to support this theory by assessing the 
effects of myofibroblast paracrine factors on their ability to promote the creation of 
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differentiated intestinal epithelium enteroids and for their successful engraftment in vivo  
into C57BL/6 mice. They found that in vitro enteroid development was enhanced by co-
culture with myofibroblast and that in vivo implantation was not possible with 
monoculture organoids, suggesting an important role in sub-epithelial myofibroblasts in 
crypt and epithelial maintenance and development. Additionally, there is further evidence 
that intestinal myofibroblast populations act as mediators of inflammation within the 
intestine, playing a key role in inflammatory bowel diseases such as Crohn’s disease. 
(181,182)  
 
Pericytes are often thought to be supportive cells of endothelial layers rather than 
epithelial, important in the development and maintenance of blood vessels in much the 
same way myofibroblasts are thought to maintain epithelial layers. (183,184) Pericytes 
structural morphology is similar to that of myofibroblasts making them impossible to 
identify apart with simple light microscopy. Pericytes are also shown to be αSMA positive 
and as such distinguishing immunofluorescence between myofibroblasts and pericytes is 
difficult, due to their overlapping function in addition to their expression profile. Indeed, 
many have argued that αSMA cells located immediately below epithelial layers are more 
likely to be pericytes than myofibroblasts. (185) However, in this instance smooth muscle 
or pericyte lineages in the cells is unlikely due to the absence of positive Desmin staining, 
a key marker for both in vivo with smooth muscle cells staining strongly positive  and 
pericytes staining weakly for Desmin expression. (180,186–188) 
 
Tubulin is a highly conserved microtubule protein found within eukaryotic cells. In this 
instance Tubulin staining was utilised as a marker of cellular structure rather than as a 
tool for the distinguishing of cell type. Actin was used in a similar way. Actin should be 
strongly conserved and stained in all fibroblast cells and as such weak staining seen here 
may not be physiologically mimetic, potentially suggesting a failure in the staining 
process. 
  
The expression profile of immunostained fibroblasts utilised in this study suggests a 
myofibroblast type cell in all instances, phenotypically somewhere between a true 
fibroblast and a smooth muscle cell. HDFn and HIC cells show a similar expression 
profile to that of CCD-18co suggesting myofibroblast lineage.  It should be noted that far 
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weaker αSMA staining was seen of HDFn cells when compared to myofibroblasts derived 
from the intestine. This could potentially reflect the decreased proportion of 
myofibroblasts that are naturally found within the human skin (generally produced as a 
consequence of damage as a wound healing response) compared to the intestine mucosa. 
(189) However, the similarity in the overall HDFn expression profile lends validation as 
potential cells to be utilised within intestinal models; with benefits including improved 
availability, replicative potential and cost over similar primary intestinal fibroblast cells.  
 
3.5.3 Paracrine influences on structural morphology and 
Trans-Epithelial Electrical Resistance (TEER). 
The change of structural morphology seen in co-culture intestinal models implies that 
paracrine factor(s) present within the conditioned media are having effects on the 
development/ differentiation of the Caco-2 membrane over time. Interestingly, the 
phenotype change between models is different dependant on the myofibroblasts utilised 
to create the conditioned media, suggesting multiple mechanisms of action. What is more 
likely is that a complex cocktail of paracrine factors are being released into the 
conditioned media, resulting in the variable effects seen. In all cases except Caco-2/ 
HDFn culture a monolayer of cells was observed with varying polarity along the 
membrane length. Caco-2/ HDFn layers resulted in a taller multilayer epithelium. 
 
Changes in structure have been shown to have intimate effects on the function of cells. 
Indeed, the intestine itself has been shown to change the structure of epithelial enterocyte 
cells in response to a number of external stimuli such as the composition of dietary lipids 
in the intestine. (190) TEER is the foremost way in which the membrane integrity of 
Caco-2 Transwell layers is monitored throughout the models culture period. Furthermore, 
TEER is used as a quality control mechanism whereby models with a TEER above or, 
more usually, below, pre-set values are excluded from analysis. The utilisation of this 
method, whilst prevalent throughout industry, can be flawed, with low intra-lab but high 
inter-lab variation between models. Indeed, Caco-2 Transwell models have reported 14-
21 day culture TEER values of anything from 150 to 3000 ohms per cm2, 
(16,161,191,192) with differences seen without any changes in protocol between labs.  
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Caco-2 cells are well known to express a heterogenous population of cell morphologies 
when cultured in standard 2D conditions. (193) Beaulieu and Quaroni et al were one of 
the first to quantify this heterogeneity by demonstrating the mosaic expression of sucrase-
isomaltase within Caco-2 populations. (194) Caco-2 heterogeneity is seen in this study in 
the images of Caco-2 cells conducted within this work, with simple phase microscopy 
and cell shape as outlined by Occludin staining. A multitude of variable cell sized 
throughout pre and post confluent Caco-2 monolayer can be observed. Additionally, 
expression of surface transporter proteins such as MDR1 (p-gp) and MRP2 are expressed 
inconsistently across the membrane, highlighting single or small groups of cells in a 
mosaic fashion as described in other works. (193,195) This can be most clearly seen when 
cells have been cultured on Transwell membrane and allowed to differentiate for 21 days. 
MDR1 staining in particular is shown to be clearly positive in very specific cell sub-
populations throughout the model, especially in those treated with CCD-18co conditioned 
media.  
 
One possible explanation for the variation seen in Caco-2 studies between different labs 
is the accidental formation and utilisation of Caco-2 subclone populations and  is a huge 
issue in the reproduction of results between labs. Indeed, there are many well-known sub-
population of Caco-2 cells which have different structural and functional 
morphologies.(196) A simple experiment conducted by Woodcook et al (197) highlights 
the heterogeneity of Caco-2 populations. They showed that by taking a parental Caco-2 
cell line, diluting a trypsinised solution to 100 cells per flask, isolating colonies and 
utilising the cell lines produced, that significant differences could be seen in cloned 
populations TEER values in addition to changes in their transport capabilities of 
taurocholic acid.  
 
Close following of protocols is critical to maintaining reproducible TEER values over 
time and include close regulation of factors such as measurement media 
temperature(198), pH(199), passage number of cells used (200) and measurement point 
in culture period. In this study Caco-2 controls are seen to display an area corrected TEER 
value of around 2000 ohms per cm2, which, whilst on the higher end of reported values 
for Caco-2 cells, does have precedence within the literature. (201,202) Caco-2 cells are 
provided by ECACC at passage 44 with the majority of Transwell work occurring 
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between passage 48 and 55. Briske-Anderson et al showed in their study of TEER in 
Caco-2 cell models that TEER values tend to increase with increasing passage number up 
to approximately P70 whereby TEER values rapidly decrease. In fact the reported values 
of around 2000 ohms per cm2 correlate almost exactly with the TEER values of Caco-2 
cells at passage 50 in this study.(200) When compared to human tissue TEER values, 
Caco-2 cells, due to their colonic origin, are expected to provide values more in line with 
those seen in the distal regions of the intestine. Indeed, TEER values of 300 ohms per cm2 
would be in line with that seen in in vivo colon (203), but not small intestine which has 
general TEER values of below 100 ohms per cm2. (204) 
 
CCD-18co, HDFn and HIC conditioned medium was shown to have a significant 
decreasing effects on the TEER values of the epithelial membrane models. CCD-18co 
and HDFn have the largest effects on TEER values, causing a significant reduction after 
day 7 and an end TEER measurement of  approximately 500 Ohms per cm2 when 
measured at 21 days in culture, a value which is significantly more physiologically 
relevant (300 ohms per cm2 in colonic tissue) when compared to control Caco-2 layers.  
 
Whilst it is possible that changes in TEER in conditioned mediums could be effected by 
factors such as medium temperature, pH and presence of metabolic factors (17), a number 
of redundancies were used in the experimental design to mitigate these factors. 
Temperature, pH and the presence of metabolites was controlled in two mechanisms. 
First, conditioned medias were mixed 1:1 with fresh medium prior to being added to 
Caco-2, diluting any negative implications brought about by depletion of key media 
components by “conditioning” fibroblast cells. Additionally, mixing with fresh media 
allowed for a further buffering of pH levels back to normal. Second, Temperature was 
controlled through a normalisation period of 30 minutes at 37oC prior to taking 
measurements, ensuring all wells were back to 37oC during the measurement procedure.  
 
Changes in TEER measurements of Caco-2 monolayers in the presence of paracrine 
fibroblasts have also been observed in past studies. Pereira et al also showed significant 
decreases in TEER measurement when Caco-2 cells were cultured with CCD-18co cells 
in their in vitro model of the intestine. (162) They hypothesised that this decrease in TEER 
was due to the interspersing of CCD-18o cells within the Caco-2 layer, creating areas of 
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low resistance and as such lowering the total resistance measurement of the complete 
model. These experiments however, do not include direct co-culture of CCD-18co with 
Caco-2 cells within the model. Instead, models relied here on the use of conditioned 
media to induce changed in epithelial development. This media is rendered acellular 
through syringe filtering before application to the Caco-2 models, suggesting that the 
changes seen in this model are due to a secreted paracrine factor having effects on the 
growth and development of Caco-2 cells layers. As will be shown and discuss later, when 
direct co-culture in 3D models is achieved there is no evidence to suggest that CCD-18co 
physically disrupt the epithelial layer  within the model. Indeed, staining of epithelial 
specific markers such as E-cadherin or Occludin shows a consistent monolayer of Caco-
2 cells on the surface of the model without interruption from stromal located fibroblast 
populations. 
 
3.5.4 Tight junctional formation in Caco-2 control and 
paracrine treated layers and its effect on epithelial layer TEER 
and permeability. 
TEER, as previously described is the main way in which Caco-2 layers are observed 
throughout the cell culture process. The cell membrane is a poor conductor of electrical 
activity (205) and a basic principle of electrical current is that it will always follow the 
path of least resistance.  Therefore, epithelial resistance measurements mostly measure, 
and are dependent on, tight junctional formation and composition between cells, with 
higher TEER values generally correlating with increased tight junction formation and 
consistency over the entire epithelial layer. The function of tight junctions are to provide 
a barrier against the passive absorption of large macromolecular molecules which cannot 
cross the membrane passively.(206,207) These molecules are normally either 
enzymatically processed in the intestinal lumen before absorption or are actively 
transported across enterocyte membranes by the multitude of transporter protein 
complexes found embedded within the apical microvilli epithelial surface layer.  
 
Occludin is a protein found within the tight junctional complex and as such is utilised in 
this study as a marker of tight junction abundance and localisation within a cell. Caco-2 
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cells within this study are shown to express Occludin between cellular boundaries after 
as little as 2 days in culture. This staining remains strong throughout the culture period 
and increases in abundance as cells become more confluent. After confluency has been 
reached further increases in Occludin staining are difficult to quantify through 
immunofluorescence alone. Cells appear to become smaller and more uniform overtime, 
especially within HIC treated samples which can be seen visually (Not quantified) to be 
significantly smaller than control and CCD-18co/ HDFn treated samples. Smaller more 
tightly packed cells would infer an increased abundance of tight junctional complexes 
throughout the model. This observation when referred back to the TEER values gained in 
the previous section correlate well, with HIC treated monolayers having a significantly 
higher TEER value compared to other treated samples whilst still being significantly 
lower when compared to the control samples. 
With a decrease in model TEER measurement, one would expect the overall paracellular 
permeability of the epithelial model to increase. Lucifer yellow was utilised here as a 
marker of paracellular transport. Interestingly, changes in TEER measurement did not 
correlate directly with increases in permeability of lucifer yellow. Significant decreases 
in TEER values did not result in a significantly more “leaky” epithelial models, 
suggesting changes in TEER values are potentially through a different mechanism than 
modulation of tight junction complex integrity or abundance. Although, a non-significant 
increasing trend in permeability is seen with conditioned media samples compared to 
controls.  
 
Addition of KGF to the epithelial layers resulted in a highly significant decrease in TEER, 
whilst also decreasing membrane permeability. This is in contrast to paracrine media 
layers which, whilst non-significantly different from control layers, did show a moderate 
increase in permeability values. The opposite effect when culturing Caco-2 cells with 
KGF suggests that KGF is not the driving factor in conditioned media experiments, with 
apparent differences in mechanistic action. However, these differences could also be due 
to any number of complex small molecule co-interactions present in the conditioned 
media which are not present in the pure KGF spiked samples.  
 
Kim et al (208) conducted a similar experiment whereby they co-cultured Caco-2 
Transwell monolayers with direct and Paracrine CCD-18co conditioned media in addition 
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to adding supplemental KGF to culture media. Their results reflect what is seen in this 
present study whereby CCD-18co conditioned and KGF supplemented media both had 
the effect of reducing TEER values of mature models. Interestingly, the authors also show 
that addition of KGF to culture media results in an increase in Claudin 2 (Tight junctional 
component protein) without any increases in other significant tight junctional proteins 
such as Claudin 1, Occludin or ZO-1. On the surface, increased expression of a tight 
junctional component, resulting in a decreased epithelial resistance, seems to lack sense. 
However, more recent studies of the function of Claudin-2 have implicated it in the 
creation of “leaky” tight junctions through channel formation within the tight junctional 
complexes, making them more permeable to paracellular water flux. (209–211) This 
leakier tight junctional complex could then explain the decreases seen in TEER values of 
myofib conditioned and KGF treated layers. This “leaky” tight junctional complex is 
thought to be permeable to Li+, Na+ and K+ ions in addition to being permeable to water 
molecules less than 2.8Å in diameter.(209) Lucifer yellow has been shown to have a 
diameter of approximately 9.9Å in diameter, (212) and as such would be too large to fit 
through the “leaky” claudin-2 expressing tight junctions. This puts the data found in this 
study into context whereby TEER has been shown to decrease without any significant 
changes in Lucifer Yellow permeability. Increases in claudin-2 expression can also be 
seen in diseases such as IBD, where by the proliferative progenitor cells at the base of the 
intestinal crypt show heighted levels of Claudin-2 expression correlating with an increase 
in the rate of proliferation. (211,213)  
 
The addition of KGF to Caco-2 monolayers has significant effects on the metabolic 
activity of the cells. Indeed, close analysis of the curve created by measuring the change 
in metabolic activity over time shows that KGF prolongs the exponential phase of growth, 
resulting in a significantly higher MTT value after 10 days in culture. Whilst not tested 
in this study my hypothesis would be that the more metabolically active cell layers show 
similarly heightened levels of Claudin-2 expression mediated by KGF paracrine factors.  
Indeed, when looking at growth curves of models grown in conditioned media it was clear 
that addition of CCD-18co conditioned media has a similar effect on metabolic activity 
over time to that seen in the KGF spiked media assays. Interestingly, HIC and HDFn 
conditioned media does not create the same effect, with no significant differences seen 
between the growth curves of those conditions compared to the controls. CCD-18co MTT 
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curves in particular do not reach plateau like values seen in control samples. This could 
suggest the initiation of a proliferative (inflammatory) repair response as discussed 
earlier.  
 
KGF levels secreted into the conditioned media by ELISA was quantified to assess 
changes in secretion amounts between culture conditions. The results show that compared 
to other conditions, CCD-18co cells secrete far more KGF than their HIC and HDFn 
counterparts both in 2D and 3D models (3D model development will be discussed in 
chapter 5). This ties in nicely with the data discussed previously, whereby CCD-18co 
conditioned media experiments have a significantly lowered TEER value, an increased 
MTT growth curve reminiscent of KGF spiked media experiments and a non-significantly 
different passive permeability to lucifer yellow.  
 
Interestingly, when comparing 2D to 3D cultured CCD-18co fibroblasts there is a 
significant decrease in KGF secretion, when normalised to DNA content, down to 
approximately the same levels of KGF secreted by normal (Non-carcinoma origin) human 
cells. 3D culture within Alvetex® therefore appears to be modulating the physiology of a 
cancer derived cell line back into a normal phenotype. Saavedra et al (214) utilised 
Alvetex Scaffold® for the culture of human mesenchymal stem cells (hMSC) in 3D to 
assess the secretome changes of these cells between 2D and 3D conditions. They found 
that significant changes were induced through 3D culture, some small molecules such as 
IGF-1 were shown to increase whilst others such as VEGFR-1, MCP-1 and IL-6 
decreased in 3D culture. In each case they showed that 3D paracrine media has beneficial 
effects on the differentiation of both HUVEC and Osteoclasts into functional tissues, 
highlighting the physiologically relevant changes induced through 3D culture. Other 
studies such as the Melissaridou et al showed that the 3D culture of cells created a more 
mimetic model of cancer growth by enhancing the inherent phenotype of the cells used 
within the model. (215) It could be hypothesised that normal KGF levels within the 
intestine are similar to those secreted by HDFn and HIC cells seen within this study. 
Under this assumption culture of CCD-18co cells in 3D reduces the KGF amount secreted 
to more physiological levels. Indeed, previous studies have shown that cancer cells are 
well known to over express KGF within the intestine.(213,216) For example, Watanabe 
et al showed in their study that 10 out of 12 cases showed significantly increased KGF 
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expression within cancerous tissues compared to normal tissues of the same origin. KGF 
is a known regulator of cell proliferation as discussed previously, and as such is thought 
to have proliferation promoting effects on epithelial cells within cancer tissues, 
potentially contributing to the rapid proliferating cancer phenotype and hence the 
significant effects in Caco-2 cells. Riedl et al (217) recently showed how Colorectal 
adenocarcinoma cell lines, normally utilised for intestinal modelling such as Caco-2 and 
HT29, when grown in 3D spheroids, significantly reduced their proliferative “cancer-
like” phenotype as well as rewiring in signalling and a reduction in the AKT–mTOR–
S6K pathway, known to be important in regulation of the cell cycle.(217,218) To suggest 
that CCD-18co cells “lose” their cancer phenotype based on evidence in this study is 
premature. However, evidence does seem to point to a more physiologically “normal” 
cell compared to their 2D cultured counterparts. 
 
Analysis of KGF ELISA results also shows that when CCD-18co cells are cultured in the 
paracrine media of Caco-2 cells there is a significant reduction in KGF secreted into the 
paracrine media. This decrease is seen in both 2D and 3D cultured cells and is decreased 
proportionally by approximately the same relative amount in each. Evidence of Caco-2 
cross-talk with underlying myofibroblasts is seen throughout the literature. Drygiannakis 
et al studied the effects of Caco-2 conditioned media on myofibroblasts (Human Crohns 
and CCD-18co) paracrine secretion. They found that Caco-2 cells secreted significant 
levels of TGF-β1 without any additional stimuli. (219) This secretion was seen to induce 
modulation of myofibroblast secretome, with changes in MMP-9 and collagen secretion. 
Further to this, Brenmoehl et al showed that TGF-β has differentiation inducing effects 
on sub-epithelial myofibroblasts,(220) with increased levels of smooth muscle actin 
formation in treated cells.. This activation event mediated through TGF-β secretion is 
normally important in tissue repair and remodulation. This study was one of the first to 
show that Caco-2 conditioned media has the effect of decreasing KGF secretion in 
carcinoma derived sub-epithelial myofibroblasts, specifically CCD-18co cells. Whilst not 
shown here it was hypothesised that stimulation of CCD-18co cells by TGF-β1 causes 
CCD-18co cells to differentiate further, expressing greater levels of αSMA and 
decreasing KGF secretion into paracrine media.  
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HIC cells only induced a marginal decrease in TEER values and have no significant 
effects on membrane metabolic activity suggesting any physiological differences between 
control and HIC layers are not induced through the paracrine effects of KGF. This is 
further suggested through analysis of KGF concentration within conditioned media 
samples. Only marginal levels of KGF were detected within HIC conditioned media 
(~KGF concentration of 30-40 pg/ml). 
 
Interestingly, HDFn paracrine co-culture reduces the TEER values of Caco-2 models to 
a similar degree as CCD-18co conditioned media, without the similar changes in 
metabolic activity. KGF ELISA results show only marginal secretion of KGF into HDFn 
conditioned media at levels far lower than those tested in KGF treated samples (~KGF 
concentration of 50 pg/ml). This suggests that the reduction in TEER mediated by HDFn 
conditioned media is not induced through KGF secretion but by some other paracrine 
small molecule. KGF is thought to be secreted in the dermis of the skin but evidence 
shows that heightened levels are only observed in the case where cells are activated in a 
disease state. (221) Canady et al showed through ELISA based detection that normal 
HDFn cells secrete KGF at a rate of approximately 10 pg/ml. Levels very similar to those 
seen in this study. What then could be effecting the Caco-2 layer in such a way to 
significantly reduce TEER?  
 
FGF-10, epidermal growth factor (EGF) and interleukin 6 (IL-6) have all been shown to 
be released by HDFn cells, having effects on the development and maintenance of the 
overlying keratinocyte layers. (222) FGF-10(223) and EGF(224) both are known as 
epithelial mitogens, as such are unlikely to be involved in the phenotypic change seen in 
Caco-2 cells in this study. Interestingly, IL-6 has been shown to modulate Claudin-2 
expression, increasing tight junction permeability similarly to the mechanism induced by 
KGF. (225) Miyake et al showed that IL-6 also has effects on the transport capabilities of 
the Caco-2 membrane, increasing P-gp and MRP mediated transport. (226). The transport 
capabilities of the models will be discussed in further depth in Chapter 7.  
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3.5.5 Understanding the effects of conditioned media and KGF 
spiked media on the relative expression of key junctional and 
transporter proteins as assessed through qPCR analysis of 2D 
Caco-2 layers. 
Quantitative mRNA analysis of Caco-2 layers shows significant changes occur when cells 
are cultured in the paracrine effects of CCD-18co, HIC and HDFn cells. The first analysis 
that was attempted was in understanding the effects of different culture conditions on the 
composition of the tight junction complex. Three mRNA sequences were tested, 
Occludin, Claudin 2 and ZO-1. As discussed previously here Claudin-2 was of particular 
interest due to the hypothesis described earlier whereby KGF enhances the production of 
Claudin-2, increasing the permeability of the resultant tight junction to ions and small 
water soluble compounds. What was discovered however was the converse with KGF 
treated layers having significantly less Claudin-2 mRNA in comparison to control levels.  
 
Whilst this at first may seem to disprove the hypothesis formulated here it is important to 
remember that mRNA analysis of lysed samples provides only a single snapshot of the 
cells expression levels. Essentially, mRNA levels do not always reflect the abundance of 
a particular protein within a cells. For example, data shown earlier in this work shows 
that tight junctions formation between Caco-2 cells begins immediately upon cell contact, 
with even sub-confluent populations of cells showing strong expression of Occludin, a 
key tight junctional component between adjacent cells. By 21 days in culture one would 
expect tight junctions to be completely constructed through the cells. As such any new 
mRNA translation would be to maintain expression levels rather than creating new 
junctions.  Indeed, Claudin-2 has been shown to be a relatively long lived tight junctional 
component with Van Itallie et al (227) demonstrating how the cytoplasmic tail of Claudin-
2 is important in the proteins longevity, with a half-life in excess of three times that of 
Claudin 4. These could have significant effects on the levels of mRNA expression within 
the cells with lower levels not necessarily representing true protein abundance.  
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Expression levels of important efflux proteins such as MDR1, MRP1 and MRP2 also 
showed significant variation between models with conditions often showing the largest 
changed in relative mRNA whereas HIC conditioned media either resulted in no 
significant differences or a reduction relative to the control. MDR1 levels were seen to 
drastically and significantly increase in the presence of KGF supporting the conclusion 
that KGF is important in the maturation and differentiation in the intestinal epithelium. 
MDR1/ P-gp levels are generally thought to be under expressed in the Caco-2 layer. An 
increase in the amount of P-gp present within the Caco-2 layer has implications in the 
functionality of the resultant models, allowing for more sensitive assays for the detection 
of potential substrate of P-gp in the human intestine. Potentially, heighted P-gp levels 
could identify compounds which fall under the functional detection range of current 
models.  
 
Analysis of both mRNA expression levels and protein abundance through western blot 
would give a more representative idea of the mechanisms within the cells resulting in the 
observed changes in phenotype. Often these mechanisms are far too complex to get a 
definitive answer without utilising multiple methods of analysis and testing the models 
through multiple mechanisms. The mRNA analysis done here is simply a first step in this 
process and could not be justified utilised as standalone data.  
 
3.6 Conclusion 
A complete understanding the complexity of the formation, maintenance and 
differentiation of Caco-2 cells in addition to intestinal epithelia in general is far beyond 
the scope of this work. What was shown here is that the paracrine secretome of intestinal 
fibroblasts, both of normal and carcinoma origins along with general skin fibroblasts can 
have significant effects on epithelial structure, TEER values of a membrane, cellular 
metabolism and on the expression of functional mRNAs important in the production of 
key tight junctional and functional efflux transporter proteins. It was postulated that KGF 
was one of the paracrine influences having a significant effect on the above phenotypes. 
It was found that KGF does indeed have many of the same effects as conditioned media 
samples and that CCD-18co cells were able to secrete KGF at physiological 
concentrations into the conditioned media. Differences were seen on further downstream 
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analysis between conditioned media samples and pure KGF spiked media conditions, 
suggesting that whilst KGF does have an important role to play, at least in CCD-18co 
conditioned media samples, it is not the only paracrine factor which is having effects on 
the epithelial phenotype. HDFn and HIC mechanistic action is more difficult to identify 
with only small amounts of secreted KGF detected in conditioned media samples. Indeed, 
without a large scale broad study of the paracrine media, finding potential candidates is 
largely a matter of careful reading of past literature and, to a greater scale, luck. 
 
Further work in this area should include said broad, large scale analysis of the fibroblast 
secretome, perhaps through modern sequencing techniques, in order to precisely identify 
potential candidates for further analysis and quantification. Additionally, further work 
could be done on the quantification of total protein levels through western blot analysis 
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4. Epithelial - Goblet cell co-culture and its effect on model 
function. 
4.1 Introduction 
Many attempts over the past decade have been made to improve the standardised Caco-2 
models in such a way to increase the relevance of Caco-2 studies whilst maintaining the 
high throughput nature of the assay and its low cost. As the described in the previous 
chapter, one simple way of achieving this is through the paracrine action of tissue specific 
fibroblasts on the development of the epithelial membrane. Another strategy is through 
the addition of other cell lines with distinct functions to the Caco-2 cellular models at the 
appropriate physiological ratios. The addition of goblet cells is one of the main areas in 
which this concept has been applied. 
 
4.1.1 Understanding the structure of the mucus layer and its 
importance on the functional aspects of the human intestine. 
The goblet cells and the associated mucous layer is highly variable dependant on the 
region of the intestine studied. Structurally the mucus layer changes in distinctive ways 
from the proximal small intestine to the distal colon, with the changes in structure 
correlating with distinct changes in function. (129) The small intestine mucus is primarily 
formed of MUC2 and forms a single layer over the surface of the villus tips. This mucus 
layer is not impermeable to bacteria as the small intestine requires ease of movement of 
soluble nutrient to facilitate uptake into the body. (91) Instead, this single layer of mucus 
is populated with secreted antimicrobial proteins and peptides in order to limit enterocyte/ 
bacterial contact. In contrast the colon consists of an outer mucus layer which is home to 
many commensal bacterial populations with an inner layer which is essentially acellular. 
(54)  
 
Very generally, the mucus layer is important in a number of key functions of the intestine, 
namely as a matrix for the colonisation of bacteria away from the surface epithelial layer, 
maintaining a sterile layer immediately above the epithelial layer and in the controlled 
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absorption/ as a barrier to macromolecules.(91) Indeed, the mucous layer has been 
demonstrated repeatedly to be highly important in assessing the absorption kinetics of 
drug compounds into the blood stream. (228–231) 
 
The mucous produced within the intestine is composed of proteins known as mucins 
which can be further categorised in to 2 main types; 1. Transmembrane and 2. Secretory 
mucins. Transmembrane mucins are created by enterocytes and, as the name suggests, 
are anchored to the enterocyte apical membrane. The exact function of the transmembrane 
mucins within the body is poorly understood. Enterocytic transmembrane proteins such 
as MUC3 (232), 13, 12 and 17 are most likely to form a physical absorption barrier to 
large macromolecules, not readily absorbed by the intestinal epithelium and are almost 
certainly the components which make up the Glycocalyx in the intestine. (56,233) 
Additionally, it is thought that the cytoplasmic domains of these transmembrane proteins 
interact with signalling pathways within the enterocyte cytoplasm which are involved in 
the apical membrane organisation, inflammation, differentiation, apoptosis and ion 
channel presentation. (234,235) This suggests that these transmembrane mucins may be 
utilised as a primitive sense organ, allowing for some dynamic, active, remodelling 
dependant on cellular environment. Interestingly, regarding the immune component of 
mucins there is further evidence to support the hypothesis that resident probiotic microbes 
within the intestine may also be important in the intestines innate immunity through their 
ability to induce mucin secretion in the presence of competing pathogenic organisms. 
(236) The transmembrane mucins have been shown to contain with extracellular domains 
able to bind bacteria, initiating a shedding of affected mucin complexes and the 
stimulation of an inflammatory response. (234,237) 
 
4.1.2 Limitations of the Caco-2 system to model the effects of 
mucus on the drug pharmacokinetics and methods to more 
accurately mimic the intestinal epithelium.  
Caco-2 cells have been shown to produce a very small, if any, amount of mucous. (238) 
Therefore, in its gold standard format, the Caco-2 cell assay poorly recapitulates the 
mucous layer of the intestine, lacking structure and the complex cocktail of mucin 
Chapter 4 – Goblet cell co-culture model of the intestinal epithelium  
Page | 195 
 
proteins produced by true goblet cell lineages and hence the complex signalling 
environment created by a mucous membrane. (239)  
 
The HT29-MTX cell line is a methotrexate treated sub-population of the parental HT29 
population.(240) This line is known to exhibit goblet cells “like” characteristics with 
ample mucous production seen in standard cell culture conditions.(241,242) The benefit 
of this cell line lies in its easy availability and reproduction, making it a valuable tool for 
application into standardised epithelial models. Since the protocol for its formation was 
published in the early 90s, HT29-MTX cells have been explored as potential co-culture 
candidates with Caco-2 cells quite extensively with the aim of creating an epithelial 
construct with absorptive and mucus barrier functions. Careful optimisation and 
calibration of culture conditions is required in co-culture systems in order to maintain the 
correct cellular ratios throughout the culture period and in the final models. Many 
differing methods have been developed to tackle this with the simplest such as in the 
study by Hilgendorf et al (161) where they create the co-culture models through ratio 
seeding of Caco-2 and HT29-MTX cells at day 0 of the model culture period. Also in the 
study by  Lozoya-Agullo et al (131) where they did the same at a 90:10 Caco-2 to HT29-
MTX ratio. Even these simple culture methods however resulted in a stepwise decrease 
in TEER in models with higher HT29-MTX content with an increasing permeability to 
passive absorption test compounds as the percentage of Caco-2 cells per model decreased. 
Unfortunately, neither of the authors quantified the absolute levels of HT29-MTX cells 
in the end culture so it is impossible to know if the original seeding ratios were maintained 
throughout the culture period.  
 
More complex culture methodologies such as that by Béduneau et al (243) focus on the 
addition of HT29-MTX cells at different stages of development of the Caco-2 epithelial 
constructs. This method is able to create models with decreasing TEER with increasing 
levels of HT29-MTX and changes in the functional permeability of the resultant model  
in the same way as day 0 ratio culture achieves. Whilst the authors here did attempt to 
quantify the extent of HT29-MTX cells in the end cultures, primarily through p-gp 
expression rates, no definitive test has been created which can give definite cellular ratios 
in co-culture intestinal equivalents. The addition of further complexity to this co-culture 
model is highly limited in the literature, with a few examples attempting to add an 
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immune component to the epithelial models, (131) in understanding the complex cross 
talk between bacterial populations and intestinal epithelial layers (244,245) or in 
fibroblast effects on goblet cell morphology. However, regardless of the culture 
methodology widespread adoption of a Caco-2/ HT29-MTX model of the intestinal 
epithelium is still unfortunately limited. New methods for the formation of co-culture 
models which can reliably form constructs with defined cellular ratios are required before 
extensive use can be expected. 
 
As shown in the previous chapter addition of fibroblast conditioned media can have 
distinct effects on the physiology and function of intestinal epithelial cells, namely Caco-
2. Examples of co-culture models of Caco-2/ HT29-MTX cells with influences from 
fibroblast conditioned media are lacking in the literature. The novel aspect of this chapter 
is in the attempted creation of  a reliable intestinal model incorporating goblet cell 
morphology through ratio based seeding techniques and co-culture with conditioned 
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4.2 Hypothesis, Aims and Objectives 
4.2.1 Hypothesis 
It is hypothesised that the co-culture of Caco-2 cells with HT29-MTX “goblet-like” 
epithelial cells will result in an epithelial construct with improved functional capabilities 
over current Caco-2 gold standards. Further to this it is hypothesised that paracrine factors 




The aims of this chapter were to create an epithelial co-culture model of the intestinal 
epithelium, incorporating both Caco-2 enterocytes and HT29-MTX “goblet” cells and 
assessing the effects of paracrine media on the formation of the enterocyte/ goblet cell 
co-cultures. Resultant models were to be assessed in terms of both structure and function. 




The objectives of this chapter are summarised below; 
• Assess changes in TEER values caused by goblet cell co-culture and CCD-18co 
paracrine media. 
• Structurally assess resultant models through H+E staining and mucous production 
rates by PAS staining. 
• Immuno-characterisation of key junctional and transporter proteins.  
• TEM ultra-structure analysis. 
• qPCR quantification of relative expression of key genes of interest involved in 
junction formation and transporter protein expression. 
• Functional assessment of co-culture models through Rhodamine 123 transport. 
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4.3 Materials and Methods 
4.3.1 Generation of epithelial co-culture models consisting of 
Caco-2 and HT29-MTX cells. 
Caco-2 and HT29-MTX cells were passaged and counted as previously described 
(Section 2.2). 250,000 cells were seeded per Snapwell Transwell insert in 500μl of pre-
warmed DMEM. The number of models was calculated before hand and a master mix of 
seeding solution was prepared to reduce the variability between models of a single batch. 
500μl of seeding solution containing Caco-2 and HT29-MTX cells at the correct seeding 
density and ratio was added to the apical compartment of the Snapwell Transwell and 3ml 
of DMEM is added to the outside compartment. Models were incubated for 21-25 days 







500μl Cell Mix 
21-25  
Days 
Figure 4.1: Schematic diagram of the process for the set up and culture of Caco-2/ HT29-MTX 
co-culture mucus models of the intestinal epithelium – Caco-2 and HT29-MTX cells are 
trypsinised as normal and placed at the correct proportions into a cell mix. Cells are diluted to 250 
000 total cells/ 500μl and cultured in Snapwell inserts 
Caco-2 
HT29-MTX 
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taken throughout the culture assay when required or immediately before analysis. TEER 
measurements were taken as previously described (Section 2.16) 
 
For CCD-18co paracrine co-culture, models are initially set up as described above. CCD-
18co paracrine conditioned media is created as previously described (Section 2.12) before 
being added to the models after an initial 2 days of culture in normal DMEM to allow for 
establishment of cells onto the Transwell surface. CCD-18co media is replaced every two 
days for a growth period of 21-25 days.  
 
4.3.2 H&E, PAS staining of sectioned and wholemount Caco-2/ 
HT29-MTX co-culture models. 
Epithelial co-culture models were fixed in PFA, embedded and sectioned as previously 
described (Section 2.3.1). For sectioned slides H&E and PAS staining was also as 
previously described (Section 2.5.1 and 2.5.2 respectively). Whole mount staining was 
achieved utilising the previously described (Section 2.4.3). Briefly, all processing and 
staining steps were done with the Transwell still attached to the Snapwell insert. Samples 
were fixed in 4%PFA before being dehydrated through ethanol, incubated in Histoclear 
and rehydrated. This step was done to reasonably limit any variations in staining colour/ 
intensity when comparing against paraffin embedded sectioned samples which must go 
through the previous steps. H&E or PAS staining was then done following a normal 
protocol as described previously. Stained Transwell models were removed from Snapwell 
inserts immediately prior to mounting on a standard Super frost microscope slide. After 
mounting of the sample, gentle pressure was applied to the slide whilst drying in order to 
ensure Transwell layers remained flat against the glass.  
 
4.3.3 Toludine blue staining of epithelial co-culture models. 
Samples were processed into resin as previously described in the main methods sections 
(Section 2.7). Semi-thin (1μm) sections were placed onto a glass slide suspended in water 
before being heat dried using a medium heat hot plate. Once dry samples were stained by 
addition of one drop of Toludine Blue (pH 2-2.5) for a period of 2 minutes. Stained 
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sections were washed well with distilled water until the slide and water ran off clear. 
Slides were dehydrated, cleared and mounted utilising normal protocols.  
 
4.3.4 TEM analysis of Caco-2/ HT29-MTX co-culture 
constructs. 
Samples were processed into resin as previously described (Section 2.7) before sectioned 
ultra-thin and transferred to copper grids. Copper grids were then double contrast stained 
with Uranyl Acetate and Lead citrate before being imaged on (H7600 TEM) 
 
4.3.5 qPCR analysis of Snapwell Transwell epithelial co-
culture constructs. 
Samples were processed as described previously (Section 2.9). RNA was isolated and 
quality checked utilising a nanodrop spectrometer. RNA was immediately converted into 
cDNA and stored at -20oC. A SYBR detection system was used. 
 
4.3.6 Rhodamine 123 transport analysis of epithelial co-culture 
constructs. 
Snapwell epithelial construct were removed from culture after 21-25 days and first 
washed gently in PBS to remove remaining media. Inserts were carefully added into the 
Ussing system into CH8 chambers specifically designed for use with Snapwell inserts. 
15ml of prewarmed HBSS containing 1g glucose per litre, which will be referred to as 
Transport media from here onwards, was added to each side of the Ussing chamber 
reservoirs. 95% O2 5% CO2 was gently bubbled through the HBSS. The entire equipment 
set up was maintained at 37oC through use of a circulating water bath and a fluid jacket. 
Models were left in the chamber for a minimum of 30 minutes to allow for full 
acclimatisation. Rhodamine 123 was then added to the donor compartment to create a 
final concentration of 5μM. Samples were taken from the receiver reservoir at 60 minute 
intervals. Any volume removed was replaced with fresh transport media. 
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Figure 4.2: Schematic diagram of the process for the set-up of Caco-2 co-culture models within 
an Ussing chamber system – The systems consists of two reservoirs encircled by a circulating water 
bath maintaining an constant 37oC. Analyte of interest is added to either of the reservoirs dependant 
on the experiment (B-A or A-B). Carbogen gas is bubbled through the reservoirs to both oxygenate 
and circulate the system. Models are placed in a chamber system attaching to the reservoirs providing 
a singular interface between reservoirs. Samples are taken after set time points with any volume 
removed being replaces so as not to induce pressure changes between chambers. 
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4.4 Results 
4.4.1 Trans-epithelial resistance measurements of Caco-
2:HT29-MTX co-cultures and the effects of CCD-18co 
conditioned media on resultant co-culture layers. 
Caco-2 cells were co-cultured in a number of key ratios, determined through analysis of 
histological section of Human intestine, with HT29-MTX cells on Snapwell Transwell. 
Figure 4.2 shows the data gained from analysis of TEER of resultant Transwell models 
over the course of 21 days culture. As seen previously untreated Caco-2 layers show a 
relatively linear phase of growth with a short lag phase before a rapid increase in TEER 
values between days 6 and 16 followed by a final plateau until 21 days in culture. Final 
TEER values of untreated Caco-2 layers as similar to that as seen previously at 
approximately 2000-2500 ohms (Figure 4.2 A) 
 
The addition of HT29-MTX cells to the Caco-2 layers results in a significant decrease in 
TEER values throughout the course of the culture period with maximal 21 day TEER 
values of 1200 and 1000 ohms in 90 and 80% Caco-2: HT29-MTX co-cultures 
respectively. The curve generated through analysis of co-culture TEER over the 21 day 
culture period results in a trend line with a linear increase in TEER values over time with 
less pronounces lag, log and plateau phases. Culture of HT29-MTX cells alone results in 
a maximal TEER value of <100 ohms, significantly less than Caco-2 cells (Figure 4.2D) 
The addition of CCD-18co conditioned media to the co-culture Transwell layers has 
differential effects depending on the ratio of HT29-MTX cells which are present in the 
culture. Caco-2 cells control models show a similar phenotype as to that shown earlier in 
the previous chapter (Figure 3.9) with a significant decrease in measured TEER values 
under conditioned media conditions. Conversely, the addition of CCD-18co conditioned 
media to Caco-2: HT29-MTX co-culture layers results in a significant increase in the 
resultant models measured TEER values over control values of the same cellular ratios. 
Figure 4.2 B shows a consistent, stable increase in TEER value of between 500 and 1000 
ohms over the 90% control after day 6 in culture. Figure 4.2 C shows a trend in the 80% 
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co-culture with an increase in TEER values over the control samples consistently 
throughout the course of the 21 day co-culture. By day 21 the difference in TEER values 
between the control and CCD-18co treated samples is approximately double that of the 
control. HT29-MTX cells grown in the paracrine presence of CCD-18co fibroblasts 
shows a significantly increased TEER value over the HT29-MTX control. 21 day HT29-
MTX co-cultures ended with a TEER value of approximately 2000 ohms in comparison 
to the less than 1000 ohms of the control samples. Interestingly, the TEER values of the 
treated HT29-MTX co-culture was very similar to that of the Caco-2/ CCD-18co 
paracrine culture suggesting a change from a goblet cell phenotype to one more similar 
to that of a standard enterocyte.  
 
Figure 4.3 shows the different culture conditions compared to one another, both in control 
and CCD-18co paracrine conditions. Figure 4.3 A, shows the stepwise decrease in TEER 
values induced through co-culture of Caco-2 cells with HT29-MTX without the effects 
of paracrine media. As can be seen, increasing levels of HT29-MTX presence directly 
correlates with a decrease in overall TEER value of the models. Figure 4.3 B shows the 
effects of the same ratios together with CCD-18co paracrine media. As seen be seen the 
result of this effective triple co-culture is the convergence of TEER values to a similar 
level in each condition regardless of the HT29-MTX ratio in the models.  
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Figure 4.3: Caco-2/ HT29-MTX co-culture decreases the TEER values of resultant epithelial 
constructs – A) 100% Caco-2, B) 90%/10% Caco-2/ HT29-MTX, C) 80%/20% Caco-2/HT29-MTX, 
D) 0%/100% Caco-2/ HT29-MTX. All cellular ratios were performed in the presence (+) and absence 
(-) of CCD-18co conditioned media. Addition of CCD-18co paracrine media to HT29-MTX cells 
results in an increase in the TEER levels of the resultant model. The converse is true in Caco-2 
monocultures which decrease in TEER. n=3-6 from a minimum of 3 independent experiments. 
Significant differences calculated by one way ANOVA with Tukeys post-test analysis *** = P<0.0001, 
** = P<0.001, * = P< 0.01. (Tables 4.1) Error bars represent ±SEM of average values. 
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Figure 4.4: CCD-18co paracrine co-culture with Caco-2/ HT29-MTX epithelial constructs 
increases TEER values compared to non-treated controls  – A) Co-cultures without the presence 
of CCD-18co conditioned media. Co-culture layers show increasing TEER values over time with 
maximal TEER values decreasing correlating to increased HT29-MTX proportion.  B) Co-culture 
Transwell models in the presence of CCD-18co conditioned media show increased TEER compared 
to control layers. Treated models show approximately double the TEER values of control 
conditions. n=4-8 N=from a minimum of 4 independent experiments. Error bars represent ±SEM 
of average values. 
A 
B 
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Caco-2 Day 8 vs Caco-2 Day 14 * 90%/10% Day 8 vs Caco-2 CCD+ Day 14 *** 80%/20% Day 14 vs 80%/20% CCD+ Day 14 * 
Caco-2 Day 8 vs Caco-2 Day 20 *** 90%/10% Day 8 vs Caco-2 CCD+ Day 20 *** 80%/20% Day 14 vs 80%/20% CCD+ Day 20 *** 
Caco-2 Day 8 vs 80%/20% Day 8 ** 90%/10% Day 8 vs 90%/10% CCD+ Day 14 ** 80%/20% Day 14 vs HT29-MTX CCD+ Day 20 *** 
Caco-2 Day 8 vs HT29-MTX Day 8 ** 90%/10% Day 8 vs 90%/10% CCD+ Day 20 *** HT29-MTX Day 8 vs Caco-2 CCD+ Day 8 *** 
Caco-2 Day 14 vs 90%/10% Day 8 *** 90%/10% Day 8 vs 80%/20% CCD+ Day 14 ** HT29-MTX Day 8 vs Caco-2 CCD+ Day 14 *** 
Caco-2 Day 14 vs 90%/10%Day 14 *** 90%/10% Day 8 vs 80%/20% CCD+ Day 20 *** HT29-MTX Day 8 vs Caco-2 CCD+ Day 20 *** 
Caco-2 Day 14 vs 80%/20% Day 8 *** 90%/10% Day 8 vs HT29-MTX CCD+ Day 14 * HT29-MTX Day 8 vs 90%/10% CCD+ Day 14 *** 
Caco-2 Day 14 vs 80%/20% Day 14 *** 90%/10% Day 8 vs HT29-MTX CCD+ Day 20 *** HT29-MTX Day 8 vs 90%/10% CCD+ Day 20 *** 
Caco-2 Day 14 vs HT29-MTX Day 8 *** 90%/10%Day 14 vs Caco-2 CCD+ Day 14 *** HT29-MTX Day 8 vs 80%/20% CCD+ Day 14 *** 
Caco-2 Day 14 vs HT29-MTX Day 14 *** 90%/10%Day 14 vs Caco-2 CCD+ Day 20 ** HT29-MTX Day 8 vs 80%/20% CCD+ Day 20 *** 
Caco-2 Day 14 vs HT29-MTX Day 20 ** 90%/10%Day 14 vs 90%/10% CCD+ Day 14 * HT29-MTX Day 8 vs HT29-MTX CCD+ Day 14 ** 
Caco-2 Day 14 vs 90%/10% CCD+ Day 8 ** 90%/10%Day 14 vs 90%/10% CCD+ Day 20 ** HT29-MTX Day 8 vs HT29-MTX CCD+ Day 20 *** 
Caco-2 Day 14 vs 80%/20% CCD+ Day 8 * 90%/10%Day 14 vs 80%/20% CCD+ Day 20 *** HT29-MTX Day 14 vs Caco-2 CCD+ Day 14 *** 
Caco-2 Day 14 vs HT29-MTX CCD+ Day 8 *** 90%/10%Day 14 vs HT29-MTX CCD+ Day 20 ** HT29-MTX Day 14 vs Caco-2 CCD+ Day 20 ** 
Caco-2 Day 20 vs 90%/10% Day 8 *** 90%/10% Day 20 vs 80%/20% Day 8 * HT29-MTX Day 14 vs 90%/10% CCD+ Day 14 * 
Caco-2 Day 20 vs 90%/10%Day 14 *** 90%/10% Day 20 vs HT29-MTX Day 8 * HT29-MTX Day 14 vs 90%/10% CCD+ Day 20 *** 
Caco-2 Day 20 vs 90%/10% Day 20 ** 80%/20% Day 8 vs Caco-2 CCD+ Day 8 *** HT29-MTX Day 14 vs 80%/20% CCD+ Day 14 * 
Caco-2 Day 20 vs 80%/20% Day 8 *** 80%/20% Day 8 vs Caco-2 CCD+ Day 14 *** HT29-MTX Day 14 vs 80%/20% CCD+ Day 20 *** 
Caco-2 Day 20 vs 80%/20% Day 14 *** 80%/20% Day 8 vs Caco-2 CCD+ Day 20 *** HT29-MTX Day 14 vs HT29-MTX CCD+ Day 20 *** 
Caco-2 Day 20 vs 80%/20% Day 20 ** 80%/20% Day 8 vs 90%/10% CCD+ Day 14 *** Caco-2 CCD+ Day 8 vs HT29-MTX CCD+ Day 8 ** 
Caco-2 Day 20 vs HT29-MTX Day 8 *** 80%/20% Day 8 vs 90%/10% CCD+ Day 20 *** Caco-2 CCD+ Day 14 vs HT29-MTX CCD+ Day 8 *** 
Caco-2 Day 20 vs HT29-MTX Day 14 *** 80%/20% Day 8 vs 80%/20% CCD+ Day 14 *** Caco-2 CCD+ Day 20 vs HT29-MTX CCD+ Day 8 *** 
Caco-2 Day 20 vs HT29-MTX Day 20 *** 80%/20% Day 8 vs 80%/20% CCD+ Day 20 *** 90%/10% CCD+ Day 14 vs HT29-MTX CCD+ Day 8 ** 
Caco-2 Day 20 vs Caco-2 CCD+ Day 8 *** 80%/20% Day 8 vs HT29-MTX CCD+ Day 14 ** 90%/10% CCD+ Day 20 vs HT29-MTX CCD+ Day 8 *** 
Caco-2 Day 20 vs 90%/10% CCD+ Day 8 *** 80%/20% Day 8 vs HT29-MTX CCD+ Day 20 *** 80%/20% CCD+ Day 14 vs HT29-MTX CCD+ Day 8 ** 
Caco-2 Day 20 vs 80%/20% CCD+ Day 8 *** 80%/20% Day 14 vs Caco-2 CCD+ Day 14 *** 80%/20% CCD+ Day 20 vs HT29-MTX CCD+ Day 8 *** 
Caco-2 Day 20 vs HT29-MTX CCD+ Day 8 *** 80%/20% Day 14 vs Caco-2 CCD+ Day 20 *** HT29-MTX CCD+ Day 8 vs HT29-MTX CCD+ Day 14 * 
Caco-2 Day 20 vs HT29-MTX CCD+ Day 14 ** 80%/20% Day 14 vs 90%/10% CCD+ Day 14 ** HT29-MTX CCD+ Day 8 vs HT29-MTX CCD+ Day 20 *** 
90%/10% Day 8 vs Caco-2 CCD+ Day 8 ** 80%/20% Day 14 vs 90%/10% CCD+ Day 20 *** 
  
 
Table 4.1: Significancy calculation between TEER values measured in epithelial co-culture Transwell models of the intestinal epithelium - Significancy 
was calculated by one way ANOVA with Tukeys post-test analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. Only days 8, 14 and 
20 were used in significancy calculations. n=4-8 N=4-8 
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4.4.2 Histological investigation of Caco-2:HT29-MTX 2D co-
culture on Snapwell Transwell membranes. 
Figure 4.4 shows the H&E stained models of Caco-2 (Figure 4.4 A, D & G), 90:10 Caco-
2: HT29-MTX (Figure 4.4 B, E & H) and  HT29-MTX (Figure 4.4 C, F & I).  
 
Histologically, Caco-2 control membranes exhibit a flattened squamous monolayer 
morphology which is consistent through the length of the samples (Figure 4.4 A, D). 
Figure 4.4 G shows the top down stained model membrane. Staining is consistent over 
the entire samples with little heterogeneity, as would be expected from a single cell type 
phenotype. Conversely, figure 4.4 B & E shows the 90:10 co-culture membranes. It can 
be clearly shown that two cell types are present in this sample with the Caco-2 cells 
having weaker cytoplasmic staining when compared to HT29-MTX cells in addition to 
being far flatter than their goblet cell comparisons. Interestingly, the Caco-2 cells, even 
when non-adjacent to goblet cells, appear taller in co-culture samples than the controls.  
 
Figure 4.4 H shows the top down staining of 90:10 co-culture model membranes. Goblet 
cells can be seen to be growing in island colonies within the Caco-2 cell monolayer. 
HT29-MTX cells appear to take up a larger proportion of the final cell model area than 
the 90:10 original culture ratio would suggest. Therefore, it can be inferred that HT29-
MTX cells grown within 2D co-culture Transwell models grow at a faster rate than the 
Caco-2 cells, overtaking then in the areas in which they are seeded.  
 
HT29-MTX monocultures grown on Snapwell Transwell exhibit a heightened cell 
morphology when compared to Caco-2 controls (Figure 4.4 C & F). This heightened layer 
is shown to have basally located nuclei with large, strongly staining vacuole like 
structures located apically to the nuclei. Figure 4.4 I, shows the top down staining of 
HT29-MTX monolayers. These stain strongly with eosin to produce a deeper purple stain 
than compared to Caco-2 monolayers. Areas of darker staining indicate places of mucous 
build up, released by the HT29-MTX goblet cell like membrane. 
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Figure 4.5 shows the Periodic acid Schiff (PAS) staining of the same Caco-2 control, 
90:10 Caco-2: HT29-MTX co-culture and HT29-MTX control layers previously. Figure 
4.5 A & D shows that control Caco-2 layers have weak staining for acidified 
mucosubstances, the PAS positive staining target. Figure 4.5 G confirms that Caco-2 cells 
are naturally weakly positive for acidified mucosubstances, potentially indicating a 
limited ability for Caco-2 cells to express membrane bound and secreted mucins.  
 
The 90:10 Caco-2: HT29-MTX co-cultures show areas of weak PAS staining and areas 
of strong positive staining, with the strong staining isolated to the taller with more densely 
stained cytoplasm, as seen by H+E staining in Figure 4.5 B, E & H and hypothesised to 
be the goblet cells in culture. The Caco-2 cells in this model don’t appear to express 
acidified muco-substances at a higher rate than in the control samples.  Figure 4.5 H, 
shows the wholemount staining of Caco-2: HT29-MTX co-culture. It is clear from the 
image that the staining of  the co-culture model is significantly stronger than the staining 
seen in the Caco-2 monoculture control models.  Additionally, the staining is seen in  a 
heterogenous manner with areas of light and dark staining within the epithelial layers.  
Finally,  Figure 4.5 C & F show strong PAS stained cells with a  heightened cell 
morphology.  When looking at the whole mount staining of this sample (Figure 4.5 I) it 
is clear to see a significantly darker stained homogenous layer of cells within the model.
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Figure 4.5: Caco-2:HT29-MTX epithelial co-cultures shows significant differences in cellular morphology between models – H+E stained sections of 21 day matured 
Caco-2: HT29-MTX co-cultures on Transwell polyester membranes. A) 100% Caco-2, B) 90% Caco-2 with 10% HT29-MTX, C) 100% HT29-MTX. Samples were fixed 
in 4% Formalin overnight before dehydration and embedding in wax. HT29-MTX goblet cells show increased cell height and polarisation with clear basally located nuclei. 
Caco-2 cells exhibit a flattened squamous cell morphology with little polarisation evident. 90:10 Caco-2 HT29-MTX co-culture appears to improve the structural 
morphology of caco-2 cells with a moderately more polarised cuboidal cell phenotype. Sections were cut at a thickness of 5μm.  Images are representative of a minimum 
of 3 independent observations. Scale 25μm. 
A B C 
D E F 
G H I 
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Figure 4.6: Mucous staining in Caco-2:HT29-MTX epithelial co-cultures – Periodic acid Schiff (PAS) stained sections of 21 day matured Caco-2: HT29-MTX co-
cultures on Transwell polyester membranes. A) 100% Caco-2, B) 90% Caco-2 with 10% HT29-MTX, C) 100% HT29-MTX. D-F) Sectioned samples of the corresponding 
model co-cultures. G-J) Top down viewed wholemount stained samples of corresponding co-culture models. Samples were fixed in 4% Formalin overnight before dehydration 
and embedding in wax. Pas staining intensity can be seen to increase with increasing proportion of HT29-MTX cells into the co-culture models. PAS stained goblet cells can 
be easily identifiable in sectioned samples of the models by intense PAS staining compared to less intensely stained Caco-2 cells. Control layers of Caco-2 monocultures 
show weak PAS staining indicating low levels of mucin production.  Sections were cut at a thickness of 5μm. Images are representative of a minimum of 3 independent 
observations. Scale 25μm 
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4.4.3 Understanding the effects of CCD-18co paracrine culture 
on the development of Caco-2/HT29-MTX co-culture 
Snapwell® membranes. 
Figure 4.6 shows the H&E stained layers of Caco-2 and HT29-MTX when cultured in the 
presence of CCD-18co conditioned media. Figure 4.6 A, B & C, shows a low powered 
magnification of the Caco-2 (Figure 4.6 A), 90/10 Caco-2/ HT29-MTX co-culture (Figure 
4.6 B) and HT29-MTX (Figure 4.6 C). In each instance the cells express a flattened or 
cuboidal cell morphology with no obvious goblet cell like morphologies in any of the 
conditions. Caco-2 cells when treated with CCD-18co paracrine media do not appear 
significantly different in structure from control samples. However, HT29-MTX cells 
become significantly shorter than their control counterparts, with no obvious goblet cell 
phenotype as seen in Figure 4.4 C & F.  
 
When looking at a wholemount perspective, Caco-2 monolayers treated with CCD-18co 
paracrine media do not look significantly different from their control counterparts with a 
normal cobble-stone distribution of approximately equal size cells. A similar phenotype 
can be seen in 90/10 Caco-2/ HT29-MTX samples (Figure 4.6 H) with a reasonably 
homogenous epithelial layer observed. On close inspection some differences can be seen 
throughout the layer betraying the presence of the HT29-MTX cells. However, when 
compared to no CCD-18co treated control layers (Figure 4.4 H) the differences are 
significant with HT29-MTX cells in control layers easily distinguishable compared to 
treated models. Finally, H&E staining of treated HT29-MTX monocultures (Figure 4.6 I) 
shows a significantly less homogenous structure compared to control models (Figure 4.4 
I). Cells appear to form a uniform monolayer across the surface of the Transwell 
Snapwell®  insert with areas of doming, similar to what is seen in Caco-2 monolayers 
cultured on non-permeable membranes.  In this instance it is more likely to be areas on 
higher mucous production.  
 
Figure 4.7 shows the effects of CCD-18co paracrine treatment on the mucous production 
of the resultant epithelial models assessed by PAS staining. Structurally there is no 
differences seen in these Periodic acid Schiff stained samples over those stained for H&E. 
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Firstly, looking at the transverse sections it was shown that the levels of positive PAS 
staining is not noticeably different between any of the epithelial co-culture conditions. 
Wholemount staining of the epithelial constructs does show differences in PAS staining 
across the surface of the monolayers. Similarly to untreated conditions, increasing 
staining presence is seen with increasing proportion of HT29-MTX cells added into the 
culture. However, what should be noted is that compared to control layers (Figure 4.5) , 
treated cultures express significantly less mucous production.  
 
Figure 4.7 H, shows PAS specifically staining populations of HT29-MTX cells which are 
growing in isolated colonies as seen in control layers.  HT29-MTX monocultures shows 
a highly heterogeneric surface expression of mucin elements, with higher levels of 
staining seen primarily in the areas identified earlier  as likely to be areas of mucous 
production. 
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Figure 4.7: CCD-18co effects on Caco-2:HT29-MTX epithelial co-cultures – H&E stained sections of 21 day matured Caco-2: HT29-MTX co  on Transwell polyester 
membranes. A) 100% Caco-2, B) 90% Caco-2 with 10% HT29-MTX, C) 100% HT29-MTX. D-F) Sectioned samples of the corresponding model co-cultures. G-J) Top 
down viewed wholemount stained samples of corresponding co-culture models. Samples were cultured in the paracrine media produced by CCD-18co fibroblasts. 
Samples were fixed in 4% Formalin overnight before dehydration and embedding in wax. Distinct differences can be seen between Control H+E stained models (Figure 
4.3) and CCD-18co treated models with changes in goblet cell morphology in treated samples. HT29-MTX exhibit a more flattened phenotype with a loss of the tall 
polarised morphology. Sections were cut at a thickness of 5μm. Images are representative of a minimum of 3 independent observations. Scale 25μm 
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Figure 4.8: Caco-2:HT29-MTX epithelial co-cultures with CCD-18co paracrine media – Periodic acid Schiff (PAS) stained sections of 21 day matured Caco-2: 
HT29-MTX co-cultures on Transwell polyester membranes cultured in the presence of CCD-18co paracrine media. A) 100% Caco-2, B) 90% Caco-2 with 10% HT29-
MTX, C) 100% HT29-MTX. D-F) Sectioned samples of the corresponding model co-cultures. G-J) Top down viewed wholemount stained samples of corresponding 
co-culture models. Samples were fixed in 4% Formalin overnight before dehydration and embedding in wax. A clear loss in PAS staining can be observed over control 
models (Figure 4.4). Less PAS staining suggests that models are secreting less mucous than in control conditions. Sections were cut at a thickness of 5μm. Images are 
representative of a minimum of 3 independent observations. Scale 25μm 
A B C 
D E F 
G H I    
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4.4.4 Analysis of Co-culture model cellular phenotype under 
CCD-18co conditioned media by Toludine blue staining of 
resin embedded sections. 
CCD-18co conditioned media was applied to Caco-2: HT29-MTX co-culture membranes 
and the structural histology was analysed through Toludine Blue staining of resin 
embedded samples.  
 
Figure 4.8 shows more clearly the effects of CCD-18co on co-culture membranes than 
paraffin embedded samples. Figure 4.8 A, shows Caco-2 controls without modification 
embedded in Resin. It can be seen that resin embedding procedures are more able to 
preserve the structural histology of the epithelial membrane with clear improvement in 
cellular height and staining resolution over the PFA fixed paraffin embedded samples. 
Figure 4.8 B & C , shows similar phenotypes as seen in the paraffin embedded samples 
(Figure 4.4 B & C) with clear distinction between the Caco-2 and HT29-MTX cell types 
present in the model (Figure 4.8 B). The increased resolution staining achieved by resin 
embedding and Toludine blue staining highlights the seemingly pseudostratified nuclei 
of the HT29-MTX control membrane. (Figure 4.8 C) 
 
Contrastingly, Figure 4.8 D-F shows the phenotype of the Caco-2 epithelial cells in the 
presence of CCD-18co paracrine media. As before Caco-2/ CCD-18co models are not 
noticeably structurally different from Caco-2 controls. However, it can be clearly seen in 
Figure 4.8 E & F that the HT29-MTX cells re-organise themselves into a very different 
structure over the 21 day culture period when in the presence of CCD-18co conditioned 
media. Figure 4.8 F, highlights this most clearly by showing HT29-MTX cells in 
isolation. It can be seen that the cells have lost their clear goblet cell like phenotype and 
have reverted into a cell more reminiscent of a standard epithelial cell such as the Caco-
2. The cells are much shorter than the control HT29-MTX and have lost the distinctive 
goblet cell vacuole seen apically in control cells.  
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Figure 4.9: Toluidine blue stained sections of Caco-2/ HT29-MTX co-cultures with and without CCD-18co conditioned media  on Transwell membranes 
– A) Caco-2 control, B) 90:10 Caco-2: HT29-MTX co-culture, C) HT29-MTX control, D) Caco-2/ CCD-18co, E) Caco-2:HT29-MTX/ CCD-18co, F) HT29-MTX/ 
CCD-18co. Toluidine Blue stained sections allow for the high magnification analysis of cellular morphology, not possible with paraffin embedded sections. A-C) 
Shows the Control conditions highlighting the flattened Caco-2 phenotype (A) and the tall morphology of HT29-MTX cells (C). CCD-18co treated Caco-2 layers 
highlights the drastic change in morphology, particularly HT29-MTX cells which appear similar in structural phenotype to Caco-2 cells when treated. Images are 
representative of a minimum of 3 independent observations.  Scale = 20μm 
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4.4.5 Analysis of Caco-2:HT29-MTX co-cultures structural 
phenotype through high resolution transmission electron 
microscopy (TEM). 
Transmission electron microscopy (TEM) was used to assess the ultrastructure of the 
Caco-2, Caco-2/HT29-MTX epithelial co-culture membranes.  Figure 4.9 A & B, shows 
both the apical and basal ultra-structure of the Caco-2 control layers. Caco-2 have large 
continuous microvilli along the apical cell surface.  Additionally, microvilli associated 
glycocalyx can be seen along the surface of the Caco-2 cells. Cell membranes between 
adjacent cells follow a convoluted line with many invaginations between the cells, 
beginning at the surface (Figure 4.9 A) and continuing to the base (Figure 4.9 B). This 
results in a large total membrane contact length between adjacent cells. Tight junctional 
complexes can be see along the apical section of the adjacent cell membranes as electron 
dense areas of staining. Cytoplasm staining of the Caco-2 cells shows abundant organelles 
throughout. However the cytoplasm itself has weak electron dense staining. 
 
Figure 4.9 C & D, shows the TEM imaging of the 90:10 Caco-2:HT29-MTX co-culture 
membranes. As in the Caco-2 control layers there is a continuous microvilli surface layer 
across the length of the model which seem to be shorter but more densely packed and 
consistent. Interestingly, The cell-cell membranes are significantly less invaginated than 
in the Caco-2 control layers with less electron dense staining indicating junctional points. 
ON the whole distinguishing between Caco-2 and HT29-MTX cells in these cultures is 
difficult due to a high degree of similarity in structural phenotype between cells. 
 
Finally, Figure 4.9 E and F shows the detailed structural morphology of the HT29-MTX 
cells grown on the Transwell membranes. These cells show none of the epithelial cell 
phenotypes such as continuous microvilli formation along the apical cell surface and tight 
junctional abundance along cell-cell membranal contacts. Instead these cells are shown 
to have a much decreased microvilli confluency, arranged into small clusters along part 
of the apical membrane. Additionally, membrane contacts between cells are long and 
straight without any invaginations as seen in Caco-2 layers.  Nuclei are basally located 
with the majority of the remaining space in the cell taken up by large vacuole like 
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structures filled with mucin and with a thick mucus layer can be clearly seen attached to 
the apical surface membrane. 
 
Figure 4.10 shows the effects of the addition of CCD-198co paracrine media to the Caco-
2/ HT29-MTX cellular model. Figure 4.10 A & B shows the Caco-2 epithelium alone. 
No noticeable differences can be observed in Caco-2 structure when co-cultured in CCD-
18co media. Contrastingly, Figure 4.10 C & D shows the effects on HT29-MTX cellular 
structural morphology when cultured in CCD-18co media. Large vacuole structured 
observed in non-treated samples are noticeably lost with denser cytoplasmic staining and 
a more differentiated epithelial surface. Consistent microvilli expression is observed 
along the apical membrane of treated HT29-MTX cells. In essence, HT29-MTX cells 
appear, in the presence od CCD-18co media, to revert back to a more enterocytic 
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Figure 4.10: TEM images of Caco-2/ HT29-MTX co-cultures – A-B) Caco-2 cell control 
cultured on a Transwell membrane for a period of 21Days, Cells show good differentiation 
with apically expressed microvilli seen throughout the section. Cells are tightly bound 
together with extensive cellular junctions throughout the length of the cell. Scale 500nm. C-
D) 90/10 Caco-2/ HT29-MTX co-culture, extensive well developed brush border is seen 
along the length of the cell. Brush border in co-culture modes appears to more consistent 
throughout the length of the cell and shorter than caco-2 monocultures. Scale 2um and 
500nm. E-F) HT29-MTX cells cultured on Transwell membranes for a period of 21 days 
showing classic goblet cell morphology. Images are representative of a minimum of 3 
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Figure 4.11: TEM images of Caco-2 and HT29-MTX cultures in the presence of CCD-18co 
conditioned media – A-B) Caco-2 grown on Transwell membranes for a period of 21 days in 
the presence of CCD-18co conditioned media C-D) HT29-MTX cells grown on Transwell 
membranes for a period of 21 days in the presence of CCD-18co cells conditioned media. 
Changes in morphology are seen when compared to normal goblet cell cultures. Cells express 
an epithelial like morphology with extensive brush boarder and cell junctions. Images are 
representative of a minimum of 3 independent observations.  Scale 2μm, 250nm 
A B 
C D 
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4.4.6 E-cadherin staining of Caco-2/ HT29-MTX layers 
highlights the changes in structural morphology when HT29-
MTX cells are exposed to CCD-18co paracrine media. 
Figure 4.11 shows the E-cadherin staining of Caco-2/ HT29-MTX co-cultured Transwell 
membranes in the absence (Figure 4.11 A-D) and presence of CCD-18co paracrine 
conditioned media (Figure 4.11 E-H). Progressively increasing HT29-MTX cell 
proportions can be easily seen between samples with the presence of tall goblet like cells, 
easily distinguishable from epithelial Caco-2 cells. This goblet cell phenotype is 
significantly attenuated in CCD-18co paracrine media treated conditions with 100% 
HT29-MTX layers exhibiting a morphology very similar to that of the Caco-2 cell line.  
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E) F) G) H) 
Figure 4.12: E-cadherin stained Caco-2/ HT29-MTX co-cultures in the presence and absence of CCD-18co conditioned media – Significant attenuation of 
HT29-MTX structural phenotype can be seen when exposed to CCD-18co conditioned media with resultant cellular phenotype similar to enterocyte morphology. A) 
100% Caco-2, B) 90% Caco-2, 10% HT29-MTX, C) 80% Caco-2, 20% HT29-MTX, D) 100% HT29-MTX, E) 100% Caco-2 + CCD-18co, F) 90% Caco-2, 10% 
HT29-MTX + CCD-18co, G) 80% Caco-2, 20% HT29-MTX + CCD-18co, H) 100% HT29-MTX + CCD-18co. Images are representative of a minimum of 3 
independent observations. Scale 20μm 
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4.4.7 qPCR analysis of the development of Caco-2:HT29-MTX 
co-culture layers in relation to key targets of function. 
mRNA expression levels of key genes of interest namely; Villin, Occludin, MRP2, 
MDR1, OATP-B and BCRP, were quantified through the use of SYBR based qPCR 
expansion and detection methods.  
 
Figure 4.12 A, shows the mRNA expression levels of the protein Villin. Villin is an 
apically expressed microvilli protein which is often used as a method of quantifying 
microvilli expression and as such enterocyte epithelial differentiation. Figure 4.12 A, 
shows a stepwise decrease in Villin mRNA expression dependant on the ratio of HT29-
MTX cells within the epithelial culture. When normalised to Caco-2 control expression 
levels it was demonstrated that addition of 10% HT29-MTX cells at the beginning of the 
culture period induces a significant decrease in Villin expression by approximately 40% 
that of the control. HT29-MTX cells grown in isolation do express Villin mRNA, albeit 
at a significantly reduced level compared to Caco-2 at approximately 50% expression of 
the control.  
 
Occludin as discussed previously is an important component of the tight junctional 
complex. Figure 4.12 B, shows the relative expression levels of Occludin when 
normalised to Caco-2 controls. Both Caco-2 control and 90:10 Caco-2: HT29-MTX co-
culture layers show no significant difference in Occludin levels between the models. 
Contrastingly, HT29-MTX layers show a significant decrease in Occludin mRNA 
expression when compared to all other conditions to a levels approximately 25% of Caco-
2 layers.  
 
MRP2, MDR1, OATP-B and BCRP are all apically expressed transporter protein shown 
to be involved primarily in the efflux of toxins from the intestine, including therapeutic 
drugs. The function and abundance of these proteins in the human intestine and their 
effects on the bioavailability of drug compounds within the intestine is a key area of 
consideration when  designing an improved biological model for use as a tool in 
biological research. MRP2, MDR1, OATP-B (Figure 4.12 C, D and E) all follow the same 
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basic stepwise decrease in expression rates with increasing HT29-MTX involvement 
compared to Caco-2 and HT29-MTX controls. Indeed, MRP2, MDR1, OATP-B are 
shown to be negligibly expressed within the samples with expression rates only a few 
percent of the control levels. In each case, the 90:10 Caco-2: HT29-MTX co-culture 
shows strong expression levels compared to HT29-MTX but are less than Caco-2 
monocultures. Contrastingly, BCRP expression shows a significant increase in mRNA 
expression in HT29-MTX cells when compared to Caco-2 controls. However, 90:10 ratio 
co-cultures were shown to be not significantly different from the Caco-2 controls in this 
instance. 
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Figure 4.13: qPCR analysis of Caco-2/ HT29-MTX co-culture Transwell models shows differential 
expression between Caco-2 and HT29-MTX cells lines – qPCR data shown here demonstrates the 
differential expression of key protein mRNA between Caco-2 and HT29-MTX cells. A) Villin, B) Occludin, 
C) MRP2, D) MDR1, E) OATP-B, F) BCRP. In most instances A-E, HT29-MTX cells show a reduction in 
the relative expression of mRNA of the key proteins tested here. This is as expected as most of the targets 
are enterocyte efflux or tight junction proteins. Interestingly however, BCRP levels are seen to increase in 
HT29-MTX cells in comparison to Caco-2 cells. This could affect the sensitivity of co-culture models to 
BCRP substrate compounds. Significancy was calculated by one way ANOVA with Tukeys post-test 
analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. n-2-3 N=2-3. Significany 
values calculated between value n=2, N=2 have been ommited from the graphs (Panel F).Error bars represent 
+ SEM of average values. 
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4.4.8 Functional characterisation of Caco-2/ HT29-MTX co-
culture Rhodamine 123 transport in Snapwell culture.  
Figure 4.12 shows the basal to apical (B-A) transport of Rhodamine 123 across Caco-2/ 
HT29-MTX co-culture layers both in control states and in CCD-18co paracrine treated 
conditions. All data points within Figure 4.13 were taken after 120 minutes within the 
Ussing chamber system with absolute donor compartment concentration calculated by 
comparison of values against a standard curve. Control layers show an approximate Papp 
of 0.4 (x10-6) which is well in line with values gained in similar experiments throughout 
the literature. Addition of the paracrine effects of CCD-18co cells resulted in an increase 
in B-A transport by about double, although the standard error here is large with significant 
variation seen between samples making differences non-significant from control layers. 
No significant differences in B-A transport can be seen in 90/10 ration cultured Caco-2/ 
HT29-MTX epithelial models from controls. However, similarly to control samples an 
increase in Rhodamine Papp can be seen in CCD-18co treated 90/10 epithelial layers 
although the magnitude of the change is less than that of control layers.  
 
Finally, HT29-MTX cultured modes show some Rhodamine 123 transport at a 
significantly reduced levels than all other conditions. Treatment with CCD-18co 
conditioned media has very little to no effects on the transport of Rhodamine 123 in 
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Figure 4.14: B-A Rhodamine 123 transport dynamics of Caco-2/ HT29-MTX co-cultures in control 
and CCD-18co paracrine treated Snapwell layers – Epithelial cell models were tested for transport of 
Rhodamine 123 within an Ussing chamber systems as previously described. All measurements were taken 
after 120 minutes assay length. Paracrine CCD-18co models were created as previously described. HT29-
MTX models have a significantly reduced Rhodamine transport capability over Caco-2 Transwell 
systems. 90/10 co-culture models show no significant changes suggesting goblet cells can be added to a 
model in small amounts without compromising the capability of said model in a functional manner, in this 
case in its capability to transport Rhodamine 123, primarily through P-gp mediated means.  n=3-6  N=3 
Significancy was calculated by one way ANOVA with Tukeys post-test analysis. No significancy was 
observed between samples. Error bars represent + SEM of average values. 
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4.5 Discussion 
The aims of this chapter were to attempt to create an epithelial co-culture model 
incorporating both the mucous element of the intestinal epithelium and the paracrine cross 
talk of supportive stromal cells, in this case CCD-18co myofibroblasts. The barrier 
function of the resultant constructs was assessed through TEER measurements as 
previously described and structure was evaluated through the use of histological 
techniques and electron microscopy. Finally, epithelial constructs were assessed 
functionally through their capability to transport the p-gp substrate, Rhodamine 123.  
 
4.5.1 Epithelial co-culture and the effects of differing seeding 
ratio on the Trans-Epithelial Electrical Resistance (TEER) of 
the tissue construct. 
Caco-2 cellular models are well known to exhibit significantly higher TEER values than 
in vivo intestinal tissues due to a heightened expression of tight junctional proteins within 
Caco-2 cells. Additionally, Caco-2 models overexpress the surface efflux protein p-gp. 
As such, these models are often poor indicators of for the transport of hydrophilic 
compounds (which primarily move paracellularly) which can appear to be highly 
impermeable to the Caco-2 constructs. (243) The usefulness of HT29-MTX cells in 
culture is primarily in their ability to produce a mucous layer along their apical surface 
when grown in 2D culture and in their significantly lower TEER values when compared 
to Caco-2 cells through interspersion of goblet cells between enterocytes. As such these 
cells have been widely utilised as a stand in for goblet cells in many cellular models of 
the intestinal epithelium. (131,243,246–248) In this study the co-culture Caco-2 cells with 
HT29-MTX at a range of physiological ratios, specific to differing sections of the 
intestine was attempted. For example, there is a significantly higher proportion of goblet 
cells in the colon (25-55%) (249) than the small intestine, with a gradual increase as the 
small intestine descends. (92) 
 
Figure 4.2 and 4.3 of this chapter show the effects of epithelial cell co-culture on the 
development of the model TEER values over the course of 21 days in culture. HT29-
Chapter 4 – Goblet cell co-culture model of the intestinal epithelium  
 
Page | 229 
 
MTX cells are generally known to express lower TEER values than Caco-2 cells with 
reported values ranging from less than 50 to ~200 ohms per cm2. (243,244) Whilst the 
TEER values gained here for HT29-MTX monocultures are significantly higher than 
some of the values which are published, they are still significantly lower than the TEER 
values of the Caco-2 cells utilised in the co-culture models. The methodology for the 
measurement of TEER values of HT29-MTX layers differs significantly lab to lab and, 
much like how Caco-2 reported TEER values can vary between individuals and labs the 
same applies to other cell lines. Additionally, the possibility of the membrane associated 
and secreted mucous on the TEER values of the epithelial layers was not tested for here 
and is not fully understood. Theoretically, the density of the mucous layers could 
contribute to the overall TEER values of the models. (230) 
 
When looked at histologically, HT29-MTX cells can be seen to be organised into tall, 
often multicellular layers. As such this could in part explain why TEER values for these 
cells were so high due to the long convoluted membrane length and multicellular nature 
of the model. HT29-MTX cells are seen to become more organised when co-cultured with 
Caco-2 cells, with clear monolayer formation and basally located nuclei. As such one 
would expect that these cells within the co-culture model exhibit a decreased TEER 
compared to their control HT29-MTX counterparts. Therefore, the decrease in TEER 
which is seen when co-culturing Caco-2 cells with HT29-MTX follows a logical course 
assuming that Caco-2 and HT29-MTX cells don’t interact with one another in a way to 
change their individual epithelial resistances.  
 
Indeed, this stepwise decrease in TEER value was also observed by Béduneau et al in 
their tuneable co-culture model in which they culture both of these cells lines together. 
(243) In this study the authors created Caco-2: HT29-MTX models on Transwell 
membranes utilising a culture method different from that used in this study. Different 
density models were created through the simple seeding of mix ratio dependant 
populations with all cells seeded on day 0. Béduneau et al also cultured different ratios 
of cells but also changed the time at which the HT29-MTX cells were added to the model 
with additions ranging from -1-7 days post Caco-2 seeding. Whilst this is an interesting 
methodology for controlling the end model population ratio of cells this study doesn’t 
appear to have controlled for the fact that cells will be of different maturities in the end 
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model. For example, HT29-MTX cells seeded 7 days post Caco-2 seeding will have a full 
week less time to grow and importantly, differentiate than their day 0 counterparts. This 
again highlights the difficulties in directly comparing model results between studies as 
the culture methods and materials often differ significantly.  
 
Similarly to the work here, Béduneau et al evaluated their models through Rhodamine 
transport and lucifer yellow permeability. They found that increasing the number of 
HT29-MTX cells within the co-culture system resulted in decreases in overall construct 
TEER measurements in addition to stepwise decreases in the Papp of lucifer yellow, 
indicating that models with high proportions of HT29-MTX cells were more passively 
leaky than Caco-2 controls. Additionally, they observed that rhodamine transport 
decreased with increasing HT29-MTX percentage most likely due to less active 
enterocytes in the end culture and the effects of the mucous barrier created by the HT29-
MTX cells. 
 
4.5.2 Functional transport characteristics of epithelial co-
culture layers. 
Figure 4.13 of this study shows the B-A Rhodamine 123 transport conducted in this study. 
Significant differences between Caco-2 and 90/10 co-culture conditions was not 
observed. However, HT29-MTX monocultures did transport Rhodamine 123 at a 
significantly lower rate than Caco-2 controls. Having said that however, the HT29-MTX 
B-A Papp values for Rhodamine 123 were still a significant proportion of the control 
Caco-2 levels. This along with the abnormally heightened TEER values in control HT29-
MTX layers compared to values normally published in the literature lends evidence to the 
idea that these cells used in this study may be a different subtype. Alternatively, culture 
conditions have been shown to significantly affect the structure and differentiation of 
matured cell lines. For example, Navabi et al (250) cultured HT29-MTX in RPMI 1640 
media compared to the DMEM utilised in this study. As such, the histology of the control 
HT29-MTX layers in their study appear significantly different in structural morphology 
than seen here with their cells forming cuboidal monolayers more reminiscent of 
enterocytes than the goblet cell morphology seen in this study. Interestingly, even through 
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the morphology of their cells appear more enterocyte like the TEER values of the resultant 
HT29-MTX models were still low at around 150 ohms, significantly less than seen here. 
Unfortunately, there is little standardisation between labs in the methods to culture these 
cells thereby increasing the likelihood or differences arising between studies.  
 
The model by Beduneau et al  showed the functional transport of Rhodamine 123 across 
HT29-MTX/ Caco-2 layers of varying ratio. (243) Essentially, the outcomes of teir study 
are reflected here with a decreased functional transport of Rhodamine 123 in HT29-MTX 
cell systems, an expected outcome due to HT29-MTX’s known function as a goblet cell 
rather than an enterocyte. Given the usual under representation of Caco-2 cells models 
regarding MDR1 activity, addition of HT29-MTX cells which further reduce the models 
functional MDR1 based capabilities would be counterproductive. Culture of HT29-MTX 
cells with Caco-2 sub-populations known to possess a more homogenous expression 
profile such as Caco-2/TC7 (251) are another possibility to attempt to counteract efflux 
protein under expression. Pontier et al showed the transport capabilities of a number of 
compounds between Caco-2/TC7 and HT29-MTX. Interestingly, they showed how 
HT29-MTX cells are able to increase permeability to an number of compounds compared 
to Caco-2 monocultures. Taken together they suggest that differences between the two 
cell lines are relatively minimal when a wide range of compounds are taken into account. 
However, in their TEER analysis the HT29_MTX cells in their cultures has a significantly 
higher resistance value than their control Caco-2 monocultures. This is in complete 
contrast to the phenotype observed here and again highlights the importance of culture 
conditions on cellular phenotype.  
 
4.5.3 Understanding the effects of CCD-18co conditioned 
media on the development of the epithelial construct layers.  
To my knowledge, whilst the co-culture of Caco-2 and HT29-MTX cells together is a 
routinely, if not widely adopted, model of the intestine as previously discussed. Addition 
of the paracrine factors present in CCD-18co conditioned media is a novel addition to this 
system. As has been discussed and shown in the previous chapter, one of the main known 
components of CCD-18co paracrine media, with biological morphogenic properties, is 
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KGF. A search of the literature suggests that the action of KGF on HT29-MTX cells 
specifically is poorly understood and understudied, although it is logical to assume that 
KGF will have many of the same functions on HT29-MTX cells as with any other 
intestinal epithelial cell lines, namely; cellular/ lineage differentiation and regulating 
cellular proliferation. (213) 
 
In this study, HT29-MTX cells when cultured with CCD-18co conditioned media are 
shown to change significantly in both their structure as seen by H&E, Toludine Blue 
staining and TEM, and in function as seen with changes in PAS staining, a stain which 
specifically targets acidified mucosubstances normally produced by goblet cells. Indeed, 
close analysis of HT29-MTX cells after co-culture with CCD-18co conditioned media 
shows that the cells have morphed into an enterocyte like cell line with regular cuboidal 
structure, basally located nuclei and a single monolayer formation without evidence of 
multilayering. When further investigated with TEM HT29-MTX cells are seen to 
transform from a large vacuous cell with significant apical mucous and only sporadic 
microvilli formation into a densely cytoplasmic enterocyte with continuous well-formed 
apical brush border and cell junctions. This change can also be seen reflected in the TEER 
assessment at the beginning of the chapter whereby the culture of HT29-MTX containing 
models with CCD-18co conditioned media increases TEER values in each case. This is 
in direct contrast to co-culture with Caco-2 cells which results in a TEER decrease with 
paracrine co-culture.  
 
HT29-MTX cells as discussed earlier are in reality simply HT29 cells which have been 
treated with Methotrexate in order to isolate a goblet cell like subclone from the parental 
line. (240) It was hypothesised that the co-culture of HT29-MTX cells with CCD-18co 
paracrine media results in a reversion of this goblet cell like phenotype back into a cell 
more similar to the parental HT29 morphology. This could be potentially through a KGF 
mediated pathway (KGF is important in cancer phenotype homeostasis in the intestine) 
(213) although this was not looked into in any depth in this study. This kind of cellular 
reprogramming can be seen throughout the literature. In the context of HT29-MTX cells 
specifically, Xu et al considered the effects of small molecules on HT29-MTX cells in 
their paper studying the role of NHE8, its regulation by TNF-α and its effect on the 
production of mucous in HT29-MTX cells. (252) Briefly they found that NHE8 was 
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downregulated by TNF-α resulting in a decrease in the mucous production of the HT29-
MTX cells. TNF-α is a proinflammatory cytokine primarily produced by cells of the 
immune system, namely activated macrophages (253) but can also be produced by 
endothelial cells and importantly, fibroblasts. Whilst not tested for it is possible that CCD-
18co cells are able to produce TNF-α, especially if in a proinflammatory state as seen by 
high levels of α-SMA, potentially reducing HT29-MTX mucous production through this 
method. With structure comes function, therefore a reduction in functional ability would 
imply similar variations in cellular structure. However, whilst Xu et al did provide 
indicative evidence suggestive that downregulation of NHE8 reduced mucous production 
they did not analyse the structure of the resultant cells so it is not possible to know if the 
same morphological changes were seen in their study as here.  
 
Visco et al (179) showed in their study that KGF was able to have effects on the growth 
rate of HT29 cells in vitro with significant increases seen in Ki67 expressing cells, 
suggesting an improved rate of proliferation. Interestingly, in this study the authors also 
note that CCD-18co conditioned media has stronger proliferation inducing effects than 
KGF treatment alone, suggesting that other small molecules are being released by CCD-
18co cells that are having compounding morphogenic effects on Caco-2 and HT29 
epithelial cultures. Whilst this study doesn’t go into any depth about the change in 
function of treated cells it does show that HT29 cultures are sensitive to KGF treatment. 
As such one could expect that HT29-MTX cells, derived from HT29 parental lines, would 
also be sensitive to KGF and in similar ways, which in this instance was an increase in 
cell proliferation.  
4.6 Conclusion 
Work done in this chapter highlights the importance of simulating multiple aspects of the 
intestinal epithelium when creating a co-culture model of the intestine. Goblet cells can 
have significant effects on the capability of the resultant epithelial constructs with 
changes in transport capabilities induced through a reduction in transport capable 
enterocytes and the formation of a mucous layer which can have inhibitory effects on 
compound movement and availability to the enterocyte epithelium. Additionally, CCD-
18co cells have been further shown to have bioactive effects on the development of 
epithelial layers. Indeed, reversion of HT29-MTX cells into a less goblet cell state, whilst 
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not ideal for the resultant model, could be argued to be more biologically relevant, with 
increasing model complexity enhancing cell phenotypes. As HT29-MTX cells are not 
true goblet cells, in this instance the enhanced phenotype that would be expected is that 
of the enterocyte. Results found within Chapter 3 along with the work discussed here has 
been invaluable in understanding the effects of simple cell co-cultures in Transwell based 
systems. 
 
Future work within the scope of this chapter could include further elucidation of the exact 
mechanism for the changes in structural phenotype seen when Caco-2 cells are cultured 
with CCD-18co conditioned media. For example, understanding if this mechanisms is 
controlled through KGF secretion could help to identify the function of KGF in the 
development and maintenance of epithelial layers. The initial purpose to optimising Caco-
2/ HT29-MTX/ CCD-18co cells in Transwell was to apply the knowledge gained into a 
3D model of this intestine. Due to the negative interactions of HT29-MTX cells with 
CCD-18co paracrine factors it was decided that no further development would take place 
in this study. Further work should focus on overcoming these challenges to create a true 
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5. Optimisation & characterisation of an in vitro model of the 
intestinal mucosa and development of associated technology.  
5.1 Introduction 
5.1.1 The biological relevance of 3D culture. 
Conventional Transwell culture as seen in the previous chapters of this work is clearly 
the gold standard technique for the modelling of the human intestinal epithelium in both 
industry and academia. Since the inception of the Caco-2 cell line in the early 90’s and 
its application to drug discovery purposes there has been little change seen from the 
original model principle developed by Artusson et al (254) and others of Caco-2 cell 
layers cultured on permeable hanging inserts.  
 
As has been discussed previously, others have attempted to modify/ enhance the Caco-2 
model system through the application of other cell types/ cell lines such as the addition 
of goblet cells into the culture in order to recapitulate the mucous layer (228,255) or in 
the co-culture of Caco-2 cells in paracrine media such at by Ghadban et al  in their work 
with immune cells and their effects on the differentiation and function of the Caco-2 and 
High Throughput 
In vivo relevance 
Figure 5.1: The progressive complexity of biological research – With increasing relevance 
comes increasing cost, 3D models are designed to be a midpoint between simple 2D models of the 
intestine and more ethically challenging options such as animal and humans testing. 
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IEC epithelium.(256) Generally, these modifications still rely on the original hanging 
insert technique without much additional innovation.  
 
The immediate reasons for this are three-fold; 
1. The Caco-2 model is reasonably predictive of the pharmacokinetic properties of 
the intestine of a number of drug classifications without additional modification, 
especially when utilised alongside other simple models such as PAMPA. 
2. The Caco-2 model is inexpensive and well characterised compared to novel 3D 
systems. 
3. The Caco-2 model is simple to culture and as such is relatively easy to apply to 
high throughput applications. 
 
Whilst the advantages of the Caco-2 cell line seem numerous, the models do suffer from 
a number of major drawbacks, primarily in their bio predictability of certain drug 
classifications such as in their poor indicatives of lipophilic compounds due to retention 
within the Caco-2 cell layer and non-specific binding to the Transwell surface. (257) As 
such the Caco-2 models are often utilised alongside more ethically challenging systems 
such as in vivo animal models which are simultaneously far less high throughput and 
significantly more expensive than their 2D cell-based model counterparts. More 
sophisticated models of the intestinal epithelium which are able to bridge the gap between 
simple cell based and animal systems have the potential to streamline the drug discovery 
process; increasing the identification rates of pharmacokinetically viable compounds, 
decreasing the reliance on animal models and ultimately saving both time and money 
throughout the process.  
 
5.1.2 Different applications of the Caco-2 cell line to 3D systems 
of the intestinal epithelium. 
In an effort to close the gap between cell based and animal models new and emerging 
models of the intestinal epithelium are published on a regular basis focussing primarily 
on the application of the Caco-2 cell line to 3D culture systems. As discussed in the 
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general introduction to this thesis, one of the main powers of 3D culture is its flexibility, 
allowing it to take many forms and be tailored to the required specifications of the user. 
 
For example, Yu et al (258) created a model which incorporated the 3D architecture of 
the intestinal villus through the use of a hydrogel construct formed into villi structures, 
cultured in a hanging insert, onto which they cultured Caco-2 epithelial cells. They 
demonstrated that simply changing the architecture onto which the cells were cultured 
had significant effects on the differentiated phenotype of the resultant model. For 
example, they showed significantly reduced TEER values in 3D constructs over 2D 
controls and hydrogels without the 3D structure. This TEER decrease when compared to 
rat intestinal tissues which showed a significantly more in vivo TEER phenotype in the 
3D constructs. Additionally, calculated permeability co-efficients were more 
physiologically relevant in 3D models when compared to human tissues than 2D model 
controls. 
 
The most important part of this model was its simplicity. No additional cell lines or 
supplementary signalling were required to produce an model with improved “in vivo” 
characteristics over 2D controls. As such, this highlights the power of the 3D 
environment, suggesting that the structure of the cells implies their function, a critical 
phenotype missing in 2D cultures. This concept of structure influencing the function of 
cells is often referred to as mechano-transduction and is a relatively well studied area of 
biology. For example Wang et al (259) in their recent paper looked at the effects of the 
organisation of the ECM on the phenotype of MSC cells cultured within a tuneable ECM 
scaffold. They found that by altering the properties of their material such as fibre 
diameter, stiffness and alignment they could alter the 3D structure of the scaffold. The 
microscopic structures within the scaffolding materials (Voids and channels) had 
significant effects on the shape and actin cytoskeleton morphology of 3D cultured cells. 
This lead to changes in cellular differentiation and as such the function of the tissues 
created by the 3D cultured cells. Again, this is another example whereby cell fate is 
influenced by the 3D structure in/ on which the cells are cultured without any additional 
influencers. One postulated mechano-transduction mechanism in Caco-2 cells works 
through integrin adhesions (an adhesion to the ECM) and the YAP pathway. (260) In 
many ways the simple scaffold created by Wang et al is similar to Alvetex® (utilised in 
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this study) in that scaffold pore size can be altered to suit experimental needs. These levels 
of 3D tunability are simply impossible in 2D cultures in which cells are expected to 
differentiate in an alien environment and without the signalling queues found in vivo.  
 
Organoid cultures are another area of current intense research interest since their 
inception and by Hans Clever. (117) These models utilised primary intestinal stem cells 
or isolated intestinal crypts to grow highly advanced, well differentiated cellular 
epithelium with a whole range of different cell types with variable function. 
Unfortunately, their application to drug discovery functions are limited due to the 
inability to create a single polarised monolayer from these cells. However, these models 
are still highly valuable for a range of uses such as understanding tissue development 
(261) and disease modelling (262). Newer techniques are being developed to apply these 
advanced culture systems to pharmacokinetic applications. Onozato et al described a 
process whereby they tested a number of compounds on organoid cultures such as 
Rhodamine 123 and FD-4. (263) Their model however, still suffered from the 
aforementioned disadvantages of their technique such as; only A-B transport could be 
tested and quantification of total drug absorption/ efflux was not possible.  
 
Scaffolding technologies, as utilised in this study are another potentially powerful tool 
for the creation of 3D culture models. Scaffolds can come in a range of formats from 
decellularised matrices which straddle the boundaries between tissues, hydrogels and 
scaffolds, to polystyrene structures (as used in this study) which are significantly more 
reproducible, standardised formats, good for use in routine sample analysis etc whilst 
sacrificing the intrinsic signalling properties of scaffolds made from biological substances 
such as ECM components. In many instances however models are created to utilise 
multiple technologies together. The coating of the often bio-inert surfaces of polymer 
based scaffolds with hydrogels such as collagen I is a fairly ubiquitous technique to 
improve the attachment and differentiation of cells in culture through the provision of a 
basement membrane. Indeed, collagen coating techniques are used regularly even in 2D 
culture, in many ways blurring the definitions of 2D and 3D culture systems. (264–268) 
 
3D models for all of their advantages do have a number of significant drawbacks which 
have ultimately stopped their widespread use throughout industry. Often it is the very 
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advantages of 3D culture which works against their extensive use. For example, as 
discussed previously, 3D culture technologies can be highly variable, have very niche 
applications, and allow for tailor made models incorporating a single or multiple methods. 
Whilst this is an advantage in academia, allowing for the creation of distinct models with 
unique capabilities it effectively dilutes the ongoing characterisation of each model most 
often to the lab from which it originated. 
 
Unlike the Caco-2 Transwell model which has been widely characterised the world over, 
there is no gold standard 3D model of the intestine. As such, many labs have their own 
model variation which differs from others in its own unique ways, be that in terms of: cell 
line used, hydrogel composition, scaffold material, surface treatments, media 
composition/ small molecule additives, model culture time, etc. This lack of cross 
comparability between unique models and their generally limited characterisation means 
that individual models cannot be trusted to be more pharmaco-predictive that Caco-2 
Transwell models already being utilised. (162,246–249,251,258,269) Furthermore, lack 
of characterisation leads to non-approval by regulators such as the FDA, a key step that 
must be taken for a concerns to be utilised as an appropriate test model for novel 
compounds.  Ultimately, in order for the cutting of the red tape limiting 3D model 
progression one model has to “win out” over the others as a new gold standard. Without 
this the amount of variation which can be incorporated between 3D models make it 
unlikely any will be sufficiently characterised and approved for large scale use in industry 
in a reasonable timescale.  
 
Other considerations which have to be made when utilising 3D models are their expense 
and labour costs. 2D models are “cheap”, with Caco-2 cells, DMEM and Transwell being 
relatively low cost. Contrastingly, 3D models often utilise technologies which either have 
not been commercialised or if they have to a relatively low volume and scale compared 
to 2D systems. Essentially, 3D models will be more expensive than 2D alternatives, at 
least until high volume production of a single gold standard 3D model is achieved.  In 
terms of labour, 2D Transwell models are relatively easy to culture with 2-3 media 
changes per week, requiring minutes of work per model. Often 3D models incorporate 
more cells, of varying lineages, with more complex media requirements, increasing the 
time required per model and the potential for mistakes in the more complex system. 
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Additionally, 3D constructs are often created in stages, together taking longer to culture 
than their 2D counterparts, increasing overall labour and material needs. The burden is 
for 3D models to prove that the added cost is worth the increased functionality and bio-
predictability. A 3D model which is 10% improved at predicting clinical outcomes in 
humans but costs twice as much and takes three times the work is unlikely to be utilised 
over simpler models. Especially when the alternatives are more scalable to high-
throughput work. 
 
The data novel herein will cover the creation and optimisation and structural 
characterisation of three 3D models of the intestinal mucosa one for each of CCD-18co, 
HDFn and HIC lineages as discussed previously. Additionally, work in this chapter will 
cover attempts at creating a high throughput version of the 3D models through the design 
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5.2 Hypothesis, Aims and Objectives 
5.2.1 Hypothesis 
It is hypothesised that a novel intestinal mucosal model can be created utilising Alvetex 
Scaffold® and a range of intestinal fibroblasts (CCD-18co, HDFn and HIC) and epithelial 
cells (Caco-2). Additionally, it was expected  that through advanced culture methods a 
well populated sub-epithelial layer could form to create a dense ECM cellularised matrix 
for the support and population of Caco-2 cells apically, forming a single monolayer of 
enterocyte epithelium. Furthermore, it was  hypothesised that cells of different lineages 
will show a degree of cross talk and interaction through the formation of a basement 




The aims of this chapter are two-fold  
1. To create an advanced 3D model of the intestinal mucosae utilising multiple cell 
types from both stromal and epithelial compartments. It was proposed to 
understand how fibroblasts from multiple origin points as used in Chapter 3, 
namely CCD-18co, HDFn and HIC cell lines, are able to form a well populated 
basement scaffold on which could be cultured Caco-2 epithelial cells for a period 
of 21 days. Protein expression profile and structure of 3D models was compared 
to the expression seen in human tissue sections to show close similarity.  
 
2. To create tools in which the functional characteristics of the 3D models could be 
quantified. E.g. creation of bespoke Ussing chambers to study drug /ion transport 
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5.2.3 Objectives 
The objectives of this chapter are summarised below: 
• Development of fibroblasts stromal compartment of the model to allow for the 
culture of Caco-2 in a monolayer without invasion into the underlying stromal 
layers.  
• Immunohistochemical characterisation of 3D constructs and comparison to 
human intestinal tissues to highlight similarities and enhance the differences seen 
in Transwell models 
• Utilise TEM to show cellular ultra-structure and cross talk between epithelial and 
stromal cell lines.  
• Create novel bespoke Ussing chambers for the functional transport analysis of 3D 
models. 
• Develop a method for the higher throughput production and functional analysis of 
Alvetex® based 3D models. 
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5.3 Materials and methods 
5.3.1 Seeding Caco-2 cells onto Alvetex® of varying format. 
Alvetex® 12-well discs were processed for cell culture through submersion into 70% 
ethanol for 5 minutes followed by two washes in sterile PBS to remove any remaining 
ethanol. This was done to render the Scaffold hydrophilic for cell culture.  Cells were 
seeded at a density of 250,000 cells per insert and cultured in DMEM for a period of 7 
days. At culture end models were fixed in 4% paraformaldehyde and processed into wax 
utilising the standard paraffin embedding protocol described previously (Section 2.3.1) 
 
5.3.2 Basement membrane addition to Alvetex Scaffold®. 
Alvetex® 12-well discs were processed to be hydrophilic for culture as described 
previously (Section 5.3.1). Collagen I, Matrigel® and Puramatrix® solutions were made 
up following manufacturers specification to a concentration of 2 mg/ml. Basement 
membrane solutions were added to scaffolds at a density of 200μl per scaffold and 
allowed to gel completely in a humidified environment at 37oC for 30 minutes before the 
addition of cells. Caco-2 cells were seeded onto Alvetex®/ Gel constructs at a density of 
250 000 cells/ insert and left to culture for either 14 or 28 days. At the end of cell culture 
models were fixed in 4% paraformaldehyde and processed into wax as previously 
described (Section 2.3.1) 
 
5.3.3 Differential CCD-18co seeding density on model 
development. 
The epithelium of the intestine is formed of a monolayer of enterocytes and other cell 
lineages supported by a basement membrane and an underlying stroma of myofibroblasts 
and fibroblasts. 24-well scaffold with area of 0.77cm2 were seeded with 77,000 
(100,000/cm2), 192,000 (250,000/cm2), 385,000 (500,000/cm2) and 777,000 
(1,000,000/cm2) fibroblast cells per model. Cells were grown in standard media as 
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described previously (Section 2.2) for a period of 2 weeks. After 2 weeks of culture Caco-
2 cells were added to the apical side of two thirds of the models and allowed to attach at 
air liquid interface overnight before subsequent submergence in Caco-2 complete 
medium  (complete DMEM) for a further period of 2 weeks. The remaining models were 
analysed by MTT assay at the 14 day timepoint without Caco-2 addition as previously 
described (section 3.2.5). At experiment end, replicates of individual models were either 
fixed and  processed into paraffin as previously described (Section 2.3.1) or were analysed 
by MTT as previously described (Section 3.2.5) 
 
Paraffin embedded samples were sectioned at 7μm and stained with H&E. Images were 
taken along the length of each sample with a ICC50 HD microscope (Leica) and stitched 
together and analysed using image J. Multiple sections per condition were measured 
ensuring each section was a minimum of 50μm from the previous section. Image analysis 
consisted of measuring the epithelial area relative to the area of the entire model. This 
was achieved by overlaying images with a 500μm2 grid with grid squares chosen for 
analysis by random number generator.   
 
5.3.4 The effect of culture time on model development. 
CCD-18co cells were seeded into culture treated Alvetex® Scaffold discs at a density of 
250,000 cells/ cm2 (192,000 cells per insert). Scaffold were cultured for 14, 21 or 28 days 
before analysis. One third of the models were stopped at their respective timepoints and 
tested for metabolic activity by MTT assay. Other models were seeded with Caco-2 cells 
at a density of 223,000 cells per cm2 (172,000 cells per insert, the same as the seeding 
density of Transwell). Caco-2 cells were allowed to attach overnight at the air liquid 
interface (ALI) before being subsequently cultured for a period of 14 Days. After 14 days 
of Caco-2 culture models were either processed into paraffin as previously described 
(Section 2.3.1) or were analysed by MTT as previously described. (Section 3.2.5) 
Paraffin embedded samples were sectioned at 7μm analysed in Image J for the % Caco-2 
penetration into the scaffold as previously described.  
 
Chapter 5 – Development and characterisation of a novel 3D model of the intestinal mucosa 
Page | 245 
 
5.3.5 MTT assay analysis of CCD-18co cells grown in Alvetex® 
Scaffold. 
MTT assay analysis of CCD-18co metabolic activity was achieved as previously 
described (Section 3.2.5)  
 
Briefly, whole Alvetex® Scaffolds containing CCD-18co cells were washed in sterile PBS 
twice. 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide was dissolved 
into phenol free DMEM at 2mg/ml. Solution was heated to 37oC and agitated sufficiently 
to ensure complete dissolution. MTT solution was sterile filtered through a 0.2μm filter 
before use.  4.5 ml of MTT solution per well was added to the 24 well format Alvetex 
Scaffold® and left at 37oC for 1 hour. After 1 hour models were removed from MTT 
solution and washed twice in sterile PBS. Models were then unclipped carefully from the 
well supports to limit any disturbance of the cell layers and placed at the bottom of a fresh 
12 well plate. 1ml of acidified isopropanol was added to the models to liberate the dye. 
Models were placed at 150 RPM for 15 minutes to ensure complete dye removal from the 
3D scaffold material. 200μl of dye solution was placed into a 96 well microtiter plate and 
read at 590nm 
 
5.3.6 SEM processing of differential seeded CCD-18co 
Alvetex® layers.  
CCD-18co cells were liberated from 80% confluent T175 culture flasks and counted as 
previously described (Section 2.2.3). Cells were seeded onto cell culture treated Alvetex 
Scaffold® layers at differential densities of 77,000, 192,000, 385,000 and 777,000 cells 
per model equating to 100,000, 250,000, 500,000 and 1,000,000 cells per cm2 or by 
utilising the multiple seeding technique which involves seeding 192,000 cells on days 0, 
7, 9 and 11 for a total of 768 000 cells per model. Models were cultured in standard 
DMEM formulation for 14 days with media changes every other day. After 14 days 
models were fixed and processed for SEM as previously described (Section 2.6) 
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5.3.7 3D model processing for TEM analysis 
The general protocol for the processing and staining of samples for TEM analysis is 
described previously (Section 2.7) 
 
5.3.8 Toluene Blue stained samples  
3D models stained for Toluene Blue were set up utilising the standard 3D model set up 
protocol as previously described (Section 2.15). Samples were cultured for the full culture 
period before being processed into resin (Section 2.7). Resin embedded samples were 
sectioned semi-thin (approx. 1μm) utilising a glass knife. Resin embedded sections heat 
fixed onto a glass slide before being submerged in Toluene Blue solution for a period of 
5 minutes. Stained samples were rinsed in cold running water to remove excess stain. 
Stained samples were mounted with DPX before being imaged on a light microscope 
(ICC50 HD, Leica) 
 
5.3.9 Clearing of Alvetex Scaffold for high resolution lighsheet 
imaging of 3D intestinal models. 
3D models were fixed in 4% PFA as previously described before being washed twice in 
PBS for 30 minutes each time. Samples were  dehydrated in methanol following a 50%, 
80% and 100% gradient (Methanol: PBS) for one hour at each concentration. Samples 
are bleached in 5%H2O2 in 20%DMSO/ Methanol overnight at 4
oC in the fridge. Samples 
are washed twice in 20% DMSO/ Methanol for one hour each time. This is followed by 
rehydration through methanol (80%, 50%) for one hour each before being washed in PBS 
twice and PBS/0.2% Triton for at least one hour before further processing. Samples were 
Immunostained utilising the normal protocol for immunostaining as previously described 
(Section 2.4.1)Samples are incubated overnight in 50:50 tetrahydrofuran (THF): H2O. 
Samples are incubated in 80% THF and 100% THF for 1 hour per concentration. Samples 
are then processed into dichloromethane (DCM) for 30 minutes followed by storage in 
dibenzyl ether (DBE) at room temperature at which point Alvetex Scaffold® becomes 
completely transparent within DBE. Protocol taken from a method devised by Renier et 
al (270) 
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For imaging on a lighsheet microscope (Zeiss lighsheet Z.1) Alvetex® must remain within 
DBE to remain transparent. Alvetex® sections were attached to a metal rod with agar 
before being placed within a capillary tube containing DBE. The tube was sealed so that 
DBE could not leach into the microscope imaging chamber.  
 
5.3.10 Immunostaining of 3D models and human intestinal 
tissue.  
Both tissues and models were fixed and embedded in paraffin wax as previously described 
(section 2.3.1) prior to sectioning at 7μm intervals and heat fixing to glass slides. Prior to 
staining slides were dewaxed in Histoclear and brought to water through a series of 
ethanol gradients. The general protocol for the process of immunostaining 4% PFA fixed 
tissues and models is described previously (Section 2.4.1). All slides were analysed on a 
Zeiss 880 confocal microscope 
 
5.3.11 Developing a 24 and 96 well Ussing chamber design for 
the efficient functional analysis of Alvetex intestinal models. 
Both 24 and 96-well Ussing chamber designs were created by myself in the 3D CAD 
software Autodesk. Schematics for finalised designs were send to mechanical engineering 
services, a part of the Department of Physics at Durham university for manufacture. 
Chambers were made out of optically transparent Acrylic. It is important that chamber 
systems at no point are in contact with ethanol of any concentration as plastic will fracture 
on/ shortly after contact. 
 
Deep well plates for the culture of 96-well inserts were designed by myself and 3D 
modelled in collaboration with e3design ltd (Newcastle, UK). Concept and application 
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5.4 Results 
5.4.1 Caco-2 growth characteristics in different Alvetex® 
configurations. 
In order to understand the best way to construct the 3D model of the intestine the first 
thing that must be understood is the growth characteristics of the cell lines within 
Alvetex®. Alvetex® comes in 3 different formats; Scaffold, Strata and Polaris, with the 
difference between each of the formats linked to the void size of the material. Scaffold 
has the largest void size at an average of 42μm, Strata has a void size of an average of 
15μm and Polaris has the smallest pore size (not quantified) 
 
Caco-2 cells were seeded onto each of the Alvetex® formats at a seeding density of 
250,000 cells per cm2 for a period of 7 days before being processed into paraffin wax as 
previously described. Figure 5.1 shows the H&E staining of Caco-2 cells on A) Alvetex 
Scaffold®, B) Alvetex Strata® and C) Alvetex Polaris®. Figure 5.1 A shows that in the 
scaffold format Caco-2 cells are able to form a well-defined multilayer of cells at the 
surface of the scaffold structure. Additionally, Caco-2 cells can be clearly seen to line the 
surface of the scaffold voids creating a pore like structure within. Cells are shown to be 
able to penetrate through some of the Alvetex scaffold® but generally remain within the 
upper third of the 200μm thickness. When cells are grown on Alvetex Strata® (Figure 5.1 
B) Caco-2 cells are shown to create a monolayer not dissimilar from that seen in Caco-2 
Transwell models. Cells are confined to the surface of the material without any invasion 
into the underlying stroma. Similarly, when cells are grown on Polaris (Figure 5.1 C) no 
invasion through the Alvetex® material is seen. However, Polaris culture seems to induce 
a multilayering phenotype within the Caco-2 cells not seen in Strata or scaffold. 
 
Alvetex Scaffold was chosen as the preferred substrate for model development because 
of its high porosity. Initial experiments (Data not shown) suggested that both Strata and 
Polaris Alvetex® formats  would be poorly suited to pharmacokinetic analysis due to 
compound sequestration. Additionally, Scaffold® allowed for the culture of fibroblasts 
cells throughout the length of the substrate with ample room for ECM deposition. 
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A) Scaffold B) Strata C) Polaris 
Figure 5.1: Understanding the growth characteristics of Caco-2 cells in different formats of Alvetex® polystyrene supports – A) Alvetex Scaffold® has the largest 
pore size of the different formats with an average void of (33-55μm). Caco-2 cells can be seen growing along the first third of the scaffold thickness, lining the pores to 
create small epithelial lines spheroids. B) Alvetex Strata® has an average pore size of (<20μm). Caco-2 cells form a monolayer across the surface of the model with no 
invasion into the underlying support. C) Alvetex Polaris® has the smallest pore size with an average diameter of (3-4μm). Similar to that seen in Strata, Polaris allows for 
the formation of a monolayer along the surface of the support, with some areas of multilayering. Images are representative of a minimum of 3 independent observations. 
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5.4.2 Addition of a basement membrane protein to the surface 
of Alvetex Scaffold®. 
Figure 5.1 shows that it is impossible to culture Caco-2 within a 3D Alvetex Scaffold® 
and create a consistent monolayer without the addition of some other factor to limit Caco-
2 cell invasion. One method attempted to limit Caco-2 movement was application of 
basement membrane proteins to the surface of the Scaffold, onto which cells could be 
seeded. Figure 5.2 shows Caco-2 cells on Collagen I, Puramatrix and Matrigel layers.  
 
Figure 5.2 A shows Caco-2 cells forming a continuous layer with good cellular 
morphology on Collagen I layers. No invasion into the underlying stromal section 
indicates a continuous gel layer. Puramatrix (Figure 5.2 B) and Matrigel (Figure 5.2 C) 
layers result in significant stromal Caco-2 invasion by 14 days of culture. Cells are seen 
lining the internal pores of the Alvetex Scaffold®. Puramatrix® Caco-2s’ remain in the 
upper third of the Scaffold whereas Matrigel induces cellular invasion almost to the full 
thickness of the scaffold at a greater rate than the uncoated surfaces (Figure 5.1 A). 
 
The phenotype described above is the same at 21 days of culture, with Collagen layers 
limiting Caco-2 cells to a single monolayer at the surface and Puramatrix and Matrigel 
layers allowing full cellular infiltration across the depth of the scaffold over 28 days of 
culture.  As such, from a structural standpoint alone, Collagen I was shown to be the best 
suited Basement membrane protein for long term culture of Caco-2 cells in 3D.  
 
Figure 5.3 shows the optimisation of Collagen I layers on the surface of Alvetex 
Scaffold®. Figure 5.3 A, shows the Analine Blue staining of Collagen I of 2mg/ml, 200 
μl per cm2 scaffold area, B is 1 mg/ml and C is 0.5 mg/ml. It can be clearly shown that 
only 2mg/ml was able to form a continuous layer of collagen across the surface of the 
model as such this concentration was utilised through the proceeding experiments. It was 
decided at this time that focus on the development of a populated stromal fibroblast layer 
was more in line with the overall goals of the project. As such addition of a collagen 
membrane was dropped in favour of optimisation of a sub-epithelial fibroblast 
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compartment, sufficiently populated to limit Caco-2 invasion without the requirement of 
the addition of further basement membrane proteins. 
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Figure 5.2: Application of basement membrane proteins to Alvetex Scaffold® to limit the invasion phenotype into the underlying stromal compartment.  – A) 
Caco-2/Collagen I, 14 days, B) Caco-2/ Puramatrix, 14 days ,C) Caco-2/ Matrigel, 14 days, D) Caco-2/Collagen I, 28 days, E) Caco-2/ Puramatrix, 28 days, F) Caco-2/ 
Matrigel, 28 days. Collagen 1 was the only protein gel mix that experienced reasonable success in the limiting of Caco-2 invasion with clear monolayer formation on the 
apical side of the collagen gel at days 14 and 28. Matrigel and Puramatrix had little effects on the limiting cellular invasion. Indeed, in both instances it could be easily 
argued that these protein mixes had the opposite effect, promoting cellular growth and motility into the Scaffold. Scale =100μm Images are representative of a minimum 
of 3 independent observations. 
A) Collagen I B) Puramatrix C) Matrigel 
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5.4.3 CCD-18co conditioned media effects on Caco-2 
development on Collagen I Basement membranes in Alvetex 
Scaffold®. 
Figure 5.4 A-F, shows the morphology of Caco-2 cells grown on Alvetex® Collagen I 
membranes in the presence of CCD-18co conditioned media. Figure 5.4 A shows H+E 
staining of 7 day paracrine cultures. Analysis of staining shows strong nuclei staining and 
weak cytoplasmic staining, characteristic of Caco-2 cells. Cells appear to grow in a 
homogenous monolayer across the entire samples with no obvious places whereby cells 
have penetrated into the underlying stromal compartment. This same morphology is also 
seen in both the 14 and 21 day cultures (Figure 5.4 B&C respectively). 
 
Higher magnification analysis of the slides (Figure 5.4 D, E & F) shows how the Caco-2 
cells are tall and undifferentiated at day 7, possibly arranged into thick multilayers of 
cells. Over time this phenotype decreases until by day 21 there is a continuous monolayer 
of cells across the membrane with well-defined polarity with Nuclei clearly arranged 
close to the basement membrane and cuboidal shaped epithelial cells. Darker eosin 
staining at the surface of the 21 day differentiated Caco-2 cell models (Figure 5.4 F) 
potentially indicates the presence of microvilli and associated glycocalyx.
A) 2mg/ml B) 1mg/ml C) 0.5mg/ml 
Figure 5.3: Optimising the volume and concentration of Collagen I gels to add to the surface of 
the Scaffold to limit cellular invasion.  – Analine blue staining of collagen I gel on the surface of 
Alvetex Scaffold®. A) 2mg/ml, B) 1mg/ml, C) 0.5mg/ml. Staining clearly shows that only 2mg/ml was 
capable of creating a consistent layer across the surface of the Alvetex Scaffold®. All other conditions 
created weak layers at the surface and lined the pores of the Alvetex Scaffold®. Images are 
representative of a minimum of 3 independent observations. Scale =100μm. 
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A) 7 Days B) 14 Days C) 21 Days 
D E F 
Figure 5.4: CCD-18co paracrine treatment of Caco-2 cells cultured on 2mg/ml Collagen I gel layers shows an enhanced Caco-2 
phenotype over control layers – CCD-18co paracrine media was cultured with Caco-2 collagen models for a period of A) 7 days, B) 14 
days , C) 21 days. Caco-2 cells can be seen to increase in membrane organisation over time, starting with a disorganised multilayer of cells, 
progressing over time to form a single monolayer of polarised epithelium at day 21. Images are representative of a minimum of 3 
independent observations. Scale 100μm and 50μm respectively.  
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5.4.5 Optimisation of CCD-18co cells seeding density within 
Alvetex Scaffold® to create a surface layer to support the 
culture of Caco-2 epithelial cells. 
The use of Collagen I as a substitute basement membrane was ruled out at this point. All 
further experiments with the development of a 3D model system are done so without the 
addition of exogenous collagens. Figure 5.5 A-D shows the effect of CCD-18co seeding 
density on the ability of Caco-2 cells to create an epithelium.  Figure 5.5 A shows Caco-
2 cells cultured on an Alvetex Scaffold® populated with 77,000 cells per insert (100,000 
cells/ cm2) after being cultured for 14 days.  Caco-2 cells invade up to halfway through 
the scaffold with cells growing characteristically as described previously within the 
Alvetex®.  Figure 5.5 B, C and D shows the same phenotype as described for Figure 5.5 
A however the initial fibroblast seeding densities in each case are 192k (250,000 cells/ 
cm2), 385k (500,000 cells/ cm2) and 777k (1,000,000 cells/ cm2). Interestingly, the initial 
seeding density of CCD-18co cells does not appear to have a significant effect on the 
rates of Caco-2 invasion until the 777k seeding density. The 777k condition (Figure 5.5 
D) does appear to have a small effect on Caco-2 invasion rates but is still insufficient to 
stop some cellular infiltration into the underlying stroma.  
 
Figure 5.6 shows the quantified effect of CCD-18co seeding density on Caco-2 invasion 
rates. Figure 5.6 A, shows the methodology whereby “Invasion rate” is quantified as a 
percentage of the area of Caco-2 staining compared to the total area of scaffold present. 
Values are normalised to a 500μm2 grid. Figure 5.6 B , shows the quantified difference 
in Caco-2 invasion rates between the different seeding concentrations. There is no 
significant difference between the rate of Caco-2 invasion between any of the conditions 
although a downwards trend is seen with increasing CCD-18co density, with the 
maximum decrease seen in the 777k samples of around 10-15% compared to 77k. 
Significancy was calculated by one way ANOVA with Tukeys post test analysis however 
no significancy between values was observed. 
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Figure 5.5: Optimisation of fibroblast seeding density to limit the invasive characteristics 
of Caco-2 cells  – Multiple seeding densities (Cells/ cm2) were tested for their capabilities to 
create a well populated, ECM rich foundation for the culture of Caco-2 cells. Ideally, CCD-
18co populated Alvetex should be able to support the culture of a Caco-2 monolayer without 
the need for additional basement membrane protein additions. CCD-18co cells were cultured 
for a period of 14 days prior to the addition of Caco-2 cells which were also cultured for 14 
days prior to invasion analysis.  A) 77K, B) 192K, C ) 385k, D) 777K. As can be seen here, no 
singular seeding density was sufficient for complete repulsion of Caco-2 cells from the internal 
Alvetex Scaffold. Representative images of 14 day Caco-2 calls on different seeding densities.   
Images are representative of a minimum of 3 independent observations. 
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Figure 5.6: Creating a quantifiable technique for the analysis of model sections for the percentage invasion of Caco-2 cells within the Alvetex scaffold®– A method 
was required which was able to quantify the levels of invasion of the overlying Caco-2 cells into the underlying stromal compartment. A percentage invasion was calculated 
by first measuring the area of the stained caco-2 cells and then the area of the whole model. Percentage invasion is calculated through comparison of the two measured areas.  
A) Methodology for the measurement of Caco-2 infiltration into underlying scaffold. A full length image of the sections was taken and stitched together in image J. For 
quantification an overlying grid of 500μm2
 
was used to take random samples along the model. Minimum of 4 images were quantified per section. B) Graph showing results as 
a percentage of area quantified. n = 12 from a minimum of 3 independent experiments. Significancy was calculated by one-way ANOVA, No significancy was observed 
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5.4.6 Metabolic activity assessment of CCD-18co seeding 
optimisation experiments. 
Figure 5.7 A, shows the MTT assay results of the 14 day cultures of CCD-18co in Alvetex 
Scaffold® with differential starting seeding densities. No significant differences can be 
seen in the metabolic activity between any of the seeding densities at the 2 week 
timepoint, although there is a small non-significant trend toward increasing MTT value 
with increasing cell seeding density. However whilst there is a small trend the difference 
is disproportionate to the increase in cell number at the beginning of the experiment For 
example, 777k seeding density with 10 times the original staring density of CCD-18co 
cells compared to 77k only shows a marginal increase in MTT absorbance of 
approximately 10-20% over the 77k seeding condition. In contrast, the multiple seeding 
technique as described previously (Section 2.15) seeds a total of 576k cells into the 
scaffold over the duration of the 14 day culture time. This is 201k cells less than the 777k 
condition but produces a significantly higher absorbance value than any other condition 
suggesting a compounding effect. 
 
When Caco-2 cells are added to the fibroblast stromal models and cultured for a further 
14 days (Figure 5.7 B) there is no significant differences seen in the terminal MTT values, 
suggesting that Caco-2 cells have invade into the underlying stroma and scaffold and have 
proliferated to similar extends in each of the conditions, providing evidence that these 
seeding densities are unable to stop Caco-2 invasion into the underlying stroma. 
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Figure 5.7: Metabolic activity of the models shows that seeding higher densities of CCD-18co cells at the beginning of model culture has little effect on the 
number of surviving fibroblasts at the time of analysis – A) MTT data of differing seeding densities of fibroblasts grown in Alvetex Scaffold for 14 days. 
Compared to current multiphasic seeding method. Data shows that there is a non-significant difference between low number seeding densities (77,000/ model) and 
high number seeding densities (777,000/ model) multiphasic seeding (OP SMUL) whereby 777,000 cells are added over time rather than all on day 0 shows 
significant increases over other conditions suggesting a higher proportion of surviving fibroblasts. B) MTT values of 14 day fibroblast models plus 14 days of caco-
2 culture. Heightened MTT values indicate significant Caco-2 cellular infiltration into the underlying scaffold. No significant difference between models suggests  
all of the models allow for Caco-2 infiltration at similar rates. n=3, N=3 Significancy was calculated by one way ANOVA with Tukeys post-test analysis. Error bars 
represent +SEM of average values. 
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Figure 5.8: SEM topographical analysis of optimisation CCD-18co layers shows significant gaps in the surface support for the culture of Caco-2 cells  – 
Different seeding densities of fibroblasts were added to Alvetex Scaffold. A) 77k, B) 192k, C) 385k, D) 777k, E) Multiple seeding technique. Areas for the 
invasion of Caco-2 cells into the underlying stromal support can be clearly seen in all conditions except when CCD-18co cells are seeding into models utilising 
the multiple seeding technique. Images are representable of the average phenotype of the entire surface layer and multiple observations. 
77,000 192,000 385,000 
777,000 Multi-seeded 
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5.4.7 SEM analysis of the surface topography of CCD-18co 
seeding density layers. 
Surface topography of CCD-18co cells grown in Alvetex scaffold® is clearly shown 
through SEM imaging. Figure 5.8 A, shows 77k seeding density at the 14 day timepoint. 
Whilst cells can be clearly seen on the surface of the Scaffold®, there are clear gaps in the 
surface fibroblast layers, inevitably resulting in Caco-2 invasion into the Alvetex 
Scaffold® below. Figure 5.8 B, C & D correspond to higher seeding densities, show 
similar gaps, albeit appearing to decrease in regularity, in the surface layer. Figure 5.8 E 
however shows the effects of multiple seeding on CCD-18co surface layers. A continuous 
layer of cells is demonstrated across the entire surface of the model with no gaps available 
for the invasion of Caco-2 cells into the scaffold. Indeed, the cracks seen on the SEM 
images are due to processing of the samples for SEM analysis rather than for a biological 
reason.  
 
5.4.8 The effects of extended culture time on the population of 
Alvetex Scaffold® with CCD-18co cells. 
Figure 5.9 shows the histological sections of samples cultured for  a period of either 14, 
21 or 28 days. Observation of the slides highlights the lack of CCD-18co growth over 
time when cultured in 3D. Cells appear to colonise the substrate before proliferatively 
quiescing, maintaining cell numbers without proliferation (Figure 5.9 D). 
 
Figure 5.10 shows the effects of fibroblast culture time on the MTT values of the stromal 
cell models. What is clear is increasing culture time seemingly has no effect on model 
metabolic activity, suggesting that CCD-18co cells do not proliferate in 3D. Analysis of 
Caco-2 invasion (Figure 5.11) as described previously, reflects MTT values with no 
significant differences. In contrast  multiphasic culture significantly increases the MTT 
absorption values and decreases Caco-2 invasion into the underlying stroma when 
compared to other timepoint conditions.  
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Figure 5.10: Understanding the effects of time on the growth of CCD-18co population in 3D Alvetex 
models  –  MTT data of 192k cells/cm2 at differing timepoints. 14D, 21D, 28D. Data shows that time has little 
effect on the overall population size of CCD-18co cells cultured in Alvetex Scaffold. No significant differences 
can be observed between 14, 21 and 28 day timepoints with the highest levels being at around 21 days in culture, 
after which levels once again begin to drop. Multiphasic culture design is added here for comparison only, cell 
numbers and time are not controlled in multiphasic cultures in the same way as other conditions here. n=3 
Significancy calculation performed by one way ANOVA with Tukeys post-test analysis. n=3, N=3 Error bars 
represent + SEM of average values. 
A) 14 Days B) 21 Days C) 28 Days 
14 Days 21 Days 28 Days 
Figure 5.9: The effects of time on the growth of CCD-18co population in 3D Alvetex models shows 
little active proliferation when cultured in 3D  –  A) 14 days CCD-18co culture, B) 21 days, C) 28 days. 
D) Quantified data showing nuclei per field of view between samples. n=3 N=3. Histological analysis of 
paraffin embedded sectioned samples shows no significant differences between 14, 21 or 28 days of culture 
on the population of CCD-18co cells populating the Alvetex Scaffold. Images are representative of a 
minimum of 3 independent observations. Error bars represent + SEM of average values. 
Scale 100μm Error bars represent SEM of average values. 
D)  
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5.4.9 SEM analysis of stromal fibroblast cell layers. 
Figure 5.12 shows the protocol for the culture of CCD-18co cells growing within the 
Alvetex Scaffold® support. Figure 5.12 A shows the full thickness of the Alvetex 
scaffold® with CCD-18co growing within. It can be clearly shown that CCD-18co cells 
grow throughout the full 200μm scaffold thickness. ECM growing within the Alvetex® 
voids (Figure 5.12 B) is seen as strands of proteins spanning along the void spaces. ECM 
does not fully fill the space within the voids but instead spans between the cells and the 
voids. Figure 5.12 C & D shows the CCD-18co fibroblast phenotype along the surface of 
the Scaffold with a classical spindle shape layering the surface. The purpose of optimising 
the culture of the CCD-18co cells within the Alvetex Scaffold® was to limit the number 
of places whereby Caco-2 cells could invade into the underlying stroma. Figure 5.12 C 
shows that whilst the multiphasic culture strategy is more capable at creating said layer 
than all other conditions, there are still instances of areas on the surface of the scaffold 
whereby Caco-2 penetration could feasibly occur.   
Figure 5.11: Caco-2 invasion characteristics show that CCD-18co culture time has no 
significant effects on reducing the levels of Caco-2 invasion in Alvetex models – 192 000 
cells were added to Alvetex Scaffold on day 0 and allowed to grow in 3D for either 14, 21 or 
28 days. Results show no significant effect of culture time on the capabilities of the resultant 
model to limit Caco-2 cellular ingrowth with an average invasion amount of approximately 
30% of the model area. Error bars represent + SEM of average values. n=3, N=3 
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5.4.10 Structural analysis of optimised multiphasic seeded 
Caco-2/ CCD-18co Alvetex Scaffold® intestinal models.  
Histological cross sections of 3D Alvetex ®models highlights the structural morphology 
of cells within the Scaffold support (Figure 5.13 A & B). All models were cultured for a 
period of 35 days (14 days stromal culture followed by 21 days Caco-2 differentiation). 
High quality images show the heightened Caco-2 cells morphology located apically in 
the models. Caco-2 cells appear to create a single monolayer of cells for the majority of 
the models length however there are areas where multilayering seems to occur. However, 
A B 
D 
Figure 5.12: SEM Images of CCD-18co cells cultured in Alvetex Scaffold for a period of 21 
days shows significant ECM depositions within the Scaffold matrix- A-B) Fibroblasts provide a 
continuous surface layer in addition to penetration of the Alvetex inter-pore spaces and deposition 
of ECM proteins. Scale 200 and 50 μm C) High magnification image of the surface layer of the 
intestinal model. Image shows multiple layers of stretched fibroblasts providing supportive layer. 
Arrows (*) indicate points in the surface layer where Caco-2 penetration could occur. D) High 
magnification image of surface CCD-18co cells showing stellate morphology. Images are 
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differentiation between Caco-2 and CCD-18co cells is difficult at the epithelial-
mesenchymal boundary so these areas of “multilayering” could simply be CCD-18co and 
Caco-2 cells closely interacting. The cells growing within the Alvetex Scaffold® matrix 
can be clearly identified as CCD-18co cells from their basic cell morphology and growth 
patterns. Cells can be seen to be evenly dispersed throughout the model with thin layers 
at the base of the model in addition to the surface whereby they create a supportive 
foundation for the culture of the Caco-2 epithelium. This supportive layer is clearly able 
to limit the invasion of Caco-2 cells into the Scaffold with no evidence of invasion seen 
in this sample. 
 
Periodic Acid Schiff staining (Figure 5.13 C) of the 3D model cross section for detection 
of acidified mucosubstances, indicating mucous production, shows strong positive 
staining in both the CCD-18co and Caco-2 cell layers. throughout the model but primarily 
located within the Caco-2 layer. Caco-2 cells are not known to secrete significant levels 
of mucous. 
 
Figure 5.14 shows Toludine blue stained semi-thin resin embedded sections of 3D CCD-
18co Alvetex Scaffold. Resin embedding allows for a higher resolution image. Unlike in 
Figure 5.13, Caco-2 cells can be clearly seen to arrange themselves into a monolayer 
epithelium at the surface of the model with a supporting fibroblast mucosa. Brush border 
formation can be observed apically to the epithelial cells in addition to membrane 
associated glycocalyx proteins.  
 
SEM ultra-structural analysis of the surface of 3D Caco-2/ CCD-18co models shows the 
classical cobblestone morphology of epithelial cells growing on the supporting fibroblast 
surface layer (Figure 5.15 A). A closer analysis of the surface shows a homogenous layer 
of microvilli formation across the surface of the sample which can be identified as short 
column like protrusions from the apical cell membrane (Figure 5.15 B). A mesh-like mix 
of glycocalyx glycoproteins and acidified mucosubstances can be seen associated with 
the microvilli on the surface of the model, making individual microvilli difficult to isolate 
due to the overlapping glycocalyx weave. 
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TEM structural analysis of 3D Caco-2/ CCD-18co models reaffirms what is seen in the 
SEM analysis of the model. Figure 5.16 A & B highlights the apically based microvilli 
structures seen across the entire surface of the model. Additionally, Figure 5.14 A shows 
apical-lateral electron dense staining at cell-cell junctions indicating the presence of tight 
junction complexes between cells. A clear boundary between Caco-2 and CCD-18co cells 
can be seen at the base of the epithelial layer within the model (Figure 5.16 C). Electron 
dense staining at the epithelia-mesenchymal boundary suggests the formation of a 
basement membrane between the two cell populations. Additionally, active vesical 
formation at the base of Caco-2 cells suggests cross talk between cellular compartment 
(Figure 5.16 D).  
Chapter 5 – Development and characterisation of a novel 3D model of the intestinal mucosa 
Page | 267 
 
  
Figure 5.13: 14 day multi-phasic culture design using young intestinal CCD-18co fibroblasts results in the formation of an intestinal model with 
little observable Caco-2 infiltration  – A) 40x B) 20X H+E staining of model. Note heightened epithelial cell morphology and well populated sub-
epithelial compartment. Caco-2 cells grow and self-organise into a monolayer epithelium without the added necessity for basement membrane protein 
additions to the model. Naturally secreted ECM creates a support structure for the culture of Caco-2 cells apically. C) PAS staining of intestinal models 
reveals moderate secretion of acidified mucosubstances in line with that seen in normal Caco-2 culture. Total model culture time = 35 days. All images 
were taken after 35 days in culture (21 days post-Caco-2 addition) Images are representative of a minimum of 3 independent observations. Scale: 50μm 
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Figure 5.14: Toludine blue stained samples provides enhanced resolution over H&E stained images allowing for closer analysis of the structural 
morphology of Caco-2 layers on the surface of CCD-18co models – Representative images of CCD-18co/ Caco-2 Toludine blue stained semi thin resin embedded 
sections.  A) 40 x magnification image of multiphasic culture CCD-18co/ Caco-2 intestinal model, B) 100x magnification. Total model culture time = 35 days. All 
images were taken after 35 days in culture (21 days post-Caco-2 addition) Images are representative of a minimum of 3 independent observations. Scale bar 100μm 
and 50μm respectively.  
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Figure 5.15: High magnification analysis of Caco-2/ CCD-18co 3D models reveals differentiated enterocytes with clear microvilli 
formation and associated glycocalyx – Samples, increasing magnification from left to right. Surface structures seen through SEM microscopy 
are highly reminiscent of microvilli structures seen in the literature. These structures indicate a well-established and differentiated caco-2 layer 
within the model. Total model culture time = 35 days. All images were taken after 35 days in culture (21 days post-Caco-2 addition). Images are 
representative of a minimum of 3 independent observations.  Scale bars: 30 and 1 μm respectively.  
A B 
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Figure x: TEM Images of full thickness short 
multiphasic intestinal model – TEM images of 
60nm thick resin embedded sections reveal 
the presence of tall microvilli structures and 
tight junction complexes organised apically 
to the caco-2 monolayer present within the 
2μm 
Figure x: TEM Images of full thickness short 
multiphasic intestinal model – TEM images of 
60nm thick resin embedded sections reveal 
that microvilli expression is consistent over 




Figure 5.16: TEM ultra-thin cross sections of CCD-18co 3D co-culture model showing 
microvilli, intercellular junctions and basement membrane formation – A) Microvilli 
formation on the apical surface of Caco-2 cells, B) Low magnification image of the surface of 
one Caco-2 cell showing microvilli formation along the total apical length of the cells, C) Caco-
2/ CCD-18co contact points showing electron dense basement membrane, D) Vesicle formation 
between CCD-18co and Caco-2 cells. Total model culture time = 35 days. All images were 
taken after 35 days in culture (21 days post-Caco-2 addition). Images are representative of a 
minimum of 3 independent observations. 
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5.4.11 Optimisation and structural analysis of Caco-2/ HDFn 
Alvetex Scaffold® intestinal models.  
Figure 5.17 shows the differential morphologies of cells seen in 3D at different timepoints 
of Caco-2 culture on the surface of the HDFn models. The purpose of this experiment 
was to observe the 3D model during the culture period. The culture of HDFn models in 
the absence of Caco-2 cells shows good model stability overtime without any significant 
effects in model morphology even over long periods (data not shown). The addition of 
Caco-2 cells for a period of 7 and 14 days  (Figure 5.17 A,B & D,E) shows good Caco-2 
morphologies with tall columnar cells, basally located nuclei and, under close 
examination, apical microvilli formation. However, Fibroblast layers are seen to 
dramatically decrease in size between 7, 14 and 21 days. 
 
Caco-2 cells were not expected to have any negative effects on the culture or morphology 
of the HDFn membrane however by 21 days in culture significant decreases in cellular 
number and changes in cell morphology can be easily observed with fibroblast cells 
taking on a flattened, compacted morphology, potentially indicating cell death. Caco-2 
cells at day 21 (Figure 5.17 C & F) are cuboidal in cell, cytoplasmically dense and form 
a tight monolayer at the surface of the model. Whilst this morphology is significantly 
different than 7 and 14 day cultures, compared to 2D Caco-2 cells shown previously, there 
is still a significant improvement toward in vivo like characteristics of polarised columnar 
cells.  
 
Figure 5.18 shows methyl blue staining of the 3D HDFn cultured models described 
previously in Figure 5.17. Methyl Blue is a well-known stain for Collagen showing a high 
specificity here with little background staining often seen in Alvetex® based models. 7 
and 14 day cultures (Figure 5.18 A-B, D-E & G-H) show clear collagen deposition within 
the scaffold matrix, with long fibrous strands stretching across voids and pores. This 
allows for the full 3D culture of the cells within the scaffold through the deposition of 
tissue specific hydrogels and proteins within the 3D matrix itself. By day 21 Collagen 
deposition within the scaffold is seen to be significantly diminished over 7 and 14 day 
samples, with only weak, diffuse staining seen.  
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Due to the decreases in cell numbers and collagen deposition as seen in Figures 5.17 and 
5.18 respectively, the multiphasic approach to fibroblast culture was attempted with the 
same methodology as was proven to be successful with CCD-18co cells previously.   
 
Figure 5.19 shows the H&E staining of multi-seeded mature HDFn intestinal models. 
Figure 5.19 A shows the Caco-2 epithelial layer at high magnification, highlighting the 
cuboidal shape of the cell layer and the lack of both invasion into the underlying scaffold 
and the ability of the cells to create a single layer thick monolayer epithelium as would 
be seen in the human intestine. Figure 5.19 B shows the H&E stained model at a lower 
magnification, highlighting the well populated Alvetex® Scaffold substrate and the dense 
fibroblast layers at both the apical and basal sides of the HDFn intestinal model. PAS 
(Figure 5.19 C) staining shows a similar morphology to that seen previously in the CCD-
18co intestinal model (Figure 5.13 C) whereby Caco-2 cells stain weakly positive, 
suggesting some low level mucous production in these cells. HDFn cells appear to also 
weakly stain with PAS reagent suggesting some level of background staining within the 
image.  
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Figure 5.17: H+E staining of 7, 14 and 21 day cultures of Caco-2 on 28 day matured dermal equivalents show a changing fibroblast morphology over time -  500 
000 Caco-2 cells were seeded per 12 well format Alvetex Scaffold insert pre-cultured with dermal cells after day 28 of HDFn growth within Alvetex Scaffold. Caco-2 cells 
were cultured for variable time for either 7 days (A,D), 14 days (B,E) or 21 days (C,F). HDFn layers can be seen to reduce in thickness over time at both the apical and basal 
sides of the Alvetex Scaffold. Additionally, Caco-2 Morphology is clearly seen to change from a relatively tall, columnar shape to the more regular cuboidal culture after 21 
days.  Samples were fixed in 4% PFA overnight at 4oC prior to dehydration and embedding in paraffin. Images are representative of a minimum of 3 independent observations. 
Scale 100μm (A-C) and 20μm (D-E) 
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Figure 5.18: Methyl Blue stained Collagen staining of the 7, 14 and 21 day cultured Caco-2 models shows how Collagen deposition decreases after 21 days in 
culture – Collagen levels indicated through blue staining of structures within the Alvetex Scaffold® show clearly that fibrous collagen deposition has occurred during the 
culture of the HDFn cells within the Scaffold prior to the seeding of Caco-2 cells apically. Interestingly, deposited Collagen within the Scaffold seems to decrease over time 
with the length of Caco-2 culture diminishing both Collagen deposition and HDFn populations. Images are representative of a minimum of 3 independent observations. 
Scale 100μm (A-C) & 20μm (D-I) respectively. 
7 Days 14 Days 21 Days 
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Figure 5.19: 14 day multi-phasic culture design using low passage HDFn  fibroblasts results in the formation of an intestinal model with little 
observable Caco-2 infiltration  – A) 40x B) 20X H+E staining of model. Note cuboidal epithelial cell morphology and well populated sub-epithelial 
compartment. HDFn cells can be seen growing within the interior of the Alvetex Scaffold® in the self-organised 3D environment created by long term 
3D cell culture. Similar to that seen in the CCD-18co 3D model, Caco-2 cells grow and self-organise into a monolayer without the addition of 
basement membrane proteins to the model. Naturally secreted ECM creates a support structure for the culture of Caco-2 cells apically. C) PAS 
staining of intestinal models reveals moderate secretion of acidified mucosubstances in line with that seen in normal Caco-2 culture and a similar 
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Figure 5.20: 14-day multi-phasic culture design using low passage HIC fibroblasts results in the formation of an intestinal model with poor Caco-2 structure 
when compared to CCD-18co and HDFn optimised models – A) 40x, B) 20x H&E staining of the model shows poor Caco-2 differentiation across the surface of 
the model. Relatively low levels of Caco-2 cellular infiltration are observed however infiltration is more prevalent that CCD-18co and HDFn models. C) PAS staining 
of HIC 3D model sections shows no positive staining throughout the model, unlike in other conditions. Images are representative of a minimum of 3 independent 
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5.4.12 Histological analysis of the structure of Caco-2/ HIC 
Alvetex Scaffold® intestinal models.  
Figure 5.20 shows the histological analysis of Caco-2/ HIC models created utilising a 
multi-seeding approach with Alvetex® Scaffold. Figure 5.20 A & B, shows H&E stained 
sections at high and low magnification respectively. A consistent Caco-2 epithelium is 
observed across the length of the model however, cellular morphology is highly 
squamous similar to that seen in control Caco-2 Transwell cultures. PAS staining (Figure 
5.20 C) shows no positive staining throughout the section. This is in contrast with both 
CCD-18co and HDFn cultured models in which a small degree of mucous producing 
capability, especially in Caco-2 epithelial layers, could be observed. Caco-2 cells are 
primarily of enterocyte origin and function therefore, it is possible that this is a 
physiologically consistent change in cellular phenotype. 
 
5.4.13 Human colonic and small intestinal characterisation for 
comparison to 3D co-culture models. 
Figure 5.21 shows the histological characterisation of normal human colonic tissue 
obtained from Biopta (Glasgow, UK). Figure 5.21 A & B, shows samples of normal 
human colonic tissues which have been H&E stained to view the cellular morphology. 
Tissue is shown in both transverse and longitudinal sections showing abundant goblet 
cells within the epithelium and deep crypt formations. Goblet cell abundance is confirmed 
through PAS staining of tissue sections with strong positive staining seen along the length 
of the epithelium and into the crypt structures. Figure 5.21 E & F Massions Trichrome 
staining highlights the extracellular matrix compositions seen along the base of the 
epithelial layers, secreted by sub-epithelial myofibroblasts, supporting epithelial 
differentiation.  
 
Immunofluorescence characterisation of human colon tissue sections (Figure 5.22, 5.23) 
shows the characteristics staining patterns of some key protein of interest, namely of ECM 
deposition, junctional formation and functional efflux protein expression. Collagen I, III 
and IV are intercellular and secreted collagen proteins found extensively throughout the 
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body. Figure 5.22 A-C, shows the deposition patters of these collagens in human colonic 
tissues. Collagen I (Figure 5.16 A) is clearly seen to be highly abundant in both the crypt 
walls and the basal muscular layers with no positive staining seen in epithelial tissues. 
Collagen III (Figure 5.22 B) shows limited staining throughout the colon tissue section 
with only small amounts of positive staining seen, primarily located in the crypt core and 
the underlying smooth muscle layers. Collagen IV (Figure 5.22 C) shows extensive 
staining throughout the crypt core and the sub mucosal layers. Collagen IV is normally 
known as a basement membrane protein, primarily located on the basal lamina. 
Interestingly, whilst some of the staining does seem specific to the areas immediately 
beneath the epithelial layer, staining seen here suggests a more diffuse expression profile 
with extensive staining also seen in the sub-mucosal layers. Negative controls (Data not 
shown) do not show any positive staining in the absence of the primary antibody, 
suggesting the staining seen here for Collagen IV particularly is true staining. It is possible 
however, that some levels of cross specificity between Collagen types is present with this 
antibody, resulting in the non-physiological diffuse pattern of staining. αSMA staining 
designates myofibroblast locations within the sub-epithelial mucosa. αSMA staining here, 
compared to vimentin (Figure 5.23 A, D staining (general mesenchymal marker) shows 
a high proportion of myofibroblasts within the colonic tissues compared to total 
mesenchymal population. Elastin staining (Figure 5.23 B, D) is primarily located within 
the muscle layers immediately beneath the crypt structures. MDR1 (P-gp) colonic 
staining (Figure 5.23 C,E) demonstrates positive localisation to the crypt tips alone, 
generally thought to be the tissue within the colon most fully differentiated for enterocytic 
functions. No positive staining is seen within the crypt structured suggesting good 
staining specificity. Interestingly, MDR1 cellular localisation is not specific to the apical 
membrane as would be hypothesised, with staining also seen along lateral membrane 
boundaries. 
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Figure 5.21: Histological analysis of normal human colonic tissue sections – A-B) H+E staining of 
longitudinal and transverse sections of the colonic crypt. C-D) PAS staining of longitudinal and 
transverse sections of the intestinal crypt. E-F) Masson’s Trichrome staining showing the collagen 
deposition between the intestinal crypts. A-E Images were taken at 20x, F) was taken at x40 
magnification to show subtle blue staining. Images are representative of a minimum of 3 independent 
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Figure 5.22: Immunofluorescence analysis of normal Human Colonic tissue sections shows significant Collagen I, III and IV staining located at the sub-
epithelial compartment of the tissues  – A-D) longitudinal sections of Human Colonic tissue. Collagen deposition can be seen throughout the core of the crypt 
structures. αSMA staining indicated the presence of myofibroblasts located in the sub-epithelial compartment of the tissues. E-H) Shows the transverse sections 
of the crypt structures. Again, Collagen can be seen to be deposited immediately beneath the epithelial layers in the tissues. Internal non-stained circular areas 
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Figure 5.23: Immunofluorescence analysis of normal human colonic tissue sections highlights the two distinct cellular populations between epithelial and stromal 
lineages – A,D) Shows the longitudinal and cross sectional staining of the protein Vimentin, a type III intermediate filament protein found in mesenchymal cells. Staining 
intensity shows primary location in the sub-epithelial stromal compartment, highlighting the location of supportive fibroblast cells beneath the epithelial structures. B,E) Stains 
for Elastin, a component of the ECM of many tissues, important for tissue elasticity. C,E) MDR1 staining is shown to be located primarily at the crypt surface with less intense 
staining seen further into the crypt structure. Longitudinal staining shows only small expression in some crypt structures. Images are representative of a minimum of 3 
independent observations. Scale: A-C) 200μm, D-F) 100μm 
B C 
D E 
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5.4.14 Human small intestine characterisation for comparison 
to 3D co-culture intestinal models. 
Small intestinal tissue was also acquired from Biopta (Glasgow, UK). Figure 5.24 A, B  
shows the histological staining of the small intestinal tissue with H&E. Classical tall villus 
structures can be seen with a well-defined epithelium, supportive mucosa and basal 
smooth muscle layers. Transverse sections of the tissue show round structures indicating 
the cross sectioned villus. Large numbers of supportive fibroblasts can be easily identified 
with seemingly much denser staining that that seen in the colon tissue ( Figure 5.21 A,B). 
Figure 5.24 C, D show PAS staining of the intestinal tissue. Goblet cells, as identified by 
positive PAS staining are shown to be interspersed throughout the villus crypt axis 
between non-stained enterocyte lineages. Small intestinal tissue sections when compared 
to their colonic counterparts (Figure 5.21 C, D) show significantly less positive goblet 
cell staining indicative of the change in function between the tissues, with small intestine 
primarily tooled towards high absorptive properties. Trichrome staining (Figure 5.24 E, 
F) shows significant collagen deposition throughout the entirety of the tissue but primarily 
located at the base of the villi structures. 
 
Similar to that seen in colonic tissues, Collagen I, III and IV staining (Figure 5.25 A-C) 
is observed throughout the tissue structures, primarily in the sub-epithelial compartment 
immediately beneath the epithelial layers. αSMA staining (Figure 5.25 D) is equally 
dispersed throughout the tissue. However, compared to Vimentin (Figure 5.26 A) αSMA 
is only a small proportion of total mesenchymal staining. This is in contrast to staining of 
the colon and suggests that the small intestine harbours a smaller number of myofibroblast 
cells as a percentage of the total fibroblast population. Elastin staining (Figure 5.26 B) 
shows a specific, punctate staining throughout the small intestine mucosae most likely 
representing smooth muscle cells. MDR1 (Figure 5.26 C) shows a similar expression 
profile in small intestine as was observed in colonic tissues, namely a localisation to the 
apical cells of the villi structures and apical/ apical-lateral staining in the cells themselves. 
Small intestinal tissue sections were also stained for Occludin and E-Cadherin (Figure 
5.27 A, B) which were localised to the epithelial layer alone, with either apical or lateral 
staining for Occludin and E-cadherin respectively, as expected.  
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Figure 5.24: Histological analysis of normal Human Small intestinal tissue sections – A,B) 
Histological analysis of tissue structure by H&E staining of intestinal villi and muscularis layers. C,D) 
PAS staining of goblet cell populations within the small intestinal villus. Significant numbers of goblet 
cells ca be seen throughout the length of the intestinal Villus. Goblet cell population rates are 
significantly lower than that seen in the large intestinal sections (Figure5.15 C,D). E,F) Massions 
Trichrome staining of intestinal sections showing collagen depositions along the villus axis, Intense 
staining can be seen around the serosal layer of the tissue and in between villus structures. Images are 
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Figure 5.25: Immunofluorescence study of normal Human Small intestinal tissue sections for the analysis of ECM deposition in the stromal intestinal 
tissues – As was seen with immunofluorescence staining of Colonic tissues, ECM deposition can be located primarily beneath the Epithelial layers with a strong 
band of staining showing the supportive basement membrane of the epithelial layer. Low levels of αSMA (D) staining can be seen throughout the tissue sections, 
especially in the stromal and smooth muscle layers of the tissues. Images are representative of a minimum of 3 independent observations. Scale 100μm 
Collagen III 
Collagen IV αSMA 
Collagen I A B 
C D 
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Figure 5.26: immunofluorescence analysis of normal Human Small intestinal tissue sections 
shows distinct population of cells within the epithelial and stromal compartments – A) 
Vimentin, Mesenchymal intermediate filament protein B) Elastin, a secreted ECM component found 
within many body tissues, important for tissue elasticity C) MDR1, Apically expressed efflux protein 
found in enterocytes within the intestine Images are representative of a minimum of 3 independent 
observations.Scale 100μm 
 Occludin E-cadherin 
Figure 5.27: Immunofluorescence analysis of normal Human Small intestinal tissue sections 
– A) Occludin, tight junctional component protein, B) E-cadherin, Adherens junction component 
protein. Images are representative of a minimum of 3 independent observations. Scale 100μm 
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5.4.15 3D CCD-18co intestinal model immunostaining 
characterisation. 
Figure 5.28 shows the immunostaining characterisation of the 3D CCD-18co Alvetex 
®model of the intestinal mucosae. A-C shows the extracellular Collagen deposition by the 
CCD-18co fibroblasts within the Alvetex Scaffold®. Namely, Collagen I, III and IV are 
shown here and are seen to be homogenously dispersed throughout the Alvetex®, 
covering the pore surfaces and in some cases are seen spanning the void distance.  
 
Figure 5.28 D and E, shows Vimentin and aSMA staining respectively. Vimentin is used 
in this instance as a marker for cells of mesenchymal origin and should therefore stain 
fibroblasts specifically, including both normal and myofibroblast cells. αSMA is a marker 
specifically for cells of a myofibroblast origin. By comparing the relative expression of 
Vimentin to αSMA one could understand the frequencies of different cell populations 
within the intestinal and 3D model stromal compartments.  Figure 5.28 D & E, shows 
staining of both markers within the 3D model. αSMA is shown to be significantly less 
expressed than Vimentin and as such suggesting a mixed population of normal and 
myofibroblasts within the 3D model stroma, as was seen in the human colonic and small 
intestine tissue sections (Figure 5.21 E & F and Figure 5.25/26). 
 
Cellular junctions within the 3D model were assessed through the staining of E-cadherin 
and Occludin (Figure 5.28 F & G) . Clear junctional formation could be observed in the 
epithelium of the 3D model with consistent E-cadherin formation along the length of the 
entire epithelium. Additionally, E-cadherin staining shown how cells are arranged into a 
tall epithelial monolayer rather than multilayering. Tight junction expression as assessed 
through Occludin staining is also seen throughout the epithelium with staining primarily 
located at the apical lateral point of the Caco-2 cells membrane with specific tight junction 
localisation also inferring cell polarisation. Finally, MDR1 staining (Figure 5.28 H) is 
shown to be specific to the epithelial layer. However, MDR1 does not show the expected 
apical localisation within the cells with significant expression seen along the length of the 
apical and basal membrane along with some disperse cytoplasmic staining similar when  
compared to the expression seen in tissue.
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Figure 5.28: Immunofluorescence analysis of CCD-18co/ Caco-2 Alvetex 3D models shows significant ECM deposition within the substrate 
in addition to well defined epithelial layers - A) Collagen I, B) Collagen III, C) Collagen IV, D) Vimentin, E) Alpha- SMA, F) E-cadherin, G) 
MDR1. Images are representative of a minimum of 3 independent observations. Scale 100µm. 
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5.4.16 3D HDFn intestinal model immunostaining 
characterisation. 
Figure 5.29 shows the immunofluorescence staining for optimised HDFn 3D Alvetex 
Scaffold® models of the intestine. Figure 5.29 A-C shows the extra and intra-cellular 
staining of Collagen proteins important in normal tissue function and homeostasis, 
namely, Collagen I, III and IV. Collagen I shows a limited amount of expression within 
the Scaffold, primarily located to the basal and apical surfaces of the Scaffold. This is 
most likely intracellular Collagen I as the positive staining location strongly correlates 
where the largest population of HDFn cells reside within the model. Collagen III (Figure 
5.29 B) is, for the most part, absent from this model. Collagen IV (Figure 5.29 C) is by 
far the strongest stained of the Collagen so far, with extensive deposition throughout the 
model.  
 
Figure 5.29 D and E show vimentin and αSMA staining respectively. Vimentin is utilised 
as a stain for mesenchymal cells, and as such, specifically stains HDFn cells at a higher 
intensity than Caco-2. Vimentin staining shows significant fibroblast populations 
throughout the model, however, there does appear to be a bias toward the apical surface 
of the models, most probably due to the sequential seeding techniques. Figure 5.29 E 
shows αSMA, very little positive staining is seen within the HDFn model. Some positive 
staining can be observed indicating a small subpopulation of αSMA positive fibroblasts/ 
myofibroblasts. Figure 5.29 F shows E-Cadherin staining along the entire length of the 
Caco-2 epithelium. Caco-2 cells are able to differentiate forming well defined junctions 
between cells within the epithelium. Occludin staining (Figure 5.29 G) shows a similar 
pattern with primarily apically located expression along the epithelial layer. Finally, 
MDR1 staining (Figure 5.29 H) is shown to be strongly located to the basal layer of the 
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Figure 5.29: HDFn/ Caco-2 Alvetex models show well defined epithelial layers without the significant Collagen deposition within the 
substrate as seen in CCD-18co models - A) Collagen I, B) Collagen III, C) Collagen IV, D) Vimentin, E) Alpha- SMA, F) E-cadherin, G) MDR1. 
Images are representative of a minimum of 3 independent observations. 
 Scale 100µm. 
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5.4.17 3D HIC intestinal model immunostaining 
characterisation. 
Figure 5.30 shows the immunostaining characterisation of 3D cultured models created 
with the HIC cells (Human intestinal cells, isolated in Durham). Histological analysis 
seen previously (Figure 5.20) shows how the 3D structure in this model is limited in its 
in vivo mimicry of the intestine. Therefore, it would be unreasonable to expect the 
immunofluorescence staining to show anything less than the disorganised structure 
already analysed histologically. Similar to HDFn staining, Collagen I and III (Figure 5.30 
A & B) show limited deposition within the Alvetex Scaffold similar to HDFn primary 
cells. Collagen IV (Figure 5.30 C) shows significant staining throughout the scaffold with 
an even deposition moving from the apical to basal sides of the substrate.  Vimentin and 
αSMA staining is similar to that seen in other models with higher levels of Vimentin than 
αSMA when compared, suggesting a mixed myofibroblast population.  E-cadherin and 
Occludin staining highlights the failure of the HIC cells to create a foundation for the 
culture of Caco-2 cells localised to the apical surface of the model. Whilst some epithelial 
organisation can be observed, there is a large amount of Caco-2 infiltration into the 3D 
scaffold as suggested by positive junctional staining throughout the substrate. MDR1 
similarly shows a lack of organisation with  positive staining seen throughout the scaffold. 
Structure implies function. Therefore, without the correct tissue organisation one would 
expect a decrease in the functional attributes of a model and its capabilities to mimic the 
in vivo  intestine. 
 
HIC 3D models were a late addition to the project. Additionally, only limited numbers of 
HIC cells were available for use. As such only minimal optimisation of culture techniques 
was achieved with HIC 3D models. The model disorganisation in comparison to the other 
models utilised in this study highlights the importance of optimisation in the culture 
process. 3D HIC models were carried through to functional pharmacokinetic assessment   
to maintain consistency and provide a comparison with HIC paracrine media cultured 
achieved in Transwell. 
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Figure 5.30: HIC/ Caco-2 3D models are shown to secrete significant levels of Collagen IV with only minor amounts of other ECM components, 
epithelial layering is significantly diminished compared to other model systems - A) Collagen I, B) Collagen III, C) Collagen IV, D) Vimentin, E) 
Alpha- SMA, F) E-cadherin, G) Occludin, H) MDR1. Images are representative of a minimum of 3 independent observations. Scale 100µm. 
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5.4.18 Lighsheet analysis of 3D model immunostaining 
morphology. 
Light sheet analysis was attempted to form a 3D immunostaining image of the intestinal 
model in order to understand the dispersion of ECM within the Alvetex Scaffold®. Due 
to the limitations of the Alvetex Scaffold’s® optical properties a novel clearing method 
based on the paper by Renier et al  (270) was required to penetrate any significant distance 
into the Alvetex® model. 
 
Figure 5.31 shows the expression of αSMA and Vimentin (Both markers of 
myofibroblasts and mesenchymal cells respectively) in addition to E-cadherin, utilised 
here to highlight the formation of the epithelial layers. The differential expression rates 
of αSMA and Vimentin clearly show that αSMA positive cells are a small yet significant 
sub-population of the added fibroblasts. Vimentin staining shows the levels of CCD-18co 
population within the Alvetex Scaffold®. It clearly shows that the cells form a continuous 
layer across the surface of the scaffold, sufficient for the subsequent seeding and culture 
of Caco-2 cells across their surface with minimal epithelial invasion into the underlying 
stromal section of the model. The continuous monolayer formation of Caco-2 cells in the 
model is further highlighted by the E-cadherin expression showing a clear monolayer 
across the surface of the construct.  
 
Figure 5.32 highlights the levels of collagen deposition within the scaffold. The tested 
collagens, Collagen I, III and IV all show significant deposition within the scaffold with 
collagen III being potentially the most abundant and Collagen IV the least. In either case 
it is clearly shown the CCD-18co cells are able to secrete significant levels of ECM into 
the Alvetex Scaffold® throughout the culture period. It was decided that light sheet 
analysis for this application did not provide significant additional value over sectioned 
samples due to the poor penetration of the imaging into the sample. As such full scale 
immunological assessment did not proceed past this point with this technique.  
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Figure 5.31: 3D cellular organization of CCD-18co fibroblasts and Caco-2 cells – A, B) 
αSMA staining of myofibroblast sub populations, B) 90o rotation of A. C, D) Vimentin 
staining of mesenchymal cells, D is a 90o rotation of C. E, F) E-cadherin staining of Caco-2 
cells, F is a 90o rotation of E. Images are representative of a minimum of 3 independent 
observations. Scale 100μm 
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Figure 5.32: 3D cellular organization of CCD-18co fibroblasts and Caco-2 cells – A, B) 
Collagen I, B) 90o rotation of A. C, D) Collagen III staining of mesenchymal cells, D is a 90o 
rotation of C. E, F) Collagen IV staining of Caco-2 cells, F is a 90o rotation of E. Images are 
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5.4.19 Development of an Ussing chamber for the 
incorporation of the 24-well format Alvetex Scaffold®.  
Alvetex Scaffold®, unlike Transwell in the Snapwell format, does not come in formats 
friendly to easy addition  into Ussing chamber designs currently available on the market. 
All model development and optimisation steps were performed in the 24-well Alvetex 
Scaffold® format due to its small culture area, reducing cellular load and ease of use in 
standard format 12-well plates. It was necessary to ensure that the model would have 
minimal disruption when taken from cell culture to utilisation within the Ussing chamber. 
As such, unclipping the Alvetex® model (disrupting the epithelium) from the 24-well 
format inserts would impart mechanical stresses ultimately damaging the intestinal 
construct, prior to addition into the Ussing chamber for analysis.  
 
Figure 5.33 shows the chamber design allowing for the incorporation of the entire 24-
well insert into the Ussing chamber. The design ensures equal amounts of fluid on either 
side of the membrane when in the system. This limits any static fluid pressures which 
could ultimately influence the transport kinetics of the model. The full insert is added into 
the middle of the 3 sections and, when closed together creates a watertight seal across the 
membrane stopping any passive movement of fluid across the chamber, not associated 
with passive movement through the membrane.  
 
Ultimately, the transport experiments conducted in the following chapter utilised the 96-
well format instead of the 24-well format due to improved high through put applications. 
The 96 well format became available after the design and construction of the 24-well 
Ussing chamber. Models were moved to the 96-well format due to its enhanced 
capabilities to allow for higher throughput model culture, more simplistic/ reproducible 
chamber design and requirement of a reduced number of population limited cells for 
creation of a full intestinal model.  
 
Figure 5.34 shows pictures of the final product. 
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Figure 5.33: Wireframe schematic diagram of the 24-well Alvetex Scaffold Ussing chamber 
design – The design comes in 3 distinct sections to allow for the full incorporation of the 24-well 
insert into the Ussing chamber system. This is done in an effort to minimise the mechanical 
disruption to the model prior to analysis which unclipping the Alvetex from the culture insert 
would induce. The entire culture insert fits within part B of the chamber design with parts A and 
B mirroring the internal measurements of the 24 well format to ensure equal amounts of media on 
either side of the membrane. Parts D-F are cross sections of the corresponding A-C parts. 
A B C 
D E F 
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Figure 5.34: Photographic images of the 24-Well format manufactured Ussing chamber – A) 24 well insert with Alvetex layer (*), wing span of the insert is 
sufficient for suspension culture within a 12 well plate. B) 24 well insert placed within the acceptor compartment of the Ussing chamber device. When inserted fully the 
surface of the 24 well insert is flush with the Ussing chamber plastic. Alvetex layer (*) C) The whole Ussing chamber device with the 24 well insert ready to be 
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5.4.20 Creating a high throughput solution for the culture of 
96-well format 3D Alvetex ®models. 
24-well Alvetex Scaffold®, whilst small in its own right and on a similar scale as 12 and 
24-well Transwell inserts is not high throughput to the extent required in the 
pharmaceutical industry for the large-scale analysis of potential drug compounds. As such 
the prototype 96-well Alvetex® format was created. The 96 well models were created in 
strips of 8 wells per model with size and distancing sufficient for the culture in a standard 
96-well plate. However, it was observed that due to the extremely small media volumes 
added to a standard 96-well plate that the models were being insufficiently fed and media 
evaporation was clearly an issue for models at the edges of the plate (Data not shown). 
As such a new culture system was designed to limit the above described disadvantages. 
Figure 5.35 shows the schematic of the resultant design created for the culture of 96-well 
format models. A deep reservoir was incorporated into the design around the edges of the 
plate in order to limit any effects of evaporation seen in the culture wells. At the air liquid 
interface 1ml of media can be fit into the wells beneath the models with the final 
submerged volume of 1.5 ml. This provides ample media for the growing cellular models 
within the Alvetex Scaffold®, with media changes every other day. Utilisation of the 96-
well plate resulted in the creation of models with indistinguishable histology than other 
formats. 
 
The main advantage of this culture system over 24, 12 and 6-well Alvetex® formats is in 
the higher throughput capabilities of the system. A total of 24-models can be created in a 
single plate with a media availability per cm2, significantly higher than any other format 
by over an order of magnitude. 1.5 ml of media per model is sufficient for only a twice 
weekly feeding schedule. Minimising the work/ time needed to culture the model, 
reducing failure rates (e.g. through infection or manual mishandling of models) and 
saving money by reducing expensive media volumes required. Images of final products 
are shown in Figure 5.36
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Figure 5.35: Creating a Deep well culture dish for the maintenance of the ideal conditions to allow for 3D intestinal model growth in 96 well formats 
– A,B) Shows a top down and rotated view of the 96 well deep culture dish with 96 well inserts resting within the plate, C) shows a cross section of the plate 
through the centre of one of the 3 culture strips. * = the 1 ml void beneath the hanging culture insert to allow for the air-liquid interface culture of the models 
with sufficient media to promote cellular viability and growth. Total chamber fill amount is 2ml, 1.5 ml is the standard volume required to submerge the 
models completely. ** = the external reservoir for the addition of either sterile H2O or sterile PBS. This reservoir ensures sufficient humidity is maintained 
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Figure 5.36: Photographic analysis of 96 well deep well format – A) Well 
structure without the addition of 96 well Alvetex Scaffold inserts demonstrates 
the large reservoir running around the edge of the plate to humidify the models 
in addition to the media chambers, capable of holding up to 2ml of media per 
model. B) Alvetex strips resting within the plate system, C) Zoomed in image 




* * * 
Chapter 5 – Development and characterisation of a novel 3D model of the intestinal mucosa 
Page | 301 
 
5.4.17 Development of an Ussing chamber suitable for the 
analysis of 3D cultured 96 well format models. 
Assessment of a models functional capabilities can involve any number of assays and 
experiments in order to understand the physiological relevance of a model. This study 
primarily utilised an Ussing chamber design for all of the transport kinetic work, 
displayed in the following chapter.  
 
In order to utilise the 96-well Alvetex® format within an Ussing chamber, a custom 
designed and manufactured chamber system was created to incorporate the bespoke 
nature of the 96-well format. Figure 5.37 shows the wire frame 3D model of the resultant 
design.  Figure 5.37 A shows the aperture within which the Alvetex® and insert rests 
throughout the transport assay. Much in the same way as the 24-well chamber was 
designed the 96-well chamber is designed to incorporate the entire model insert, reducing 
the need for manual handling of the models and as such limiting the possibilities for 
accidental damage to the 3D models prior to use in the system.   Unfortunately, due to the 
96-well models design with 8 wells heat bonded per strip some manual handling is 
required for the 96-well format when applying to the chamber by clipping away the 
models from the culture strip. This is easily and cleanly done with a pair of wire snips 
prior to addition to the chamber. Figure 5.39 shows the steps for the processing of 96 well 
format Alvetex Scaffold® models into the custom designed Ussing chamber.  Once 
models are in the chamber the basic premise of the system is the same as any other Ussing 
chamber device. There are ports for the connection of reservoir in and out tubing in 
addition to ports for the attachment of Ag/Cl electrode for the measurement of the 
electrophysiology of epithelial layers.
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Figure 5.37: Wireframe schematic of the 96 well Ussing chamber system, designed for the incorporation and functional testing of 96 well format 
Alvetex intestinal models – A) A profile view down the centre line of the chamber giving a view of the orientation of the internal ports and fluid lines. B) 
Shows the acceptor compartment for the addition of Alvetex Scaffold models, * = Acceptor port. C) Shows the wireframe of the complete design when 
sandwiched together. The model is sandwiched between both sides of the chamber system. A small amount of the apical surface of the hanging insert 
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Figure 5.38: Photographic images of the 96 well format Ussing chamber with added 96 well Alvetex insert –A) Face view of the internal aperture 
of the 96 well chamber. Left) 96 well receiver chamber, Right) Sealing chamber. B) Both left and right pieces of the Ussing chamber immediately before 
sealing. The middle is completely flush with the O-ring sealing the chamber when closed. C) 96 well receiver compartment with a pre-prepared 96 well 
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Figure 5.39: Schematic diagram of the process require for addition of 96 well format inserts into the custom designed 96 well Ussing chamber 
– A) 96 well models are cultured in the custom designed 96 well format culture plate for a total period of 5 weeks, B) After 5 weeks in culture the 
models are ready for analysis. Firstly, the model strip is removed from the culture plate. C) The model strip is cut along the supporting material to 
allow for manipulation of individual models (Depending on the total number of models being analysed only part of the strip may be cut with the rest 
remaining in culture until required. D) Models for use in the Ussing chamber system are first washed twice gently in sterile PBS before snipping 
away the remaining support material, leaving just the base insert with the heat welded Alvetex Scaffold, E) The base insert is added to the receiving 
Ussing chamber, ensuring a snug fit. F) The remaining chamber is attached with the model sandwiched between the two sides. The chamber system 
is not complete and can be attached to an Ussing chamber for model analysis. 
Chapter 5– Optimisation and characterisation of a novel 3D model of the intestinal mucosa 
 
Page | 305 
 
5.5 Discussion 
Work within this chapter has focussed on the optimisation and development of several 
3D models of the intestinal epithelium utilising one of three fibroblast cell lines co-
cultured with Caco-2 cells. Alvetex Scaffold® is the principle material that has been 
utilised in the construction of these models due to its high porosity, important for the 
expected function of these models as a tool for drug permeability analysis. Models have 
been structurally characterised here with functional analysis contained within Chapter 6. 
Novel equipment designed for the culture and analysis of prototype 96-well Alvetex® 
formats have been created for use in this work.  
 
5.5.1 The properties of Alvetex® and its potential uses as a 
substrate for 3D culture systems. 
Alvetex Scaffold® is a polystyrene polyHIPE (High internal phase emulsions) with an 
average void size of 42μm allowing for the culture of cells in 3D within the scaffold 
material.(271) The large pore size and the 200μm(272) thickness of the Scaffold allows 
for the culture of cells in conditions that more accurately recapitulate the in vivo 
characteristics of human tissues. A high porosity allows free cellular movement, 
alongside easy exchange of nutrients and cellular waste. Additionally, large pore sizes 
allow for culture of multiple cell lines together, initiating direct contact and permitting a 
level of cellular cross talk which is simply not possible in two dimensions. Indeed, 
throughout the literature there are many instances of models involving the utilisation of 
multiple cell lines within Alvetex®. For example, Forrest et al (273) achieved a stable co-
culture through the direct co-culture of H441 Human lung epithelial cells and peripheral 
mononuclear cells (PMN). H441 were first cultured in the Alvetex Scaffold® at air liquid 
interface for a period of 14 days before the addition of PMN to the base of the model. The 
purpose of the experiment was to assess the rate at which these mononuclear cells could 
move through the 3D epithelial tissues. Whilst this model is suitable for answering the 
biological question of this study one would not consider this as tissue “mimetic” in the 
sense that simply culturing cells in 3D does not always infer in vivo like characteristics 
on the resultant model.   
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Outside of this work Alvetex® has been utilised for the creation of tissue mimetic models 
for a number of targets including; Skin (53,274), Lung (275) and Bone (276), with varying 
degrees of complexity and in vivo relevance. Generally, there are two decision branches 
regarding the creation of 3D models. The first involves the design and creation of a 
scaffold material containing all the necessary ECM components, signalling molecules and 
3D structures before the addition of cells which colonise the substrate and are actively 
directed.(149,277,278) The second methodology, one which is utilised in this study and 
indeed in most Alvetex® based models, is of cell driven construction.(53,275) In short, 
cells are allowed to populate a Scaffold, secrete their own ECM and paracrine 
environment with models being allowed enough time in culture to form tissue mimetic 
structures spontaneously and without excessive outside direction. That is not to say there 
is no direction in the culture of these models entirely. The layering of cells in or model 
construction in this study and the use of small molecules are good examples of this. 
 
Optimisation of the fibroblasts cultured within the Alvetex Scaffold® in this study showed 
a number of interesting observations regarding the variable phenotype of cells when 
cultures in 3D. It was observed that cellular proliferation of CCD-18co was limited in 3D 
resulting in a weakly colonised scaffold, unable to support a Caco-2 epithelium without 
significant cellular invasion. This was confirmed both by MTT assessment of fibroblast 
model metabolic activity and by histological analysis of cellular population of the 
scaffold. Previous experiments with the application of ECM proteins onto the surface of 
the Alvetex Scaffold® had shown that Collagen I was able to create a thin layer able to 
support the growth of a monolayer of Caco-2. However, it was decided that ideally, a 
model which was able to self-organise without the need for non-human exogenous protein 
application whilst also having phenotypic effects on the Caco-2 cells was an improved 
methodology. Additionally, use of Collagen gels increased the cost and variability of the 
model. Addition of fibroblasts over time was a new technique which allowed for the 
proper colonisation of the Scaffold, with far higher cellular retention rates and 
significantly lower Caco-2 invasion rates. 
 
The ability of cells to self-direct their differentiation is also shown in the model of the 
Human skin by Costello and Rogers et al, (53,274) with clear multilayer epithelial 
structures highlighting how in vivo relevant organisation can be spontaneously formed 
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within a 3D cultured tissue. Again however, cells do have to be minimally instructed 
through the addition of TGF-β and KGF to the culture system in order to create complex 
differentiation. It would be interesting to see how the addition of TGF-β and KGF 
expressing cells to these models could affect the final model. Potentially, creating a true 
self organising model of in vivo complexity. 
 
The simplicity of the Alvetex Scaffold® allows for a wide range of uses, not limited to 
the construction of tissue mimetic models. For example work with this substrate has 
included carcinoma modelling (279–282), migration studies of cells within a 3D 
environment (283), host pathogen interaction (284). Indeed, the simplicity of the system 
allows for a wide range of functions, both in terms of the study of core biological 
processes and in the construction of 3D systems for specific downstream applications 
such as drug discovery and cancer research. The power of 3D technologies such as this is 
that they can be tailored/ modified in many different ways to suit specific needs. Whilst 
no one 3D technology is perfect in all ways, the ability to modify culture substrates either 
through direct material chemistry (285) or protein or epitope coating (286,287) of culture 
substrates, broadens the use to a wide range of applications. The simple construction and 
use of Alvetex Scaffold® also lend itself well to high throughput applications, a necessary 
property for use in industrial applications such as as a tool for drug discovery and 
development.  
 
Other 3D culture systems were considered for use in this study such as nanofiber 
membranes and hydrogel systems. Indeed, both of these methods have been utilised 
throughout the literature to create intestinal models of reasonable complexity and 
reproducibility (162,258,288–291). One of the primary benefits of electrospun scaffolds 
is their ease of modification. Utilisation of different plastics for example can change the 
hardness/ stiffness of the substrate whereas subtle changes in the manufacturing protocol 
can affect properties such as fibre thickness and density. polyHIPE scaffolds, as 
previously stated, can also boast a variety of modifications although generally these are 
less simple to achieve than electrospun scaffolds. (292–294) The potential application of 
modified scaffolds can be seen in the intestinal model created by Faralli et al (295) 
whereby they cultured Caco-2 cells on electrospun scaffolds incorporating a bioactive 
compound, in this case Curcumin. Cells were able to grow on the electrospun Scaffold 
Chapter 5– Optimisation and characterisation of a novel 3D model of the intestinal mucosa 
 
Page | 308 
 
and were shown to be bioactive influenced by the encapsulated compound, with changes 
in permeability to model compounds such as Lucifer yellow and Fluorescein. One could 
imagine the capability to encapsulate highly tailored levels of compounds int a scaffold 
material in order to direct differentiation and improve functional phenotypes.  
 
Another recent paper by Patient et al (269) assessed the differences in Caco-2 functional 
morphology between the Transwell gold standards and a PET nanofiber construct with 
Caco-2 cells grown on the surface. Interestingly, even though no stromal cells were 
present in the study, simply changing the surface architecture of the membrane on which 
Caco-2 cells were cultured had significant effects on the Papp values of the model drugs 
tested in the study with improvements in the in vivo characteristics of the resultant Caco-
2 membrane. This highlights how small changes in 3D structure can have significant 
effects on the phenotype of the resultant model.  
 
Generally, however, electrospun scaffolds do not allow for full 3D culture with the 
capability of the cells to fully immerse themselves into the substrate. These scaffolds are 
more akin to a basement membrane than a true mucosal scaffold. When studying the 
histology of the model produced by Patient et al one can see how the electrospun scaffold 
looks very much like Transwell, consisting of a simple layer on which the Caco-2 cells 
are cultured. Indeed, function follows structure in regard to the functional capabilities of 
cells in vivo. When looking at Caco-2 cells cultured on nanofiber scaffolds compared to 
those cultured on Transwell inserts, little difference can be seen. This is in contrast with 
the 3D models created here in this study which show significant changed in cellular 
structure compared to Transwell layers, with improvements in cellular height and 
polarisation of the membrane.  
 
5.5.2 Optimisation of a 3D model of the intestinal epithelia 
utilising Alvetex Scaffold®. 
Initial investigations into the phenotype of Caco-2 cells in 3D culture demonstrated that, 
without additional modification to the model protocol, Caco-2 epithelial cells would 
invade into the top third of the Scaffold material before self-limiting their invasive 
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characteristics, proliferating and differentiating. There could be many possible reasons as 
to why Caco-2 cells lose their motile characteristics; two of the most probable being are 
due to the limitations of nutrient diffusion into the scaffold or reprogramming of the 
cellular phenotype due to the three dimensionalities of the substrate. Nutrient diffusion is 
difficult to quantify and will differ significantly dependant on the substrate in use. 
Conditions such as the material utilised to create the scaffold, the size of the molecule 
diffusing, its charge and its mass can all have effects on its availability. 
 
A recent study by McMurtrey (296) took a mathematical approach to understanding the 
Oxygen requirements of different cells within the body and the supply rates of different 
tissues. He concluded that the average human cell required 2.5x10-18 mol/cell x s with 
the average supply rate in human tissues and hydrogels being approximately 1x10-10 to 
1x10-9 mol2/s. Alvetex Scaffold® is highly porous with an average porosity of over 90%. 
This is far higher than would nominally be found in most tissues and hydrogels. As such 
it could be expected that Oxygen availability is less likely to be reducing cellular motility 
within the Scaffold structure.  
 
Alternatively, although there is no direct data available here to support this observation, 
it has been noted that many cell lines from variable origins appear to proliferate and 
migrate much more slowly in Alvetex scaffold® than in 2D. The attenuation of 
proliferation rates can be observed in this study when looking at the seeding density and 
time course optimisation steps for the creation of the 3D model. In particular the time 
course experiments (Figure 5.11) shows no significant increases in cell metabolic rates at 
14, 21 or even 28 days in culture. As such a novel multi-layering approach, seeding 
fibroblast multiple times over the course of 14 days was developed, allowing for more 
dense populations of cells within the Scaffold with an apical bias allowing for the culture 
of Caco-2 cells onto the stromal construct without invasion into the underlying Alvetex®. 
One hypothesis which could explain this phenotype is that many cell types simply 
differentiate upon addition to a 3D matrix, losing much of their proliferative potential in 
the process. Indeed, there was a high proportion of αSMA positive cells (Normally 
utilised as a marker of myofibroblast terminal differentiation) within the 3D constructs. 
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Alvetex Strata® and Polaris® (Not commercially available) have increasingly smaller pore 
sizes allowing less invasion into the scaffold material.  As such Caco-2 cells in these 
formats sit on the surface of the substrate without much cellular infiltration. Strata® and 
Polaris® substrates were not carried forward into full scale model optimisation as easy 
access to the internal substrate structure is needed for the culture of fibroblasts. Alvetex 
Scaffold® was chosen as the best candidate to allow for maximal direct cell contact and 
cellular crosstalk.  
 
5.5.3 What does 3D tissue engineering demonstrate about the 
biology of tissues, understanding the limitation of 3D models.  
Most of this chapter so far has discussed how the main benefit of 3D culture is in the 
higher in vivo relevancy of the 3D substrates, allowing for cellular growth in an 
environment more similar to the natural state than 2D. Whilst it would be difficult to 
argue the converse, with, on the surface levels at least, 3D substrates appearing to be 
improved growth mediums than 2D culture, work so far has focussed less on the actual 
phenotypical changes induced by 3D culture on cells. This is true for both this work and 
the literature in general, with a whole multitude of 3D cellular models but little dedicated 
research on 3D induced phenotype changes.  
 
Indeed, there could be an argument made to question if a 3D environment is necessary in 
the first place. For example, an epithelium is by definition, a polarised layer of cells. 
Many cellular models, not just of the intestine, already recapitulate the epithelium of 
tissues to a high level of complexity. A good example is of the skin where commercially 
available epidermal models already exist which show the multi-layered, highly 
differentiated cell morphology seen in in vivo tissues. EpiDermTM from MatTek is a great 
example of this with a full structure recapitulating the skin epidermis. (297) Roger et al 
(53) created both a 2D epithelial model utilising Millicell, a semi-permeable membrane 
similar to Transwell in structure allowing for the 2D culture of cells with some passive 
movement of compounds through the membrane, and a 3D cultured Alvetex model 
consisting of HDFn cells and keratinocytes. Histological H&E images comparing the 
epithelial structure of the 2D system to the 3D system in this model showed relatively 
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little difference in the epithelial structure of the tissue. Keratin 10 and 14 are regularly 
utilised markers able to show the differentiation gradient within the skin epidermis, both 
of which could be observed in both the 2D and 3D systems. (53) 
 
The epithelial keratinocyte cells in the 3D Alvetex model are cultured upon a dense layer 
of HDFn fibroblasts and are not in physical contact with the 3D substrate. The same 
observations could be made with the models created in this study and it begs the question, 
are the changes in function due to direct 3D influences on the epithelial development or 
simply due to direct and paracrine influences from co-cultured fibroblasts? Influences 
which may or may not be modified by culture of fibroblast in a 3D environment. It is my 
belief that these models are more a study in the effects of fibroblasts on the physiology 
of cultured epithelia and the effects of 3D culture on the phenotype of cultured fibroblasts 
specifically rather than a study into the effects of 3D culture on tissues in general.  
 
Due to the gold standard models now incorporating any paracrine fibroblast influences 
comparison of Gold standard Caco-2 models to 3D intestinal models is not a fair contrast. 
Fundamentally, the epithelial cells in both models are cultured in very similar ways, 
application onto a 2D surface. It is the addition of the paracrine effects of fibroblasts and 
the effects of 3D culture on those populations which is of more importance to the overall 
physiology of the model. Unfortunately, understanding the importance of fibroblasts 
within a tissue is often overlooked, even more so when it comes to determining the effects 
of 3D culture on their function.  
 
5.5.3 Overcoming the technical limitation of 3D models by 
designing a method of high throughput culture and analysis. 
One general disadvantage to 3D cell culture that is often described as potentially the main 
factor preventing the large-scale adoption within industry, is the capability to perform 
high throughput culture and analysis. Often when it comes to testing new compounds 
large scale studies could require hundreds or thousands of models for a complete analysis. 
Current 3D culture systems for the high throughput analysis of model pharmacokinetics 
fall into two categories; 1. Organ on chip/ simplistic systems which allow for high 
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throughput analysis but don’t recapitulate in vivo tissue organisation or 2. 3D cultures 
which recreate tissue architecture but are not best suitable for high throughput culture. 
Newer studies however are attempting to adapt these organ on chip systems to be more 
applicable to the drug screening process. For example, Workman et al (298) worked with 
iPSCs to create intestinal organoids which they applied to a chip system with direct 
comparison to a Caco-2 equivalent. Through western blot analysis they showed increased 
phosphorylation of STAT1 in response to increasing  IFN-γ, a marker of inflammatory 
response. This response was attenuated in Caco-2 systems compared to that of intestinal 
organoids. Furthermore, western blot analysis of biomarkers for both paneth and goblet 
cells showed marked upregulation in iPSC derived intestinal models. However, their 
work also displays some of the continued challenges associated with organ on chip 
systems. Transverse sections of the models highlight the multi-layered nature of the 
organoid model in this study with a clearly diminished structural organisation compared 
to a Caco-2 monolayer. Additionally, there was no evidence of brush border formation in 
the models, key for in vivo correlative molecular transport of chemical entities. 
Furthermore, large numbers of intestinal organoid cells were required for complete 
colonisation of the chip structure (~6 000 000 cells). This factor is of key importance for 
application to a pharmaceutical setting whereby large numbers of models are required for 
screening purposes. Adding to this is the complex nature of iPSC differentiation, further 
limiting this models capability of large scale manufacture.  
 
Others such as Kasendra et al have created similar organ chip systems. This study 
focussed instead in using patient derived primary cells instead of iPSC whilst still 
favouring the organoid method for cellular expansion. Similarly they show villus “like” 
structures and in this instance, clear brush border formation. Transcriptomic analysis of 
their models compared to Caco-2 and Human tissue highlights clear improvements over 
Caco-2 in regards to gene expression, their models closely representing Human 
duodenum although some differences still remain, primarily in genes responsible for drug 
transport. Interestingly, sucrase-isomaltase activity of both their models and Caco-2 
controls shows similar activity levels between models suggesting all cells are capable of 
differentiation into absorptive enterocytes. As with the previous example the primary 
challenges for this model lay in scalability to large studies. It is clear that these models 
provide an improved system with regards to in vivo correlation to intestinal tissues than 
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Caco-2 models (assessed by transcriptomic analysis). However, both studies lack key 
transporter data for the permeability to key model compounds to highlight the scale of 
any potential improvement. Gene analysis alone can often be misleading in regards to 
protein expression. Therefore further development of these models should focus on 
quantitative measurements of proteins such as P-gp, MRP, OCT etc.  
 
The Alvetex Scaffold used in this study was chosen due to its relatively homogenous 
structure between samples and its similarity in chemical composition to 2D cell culture 
plastics. This has allowed for the creation a culture system for models in 96 well inserts 
and the capacity to analysed them through custom designed Ussing chambers.  
 
In terms of membrane functionality, Caco-2 monolayers and 3D models are often 
ultimately compared to human tissue to show whether each model is more or less 
representative in its values for the absorption/ transport of compounds through the 
epithelial layer. It could be argued however that direct comparison like this is inherently 
flawed. The intestinal epithelium is far more complex than a 2D epithelium or even a 3D 
epithelium supported by sub-epithelial fibroblasts. It is the complex 3D architecture of 
the intestine, specifically the small intestine, that enables it to be the highly absorptive 
site that it is. 3D models are often more physiologically mimetic of human tissues 
however without the 3D architecture, 2D and 3D models are unlikely to be directly 
comparable to tissues in terms of functional transport even if normalised to model area 
due to the vast increase in surface area created by the villus crypt axis. Future work on 
this model should include development of a villus structure within the 3D model, possibly 
either through creating hydrogel templates for the surface of Alvetex or by 
micropatterning the Scaffold surface directly to create some level of 3D architecture.  
 
5.6 Conclusions 
This chapter has focussed on the optimisation, creation and construction of tools for the 
analysis of 3D models of the intestine based on the Alvetex Scaffold 3D culture platform. 
3 models have been created in this study for the functional analysis discussed in the 
following chapter. These models differ in the origins of the fibroblasts utilised in order to 
understand the influence of the stromal compartment on the development of the epithelial 
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membrane. Models including cells of different origins were created to observe differences 
in the functionality of the resultant models which could hint to the influences these 
fibroblasts have during the development of the epithelium. Equipment designed and 
manufactured during this study will allow for the full scale analysis of 3D models going 
forwards in terms of both permeability/ compound transport  and electrophysiology 
experiments. 
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6. 3D Alvetex® and paracrine Transwell model transport 
dynamics of CCD-18co, HDFn and HIC/ Caco-2 co-culture 
models. 
6.1 Introduction 
6.1.1 Chapter goals 
Three dimensional cell culture models of many organ systems are beginning to become 
more popular as research tools within both academia and industrial laboratories. 
Generally speaking, simple 2D models are still used throughout biology due to their low 
cost and simplicity which allows for a high degree of automation in many cases in 
addition to high throughput manufacture of models for application such as compound 
screening purposes. Indeed, since its inception in the late 70s Caco-2 cells cultured on 
semi-permeable membranes are still a popular in vitro model utilised for the testing of 
intestinal cells for a wide range of applications.  
 
This chapter and introduction will focus on advanced 2D and 3D cultured models 
currently recorded throughout the literature and where possible comment on the 
functional characteristics of these models, comparing conventionally cultured systems  to 
actual transport seen in human tissues. The results section of this chapter will cover the 
functional analysis of the models created in this study, both 2D paracrine and 3D tissue 
models for their permeability to model drug compounds, which will be detailed in this 
introduction.   
 
6.1.2 Understanding the disadvantages of 2D culture and 
methods for improved model in vivo physiology. 
It is reasonably well known that conventional 2D cultured models do not fully recapitulate 
the complexity of the systems they are mimicking. Indeed, in some instances this can be 
seen as an advantage as it allows researchers to specifically test cells of single lineages or 
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populations instead of whole tissues, whose complexity can often hide the interactions 
being studied. However, for the majority of applications, especially those associates with 
testing NCE’s for use in humans, there is a clear need for more complex models of human 
tissues than are currently available.  
 
Bioengineered 3D models can be based on a number of technologies, with each having 
both advantages and disadvantages over the others. The 3D model created within the 
scope of this thesis for example is based on an inert scaffold technology within which 
cells are cultured, setting up their own molecular cross talk and micro-environments. 
Myofibroblast and fibroblast addition to Caco-2 models of the intestinal epithelium is an 
area of research which is only just seeing significant insights into the physiologically 
relevant effects that these cells can have on model layers. (299–301) CCD-18co fibroblast 
cells are the primary cell line which has been used in this study and indeed are used in the 
literature as tools for understanding myofibroblast influences on epithelial development 
in both 2D and 3D systems.  
 
Pereira et al created a model of high complexity similar to what was created in this thesis 
by co-culturing CCD-18co, Caco-2 and HT29-MTX cells in a single 3D model. (162) 
CCD-18co cells were cultured within a matrigel matrix atop a Transwell membrane with 
Caco-2 and HT29-MTX cells directly seeded onto CCD-18co/ Matrigel layers. The 
results are a well-defined model with good differentiative potential as evidenced by 
significant microvilli formation on the apical surface of the epithelium. Additionally, 
TEER values of the resultant 3D models showed a physiologically relevant, significant 
decrease compared to control Caco-2 layers. To my knowledge, prior to work done in this 
study, this remains the only significant study into the effects of CCD-18co cells on Caco-
2 epithelial membranes in a 3D setting. Unfortunately, as is common with the 
development of 3D models, the systems created by Pereira et al is poorly characterised, 
focussing on the transport characteristics of insulin only. Another disadvantage with the 
model created here is its reliance on exogenous matrix proteins in the models 
construction. Not only is Matrigel non-human in origin, it’s also created from carcinoma 
cells and is not fully defined, with manufacturer specified inter-batch variances in protein 
composition. (302) Indeed, isolation of proteins from cells of tumour origin is inadvisable 
as ECM constituents of ECM have been shown to alter during a cancer phenotype. 
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(149,303) In fairness however, models created utilising the CCD-18co cell line in this 
study could also be suggested to contain cancer derived ECM proteins, hence why models 
utilising normal human fibroblasts were cultured and optimised concurrently. Regardless, 
the physiological changes in Pereira’s model function can, at least in part, be attributed 
to fibroblast addition within the model, and as such lend further weight to the involvement 
of myofibroblast influence on epithelial development.  
 
The 3D models created in this study and that of the aforementioned example by Pereira 
et al  focussed on the addition of cells to a scaffold and allowing to spontaneous self-
organisation with varying degrees of instruction. Newer methods however are being 
developed which are able to take some of the “guess” work out of the equation through 
direct bioprinting of tissue structures in vitro. Madden et al in their recent study were able 
to create complex 3D models consisting of both a subepithelial fibroblast compartment 
containing adult human intestinal myofibroblasts printed into a Matrigel hydrogel, and an 
epithelial layer consisting of epithelia cells isolated from ileal tissues. (28) Comparison 
to Caco-2 monolayers and human tissues showed a more physiologically relevant 
membrane structure with defined cellular junctions and clear mucous expression, 
something lacking from standard Caco-2 models. Analysis of gene expression showed 
clear differences in 3D bioprinter models compared to Caco-2 controls with a 
significantly more in vivo expression profile when compared to human tissues analysed 
in the same experiment.  
 
The simplest “bio-printed” systems come in the form of organs-on-chip, whereby cells 
are directly printed/ cultured on a chip scaffold in the precise organisation designed by 
the investigator. These have a number of important advantages, primarily in that they 
allow for the most direct yet controlled culture of cells together to assess changes in 
cellular phenotype. Ultimately this makes results gained from these platforms generally 
highly reproducible and highly attuned to the requirements of the project. Delon et al 
utilised this chip based methodology to investigate the effects of fluid sheer stress on 
Caco-2 culture in a miniaturised system. (304) They designed their culture system to 
provide a gradient of sheer stresses over the length of the chip. Utilising this method they 
quantified the change in expression levels between the different sheer conditions. Large 
differences in actin, villin, ZO-1 and occludin expression were seen in cultured layers in 
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addition to changes in mucous production and, most interestingly, upregulation of 
CYP3A4, a protein commonly known to not be expressed by standard Caco-2 cells. Fluid 
stress analysis lends itself to miniaturisation as conditions can be more finely tuned than 
in larger scale systems. 
 
3D printing is another area drawing significant attention (not only in biology) for the 
application of the construction of 3D models. Hsieh et al (305) demonstrated that complex 
3D designs mimicking tissues in the body can be constructed utilising this approach. 
Seeding of these tissues with stem cells, similar to that seen in decellularised tissue 
scaffolds, has the potential to be a new frontier in the construction of tissue replacements 
in a clinical setting. There is still limitation in these systems regarding the direction of 
complex differentiation and the formation of tissue relevant structures before true clinical 
applications can be considered.(306) 
 
The above examples utilised a scaffold based approach similar to this study whereby 
fibroblast cells were added to a matrix, in this case polystyrene, were cultured for a set 
amount of time before the addition of epithelial cells. That is not to say however that this 
is the only method for the creation of 3D models. Indeed, a wide variety of methods can 
be utilised such as organoid culture demonstrated by Sato et al (307) and Hans Clevers. 
The nature of the intestinal epithelium is one of rapid turnover and cell apoptosis, 
constantly making way for new cells differentiating up the villus-crypt axis. Long term 
stable culture of primary intestinal epithelial cells has for a long time been a goal of 
intestinal biologists hoping to form more in vivo correlating intestinal models. Stable 
intestinal stem cell propagation is one method whereby scientists hope to be able to 
recapitulate the entire epithelial morphology of the in vivo tissue.  
 
Current organoid techniques for the culture of said stem cells however are ill suited for 
the testing of drug compounds across the surface due to a number of factors such as lack 
of easy access to the inter-luminal space of the organoids and relatively low transport 
rates per organoid unit making Papp quantification difficult to achieve. Groups in the past 
have attempted to create intestinal monolayers from these organoids with poor results due 
to increased stem cell apoptosis when cultured on monolayer cultures. Recent advances  
have had some success in forming monolayers of advanced complexity compared to 
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Caco-2 controls. Wang et al in their recent paper were able to culture adult colonic stem 
cells in a neutralised collagen hydrogel whose surface had been stamped with a mould in 
order to create crypt structures as part of the collagen architecture. Through application 
of a chemical gradient across the crypt micro architecture they were able to not only 
culture adult stem cell in a monolayer with physiologically relevant shape, but also 
recreated the stem cell niche with only those cells at the base of the crypt structure 
showing positive markers for stem cell pluripotency. (308) This study demonstrates the 
potential for the formulation of new models incorporating both in vivo relevant cells and 
3D architecture. Wang et al showed a proof of concept, further studies onto the 
differentiation of cells within the scaffold matric and their functional phenotype could 
well lead to a new advanced model of the intestine with in vivo like properties. 
 
6.1.3 Model drugs, their mechanisms of action and relevance to 
this study. 
 
The following section overviews the model compounds used in this study to evaluate the 
functional characteristics of the in vitro models, and specifically to test Transwell 
paracrine and 3D Alvetex models against conventional Caco-2 Transwell monolayers. 
This section will detail the compounds physiologically relevant properties alongside a 
basic overview of the transport mechanisms within the model systems.  
 
6.1.3.1 Rhodamine 123 
 
Rhodamine 123 has been utilised for many years as a model substrate for  MDR1/ P-gp 
mediated transport in the intestine and in intestinal models.(309–312) Rhodamine 123 is 
lipophilic and as such was assumed to pass into the cell through a transcellular 
mechanism, bypassing the lipid bilayer.(309) Troutman et al sought to confirm this 
assumption in their study. (309) Interestingly, they made a number of observations 
which contradicted the perceived knowledge in a number of ways. Firstly, they 
noticed that Rhodamine 123 is preferentially transported B-A and that A-B 
Rhodamine 123 Papp was low, approximately as low as compounds known to travel 
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paracellularly through tight junctions. Transportation rates were unaffected by 
increasing donor Rhodamine 123 concentration. Secondly, disruption of tight junction 
complexes by calcium/ magnesium starvation caused in increase in Rhodamine 123 
transport in the A-B direction, as such insinuating that this increase in compound 
movement was through paracellular mechanisms. Finally, fluorescence imaging of 
Rhodamine 123 Caco-2 layers showed Rhodamine localisation to only the 
paracellular spaces in control and MDR1 inhibited A-B conditions. Entry of 
Rhodamine 123 into the cell in the B-A direction must then occur through a carrier 
mediated mechanism as membrane composition is not appreciable different on the 
basally than apically. Indeed, inhibition of MDR1/ P-gp resulted in an intracellular 
accumulation of Rhodamine 123 in the epithelial cell, further suggesting that carrier 
mediated uptake is not effected by standard MDR1/ P-gp inhibitors. Figure 6.1 shows 
a brief overview of Rhodamine 123 potential methods of transport. 
 
The same functional phenotype has been observed by Hirsch-Ernst et al in rat 
hepatocytes, demonstrating phenotypical conservation both between species and 
tissues.(310) They postulated that OCT 1 me be the unknown transporter able to 
actively transport Rhodamine 123 across the basal membrane of cells. However, OCT 
1 inhibition with Verapamil did not significantly effect Rhodamine 123 accumulation. 
However, as seen in this study, Verapamil is a potent inhibitor of MDR1 activity, as 
such overlapping protein inhibitions could potentially confuse phenotypic 
observations. OATP1 and 2 also appear to be potential candidates for basolateral 
uptake however their efficacy in this regard is as yet unknown.  
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Figure 6.1: Theoretical Rhodamine 123 permeability routes – A) B-A directional travel is 
thought to move in both carrier mediated and paracellular mechanisms. B) A-B permeability is 
thought to be paracellularly only, with no movement of Rhodamine 123 passively across the 
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Atenolol is a hydrophilic molecule normally utilised as a beta-blocker. Atenolol in this 
study was used as a low permeability paracellular transported compound, as is commonly 
done to assess the hydrophilic transcellular absorption routes of intestinal and blood brain 
barrier models. (66,313–315) Essentially, due to Atenolol’s highly hydrophilic nature, 
and hence inherent lipophobicity, it cannot easily cross the cell lipid bilayer. However, 
recent data does show that Atenolol may be subjected to active transport through some 
membrane associated transporter proteins such as OCT 1(313,315) 
 
There is some disagreement regarding the cellular organisation of OCT 1 in human 
enterocytes with evidence for both basal and apical expression. (316)  Han et al used the 
Caco-2 models and human and mouse enterocytes to show a bias towards apical OCT1 
expression. Unlike MDR1/P-gp, OCT 1 is an uptake protein and as such, expression at 
the apical membrane would result in an increase in Atenolol transport into the enterocytes. 
However, unless a similar transporter mechanism also exists on the basolateral sides of 
the enterocytes, Atenolol will be limited to intercellular accumulation. As such only 
passive paracellular transport will be detected and reported in permeability values. 
Perhaps a method of fluorescently tagging Atenolol could illuminate its transport 
pathways as was done with Rhodamine in the previous example. If observations by Han 
et al are accurate with basally located OCT 1 expression then logically it was expected 
that B-A permeability will be lower than A-B due to the active uptake and accumulation 
of Atenolol within the cells. However, transportation experiments are conducted at or 
above drug saturation, as such masking the small concentration change induced by 
intracellular accumulation. Figure 6.2 shows a brief overview of potential transport 
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Figure 6.2: Theoretical Atenolol permeability routes – A) B-A directional travel is thought 
to move in both carrier mediated and paracellular mechanisms. B) A-B permeability is thought 
to favour paracellular travel. Hashed arrows indicate passive movement, solid arrows indicate 
carrier mediated. 
A) B-A Transport 
B) A-B Transport 
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Similarly to Atenolol, Propranolol is a beta blocker. Unlike Atenolol however, 
Propranolol is highly lipophilic and as such is thought to readily move through the 
epithelial lipid bilayer.(317–319)  As such passive absorption rates for Propranolol are 
significantly higher than less lipophilic compounds. Zheng et al  (320) conducted a study 
into the effects of P-gp expression on the rate of Propranolol transport in MDCK and 
Caco-2 cells. They found that in standard conditions efflux ratios (a measurement of 
directional bias) for Propranolol were less than one, indicating no bias. Interestingly, they 
observed that when the apical transport medium was adjusted to a slightly lower pH of 
6.5 (approximate pH of the jejunum where propranolol is primarily absorbed) , afflux 
ratios increased to 3.63, suggesting a strong bias towards B-A transport. They attribute 
this change in permeability to the pH partition hypothesis, whereby weakly basic 
Propranolol will exist in a non-ionised form at higher pHs’. As such for Propranolol a 
lower pH provides a smaller driving force for membrane permeability. This assumes that 
only the neutral (ionised) form may easily pass through the membrane. (321) Weak bases 
are best absorbed in neutral pH conditions whereas acidic compounds are more readily 
absorbed in acidic conditions as outlined by Shore et al. Therefore, more acidic conditions 
results in less Propranolol transport. (322,323) 
 
Whilst temperature and pH (320,324) of the transport media are known to effect 
Propranolol permeability there is little evidence for carrier mediated transport activity. 
Indeed, passive transportation through the cellular membrane occurs at such a high rate  
that even were Propranolol a substrate for one or more transporters, it would be difficult 
to observe this active transport and is unlikely to be clinically relevant. Propranolol is an 
excellent model compound for transcellular diffusion. However this limits the use of 
Propranolol because of its unsuitability for use in inhibition / tight junction integrity 
studies etc. Figure 6.3 summarises Propranolol transport. 
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Figure 6.3: Theoretical Propranolol permeability routes – A,B) Both B-A and A-B 
directional transport is thought to be passive transcellular. Hashed arrows indicate passive 






A) B-A Transport 
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Etoposide is a chemotherapeutic well known for low oral bioavailability in humans. (67) 
It was used as a model drug in this instance to measure the activity rate of MRP1/2. Whilst 
it is generally considered that MRP2 is the main transport mechanism, that is not to say 
that MRP family transporters are the only methods by which Etoposide is transported in 
vivo/ in vitro. (68,325) Indeed Etoposide is a substrate for many ABC transporters with 
significant overlap observed in the literature; including MDR1/ P-gp (326), BCRP (327) 
and OCT 2  (328). Kunta et al in their study utilising rabbit intestinal sections came to the 
conclusion that A-B (Absorptive) transport was not mediated to any significant extent by 
transporter mechanisms, whereby conversely B-A transport can be inhibited by verapamil 
and saquinavir. (69) Passively, Etoposide is thought to move through the lipid bilayer, 
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Figure 6.4: Theoretical Etoposide permeability routes – A) B-A, B) A-B, Transport in 
either direction is thought to be either through paracellular mechanisms or active transport by 
MDR1, BCRP or MRP2. 
 
A) B-A Transport 
B) A-B Transport 
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Methotrexate is a Biopharmaceutical classification system (BCS) class III compound. 
Originally designed as a chemotherapeutic for use in the treatment of lymphoblastic 
leukaemia it has since been applied as an immunosuppressant for rheumatoid arthritis and 
Crohn’s disease.(330) The primary clinical pharmacological mechanism is through 
inhibition of dihydrofolate reductase, decreasing thymine production required for mitotic 
cell division. Absorption is through a number of proton dependant active transport 
mechanisms, the two known ones being RFC and PCFT, both of which are well known 
to have a high affinity for Methotrexate due to its structural similarities to folate. (331) 
RFC is expressed in virtually all cells within the body and is the primary method by which 
cells are able to uptake folates. Primarily, folates and hence Methotrexate are absorbed 
by PCFT in the duodenum and jejunum within the acidified microenvironment at the 
cellular surface. (332)  Methotrexate is a hydrophilic compounds and so, as such is poorly 
permeable through lipid bilayer membranes with long gut times required for efficient drug 
uptake. Novel methods for increasing gut longevity have included microencapsulation 
and liposome usage. Unlike other drug systems whereby some level of passive transport 
is seen either trans or paracellularly, Methotrexate is primarily transported by influx/ 
efflux proteins only. 
 
BCRP is as an active methotrexate efflux protein, (333) and is important when studying 
the bioavailability of methotrexate when administered orally. BCRP efflux assessment 
E.g Methotrexate, is the primary goal for the use of this drug in this study into the fitness 
of new models of the intestine to test for negative drug interactions of NCE in vitro. 
Maeda et al showed that methotrexate can increase membrane permeability to FD-4, a 
marker known for paracellular absorption.(334) As such suggesting methotrexate may 
behave in such a way to disrupt tight junction integrity in the intestine, (335) a common 
phenotype of chemotherapeutic compounds in the intestine. Methotrexate transport is 
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Figure 6.5: Theoretical Methotrexate permeability routes – A)B-A, B) A-B, Methotrexate 
is not thought to have any appreciable trans or paracellular passive movement across the 
epithelial layers. As such active protein action is the same in either direction with RFC and 
PCFT responsible for methotrexate uptake and BCRP the main efflux protein. 
A) B-A Transport 
B) A-B Transport 
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6.1.3.6 Lucifer Yellow 
 
Lucifer Yellow is the final compound  discussed in this thesis and is commonly utilised 
as a passive paracellular marker in the intestine and intestinal models. Lucifer yellow is 
a hydrophilic compound and as such as discussed earlier will not passively pass through 
the lipid bilayer membrane of the enterocyte. (295,336,337) Active transport of lucifer 
yellow is not known within the intestine although some evidence exists that suggests some 
cells in the body such as those in the retina are able to specifically uptake Lucifer Yellow 
into the cytoplasm through an unknown uptake mechanism. (90) Passive paracellular 
permeability of Lucifer yellow is often utilised alongside TEER as the primary methods 
for analysis of membrane integrity. Co-incubation of lucifer yellow with other drug 
compounds throughout the permeability testing is not uncommon to show a maintenance 
of membrane integrity through the assay. However care must be taken as molecules such 
as methotrexate are known to have effects on membrane passive paracellular permeability 
through tight junction disruption. Lucifer yellow transport is detailed in Figure 6.6 
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Figure 6.6: Theoretical Lucifer yellow permeability routes – A)B-A, B) A-B. Lucifer yellow 
is not thought to be actively transported in the intestine, movement is solely through passive 
paracellular pathways. 
 
A) B-A Transport 
B) A-B Transport 
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6.2 Hypothesis, Aims and Objectives 
6.2.1 Hypothesis 
It was hypothesised that conventional and paracrine cultured Caco-2 Transwell models in 
addition to bioengineered 3D Alvetex co-culture models, will exhibit changes in activity 
and enhanced function compared to conventional Caco-2 Transwell control layers widely 
utilised within industry as a gold standard from drug pharmacokinetic analysis. 
 
6.2.2 Aims 
The aim of this Chapter is to functionally test the drug transport capabilities of the 
advanced Transwell paracrine culture and the 3D Alvetex co-culture models. A number 
of different compounds, specific to a number of different transporter proteins or as passive 
markers of membrane permeability have been tested to evaluate the functional 
characteristics of the models. 
  
6.2.3 Objectives 
The objectives of this Chapter are summarised below; 
• Test the transport capabilities of Transwell and Alvetex co-culture models for the 
following drug compounds 
o Rhodamine 123 ( ± Verapamil Hydrochloride) 
▪ P-gp/ MDR1 substrate and competitive inhibitor 
o Atenolol 
▪ Low permeability paracrine transported compound 
o Propranolol 
▪ High permeability Paracrine transported compound 
o Etoposide 
▪ BCRP substrate 
o Lucifer Yellow 
▪ Low permeability paracrine transported compound 
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o Methotrexate 
▪ MRP family substrate 
• Calculate Efflux co-efficients for each of the drug compounds tested through 
analysis of the B-A compared to the A-B transport in order to understand their 
transport kinetics within the model systems in vitro.  
• Where possible compare functional data generated here to human tissue data 
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6.3 Materials and methods 
6.3.1 Ussing chamber permeability assessment of Transwell 
and 3D intestinal tissue models.  
2D Transwell and 3D Alvetex® models were set up as described in Sections 2.12 and 2.15 
respectively. Model permeability assays were achieved utilising the method as previously 
described (Section 3.2.16). Transport assay drug concentrations were as follows; 
Etoposide 50μM, Lucifer Yellow 100μM, Methotrexate 10μM, Propranolol 500μM, 
Atenolol 500μM, Rhodamine 123 5μM, Verapamil Hydrochloride 200μM. All drugs 
were diluted in DMSO with final DMSO concentrations in assay media of ≤ 0.1% (v/v). 
 
6.3.2 Efflux Co-efficient calculation from Papp permeability 
values 
Efflux co-efficients are a measure of the ratio between B-A (basal to apical) and A-B 
(apical to basal) drug transport. B-A and A-B transport values were not directly matched 
as no model was utilised twice for analysis (E.g. Used for both B-A and A-B transport 
experiments). As such B-A transport was compared to the average of the A-B transport 




































𝐸𝑓𝑓𝑙𝑢𝑥 =  
𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡𝐵−𝐴
𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡𝐴𝑣𝑒𝑟𝑎𝑔𝑒  𝐴−𝐵 
 
Figure 6.7: Schematic representation of 
directional transport within the cells – 
Directional transport to give context to 
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6.3.3 Electrophysiological measurements of Transwell 
Snapwell and 96 well Alvetex models.  
6.3.3.1 Electrode manufacture 
Firstly, electrodes were created for use within the Ussing chamber devices. Electrode 
manufacturing procedure was as follows; 
2mm diameter silver wire is carefully sanded with fine grit paper to clean the surface of 
dirt or corrosion. The ends of the wire not to be coated are wrapped in tape to protect the 
silver surface. Cleaned silver wire is submerged in bleach solution containing sodium 
hypochlorite over night to create a silver chloride surface coating. Electrode bodies are 
made from 1ml syringe tips. Current electrodes are trimmed to 3.5cm and voltage 
electrodes are trimmed to 3cm.A 4% Agar/ 3M KCl solution is heated in the microwave 
in 15 second bursts until all agar is dissolved into solution. A small hole is made in the 
rubber plunger of the 1ml syringe and the AgCl electrode is passed through Pre-cut 
electrode bodies are filled with hot agar. Whilst the agar is molten, prepared plunger/ 
AgCl electrodes are pushed into the electrode body. Electrodes are allowed to cool and 
solidify for a minimum of 30 minutes before first use.  
 
6.3.2.2 Electrophysical measurements 
The process for electrophysiology experiments is as follows: 
Carbogen gas cylinder is checked for pressure to ensure sufficient gas volume for one 
complete experiment (minimum of 50 PSI for a 4 chamber 3 hour experiment when using 
F size gas cylinders).Turn on the Power lab, Voltage clamp, circulating water bath and 
PC, allow to boot to desktop. Open Lab chart 8 and ensure Power lab is being correctly 
recognised in the system. Clean all chambers and reservoirs with appropriate solvents 
(Transwell Chambers can be cleaned with ethanol. 96 well Alvetex chambers cannot 
come into contact with ethanol under any circumstances, otherwise the plastic chamber 
will crack). Ensure all solvent is washed away with transport solution before experimental 
start.  
 
Chapter 6 –Assessment of 2D and 3D model function 
Page | 336 
 
At the beginning of each day electrode variances must be measured and corrected as 
follows: 
Connect the chambers to the Ussing equipment without the addition of a test membrane. 
Fill the reservoirs with transport media to the same level as a normal transport assay 
(Nominally 15ml of glucose (1g/L containing HBSS per reservoir)Start the gas supply 
and balance the bubble output until they are approximately equal in each reservoir. 
Bubbles should rise at the rate whereby individual bubbles are moving just quickly 
enough to be seen. Ensure all transport fluid is at 37oC and that all electrodes are bubble 
free in the chamber and securely connected to the pre-amp before taking measurements. 
All electrode variance measurements can be taken on the voltage clamp output. Turn on 
the pre-amp.  Set the voltage clamp to amplify and observe voltage measurement shown. 
(ensure the system is at the correct temperature before moving forward) Using the offset 
knob, either add or subtract from the system until the voltage reading shows zero (If the 




Silver chloride  
coated wire 
3M KCl 4% Agar 
Figure 6.8: Representative images of Ag/Cl electrodes used in electrophysiological studies 
– electrodes were made from 1ml syringe tips filled with 3M KCl 4% agar solution. Silver wire 
was coated with silver chloride through submersion in sodium hypochlorite bleach solution. 
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To correct for fluid resistance, hold down the push to adjust button, notice a new value 
for voltage shown on the voltage clamp. Whilst holding down the push to adjust button 
turn the fluid resistance knob until the value shows zero. Switch the measurement on the 
voltage clamp to measure current. Whilst pressing down the push to adjust button, the 
measurement should show 68μA (±3μA).If 68μA is shown switch back to measure 
voltage, the chamber is now correctly blanked. If not 68μA check current electrodes for 
bubbles. 
 
Remove all liquid from the chamber reservoirs. Add the model to the chamber. Carefully, 
fill the reservoirs with transport media using a 50ml syringe attached to 2mm capillary 
tubing. Ensure the capillary tubing is as far down the reservoir as possible (close to the 
test membrane) and slowly fill to avoid model disruption. Make sure bubble lift is moving 
correctly and no bubbles are lodged in the system that might disrupt drug transport or 
provide electrical insulation. Check cylinder pressure to ensure sufficient gas pressure 
remains for full experiment (~2.5 hours). Leave models in the chamber for 30 minutes as 
a minimum to acclimatise. In order to detect changes in the electrochemical properties of 
the membranes, models were current clamped to zero volts before being injected with 
10μA every 9 seconds for a duration of 1 second (10 second total per cycle). This is 
achieved by turning the master switch on the voltage clamp from amplify to Int. timer 
and ensuring the rotary dials are set up for 9 and 1 second durations. Ensure secondary 
timer is set to current clamp and that the clamp value is set to 10μA. This can be checked 
by measuring current and waiting for the 1s 10μA spike which can be read and checked 
on the voltage clamp directly. If doing electrochemical measurements start lab chart at 
this point. PC must be connected to the internet before lab chart will correctly open. One 
in the software open a new experimental file.  Each pre-amp channel is connected to a 
corresponding channel on the power lab. Each power lab channel will be shown in the 
new experimental software. The voltage of each channel from the corrected electrodes 
will be measured throughout the experiment. Membrane resistance can be calculated by 
measuring the voltage deflection and dividing by the known injected current. Voltage is 
recorded throughout the experiment and voltage deflections caused by the injected current 
were used to calculate the membranes short circuit current and resistance. Drugs are 
added to reservoirs with time and concentration dependant on the experiment.  
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At the end of the experimental timecourse stop lab chart recording, save the file, set the 
voltage clamp to amplify and turn the pre-amp off. Remove reservoir transport media by 
slowly unscrewing the model chamber. Allow the volume to drip out slowly over the 
course of a few minutes into a receiving pot. Models cannot be removed and processed 
as required. Ensure all chambers are washed with hot water followed by an appropriate 
solvent (ethanol for Transwell, water for Alvetex) immediately. 
 
37oC water baths should be cleaned and water changed regularly with microbe inhibiting 
products. Reservoirs were unhooked from the entire system once per month for a soak 
overnight in soapy water to clean any possible biological matter residue. 
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Figure 6.9: Representative images of Ussing equipment utilised in this study – A) Pre-amp, B) 96 well Ussing chamber set-up, 
placed together but not within the Ussing chamber, C) Base of the reservoir showing the attachment points of the reservoir to the 
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6.4 Results 
6.4.1 Transepithelial resistance measurements of 3D models 
compared to conventional Caco-2 standards and Human small 
intestinal sections. 
 
Figure 6.10 shows the relative TEER assessment of 3D Alvetex®  Caco-2 fibroblast 
models compared to the TEER vales of both control and paracrine conditioned media 2D 
Transwell based Caco-2 systems and typical small intestine resistance data taken from 
the literature.(338,339) Compared to the 2D control layers the 3D intestinal models all 
showed a drastic decrease in the overall resistance of the membrane with decreased 
between 30-40 times lower than seen in controls. 
 
In 3D, intestinal models incorporating either CCD-18co and HIC fibroblast cells had 
similar effects on effects on overall model trans-membrane resistance with significant 
decreases in both instances. This is in contrast to the paracrine work shown in Chapter 3 
whereby the paracrine effects of both CCD-18co and HIC fibroblasts decrease TEER 
differentially, with HIC conditioned media only having a small effect on over all model 
resistance. HDFn 3D models also resulted in a significant reduction in membrane TEER 
similar to other fibroblast formats albeit at a slightly lesser level than seen in CCD-18co 
or HIC models. Compared to human tissues however (typical values taken from the 
literature, (340–342) it is clear that the decrease in overall TEER values seen in 3D 
models are significantly more similar to that seen in vivo with the average small intestinal 
tissue resistance of around 50 Ohms.cm2 (dependant on the region of small intestine 
tested).  
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Figure 6.10: TEER Values of 3D intestinal models shows a significant physiological decrease 
in TEER compared to conventional 2D Caco-2 Transwell models – 3D models created using 
the Alvetex® based 3D culture system show a 30-40 fold decrease in TEER values compared to 
Caco-2 Transwell culture systems. Ussing chamber analysis of Human tissues derived from the 
literature show an average tissue resistance of 50-100 ohms.cm2. This is represented on the graph 
with a hashed line. n=4-10 + SEM for test data. N=3-4. n=3 for data found in the literature 
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3D CCD-18co vs Caco-2 Transwell *** 3D HIC vs Caco-2/ HDFn Transwell *** 
3D CCD-18co vs Caco-2/ CCD-
18co Transwell 
*** Caco-2 Transwell vs Small intestine *** 
3D CCD-18co vs Caco-2/ HIC 
Transwell 
*** Caco-2 Transwell vs Caco-2/ CCD-18co 
Transwell 
*** 
3D CCD-18co vs Caco-2/ HDFn 
Transwell 
*** Caco-2 Transwell vs Caco-2/ HIC 
Transwell 
*** 
3D HDFn vs Caco-2 Transwell *** Caco-2 Transwell vs Caco-2/ HDFn 
Transwell 
*** 
3D HDFn vs Caco-2/ CCD-18co 
Transwell 
*** Small intestine vs Caco-2/ CCD-18co 
Transwell 
*** 
3D HDFn vs Caco-2/ HIC 
Transwell 
*** Small intestine vs Caco-2/ HIC Transwell *** 
3D HDFn vs Caco-2/ HDFn 
Transwell 
*** Small intestine vs Caco-2/ HDFn Transwell *** 
3D HIC vs Caco-2 Transwell *** Caco-2/ CCD-18co Transwell vs Caco-2/ 
HIC Transwell 
*** 
3D HIC vs Caco-2/ CCD-18co 
Transwell 
*** Caco-2/ HIC Transwell vs Caco-2/ HDFn 
Transwell 
*** 
3D HIC vs Caco-2/ HIC Transwell *** 
  
Table 6.1: TEER expression comparison between Transwell and 3D intestinal models  - 
Individual significances calculated by one way ANOVA with Tukeys post-test analysis 99% 
confidence rating. *** = P<0.0001, ** = P<0.001, * = P< 0.01 n=4-10 
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6.4.2 Rhodamine 123 transport and Verapamil Hydrochloride 
MDR1/P-gp inhibition in Caco-2 Snapwell conditioned media 
models.  
Figure 6.12 deals with the Transwell model (control and conditioned) aspect of the full 
Characterisation only. Figure 6.12 A shows the apparent permeability (Papp) of 
Rhodamine 123 in B-A directions for Control Caco-2 Transwell models and paracrine 
media treated Caco-2 Transwell models. Additionally, the effects of Verapamil 
Hydrochloride, a known P-gp/ MDR1 inhibitor, added to the system at the beginning of 







Figure 6.11: Schematic representation of the transport processes being studied in this 
experiment – A) A simple overview of the expected mechanisms involved in Rhodamine 123 
transport in systems uninhibited with Verapamil hydrochloride. Main B-A transport is 
expected to be MDR1 mediated with any A-B transport paracellular in nature. B) shows the 
effects of the addition of verapamil hydrochloride to the assay system. MDR1 mediated 
transport is expected to be inhibited.  
A) 
B) 
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but in the A-B permeability direction. In control layers Rhodamine 123 is primarily 
transported B-A with higher B-A Papp compared to the converse. Addition of Verapamil 
hydrochloride to the assay system decreases Rhodamine 123 apparent permeability when 
measured in the B-A direction by approximately 60%. Overall, this suggests that 
Rhodamine 123 transport is primarily through an MDR1/ P-gp directed mechanism, at 
least in control Transwell models. 
 
Paracrine CCD-18co treated Transwell monolayers show a similar transport phenotype 
with directional transport biased towards B-A. Importantly, overall Rhodamine 123 
permeability between conventionally cultured Transwell controls and CCD-18co 
conditioned media treated Transwell models is not induced to increase. Similarity as in 
control models, Rhodamine 123 permeability is efficiently inhibited through treatment 
with Verapamil Hydrochloride, with a decrease in Rhodamine 123 transport of 
approximately 75%. Whilst overall Rhodamine permeability is not significantly increased 
in CCD-18co treated Caco-2 model cultures the increase in inhibitory effect of Verapamil 
hydrochloride suggests that a higher proportion of transport in CCD18co treated models 
is MDR1/ P-gp mediated compared to controls.  
 
HDFn paracrine effects on Rhodamine 123 Papp shows a very similar phenotype to both 
control and CCD-18co treated layers as described above with B-A transport bias. 
However, B-A transport in HDFn treated monolayers is significantly higher over the 
control with a Papp of around 3.5 x10-6 cms-1 compared to the control values of 
approximately 1 x10-6 cms-1, SEM however means that this change is not significant. The 
increased permeability phenotype is almost entirely reversed with the addition of 
Verapamil hydrochloride providing strong evidence for MDR1/ P-gp again for 
upregulation in HDFn treated models.  
 
Unlike other model conditions tested, HIC treated models have a slightly lower average 
Rhodamine 123 Papp level compared to controls and other tested conditions at 
approximately 0.3 x10-6 cms-1. In spite of this however, the directional polarity of the 
models is maintained with a clear bias towards B-A transport. Moreover, addition of 
Verapamil hydrochloride to the assay did not affect Papp Rhodamine 123 rates in HIC 
models. It was hypothesised that MDR1/P-gp levels are significantly decreased in HIC 
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conditions models and that the low levels of Rhodamine 123 transport can be attributed 
to passive paracellular permeability and limited expression of related protein transporters 
with a degree of cross over substrate specificity with MDR1/P-gp which are not inhibited 
by verapamil hydrochloride. However, evidence for some small level of MDR1/P-gp 
function is shown in HIC conditioned media by the slight (non-significant) increase in 
Rhodamine 123 permeability in inhibited A-B assays. The primary method of A-B 
directional permeability is through passive paracellular mechanisms. Inhibition of 
MDR1/P-gp  in A-B transport studies would logically increase A-B transport as MDR1/P-
gp activity would not work against the passive paracellular transport. 
 
Significancy values for both 2D Transwell paracrine models are summarised in Table 6.2.
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Figure 6.12: Comparative analysis of Rhodamine 123 transport across Control and paracrine media treated Caco-2 membranes shows a significant increase 
in Rhodamine 123 transport in HDFn treated Caco-2 layers – A) Values gained for B-A transport in each culture condition compared to permeability in the 
presence of Verapamil hydrochloride (V+),  B) Values gained for A-B transport in each culture condition compared to permeability in the presence of Verapamil 
hydrochloride (V+). Verapamil hydrochloride was added to the epithelial layers to test compound specificity to P-gp/ MDR1 mediated transport. n=3 N=3 HDFn V+ 
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Control BA vs Control BA V+ ns Control AB vs Control AB V+ ns 
Control BA vs Caco-2/ CCD-18co BA ns Control AB vs Caco-2/CCD-18co AB ns 
Control BA vs Caco-2/ CCD-18co BA V+ ns Control AB vs Caco-2/ CCD-18co AB V+ ns 
Control BA vs Caco-2/ HIC BA ns Control AB vs Caco-2/ HIC AB ns 
Control BA vs Caco-2/ HIC BA V+ ns Control AB vs Caco-2/ HIC AB V+ ns 
Control BA vs Caco-2/ HDFn BA ns Control AB vs HDFn AB ns 
Control BA vs Caco-2/ HDFn BA V+ ns Control AB vs HDFn AB V+ ns 
Control BA V+ vs Caco-2/ CCD-18co BA ns Control AB V+ vs Caco-2/CCD-18co AB ns 
Control BA V+ vs Caco-2/ CCD-18co BA V+ ns Control AB V+ vs Caco-2/ CCD-18co AB 
V+ 
ns 
Control BA V+ vs Caco-2/ HIC BA ns Control AB V+ vs Caco-2/ HIC AB ns 
Control BA V+ vs Caco-2/ HIC BA V+ ns Control AB V+ vs Caco-2/ HIC AB V+ ns 
Control BA V+ vs Caco-2/ HDFn BA ns Control AB V+ vs HDFn AB ns 
Control BA V+ vs Caco-2/ HDFn BA V+ ns Control AB V+ vs HDFn AB V+ ns 
Caco-2/ CCD-18co BA vs Caco-2/ CCD-18co 
BA V+ 
ns Caco-2/CCD-18co AB vs Caco-2/ CCD-
18co AB V+ 
ns 
Caco-2/ CCD-18co BA vs Caco-2/ HIC BA ns Caco-2/CCD-18co AB vs Caco-2/ HIC AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ HIC BA V+ ns Caco-2/CCD-18co AB vs Caco-2/ HIC AB 
V+ 
ns 
Caco-2/ CCD-18co BA vs Caco-2/ HDFn BA ns Caco-2/CCD-18co AB vs HDFn AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ HDFn BA 
V+ 
ns Caco-2/CCD-18co AB vs HDFn AB V+ ns 
Caco-2/ CCD-18co BA V+ vs Caco-2/ HIC BA ns Caco-2/ CCD-18co AB V+ vs Caco-2/ HIC 
AB 
ns 
Caco-2/ CCD-18co BA V+ vs Caco-2/ HIC BA 
V+ 
ns Caco-2/ CCD-18co AB V+ vs Caco-2/ HIC 
AB V+ 
ns 
Caco-2/ CCD-18co BA V+ vs Caco-2/ HDFn 
BA 
* Caco-2/ CCD-18co AB V+ vs HDFn AB ns 
Caco-2/ CCD-18co BA V+ vs Caco-2/ HDFn 
BA V+ 
ns Caco-2/ CCD-18co AB V+ vs HDFn AB 
V+ 
ns 
Caco-2/ HIC BA vs Caco-2/ HIC BA V+ ns Caco-2/ HIC AB vs Caco-2/ HIC AB V+ ns 
Caco-2/ HIC BA vs Caco-2/ HDFn BA * Caco-2/ HIC AB vs HDFn AB ns 
Caco-2/ HIC BA vs Caco-2/ HDFn BA V+ ns Caco-2/ HIC AB vs HDFn AB V+ ns 
Caco-2/ HIC BA V+ vs Caco-2/ HDFn BA ns Caco-2/ HIC AB V+ vs HDFn AB ns 
Caco-2/ HIC BA V+ vs Caco-2/ HDFn BA V+ ns Caco-2/ HIC AB V+ vs HDFn AB V+ ns 
Caco-2/ HDFn BA vs Caco-2/ HDFn BA V+ ns HDFn AB vs HDFn AB V+ ns 
Table 6.2: Significancy values from Rhodamine 123 ±Verapamil Hydrochloride 
permeability studies of Transwell conditioned media models – B-A and A-B data sets 
were analysed for significancy separately. Individual significances were calculated by one-
way ANOVA with Tukeys post-test analysis with 95% confidence rating. *** = P<0.0005, 
** = P<0.005, * = P< 0.05 
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6.4.3 Rhodamine 123 transport and Verapamil Hydrochloride 
MDR1/ P-gp inhibition in 3D Caco-2/ Fibroblast bioengineered 
intestinal equivalents. 
 
The effects of fibroblast conditioned media on the Rhodamine 123 permeability of 
Transwell Caco-2 model systems were shown to cause a range f  changes in the functional 
phenotype of the resultant intestinal model.  Results in this section focus on the 
application of the fibroblasts into a 3D cultured stromal epithelial system , designed for 
the co-culture of multiple cell types into a structurally physiological intestinal model.  
 
Figure 6.14 shows the comparative function of 3D Alvetex intestinal models compared 
to conventionally cultured control Caco-2 Transwell model function. Figure 6.14 A 
shows the comparative effects of 3D Alvetex culture compared against control Transwell 
layers, the gold standard in the B-A permeability direction. Similarly, Figure 6.14 B 
shows data in the A-B permeability direction. When first considering the B-A direction 
alone (the primary expected direction of travel for MDR1/ P-gp mediated Rhodamine 123  
transport) it was clearly shown that 3D CCD-18co cultures show a much higher 
permeability than Transwell controls. 3D CCD-18co A-B  shows a trend to be lower than 
B-A values however this change is non-significant due to the large data variation. 
Furthermore, only a small decrease in overall membrane permeability is seen when 
models are assayed with the addition of verapamil hydrochloride in B-A and no change 
at all in the A-B direction. Overall this suggests two things about the function of the 
epithelium in CCD-18co bioengineered Caco-2 intestinal models compared to 
conventionally cultured Caco-2 Transwell systems. 1. B-A permeability, whilst increased 
is not completely due to proportional increases in MDR1/P-gp expression rates because 
of similar increases in A-B permeability and incomplete inhibition when tested in the 
presence of Verapamil hydrochloride. 2. Increases in non-inhibitable Rhodamine 
permeability suggest either increased levels of similar (non-inhibitable) efflux proteins to 
MDR1 of which Rhodamine 123 shows some degree of substrate specificity or increased 
passive paracellular permeability. If one compares the TEER values gained from 3D 
Chapter 6 –Assessment of 2D and 3D model function 
Page | 349 
 
model systems compared to Transwell Caco-2 models, both conventional and modified, 
increases in paracellular permeability are not to be unexpected. In either regard increases 
in both B-A and A-B direction are a welcome change when compared to control Caco-2 
Transwell layers. Because Caco-2 Transwell models are known to underestimate 
MDR1/P-gp and are generally less paracellularly permeable than intestinal tissues. 
Results shown here suggest that both of these deficiencies may be improved upon with 
CCD-18co bioengineered 3D Alvetex® intestinal models.  
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3D HDFn models shows a similar pattern with no significant deviations in permeability 
between directions of travel or indeed with the addition of Verapamil hydrochloride. One 
main difference however is in the overall permeability of the membrane. Whereas CCD-
18co models showed a significant increase compared to Transwell controls, this improved 







Figure 6.13: Schematic representation of the transport processes of 3D Alvetex systems 
being studied in this experiment – A) A simple overview of the expected mechanisms 
involved in Rhodamine 123 transport in systems uninhibited with Verapamil hydrochloride. 
Main B-A transport is expected to be MDR1 mediated with any A-B transport paracellular in 
nature. B) shows the effects of the addition of verapamil hydrochloride to the assay system. 
MDR1 mediated transport is expected to be inhibited. 
A) 
B) 
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models decrease their active MDR1/ P-gp transporter expression whilst increasing their 
passive permeability rates.  
 
Similarly to CCD-18co cultured models, HIC models show a trend towards a large 
increase in B-A membrane permeability compared to conventionally cultured Transwell 
controls. A-B permeability was also increased when compared to conventionally cultured 
controls however was lower than HIC 3D model B-A values. Unfortunately, due to model 
variation this difference is not significant, a seemingly common issue with the use of 3D 
models, which are inherently more variable than simple 2D counterparts.  Again, as seen 
in other 3D models conditions, addition of verapamil hydrochloride does not appear to 
have any effect on the rate of B-A membrane permeability suggesting non-MDR1/P-gp 
mediated Rhodamine 123 Transport. Interestingly, addition of Verapamil Hydrochloride 
to the A-B direction in HIC 3D models results in a further significant decrease in 
membrane permeability compared to uninhibited 3D A-B transport to a level similar to 
that seen in control Transwell models. This is somewhat unexpected as inhibition of 
MDR1/P-gp should logically increase A-B transfer compared to uninhibited assays. A 
decrease in A-B transport when inhibited would suggest two hypothesis. 1. Verapamil 
Hydrochloride inhibits a mechanism involved in actively transporting Rhodamine 123 A-
B. 2. Verapamil Hydrochloride rapidly upregulates an active efflux protein able to 
transport across B-A. Either option would seem unlikely suggesting a different 
mechanism entirely may be at play. 
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Figure 6.14: Comparative analysis of Rhodamine 123 transport across Control and 3D Alvetex Caco-2/ Fibroblast intestinal tissue equivalents shows a large 
increase in Rhodamine 123 membrane permeability in CCD-18co and HIC 3D models –  A) Comparative B-A Papp values between Caco-2 Transwell controls 
and B-A values from Alvetex® based inetstinal models.. B) Comparative A-B  Papp values between Caco-2 Transwell controls and A-B values from Alvetex® based 
intestinal models. Generally, 3D models were shown to be more permeable to Rhodamine 123 than Caco-2/ Transwell controls. Addition of Verapamil Hydrochloride 
did not appear to have any significant effects on reducing membrane Rhodamine 123 permeability. n=3 +SEM. N=3 Significancys are summerised in table 6.3 
 
A B 
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Control BA vs Control BA V+ ns Control AB vs Control AB V+ ns 
Control BA vs 3D CCD-18co BA ns Control AB vs 3D CCD-18co AB ns 
Control BA vs 3D CCD-18co BA 
V+ 
ns Control AB vs 3D CCD-18co AB 
V+ 
ns 
Control BA vs 3D HDFn BA ns Control AB vs 3D HDFn AB ns 
Control BA vs 3D HDFn BA V+ ns Control AB vs 3D HDFn AB V+ ns 
Control BA vs 3D HIC BA ns Control AB vs 3D HIC AB ** 
Control BA vs 3D HIC BA V+ ns Control AB vs 3D HIC AB V+ ns 
Control BA V+ vs 3D CCD-18co 
BA 
ns Control AB V+ vs 3D CCD-18co 
AB 
ns 
Control BA V+ vs 3D CCD-18co 
BA V+ 
ns Control AB V+ vs 3D CCD-18co 
AB V+ 
ns 
Control BA V+ vs 3D HDFn BA ns Control AB V+ vs 3D HDFn AB ns 
Control BA V+ vs 3D HDFn BA V+ ns Control AB V+ vs 3D HDFn AB V+ ns 
Control BA V+ vs 3D HIC BA ns Control AB V+ vs 3D HIC AB ** 
Control BA V+ vs 3D HIC BA V+ ns Control AB V+ vs 3D HIC AB V+ ns 
3D CCD-18co BA vs 3D CCD-18co 
BA V+ 
ns 3D CCD-18co AB vs 3D CCD-18co 
AB V+ 
ns 
3D CCD-18co BA vs 3D HDFn BA ns 3D CCD-18co AB vs 3D HDFn AB ns 
3D CCD-18co BA vs 3D HDFn BA 
V+ 
ns 3D CCD-18co AB vs 3D HDFn AB 
V+ 
ns 
3D CCD-18co BA vs 3D HIC BA ns 3D CCD-18co AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HIC BA 
V+ 
ns 3D CCD-18co AB vs 3D HIC AB 
V+ 
ns 
3D CCD-18co BA V+ vs 3D HDFn 
BA 
ns 3D CCD-18co AB V+ vs 3D HDFn 
AB 
ns 
3D CCD-18co BA V+ vs 3D HDFn 
BA V+ 
ns 3D CCD-18co AB V+ vs 3D HDFn 
AB V+ 
ns 
3D CCD-18co BA V+ vs 3D HIC 
BA 
ns 3D CCD-18co AB V+ vs 3D HIC 
AB 
ns 
3D CCD-18co BA V+ vs 3D HIC 
BA V+ 
ns 3D CCD-18co AB V+ vs 3D HIC 
AB V+ 
ns 
3D HDFn BA vs 3D HDFn BA V+ ns 3D HDFn AB vs 3D HDFn AB V+ ns 
3D HDFn BA vs 3D HIC BA ns 3D HDFn AB vs 3D HIC AB ns 
3D HDFn BA vs 3D HIC BA V+ ns 3D HDFn AB vs 3D HIC AB V+ ns 
3D HDFn BA V+ vs 3D HIC BA ns 3D HDFn AB V+ vs 3D HIC AB * 
3D HDFn BA V+ vs 3D HIC BA V+ ns 3D HDFn AB V+ vs 3D HIC AB V+ ns 









Table 6.3: Significancy values from Rhodamine 123 ±Verapamil Hydrochloride 
permeability studies of Transwell control compared with Alvetex® based intestinal 
models – B-A and A-B data sets were analysed for significancy separately. Individual 
significances were calculated by one-way ANOVA with Tukeys post-test analysis with 95% 
confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05 
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6.4.4 Timecourse analysis of Rhodamine permeability across 
conventionally and conditioned cultured Transwell models and 
3D bioengineered co-culture systems. 
 
Figure 6.15 shows the permeability of Caco-2 Transwell models to Rhodamine 123 with 
timepoints taken at 0 (blank), 60 and 120 minutes. Figure 6.15 A shows control  
timecourse permeability changes, whereas, Figure 6.15 B shows Verapamil 
Hydrochloride inhibited cell culture layers. The purpose of this analysis is to assess 
whether permeability over time is linear or as seen here, dependant on time in culture. 
The main observation is that the rate of Rhodamine 123 transport increases between the 
0 and 60 minute timepoints with often, the maximal Papp value for the culture actually 
occurring at the 60 minute timepoint. Between 60 and 120 minutes in assay, permeability 
levels plateau with no additional increases in the rate of Rhodamine transport. Caco-2/ 
HDFn the only condition seen to not follow this observable trend. 
 
Figure 6.16 A and B show the same analysis with 3D cultured Alvetex models rather than 
conditioned media models.  A similar overall trend is observed albeit at the higher 
permeability values of 3D cultures. Where HDFn was the observable anomaly in 
Transwell cultures, Figure 6.16 A and B clearly shows that in 3D Alvetex conditions, 
Caco-2/ HIC models show a more linear change in Rhodamine permeability compared to 
other conditions.  It is important to note that a plateau of Papp does not mean that active 
transport is not occurring, just that the rate of active transport is stable or saturated. A 
linear change in Papp increase could indicate that Rhodamine Transport is not yet 
saturated, potentially suggesting high levels of active transporters although variability in 
3D models is generally higher than those seen in 2D.
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Figure 6.15: Time course analysis of Rhodamine 123 permeability in paracrine Transwell models throughout the assay period shows a general rapid increase 
in permeability followed by a plateau phase whereby permeability values stop increasing - A) B-A Conditioned media Transwell models, B) B-A Conditioned 
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Figure 6.16: Time course analysis of Rhodamine 123 permeability in 3D Alvetex tissue equivalent models throughout the assay period shows a general rapid 
increase in permeability followed by a plateau phase whereby permeability values stop increasing – A) B-A 3D Alvetex models, B) B-A 3D Alvetex models 
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6.4.5 Efflux co-efficient value calculation and analysis to show 
directional bias in Rhodamine 123 transport within 2D 
Transwell and 3D Alvetex ® intestinal models.  
Figures 6.17 and 6.18 show the efflux co-efficient analysis of both 2D (Figure 6.17) and 
3D intestinal cultures (Figure 6.18) Rhodamine 123 Ussing chamber transport. Efflux co-
efficients are simply calculated by comparing the Papp values of B-A transport compared 
to permeability in the A-B direction. For example a co-efficient permeability value of 2 
would suggest that the B-A direction of travel was favoured over the A-B direction 
exactly 2-fold, with twice as much compound transport B-A.  
 
Analysis of Figure 6.17 shows how significant B-A bias is seen in both Control and CCD-
18co conditioned media cultures. In both cases this is more pronounced at the 120 minute 
timepoint rather than at 60 minutes. Addition of Verapamil Hydrochloride to the culture 
system results in a significant decrease in the efflux co-efficiency to approximately one, 
suggesting no transport bias of the membranes. This suggests either a significant 
inhibition of B-A transport or an increase of Rhodamine 123 transport in the A-B 
direction in verapamil treated model assays. It was know from previous data analysis that 
changes in efflux co-efficient are likely influenced by both with the former being the 
largest driver of change.  
 
Efflux co-efficients levels of HDFn and HIC conditioned media layers, whilst still for the 
most part above a value of 2 (suggesting B-A bias) are lower than their control and CCD-
18co counterparts. This suggests that Rhodamine 123 permeability in these models is 
likely to be MDR1/P-gp mediated to a large extent, due to the comparative ratio between 
B-A and A-B permeability values, but not to the level as control and CCD-18co fibroblast 
treated systems which have a higher ratio of B-A/ A-B permeability. Addition of 
Verapamil Hydrochloride to HDFn and HIC cultures had no significant effects on efflux 
co-efficient when compared to uninhibited efflux co-efficient values. This suggests that 
Rhodamine 123 transport in these instances occurred at a similar ratio (B-A/A-B) as in 
untreated HDFn and HIC model assays. As such, Rhodamine 123 transport in these 
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instances is more likely through a method not inhibited by Verapamil Hydrochloride, 
insinuating transport may not be due to MDR1/ P-gp mediated mechanisms alone.  
 
Figure 6.18 shows an analysis of the changing efflux co-efficient seen in 3D co-culture 
models of the intestinal epithelium. Generally, 3D cultured Alvetex models didn’t show 
a significant bias to any particular direction of molecular movement through the 
membrane. This is not to say that there was no transport, indeed 3D bioengineered models 
were regularly shown to have increased Rhodamine 123 permeability across epithelial 
layers compared to conventionally cultured control Transwell values. As seen previously, 
addition of Verapamil Hydrochloride didn’t have any significant effects on the directional 
bias of Rhodamine 123 transport except in 3D HIC models whereby a large increase in 
efflux co-efficient was observed suggesting a high B-A bias in molecular transport. 
Tables 6.3 specify the significancy values of 2D conditioned media and 3D Alvetex 
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  Figure 6.17: Efflux ratio permeability calculation of 2D Transwell paracrine models for 
Rhodamine 123  -  Efflux ratio is described as a calculation to decide whether bias exist 
between differential direction of molecular movement in a drug transport assay system. Values 
over 2 suggest movement in the B-A direction is at least double that of the A-B direction. All 
uninhibited model layers show significant B-A bias. Addition of Verapamil Hydrochloride in 
most instances reduces this B-A bias significantly except in the case of HDFn and HIC 
conditioned layers where no significant change is observed.  n = a minimum of 3 independent 
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Figure 6.18: Efflux ratio permeability calculation of 3D Alvetex Caco-2/ Fibroblast 
models for Rhodamine 123  - Values for 3D Alvetex intestinal models generally speaking 
are shown to be below 2 in CCD-18co and HDFn instances. HIC models show extremely 
high Efflux co-efficient values when treated with verapamil hydrochloride, an unusual 
phenotype not readily explained by data gained in this study. n= a minimum of 3 
independent repeats. 3D CCD-18co non-inhibited and 3D HIC models V+ n=2, N=2 +SEM 
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Control 60 vs 3D HIC 120 V+ *** Caco-2/ HIC 60 V+ vs 3D HIC 120 
V+ 
*** 
Control 120 vs 3D HIC 120 V+ *** Caco-2/ HIC 120 V+ vs 3D HIC 120 
V+ 
*** 
Control 60 V+ vs 3D HIC 120 V+ *** 3D CCD-18co 60 vs 3D HIC 120 V+ *** 
Control 120 V+ vs 3D HIC 120 V+ *** 3D CCD-18co 120 vs 3D HIC 120 
V+ 
*** 
Caco-2/ CCD-18co 60 vs 3D HIC 
120 V+ 
*** 3D CCD-18co 60 V+ vs 3D HIC 120 
V+ 
*** 
Caco-2/CCD-18co 120 vs 3D HIC 
120 V+ 
*** 3D CCD-18co 120 V+ vs 3D HIC 
120 V+ 
*** 
Caco-2/ CCD-18co 60 V+ vs 3D HIC 
120 V+ 
*** 3D HDFn 60 vs 3D HIC 120 V+ *** 
Caco-2/ CCD-18c0 V+ vs 3D HIC 
120 V+ 
*** 3D HDFn 120 vs 3D HIC 120 V+ *** 
Caco-2/ HDFn 60 vs 3D HIC 120 V+ *** 3D HDFn 60 V+ vs 3D HIC 120 V+ *** 
Caco-2/ HDFn 120 vs 3D HIC 120 
V+ 
*** 3D HDFn 120 V+ vs 3D HIC 120 V+ *** 
Caco-2/ HDFn 60 V+ vs 3D HIC 120 
V+ 
*** 3D HIC 60 vs 3D HIC 120 V+ *** 
Caco-2/ HDFn 120 V+ vs 3D HIC 
120 V+ 
*** 3D HIC 120 vs 3D HIC 120 V+ *** 
Caco-2/ HIC 60 vs 3D HIC 120 V+ *** 3D HIC 60 V+ vs 3D HIC 120 V+ *** 
Caco-2/ HIC 120 vs 3D HIC 120 V+ *** 
  
Table 6.4: Efflux co-efficient analysis of Rhodamine 123 in 2D and 3D intestinal models both with and without Verapamil Hydrochloride and at both 
60 and 120 minutes assay lengths - Individual significances calculated by one-way ANOVA with Tukeys post-test analysis with 95% confidence rating. *** 
= P<0.0005, ** = P<0.005, * = P< 0.05  
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6.4.6 KGF treatment of Caco-2 Transwell models reduces its 
models capability to actively transport Rhodamine 123.  
Figure 6.19 shows the Rhodamine 123 transport of dynamics of conventional cultured 
Caco-2 Transwell layers treated with differential concentration of KGF. Cell layers were 
cultured for a period of 21 to 25 days prior to assessment of transport kinetics through 
Ussing chamber design as previously described. Figure 6.19 A shows the transport of 
Rhodamine 123 across KGF treated layers in the B-A direction of travel. Readings were 
taken after 120 minutes of transportation. A significant decrease in the levels of 
Rhodamine transport can be seen when compared with the control Papp values. Levels 
drop by approximately 50% consistently across all treated layers with no concentration 
dependent effects.  
 
Figure 6.19 B shows the B-A transfer of Rhodamine 123 in the presence of the MDR1 
(P-gp) inhibitor Verapamil Hydrochloride. Untreated Caco-2 layers show a decrease in 
Rhodamine Papp in the presence of Verapamil Hydrochloride. However, comparison of 
data levels from Figure 6.19 A and B show that addition of Verapamil hydrochloride 
caused a significant dose dependant increase in the relative Papp of Rhodamine 123 in 
KGF treated layers compared to their untreated controls. Additionally, the increase in 
Rhodamine 123 appears to be concentration dependant on the levels of KGF utilised to 
treat the Caco-2 layers during culture, with higher KGF levels corresponding with 
increased Rhodamine 123 transport. This is contrary to what is expected with the know 
physiological functional of Verapamil hydrochloride and suggests a differential 
mechanism between KGF treated layers and Rhodamine 123 transport.   
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Figure 6.19: B-A transport of Rhodamine 123 in KGF treated Caco-2 layers shows decreased 
transport in treated layers versus controls with addition of Verapamil Hydrochloride having 
a dose dependant increasing effect on membrane permeability – A) B-A transport without the 
addition of Verapamil Hydrochloride, B) Rhodamine transport with Verapamil hydrochloride. n=3 
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Control 60 vs 0.5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 60 vs 5ng/ml KGF 120 V+ *** 5ng/ml KGF 60 vs 5ng/ml KGF 120 V+ *** 
Control 60 vs 5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 60 vs 25ng/ml KGF 60 V+ ** 5ng/ml KGF 60 vs 25ng/ml KGF 60 V+ ** 
Control 60 vs 25ng/ml KGF 60 V+ *** 0.5ng/ml KGF 60 vs 25ng/ml KGF 120 V+ *** 5ng/ml KGF 60 vs 25ng/ml KGF 120 V+ *** 
Control 60 vs 25ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 vs 0.5ng/ml KGF 120 V+ *** 5ng/ml KGF 120 vs 5ng/ml KGF 120 V+ *** 
Control 120 vs 0.5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 vs 5ng/ml KGF 120 V+ *** 5ng/ml KGF 120 vs 25ng/ml KGF 60 V+ ** 
Control 120 vs 5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 vs 25ng/ml KGF 60 V+ ** 5ng/ml KGF 120 vs 25ng/ml KGF 120 V+ *** 
Control 120 vs 25ng/ml KGF 60 V+ * 0.5ng/ml KGF 120 vs 25ng/ml KGF 120 V+ *** 5ng/ml KGF 60 V+ vs 5ng/ml KGF 120 
V+ 
*** 
Control 120 vs 25ng/ml KGF 120 V+ *** 0.5ng/ml KGF 60 V+ vs 0.5ng/ml KGF 120 
V+ 
*** 5ng/ml KGF 60 V+ vs 25ng/ml KGF 60 
V+ 
* 
Control 60 V+ vs 0.5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 60 V+ vs 5ng/ml KGF 120 
V+ 
*** 5ng/ml KGF 60 V+ vs 25ng/ml KGF 120 
V+ 
*** 
Control 60 V+ vs 5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 60 V+ vs 25ng/ml KGF 60 
V+ 
* 5ng/ml KGF 120 V+ vs 25ng/ml KGF 60 *** 
Control 60 V+ vs 25ng/ml KGF 60 V+ *** 0.5ng/ml KGF 60 V+ vs 25ng/ml KGF 120 
V+ 
*** 5ng/ml KGF 120 V+ vs 25ng/ml KGF 120 *** 
Control 60 V+ vs 25ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 V+ vs 5ng/ml KGF 60 *** 5ng/ml KGF 120 V+ vs 25ng/ml KGF 120 
V+ 
*** 
Control 120 V+ vs 0.5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 V+ vs 5ng/ml KGF 120 *** 25ng/ml KGF 60 vs 25ng/ml KGF 60 V+ ** 
Control 120 V+ vs 5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 V+ vs 5ng/ml KGF 60 
V+ 
*** 25ng/ml KGF 60 vs 25ng/ml KGF 120 V+ *** 
Control 120 V+ vs 25ng/ml KGF 60 V+ ** 0.5ng/ml KGF 120 V+ vs 25ng/ml KGF 60 *** 25ng/ml KGF 120 vs 25ng/ml KGF 60 V+ ** 
Control 120 V+ vs 25ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 V+ vs 25ng/ml KGF 120 *** 25ng/ml KGF 120 vs 25ng/ml KGF 120 
V+ 
*** 
0.5ng/ml KGF 60 vs 0.5ng/ml KGF 120 V+ *** 0.5ng/ml KGF 120 V+ vs 25ng/ml KGF 120 
V+ 
*** 25ng/ml KGF 60 V+ vs 25ng/ml KGF 120 
V+ 
*** 
Table 6.5: Significancy values for Rhodamine 123 permeability between models of differing KGF concentration both with and without the addition of Verapamil 
Hydrochloride - Individual significances calculated by One way ANOVA with Tukeys post-test analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = 
P< 0.05. n=3, N=3 
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6.4.7 Atenolol Transport in Co-culture Transwell model layers. 
Figure 6.21 shows the transport kinetics of Atenolol for each of the Transwell paracrine 
conditions utilised within this study, namely; Control, CCD-18co, HDFn and HIC 
conditioned medias. Control layers are shown to be relatively impermeable to Atenolol 
in the B-A direction with an average Papp value of approximately 0.3-0.4x10-6cm/s. 
Culture of Caco-2 monolayers in paracrine media of CCD-18co cells did not significantly 
increase permeability in the B-A direction. B-A transport of Atenolol through HDFn and 
HIC conditioned Transwell layers did have significant effects on the permeability of the 
resultant model, with increases seen in both conditions. The largest change was seen in 
HIC conditioned layers. Apical to basal (A-B) transport of Atenolol (Figure 6.21 B) 
appears be higher (more permeable) that transport measured B-A in most instances, more 
so in conventionally cultured Caco-2 and CCD-18co conditioned models. In terms of how 







Figure 6.20: Schematic representation of the expected directional travel mechanisms for Atenolol 
in Transwell and 3D Alvetex® models – A) Transwell based systems, B) Alvetex® based systems. 
Primary expected directional transport is through bi-directional paracellular mechanisms. OCT1 may 
have some transport capabilities in the A-B directions 
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within the literature. Unlike some of the other protein functions tested in this study, OCT1 
is able to actively transport its substrates into the cell, acting as an uptake transporter 
rather than an efflux protein. As such one would expect that passive paracellular transport 
plus the actions of OCT 1 would result in a higher permeability in the A-B directions. 
Lack of this response in HDFn treated Caco-2 monolayers could be attributes simply to a 
downregulation of OCT 1 within these samples or an increase in an untested efflux 
mechanism with substrate homology. 
 
Figure 6.22 shows the differences in Papp between 0, 60 and 120 minutes of transport 
assay time. Figure 6.22 A shows the B-A transport changes over time. Caco-2 control and 
Caco-2/ CCD-18co co-cultures can be shown to plateau or decrease in relative Papp after 
the 60 minute timepoint whereas HIC and HDFn layers continue to rise. A rising Papp 
indicates an increasing permeability over time, suggesting the system has not yet reached 
transport equilibrium, assuming passive diffusion across the membrane. Figure 6.22 B 
shows the same trends but in the A-B direction with Papp values at comparable timepoints 
generally seen to be higher A-B than B-A.
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Figure 6.21: Apparent Caco-2 permeability of Atenolol in Transwell Snapwell model systems – 
21–25 day matured Caco-2 Alvetex co-culture models were tested for their apparent permeability of 
Atenolol. A) Comparison is of relative Papp values at 120 minutes of transport in the B-A direction of 
travel. B) relative Papp values at 120 minutes in the A-B direction of travel.   n=3-8 +SEM. N=3. 
Statistical analysis was acheved by one way ANOVE with Tukeys post test analysis. B-A and A-B 
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Figure 6.22: Apparent Caco-2 Transwell permeability of Atenolol in Transwell Co-culture systems – 21–25 day matured Caco-2 Snapwell 
monolayers cultured in the conditioned media of either CCD-18co, HDFn or HIC fibroblasts were tested for their apparent permeability of Atenolol. 
Timepoints were taken at 60 minute intervals. n=2-4 ±SEM, N=2-4 
A B 
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Caco-2 BA vs Caco-2/CCD-18co 
BA 
ns Caco-2 AB vs Caco-2/CCD-18co 
AB 
ns 
Caco-2 BA vs Caco-2/ HDFn BA ns Caco-2 AB vs Caco-2/ HDFn AB ns 
Caco-2 BA vs Caco-2/ HIC BA ** Caco-2 AB vs Caco-2/HIC AB ns 
Caco-2/CCD-18co BA vs Caco-2/ 
HDFn BA 
ns Caco-2/CCD-18co AB vs Caco-2/ 
HDFn AB 
ns 
Caco-2/CCD-18co BA vs Caco-2/ 
HIC BA 
* Caco-2/CCD-18co AB vs Caco-
2/HIC AB 
ns 
Caco-2/ HDFn BA vs Caco-2/ 
HIC BA 




6.4.8 Atenolol Transport in 3D bioengineered Alvetex models. 
Figure 6.23 shows the apparent permeability of Atenolol through the 3D Alvetex models 
created within this study, namely; CCD-18cvo, HDFn and HIC cultured fibroblasts with 
Caco-2 epithelium cultured on the surface of the fibroblast model. Caco-2 B-A and Caco-
2 A-B conditions refer to conventionally cultured Transwell models, used as control 
comparison layers. 
B-A transport (Figure 6.23 A) of Atenolol in 3D cultured CCD-18co and HIC models 
was shown to be not significantly different from that seen in controls with values ranging 
around 0.5x10-6cms-1.  B-A transport seen in HDFn layers however was significantly 
higher than that seen in other conditions at around 8.5 x10-6cms-1. A-B transport (Figure 
6.23 B) was higher in control samples as previously described but lower in all 3D cultured 
conditions than their respective B-A values. These differences between B-A and A-B 
transport however were insignificant except that of the 3D HDFn transport whereby A-B 
transport was generally lower. Reasons why A-B transport was so significantly lower 
than B-A in 3D HDFn models is not readily apparent. Decreased expression of OCT1 
would have the effect of simultaneously increasing B-A permeability whilst decreasing 
relative A-B permeability. However, it could be  hypothesised that OCT 1 downregulation 
could not result in such a large differential effect when compared to other conditions. The 
OCT family of transporter proteins is known to be expressed within the skin from a 
number cell types, mainly epithelial. (343)One potential mechanism for the functional 
Table 6.6: Significancy values for Atenolol permeability experiments - Individual 
significances calculated by One way ANOVA with Tukeys post-test analysis with 95% 
confidence rating for Atenolol transport. B-A and A-B data sets were analysed for 
significance separately *** = P<0.0005, ** = P<0.005, * = P< 0.05. n=3, N=3 
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phenotype observed here could be due to OCT 1 upregulation within the HDFn fibroblasts 
themselves as such limiting the levels of Atenolol able to reach the basal compartment 
through the HDFn biomimetic intestinal model. Increased B-A transport could be due to 
a number of mechanisms not tested for in this study such as cross-specificity of atenolol 
as a substrate for an unknown transporter protein. 
 
Figure 6.24 A, shows the Papp changes over time of 3D cultured CCD-18co, HDFn and 
HIC 3D Alvetex models.  B-A transport comparison shows Caco-2 Transwell, 3D CCD-
18co and 3D HIC models are not significantly different from one another. The general 
shape of the curve shows an increase in Papp values over time within the first 60 minutes 
followed by a plateau suggesting a constant rate of compound transfer. 3D HDFn models 
shows a decrease in permeability between 60 and 120 minute timepoints. This suggests 
permeability is decreasing within the models with later timepoints being less permeable 
to Atenolol. A-B time course graphs (Figure 6.24 B) show a similar trend with Papp levels 
plateauing after 60 minutes within the Ussing chamber. No significant deviation was seen 
up to 120 minutes.  
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Figure 6.23: Apparent Caco-2 Transwell permeability of Atenolol in 3D Alvetex Scaffold 
models systems – 21–25 day matured Caco-2 Alvetex co-culture models were tested for their 
apparent permeability of Atenolol. Comparison is of relative Papp values at 120 minutes of transport. 
A) B-A direction, B) A-B direction   n=3-8 +SEM. N=3-4 Significancy is shown in Table 6.7. 
A 
B 
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Figure 6.24: Apparent Caco-2 Transwell permeability of Atenolol in Alvetex Scaffold co-culture systems – 21–25 day matured Caco-2 Snapwell 
monolayers cultured in the conditioned media of either CCD-18co, HDFn or HIC fibroblasts were tested for their apparent permeability of Atenolol. 
Timepoints were taken at 60 minute intervals. n=2-4, N=2-4 ±SEM 
 
A B 
Chapter 6– Functional characterisation of advanced Transwell and Alvetex intestinal models 
 
Page | 373 
 
Caco-2 BA vs 3D CCD-18co BA ns Caco-2 AB vs 3D CCD-18co AB * 
Caco-2 BA vs 3D HDFn BA *** Caco-2 AB vs 3D HDFn AB ns 
Caco-2 BA vs 3D HIC BA ns Caco-2 AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HDFn 
BA 
*** 3D CCD-18co AB vs 3D HDFn 
AB 
ns 
3D CCD-18co BA vs 3D HIC BA ns 3D CCD-18co AB vs 3D HIC AB ns 
3D HDFn BA vs 3D HIC BA *** 3D HDFn AB vs 3D HIC AB ns 
 
6.4.9 Efflux co-efficient of Caco-2 Transwell and 3D bio-
engineered Caco-2 Alvetex models for Atenolol. 
Figure 6.25 shows the efflux co-efficient values for Atenolol in the 2D paracrine models. 
In each case there are no significant differences (Table 6.6) between values gained at 60 
minutes or at 120 minutes. For the most part, values tend to hover around 1 suggesting 
there is no particular bias in the direction of travel of this drug in these conditions, 
especially at the terminal experimental timepoint of 120 minutes. 
 
Figure 6.26 shows the same calculations applied to data gained from the analysis of 
atenolol transport in 3D intestinal models. 3D CCD-18co models show low efflux co-
efficient values suggesting no significant bias in movement. In contrast, 3D HDFn models 
show a large efflux co-efficient value of between 20-30, suggesting a strong bias in the 
B-A direction of travel. As discussed earlier the mechanism of action for this increase in 
B-A transport compared to A-B is unknown. 3D HIC models show a reduced efflux co-
efficient compared with 3D HDFn with levels similar to CCD-18co models, suggesting a 




Table 6.7: Significancy values for Atenolol permeability in 3D intestinal models - 
Individual significances calculated by One way ANOVA with Tukeys post-test analysis with 
95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. n=2-8. B-A and A-B data 
sets were analysed for significancy separately 
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Figure 6.25: Efflux co-efficient calculations shows no significant directional bias in 2D model 
atenolol transport – Efflux co-efficients less than or equal to 1 suggest no significant bias in the 
B-A transport of Atenolol across 2D control and paracrine treated layers. This trend is observed at 
both 60 and 120 minute timepoints. n=3-8 +SEM. N=3-4 Significancy shown in Table 6.6 
 
Figure 6.26: Efflux co-efficient calculations shows significant differences in the transport bias of 
HDFn models to other 3D systems and Transwell co-cultures – The efflux co-efficient calculations 
of 3D cultured Alvetex models all show significant bias to the B-A transport of Atenolol across models 
layers. Particularly, HDFn 3D cultured models show a highly significant bias over all other culture 
conditions. n= 3 +SEM. N=3 Significancy shown in Table 6.6 
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Caco-2 60 vs 3D HDFn 60 *** HIC 60 vs 3D HDFn 60 *** 
Caco-2 60 vs 3D HDFn 120 *** HIC 60 vs 3D HDFn 120 *** 
Caco- 120 vs 3D HDFn 60 *** HIC 120 vs 3D HDFn 60 *** 
Caco- 120 vs 3D HDFn 120 *** HIC 120 vs 3D HDFn 120 *** 
CCD-18co 60 vs 3D HDFn 60 *** 3D CCD-18co 60 vs 3D HDFn 60 *** 
CCD-18co 60 vs 3D HDFn 120 *** 3D CCD-18co 60 vs 3D HDFn 
120 
*** 
CCD-18co 120 vs 3D HDFn 60 *** 3D CCD-18co 120 vs 3D HDFn 
60 
*** 
CCD-18co 120 vs 3D HDFn 120 *** 3D CCD-18co 120 vs 3D HDFn 
120 
*** 
HDFn 60 vs 3D HDFn 60 *** 3D HDFn 60 vs 3D HIC 60 *** 
HDFn 60 vs 3D HDFn 120 *** 3D HDFn 60 vs 3D HIC 120 *** 
HDFn 120 vs 3D HDFn 60 *** 3D HDFn 120 vs 3D HIC 60 *** 
HDFn 120 vs 3D HDFn 120 ** 3D HDFn 120 vs 3D HIC 120 ** 
Table 6.8: Significancy values for Atenolol Efflux Co-efficient for both 2D and 3D intestinal 
models - Individual significances calculated by One way ANOVA with Tukeys post-test analysis 
with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05.  
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6.4.10 Propranolol Transport of 2D Transwell co-cultures and 
3D Alvetex based intestinal models. 
Figure 6.28 shows Propranolol transport data for conventionally cultured control and 2D 
conditioned media Transwell experiments. Figure 6.28 A demonstrates data in the B-A 
direction whereas Figure 6.28 B shows permeability in the A-B direction. Generally, 
Transwell membranes could be considered highly permeable to Propranolol with average 
Papp values over 10x10-6cms-1 for all conditions.  
 
Control, CCD-18co and HIC conditioned media conditions were all approximately equal 
with no significant changes in propranolol transport over Control epithelial constructs. In 
contrast, HDFn paracrine media conditions resulted in an increased permeability trend 
Transcellular 
Transcellular 
Figure 6.27: Schematic representation of the expected permeability routes of Propranolol 
across Transwell and Alvetex models – Propranolol is a mode compound generally utilised as 
a measurement of passive transcellular transport in vitro across Caco-2 Transwell model 
membranes. 
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albeit not significantly different from controls in this study. In all instances B-A and A-B 
transport appears to be approximately equal between model conditions. Propranolol is 
thought to cross across the intestinal epithelium purely through a passive transcellular 
mechanism. Data seen here follows this hypothesis with reasonably similar values seen 
between conditions and no differences between B-A and A-B directionality.  
 
3D model permeability to Propranolol (Figure 6.29 (A = B-A), (B = A-B)) showed 
increased variation over their 2D conditioned media counterparts. Generally, all models 
tested were still reasonably permeable to Propranolol with minimum average Papp values 
of  > 5x10-6cms-1 in all conditions. 3D CCD-18co Alvetex models exhibited a reduced 
permeability phenotype compared to control with average Papp values of approximately 
5x10-6cms-1, half of that seen in Control of CCD-18co paracrine 2D Transwell models. 
This reduced permeability phenotype is also seen in HIC created models albeit non-
significant in the latter’s case. Additionally, A-B transport appears to be higher than B-A 
transport in CCD-18co and HIC 3D cultures with A-B transport non-significantly 
different from Control Papp values in either case. 3D HDFn models show Propranolol 
permeability non-significantly different from 2D Control epithelial models. Interestingly, 
the heightened permeability compared to control layers seen in 2D HDFn paracrine media 
is attenuated when cultured into 3D models. However HDFn 3D models are still 
significantly higher than its other 3D counterparts. 
 
Decreased permeability values are not completely unexpected in 3D models compared to 
Transwell systems due to the lipophilic nature of Propranolol. Being lipophilic, 
propranolol is readily absorbed through the cell membrane and as such sequestered within 
the cell. The large numbers of fibroblasts within the 3D models will have the effects of 
buffering the transport capabilities to the extent that they are filled with cells and ECM 
respectively. For example, the decreased Propranolol permeability seen in 3D CCD-18co 
and HIC systems is likely due to drug-model sequestration. Analysis of data within the 
literature shows that Propranolol transportation measurement with tissues are limited due 
to this factor often making ex vivo tissue values non-comparable to Caco-2 Transwell 
models. (269) 
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Figure 6.28: 2D comparison of Propranolol transport across Control and treated 
Transwell models shows HDFn and HIC treatments increase propranolol permeability. 
– All tested conditions show high levels of Propranolol permeability over the 120 minute assay 
length. A) B-A permeability, B) A-B permeability. HDFn and HIC treated Caco-2 layers 
appear to show increased permeability over Control and CCD-18oco treated models. n=3 
+SEM, N=3. Significancy is summerised in table 6.9. 
A 
B 
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Figure 6.29: 3D comparison of Propranolol transport across Control and 3D Alvetex 
models with both CCD-18co and HIC models displaying attenuated propranolol 
permeability compared to controls – All tested conditions show high levels of Propranolol 
permeability over the 120 minute assay length. A) B-A permeability, B) A-B permeability .CCD-
18co, HDFn and HIC treated Caco-2 layers appear to show decreased permeability over their 2D 
paracrine counterparts, with levels similar to control Caco-2 membranes. n=3, N=3, 3D HDFn 
n=2, N=2 +SEM. Significancy is summerised in table 6.10 
A 
B 
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Caco-2 BA vs Caco-2/ CCD-18co 
BA 
ns Caco-2 AB vs Caco-2/ CCD-18co 
AB 
ns 
Caco-2 BA vs Caco-2/ HDFn BA ns Caco-2 AB vs Caco-2/ HDFn AB ns 
Caco-2 BA vs Caco-2/HIC BA ns Caco-2 AB vs Caco-2/ HIC AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ 
HDFn BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ 
HDFn AB 
ns 
Caco-2/ CCD-18co BA vs Caco-
2/HIC BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ 
HIC AB 
ns 
Caco-2/ HDFn BA vs Caco-2/HIC 
BA 





Caco-2 BA vs 3D CCD-18co BA ns Caco-2 AB vs 3D CCD-18co AB ns 
Caco-2 BA vs 3D HIC BA ns Caco-2 AB vs 3D HIC AB ns 
Caco-2 BA vs 3D HDFn BA ns Caco-2 AB vs 3D HDFN AB ns 
3D CCD-18co BA vs 3D HIC BA ns 3D CCD-18co AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HDFn 
BA 
ns 3D CCD-18co AB vs 3D HDFN 
AB 
ns 










Table 6.9: Significancy values for Propranolol in 2D conditioned media Transwell 
models - Individual significances calculated by One way ANOVA with Tukeys post-test 
analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and 
A_B permeability data sets were analysed for significance separately 
 
Table 6.10: Significancy values for Propranolol in 3D Alvetex® models - Individual 
significances calculated by One way ANOVA with Tukeys post-test analysis with 95% 
confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A_B permeability 
data sets were analysed for significance separately 
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6.4.11 Efflux co-efficient analysis of Propranolol permeability 
in 2D Transwell Snapwell and 3D Alvetex models. 
Figure 6.30 shows the efflux co-efficient values for Propranolol transport in 2D paracrine 
media Transwell cultures and 3D Alvetex intestinal equivalents. With regards to efflux 
co-efficient ratios, 2D cultures all show non-significant deviation from the values seen in 
control Caco-2 Transwell models. Efflux co-efficient values in each care are  
approximately 1  suggests that there is no bias in the directional movement of Propranolol 
across Transwell models of the intestine. 3D Alvetex models show a small variation in 
efflux co-efficient values with a small non-significant decrease compared to control 
layers. This decrease would suggest that A-B transport is biased in these models over B-
A transport. However, as the difference is not significant and the lowest values are still 



















Figure 6.30: Efflux co-efficient of Propranolol across 2D and 3D intestinal constructs suggests no 
bias in directional drug transport – Analysis of 2D Transwell paracrine intestinal constructs suggests 
no bias in directional movement with efflux co-efficient values of approximately 1. 3D models suggests 
a level of bias towards A-B movement however efflux co-efficient levels are not sufficiently low to 
positively rule for A-B directional bias. n=3, N=3, 3D HDFn n=2, N=2 +SEM Significancy calculated 
by one way ANOVA with Tukeys post-test analysis howevere no significat differences were seen 
between samples. 
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6.4.12 Etoposide transport of 2D Transwell co-cultures and 3D 
Alvetex based intestinal models. 
Figure 6.32 shows the 2D transport/ permeability of Etoposide through Caco-2 Transwell 
control and conditioned media constructs. Control B-A transport for Etoposide (Figure 
6.32 A) was very low at less than 0.1 x10-6cm-1. Contrastingly, addition of CCD-18co, 
HIC or HDFn conditioned media to the Caco-2 epithelial constructs resulted in a highly 
significant increase in the levels of Etoposide transport with approximate Papp values of 
between 2-4 x10-6cms-1. These values are significantly more physiologically relevant that 
the values gained from the control samples. CCD-18co and HIC models were highly 
MDR1 BCRP MRP2 OCT1 
Transcellular 
BCRP MRP2 OCT1 
Transcellular 
MDR1 
Figure 6.31: Schematic overview of the expected permeability routes of Etoposide through 
Caco-2 Transwell and 3D Alvetex intestinal models – Etoposide is transported by a number of 
critically important efflux proteins such as MDR1, BCRP, MRP2 and OCT1. In this instance 
etoposide was chosen primarily as a model drug for MRP2 mediated transport.  
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variable in their transport capabilities and as such average values are stated with a low 
degree of certainty. HDFn B-A transport was greatly different than control samples yet 
not significant. Additionally, all A-B transport experiments (Figure 6.32 B) were far less 
variable with in each instance, A-B transport was shown to be significantly less than B-
A transport. This is to be expected due to the large array of efflux proteins known to be 
able to transport this compound out of the cells back into the intestinal lumen.  
 
3D transport kinetics exhibit a very similar phenotype (Figure 6.33) with all 3D model 
cultures having significantly increased Papp values when compared to control conditions. 
In this instance 3D HIC models showed a markedly higher BA Papp (Figure 6.33 A) than 
all other conditions with values as high as 60 x 10-6cms-1. In this instance it is probable 
that permeability has been effected by a disruption to the 3D HIC due to mechanical 
breakage either during culture or through manual handling. Additionally, Caco-2 
monolayer which has been demonstrated to form multi-layered sections in parts. Lack of 
membrane polarity could cause large increases in Papp values which when compared to 
human and animal tissues are not physiologically relevant in nature. A-B transport 
(Figure 6.33 B) is significantly lower in 3D HIC conditions, and non-significantly lower 











Chapter 6– Functional characterisation of advanced Transwell and Alvetex intestinal models 
 




Figure 6.32: Etoposide 2D paracrine media Transwell comparison shown large significant 
increases compared to control values in all culture conditions – A) B-A permeability, B) A-B 
permeability.  CCD-18co, HDFn and HIC conditioned media Transwell layers all show a 
heightened Etoposide permeability compared to Control layers in both the B-A and A-B directions 
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Figure 6.33: 3D HIC and HDFn Alvetex models show significant Etoposide permeability increases 
over their 2D paracrine counterparts and 2D Caco-2 Control layers. 3D CCD-18co models similar to 
CCD-18co conditioned media models – A) B-A permeability, B) A-B permeability. All 3D models tested 
showed significantly higher Etoposide transport than Caco-2 control layers. HIC B-A transport in particular 
resulted in Papp values significantly higher than all other conditions tested. n=2-3 +SEM, N=2-3. Statistical 
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Caco-2 BA vs Caco-2/ CCD-18co BA ns Caco-2 AB vs Caco-2/ CCD-18co AB ns 
Caco-2 BA vs Caco-2/ HDFn BA ns Caco-2 AB vs Caco-2/ HDFn AB ns 
Caco-2 BA vs Caco-2/HIC BA ns Caco-2 AB vs Caco-2/ HIC AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ 
HDFn BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ 
HDFn AB 
ns 
Caco-2/ CCD-18co BA vs Caco-2/HIC 
BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ HIC 
AB 
ns 





Caco-2 BA vs 3D CCD-18co BA ns Caco-2 AB vs 3D CCD-18co AB ns 
Caco-2 BA vs 3D HIC BA * Caco-2 AB vs 3D HIC AB ns 
Caco-2 BA vs 3D HDFn BA ns Caco-2 AB vs 3D HDFN AB ns 
3D CCD-18co BA vs 3D HIC BA ** 3D CCD-18co AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HDFn BA ns 3D CCD-18co AB vs 3D HDFN AB ns 












Table 6.11: Significancy values for Etoposide in 2D conditioned media Transwell 
models - Individual significances calculated by One way ANOVA with Tukeys post-test 
analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and 
A-B permeability data sets were analysed for significance separately 
 
Table 6.12: Significancy values for Etoposide in 3D Alvetex® models - Individual 
significances calculated by One way ANOVA with Tukeys post-test analysis with 95% 
confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A-B permeability 
data sets were analysed for significance separately 
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6.4.13 Efflux co-efficient analysis of Etoposide permeability in 
2D Transwell Snapwell and 3D Alvetex models demonstrate 
the differential effects of 3D culture on the permeability of 
tissue constructs. 
Figure 6.34 shows the efflux co-efficient values for the permeability of Etoposide to 2D 
conditioned media Transwell models and 3D cultured Alvetex intestinal constructs. What 
can be clearly seen in that CCD-18co and HIC conditioned media has no significant 
effects on the efflux co-efficients of the resultant epithelial membrane model. Conversely, 
HDFn paracrine co-culture seemingly has larger effects on the directional transport bias 
of the membrane with a large increase in the efflux co-efficient values. This suggests that 
B-A transport is heavily favoured over A-B and at a significantly higher rate than Control, 
CCD-18co or HIC models, which whilst lower than HDFn paracrine constructs are still 
biased to B-A transport in their own right.  
 
Interestingly, the opposite effect is true when analysing the efflux co-efficients of 3D 
cultured models. CCD-18co and HDFn 3D constructs results in a decrease in the relative 
efflux co-efficient compared to Control Caco-2 Transwell layers. 3D HIC models are 
much higher than their CCD-18co and HDFn counterparts yet not significantly different 
from Caco-2 controls. However, it is important to note that whilst efflux co-efficient 
values are lower in 3D models when compared to the Control they are still high enough 
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Caco-2/ HDFn vs 3D CCD-18co ** 
Caco-2/ HDFn vs 3D HDFn * 
Figure 6.34: Efflux co-efficient values show significant bias toward B-A transport in all 
conditions, both 2D and 3D – Efflux co-efficient values are all above the 1.5 threshold limit for 
identification of B-A transport bias. In 2D cultures HDFn caused the most significant change in efflux 
co-efficient with a significant increase. In 3D models variation from  control was in the opposite 
direction with decreases in efflux co-efficient values being observed, with CCD-18co models being the 
most effected.  n=3  +SEM, N=3 
Table 6.13: Significancy values for Etoposide efflux co-efficient for both 2D and 3D intestinal 
models - Individual significances calculated by One way ANOVA with Tukeys post-test analysis with 
95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. 
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6.4.14 Methotrexate Transport for 2D Transwell paracrine co-
cultures. 
Methotrexate is a drug first developed in the 1940s as an anticancer drug, effective by 
reducing the capability of cells in the body to uptake folate, a key component required for 
the generation of DNA and as such cellular proliferation. Modern medicines have 
overtaken methotrexate as a chemotherapeutic and as such it is now mostly utilised as a 
medicine for rheumatoid arthritis. Methotrexate, like most drug compounds is not 
transported in the gut by a single transporter, with many transporter proteins in the 
RFC1 PCFT BCRP 
RFC1 PCFT BCRP 
Figure 6.35: Schematic diagram of the expected permeability routes of Methotrexate in 
both Transwell and 3D Alvetex intestinal models – Methotrexate is a folate analogue and 
as such is up taken by RFC1 and PCFT. In this study methotrexate was primarily utilised as a 
measure of BCRP activity in the different cellular models. 
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intestinal enterocytes having largely overlapping functions. However, in this instance 
methotrexate is being utilised as a marker for BCRP function. 
 
Figure 6.36 shows the relative Papp values of Caco-2 control plus paracrine cultured 
models. Caco-2 cells in their control format appear to transport methotrexate at a 
reasonably low rate in the B-A direction (Figure 6.36 A) with an apparent permeability 
value of around 0.2 x10-6cm/s. Comparatively, paracrine conditioned media of all types 
was able to increase the permeability of the membrane approximately 3-fold up to a value 
of 0.6 x10-6cm/s. A-B transport (Figure 6.36 B) shows no particular bias in direction, 
particularly in control layers but also in HIC and HDFn conditioned media conditions. 
Some level of directional permeability can be observed in CCD-18co conditions however 
variation on the levels of transport, particularly in the B-A direction make this difference 
non-significant in this instance. 
 
6.4.15 Methotrexate Transport for 3D Alvetex based intestinal 
models. 
 
Figure 6.37 shows the transport capabilities of 3D Alvetex models in the transport of 
methotrexate in both B-A (Figure 6.37 A) and A-B (Figure 6.37 B) directions of travel. 
In each instance A-B transport does not appear to be significantly different from B-A 
transport. 3D models in each case show marginally increased levels of transport in both 
directions over control values. 3D CCD-18co models show the most modest increase with 
an average Papp value of around 0.5x10-6cms-1. 3D HIC models express the highest levels 
of transport compared to other conditions with an average Papp or approximately 20 x 
10-6cms-1. However, large levels of data variability suggest that this may be more a flaw 
in the structural integrity of the model rather than a phenotypic response.  
 
Approximately equal uptake in either direction suggests that uptake and efflux 
mechanisms are in balance with one another. 3D HIC models show a large increase in B-
A and A-B compound transport suggesting two options. 1. The 3D HIC membrane in this 
instance is allowing the free movement of methotrexate across the epithelium. 2. Influx 
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and efflux mechanisms are closely related to one another with increases in one correlating 
with increases in another to maintain B-A/ A-B balance. The first option would seem the 
most likely if not for the conservation of this observation throughout all the 3D culture 
systems. Indeed, even though 3D HIC Papp levels are high compared to other conditions 
tested in this study, they are certainly not high enough to the extent in this case that 
uncontrolled compound-model passthrough would be likely. What is most likely, as in 
most of the compounds tested here, is that another as yet unknown mechanism is at play. 
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Figure 6.36: Methotrexate membrane permeability analysis of 2D paracrine Caco-2 co-cultures 
shows a trending increase in membrane permeability in CCD-18co, HIC and HDFn co-cultures 
– A) B-A and B) A-B directional transport of methotrexate is utilised as a marker of BCRP mediated 
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Figure 6.37: Methotrexate membrane integrity analysis of 3D Alvetex/ Caco-2 co-cultures shows 
significant increases in membrane permeability in HIC cultures – A) B-A and B) A-B directional 
transport of methotrexate is utilised as a marker of BCRP mediated active transport. n=3-5 ±SEM, 
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Caco-2 BA vs Caco-2/ CCD-18co BA ns Caco-2 AB vs Caco-2/ CCD-18co AB ns 
Caco-2 BA vs Caco-2/ HDFn BA ns Caco-2 AB vs Caco-2/ HDFn AB ns 
Caco-2 BA vs Caco-2/HIC BA ns Caco-2 AB vs Caco-2/ HIC AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ 
HDFn BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ 
HDFn AB 
ns 
Caco-2/ CCD-18co BA vs Caco-2/HIC 
BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ HIC 
AB 
ns 
Caco-2/ HDFn BA vs Caco-2/HIC BA ns Caco-2/ HDFn AB vs Caco-2/ HIC AB ns 
 
Caco-2 BA vs 3D CCD-18co BA ns Caco-2 AB vs 3D CCD-18co AB ns 
Caco-2 BA vs 3D HDFn BA ns Caco-2 AB vs 3D HIC AB ns 
Caco-2 BA vs 3D HIC BA * Caco-2 AB vs 3D HDFN AB ns 
3D CCD-18co BA vs 3D HDFn BA ns 3D CCD-18co AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HIC BA ns 3D CCD-18co AB vs 3D HDFN AB ns 
3D HDFn BA vs 3D HIC BA ns 3D HIC AB vs 3D HDFN AB ns 
  
Table 6.14: Significancy values for Methotrexate permeability in 2D Transwell based 
intestinal models - Individual significances calculated by One way ANOVA with Tukeys post-test 
analysis with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A-B 
permeability data sets were analysed for significance separately 
 
Table 6.15: Significancy values for Methotrexate permeability in 3D Alvetex® based intestinal 
models - Individual significances calculated by One way ANOVA with Tukeys post-test analysis 
with 95% confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A-B permeability 
data sets were analysed for significance separately 
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6.4.16 Efflux co-efficient values for 2D paracrine Transwell 
and 3D Alvetex methotrexate model transport. 
Figure 6.38 shows the efflux co-efficient transport dynamics of Methotrexate as assessed 
through the use of 2D paracrine Transwell and 3D Alvetex model systems. When 
considering the paracrine models alone, little change can be seen when compared to the 
control models with an average efflux co-efficient of around 1. As described previously 
this indicates that there is no bias in directional transport of material with approximately 
equal transport in both B-A and A-B directions. Comparison of this with data gained from 
3D transport systems paints a similar picture with, especially HDFn cultures showing no 
apparent directional bias. 3D CCD-18co and HIC models have a higher efflux coefficient 
of around 4 and 20 respectively, suggesting significant B-A directional bias. However, 
large data variation, especially in 3D HIC models may suggest that model integrity is to 
blame for some of the large transport variations seen here.  
Figure 6.38: Efflux co-efficient values of Methotrexate comparing controls with paracrine 
media and 3D Alvetex models – Data shows no bias toward B-A transport in all 2D paracrine 
conditions. 3D CCD-18co and HIC models appear to favour B-A transport. n=3 +SEM. N=3 
No significancy was observed between models 
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6.4.17 Lucifer yellow transport of 2D Transwell co-cultures 
and 3D Alvetex based intestinal models. 
Lucifer yellow is primarily utilised in industry as a marker of paracellular transport, and 
as such is a proxy for membrane integrity, similar to how TEER values determine a 
membranes viability for experimentation. Figure 6.40 shows the bidirectional transport 
of lucifer yellow tested across paracrine media cultured Caco-2 Transwell models. 
Control layers exhibit B-A (Figure 6.40 A) Papp values of approximately 1x10-6 cms-1 
indicating that lucifer yellow is relatively poorly permeable across control membranes. 
Addition of CCD-18co paracrine media to the Caco-2 cultures results in a modest, non-
significant increase in the apparent permeability of Lucifer yellow. Both HIC and HDFn 
conditioned media showed a marked and significant decrease in membrane permeability 
compared to control levels with Papp values approximately half of those seen in untreated 
control samples.  Control and CCD-18co samples showed a bias towards transport in the 
B-A direction, with significantly reduced Papp values when lucifer yellow is tested A-B 
Paracellular 
Paracellular 
Figure 6.39: Schematic diagram of expected lucifer yellow transportation routes through 
both Transwell and Alvetex scaffold intestinal models – Lucifer yellow is a well-known and 
characterised compound generally utilised as a marker of paracellular permeability. No known 
active transport mechanisms are thought to influence lucifer yellow transport.  
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(Figure 6.40 B). In contrast, HIC and HDFn values were approximately equal bi-
directionally with no obvious bias. 
 
Lucifer Yellow membrane integrity analysis of 3D models (Figure 6.41) shows a different 
phenotype to their 2D counterparts. In all instances (CCD-18co, HIC and HDFn) 3D 
models showed a moderate increase in  B-A permeability to Lucifer yellow with Papp 
values approximately double those of the control (Figure 6.41 A). Interestingly, the B-A 
bias seen in CCD-18co paracrine treated 2D models is lost when cultures are grown in 
3D. Indeed, all 3D models exhibited approximately equal bi-directional transport, 
consistent across all 3D models types. A-B values were significantly increased in all 3D 
conditioned compared to Caco-2 Transwell based controls (Figure 6.41 B). The lucifer 
yellow values gained for 3D HIC models (along with a similar TEER values) are not 
significantly different from the other 3D systems with improved histologically analysed 
structural morphology. As such this lends weight to the idea that whilst HIC cells do not 
histologically demonstrate the same in vivo correlation as other models created here, they 
do in fact create a confluent layer of Caco-2 cells apically to the fibroblast culture surface, 
justifying their continued use on this study.  
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Figure 6.40: Lucifer yellow membrane integrity analysis of 2D paracrine Caco-2 co-cultures 
– A) B-A and B) A-B directional transport of Lucifer Yellow is utilised as a marker of membrane 
integrity, with lower Papp values suggesting a more tightly bound and impermeable membrane to 
passive compound transport. n=3-11 +SEM N= a minimum of three independent experiments. 
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Figure 6.41: Bi-directional transport of Lucifer Yellow shows significant increase in 
membrane permeability in 3D Alvetex based intestinal models compared to 2D Transwell 
alternatives – B-A and A-B transport of lucifer yellow analysed through 3D intestinal model 
constructs shows a marked increase in permeability compared to control layers.  n=3-7 +SEM. N= 







Chapter 6– Functional characterisation of advanced Transwell and Alvetex intestinal models 
 
Page | 400 
 
Caco-2 BA vs Caco-2/ CCD-18co BA ns Caco-2 AB vs Caco-2/ CCD-18co AB ns 
Caco-2 BA vs Caco-2/ HDFn BA ns Caco-2 AB vs Caco-2/ HDFn AB ns 
Caco-2 BA vs Caco-2/HIC BA ns Caco-2 AB vs Caco-2/ HIC AB ns 
Caco-2/ CCD-18co BA vs Caco-2/ 
HDFn BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ 
HDFn AB 
ns 
Caco-2/ CCD-18co BA vs Caco-2/HIC 
BA 
ns Caco-2/ CCD-18co AB vs Caco-2/ HIC 
AB 
ns 
Caco-2/ HDFn BA vs Caco-2/HIC BA ns Caco-2/ HDFn AB vs Caco-2/ HIC AB ns 
 
 
Caco-2 BA vs 3D CCD-18co BA ns Caco-2 AB vs 3D CCD-18co AB *** 
Caco-2 BA vs 3D HDFn BA ns Caco-2 AB vs 3D HIC AB *** 
Caco-2 BA vs 3D HIC BA ns Caco-2 AB vs 3D HDFn AB *** 
3D CCD-18co BA vs 3D HDFn BA ns 3D CCD-18co AB vs 3D HIC AB ns 
3D CCD-18co BA vs 3D HIC BA ns 3D CCD-18co AB vs 3D HDFn AB ns 
3D HDFn BA vs 3D HIC BA ns 3D HIC AB vs 3D HDFn AB ns 
  
Table 6.16: Significancy values for Lucifer yellow permeability in 2D intestinal models - 
Individual significances calculated by One way ANOVA with Tukeys post-test analysis with 95% 
confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A-B permeability data sets 
were analysed for significance separately 
 
Table 6.17: Significancy values for Lucifer yellow permeability in 3D intestinal models - 
Individual significances calculated by One way ANOVA with Tukeys post-test analysis with 95% 
confidence rating. *** = P<0.0005, ** = P<0.005, * = P< 0.05. B-A and A-B permeability data sets 
were analysed for significance separately 
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6.4.18 Efflux co-efficient of lucifer yellow in 2D and 3D models  
Figure 6.42 shows the calculated efflux co-efficient of lucifer yellow permeability across 
2D Transwell Snapwell model layers, both control and condition media treated, in 
addition to 3D Alvetex models. Transwell Caco-2 control and CCD-18co treated layers 
show a significant trend toward a bias in the B-A direction of compound permeability. In 
essence, meaning that lucifer yellow in these models is more readily permeable through 
the B-A direction of travel then the converse A-B. Contrastingly, 2D HIC and HDFn 
paracrine treated models in addition to all 3D Alvetex models tested show an efflux co-
efficient of approximately 1. This suggests that there is no bias in permeability with 
compound movement approximately equal in any direction of travel.  
 
This differential efflux phenotype can be clearly seen in the original data (Figure 6.40 & 
41) whereby A-B directional transport is significantly less than the B-A counterparts.  
Figure 6.42: Efflux co-efficient of lucifer yellow analysis suggests Control and 2D CCD-
18co layers have a B-A directional bias – Efflux co-efficient analysis suggests directional 
bias in control and 2D CCD-18co treated layers. All other conditions indicate equal 
permeability in either direction. n=3-11 N=3 +SEM. No significancy was found between 
transport models 
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Rhodamine 123 0.82 ± 0.35/ 6.84 ± 2.48 0.96 ± 0.27  3.30 ± 1.2 0.29 ± 0.04 2.32 ± 0.24 1.19 ± 0.17  6.88 ± 2.90 1.8 – 3.6 
(Porcine)(269) 




2.82 ± 0.65 
(Human)(345) 





Lucifer Yellow 1.05 ± 0.34 2.58 ± 2.34 1.37 ± 0.34 0.60 ± 0.15 0.44 ± 0.03 2.05 ± 0.44 2.30 ± 0.17 2.30 ± 0.09 4.02 ± 2.20 
(Human)(345) 
Etoposide 0.05 ± 0.04 8.04 ± 1.55 2.25 ± 2.15 3.71 ± 0.16 1.47 ± 1.13 2.88 ± 0.71 13.88 ± 9.72 57.23 ± 6.33 1.13 ± 1.00 
(Rabbit) (69) 
101 ± 9 (Rat) 
(67) 
Methotrexate 0.18 ± 0.07 0.70 ± 0.50 0.61 ± 0.22 0.52 ± 0.03 0.77 ± 0.10 0.40 ± 0.32 0.89 ± 0.38 21.8 ± 10.11 Unknown 
Table 6.18: Comparative Papp values of models created in this study compared to values gained from the literature for both Caco-2 standards and intestinal 
tissues (Human and animal) – All model conditions generally show improvements over internal Caco-2 standards compared to Caco-2 values gained form the 
literature. Compared to human tissues HDFn 3D models shows the closest similarity of the different models when all test systems are compared.  
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6.5 Discussion 
6.5.1 Transport dynamics of model systems and the context for 
this chapter 
This final chapter is focussed on understanding the influence of fibroblasts of varying 
origin on the development and differentiation of the Caco-2 epithelium both in terms of 
the paracrine effects released (Transwell conditioned media experiments) and in the 
effects of direct co-culture (3D Alvetex® based models). The functional characteristics of 
the differing models were tested for their capabilities to transport a number of model drug 
compounds; namely, Rhodamine 123, Atenolol, Propranolol, Etoposide, Methotrexate 
and Lucifer yellow. These drugs were chosen specifically to assess the function of the 
models in differing ways be they passive absorption (Lucifer yellow, Atenolol and 
propranolol) (66,90,313) or actively transported (Rhodamine 123 – P-gp, Etoposide – 
MRP, Methotrexate – BCRP). Understanding the functional characteristics of fibroblast/ 
Myofibroblast conditioned models is key to understanding their relative importance in 
future research directions as tools for more advanced analysis of NCE compounds, in this 
instance for their pharmacokinetic properties. The relative transport characteristics of the 
tested models will be compared to human tissues through thorough examination of 
available literature. 
 
6.5.2 2D paracrine Transwell and 3D intestinal equivalents 
both show significantly decreased membrane resistance 
compared to conventionally cultured Caco-2 models. 
Initial investigations into the effects of 3D culture focused on the changing transepithelial 
electrical resistance of the complete model. Significant decreases in epithelial resistance 
were seen in 3D when compared to their 2D Snapwell Transwell counterparts whereby in 
2D the most significant decrease lowered TEER to approx. 500 Ohms.cm2 compared to  
approx. 50 Ohms.cm2 in 3D systems, a ten-fold difference and a level comparable to 
measurements in human intestinal tissues.  
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Understanding the likely causes for this significant decrease can be hypothesised as three 
fold.  
 
1. Unlike in the Snapwell formats whereby TEER analysis (Chapter 3) uses a 
standard EVOM-2 TEER device with chopstick electrodes (WPI, UK), a 
commonly used standard throughout the industry; Alvetex® models, due to their 
novel 96-well format were measured utilising an Ussing chamber as described in 
section 6.3.2.(347) Both systems rely on the same principle for the measurement 
of epithelial resistance however it cannot be completely ruled out that differences 
seen in the overall TEER values gained are due to differences in the equipment 
being utilised. Human tissue TEER is generally measured through an Ussing 
chamber device, potentially, explaining the similarity in measurement between 
models and tissues using this method. TEER measurements in the literature vary 
widely dependant on the lab culturing and measuring, with differences in 
equipment/ equipment operator along with variations in Caco-2 origin and 
passage generally thought to be the main contributors in this inconsistency.  
 
2. Absolute fibroblast numbers was not controlled between 2D paracrine and 3D 
models. The absolute number of cells/cm2 seeded into 3D models was far higher 
when compared to the average density of a 90% confluent 2D culture flask utilised 
for conditioned media creation. This could lead to an unbalance comparison 
between model systems with 2D paracrine Transwell models likely stimulated to 
a lesser extent than in 3D Alvetex®.  Additionally, due to the vast difference 
between Snapwell and 96-well Alvetex® formats different media volumes were 
necessarily added to each system, with 3.5ml added to Snapwell and 1.5ml added 
to Alvetex®. In essence this could result in either a dilution or concentration effect 
depending on the model being analysed. However, data in this thesis clearly shows 
that absolute seeded number in 3D does not directly correlate with cell numbers 
growing within the scaffold. Data from chapter 3 on the analysis of KGF levels 
between system types clearly shows how when normalised to DNA concentration, 
3D cultured cells appear to secrete far less KGF than their 2D counterparts.  
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3. 3D culture allows for direct contact between stromal and epithelial cells in 
addition to enhancing the paracrine secretome compared to 2D cultured cells. The 
enhanced secretome could have physiological effects on a number of ways such 
as: 1. Increasing the levels of small molecules already released in 2D, 2. Changing 
the ratios of small molecules produced initiating new pathways for differentiation, 
3. Producing new signalling molecules not seen in normal 2D conditions. Whilst 
the actual mechanism is not evidenced here, it is evident that one or a combination 
of many of these factors allow for enhanced differentiation of epithelial cells, in 
this case Caco-2, to a level more similar to the in vivo tissues. The physiologically 
relevant changes seen in 2D paracrine cultures lend evidence that changes in 
TEER within 3D constructs is more likely due to physiological differences in 
cellular phenotype rather than an artefact of differing culture system. 
 
Due to the differences in the format types between the models tested here the only way 
to reduce the uncertainty behind the mechanism for change would be to create a custom 
insert type able to culture both Transwell and Alvetex® systems in the same format. This 
could be achieved either by modifying Alvetex® to fit the Snapwell format or vice versa. 
Similar to Patient et al. (269) 
 
One of the main contributors to epithelial resistance is the expression and confluency of 
tight junctional complexes. (206)3D CCD-18co and HDFn histological analysis shows 
well defined stromal/ epithelial layers without Caco-2 penetration into the underlying 
mucosal compartment. HIC intestinal models show a far less organised structure with 
significant Caco-2 cellular invasion into the underlying mucosae. That isn’t to say 
however that a confluent layer doesn’t exist on the surface of the HIC model, just that 
without structure one would expect function to lag. Changes in Caco-2 surface 
consistency cannot be ruled out as a potential contributor to the decreases in TEER  
observed in 3D models. Indeed, the surface topography of Alvetex Scaffold® can be 
highly irregular due to the largely uncontrolled arrangement of void spaces in the 
material. Often with areas of significant Caco-2 invasion simply due to Alvetex 
topography. However, SEM surface topography, histological analysis or immunostaining 
characterisation of paracrine and 3D models does not appear to show any consistent 
inconsistencies in Caco-2 epithelial development.  
Chapter 6– Functional characterisation of advanced Transwell and Alvetex intestinal models 
 
Page | 406 
 
Occludin (a protein component of the tight junctional complex and analogous with tight 
junction expression) was utilised as a marker for tight junction expression and 
localisation. All models tested expressed physiological levels of Occludin when 
immunostained without any noticeable differences in staining intensity. More advanced 
staining techniques of the epithelial layer as seen in chapter 5 through model clearing and 
light sheet analysis clearly show a contiguous layer of epithelial cell staining across the 
surface of the 3D model. More quantitative methods of Occludin measurement were 
attempted utilising qPCR. Unfortunately, due to the multicellular nature of the 3D 
models, accurate quantification of relative protein expression cannot be made between 
different formats due to the dilution effect of fibroblast mRNA. However, analysis of the 
effects of paracrine media on protein expression showed no significant differences 
between Controls, CCD-18co, HIC or HDFn. HIC conditions did show a strong, largely 
decreased trend compared to controls suggesting paracrine HIC influences may have 
effects on tight junction formation. This hypothesis is unsupported by any significant 
evidence within this thesis however.  
 
One alternative methodology for the decreases in TEER seen here without any apparent 
corresponding disruption to tight junctional formation could be the increase in Claudin 2 
discussed in chapter 3. Recent evidence has shown that Claudin-2 expression and 
resultant use within tight junction complexes is increased through the paracrine effects of 
KGF, a significant component of CCD-18co paracrine media samples.(209,210,221) 
Claudin-2 has been shown to form “leakier” tight junctions through the creation of small 
pore structures in the junction complex allowing the movement of ions and other very 
small compounds through the epithelial layer. Unabridged movement of ions in particular 
across the membrane could provide one potential reasonable explanation as to why TEER 
levels would be decreased in these samples as ion movement would naturally result in 
decreased resistances. As mentioned earlier however, only CCD-18co conditioned media 
samples showed significant levels of KGF, other fibroblast conditions must therefore 
either decrease TEER through a different mechanism or other small molecule 
combinations could work to have the same physiological effects. 
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6.5.3 Analysis of the functional capabilities of epithelial 
intestinal equivalents through the passive paracellular 
transport assessment of model drug compounds.  
It is well known that Caco-2 models significantly underestimate the absorption rate of 
paracellularly transported compounds. (348) This study utilises 3 drugs whose main 
absorption route is through the paracellular methodology, namely; Lucifer yellow, 
Atenolol (Low general permeability) and Propranolol (High general permeability).  
 
Lucifer Yellow is a classically utilised molecule used to test barrier integrity within Caco-
2 assays, and, along with TEER is the gold standard for determining model viability 
before more complex uses. (314,349–351) Figure 6.40, 6.41 and 6.42 within this chapter 
look at the relative Lucifer yellow permeability between both paracrine and 3D models 
compared to controls. Generally speaking, Lucifer yellow Papp was shown to marginally 
decrease in HIC and HDFn whilst not changing significantly in CCD-18co paracrine 
cultures. 3D models on the other hand did see a significant increase in Lucifer yellow 
Papp suggesting disruption to the epithelial layer compared to Transwell format models. 
However, the levels to which the 3D models Lucifer Yellow Papp increased to was not 
significant enough to suggest complete failure of the epithelial membrane. In fact, Culot 
et al note that a Lucifer Yellow Papp 17x10-6 is the point at which membrane breakage is 
likely which is far above the levels seen in even the most permeable of the models tested 
in this study. (352) In reality, acceptable Papp values for lucifer yellow in industry are far 
below this outlying level and generally range between 0.5 and 2 x10-6 cms-1 dependant 
on the labs internally chosen cut off points. As such there were no concerns regarding the 
Papp values of the 3D models in particular which, whilst higher than Caco-2 Transwell 
controls, were not excessively high enough to suggest membrane malformation.  
 
Atenolol transport was significantly increased in paracrine 2D models up to four fold that 
of conventionally cultured control layers in Caco-2/ HIC conditioned media samples. 
Interestingly, some correlations can be drawn between the origin of the fibroblast lineage 
utilised in each condition and the relative changes on membrane permeability to Atenolol. 
HIC cells as mentioned previously were isolated from human small intestinal duodenum 
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samples received from Biopta, UK, for use in this study. Tissues were cut into small 
pieces and left in culture until cells began to grow out of the samples. These outgrowths 
were characterised and utilised in this study with the designation of HIC. As such these 
are technically the most in vivo relevant cells. Dahlgren et al conducted a study on the 
transport kinetics of Atenolol, alongside Metoprolol and Ketoprofen, within human test 
subject by measurement of drug plasma concentration over time. (353) Drugs were added 
to variable parts of the intestine through a intraluminal, tube-capsule technique. They 
found that small intestinal uptake of atenolol was far higher than colonic uptake by a 
factor of approximately ten-fold. Caco-2 cells are colonic in origin and as such should 
phenotypically be relatively impermeable to Atenolol, as is shown in the literature. 
(314,350,354–357) CCD-18co cells are also colonic in origin so physiologically 
shouldn’t increase Atenolol permeability significantly over controls when considering the 
physiological context. Having said that however, a small increase is seen in the CCD-
18co and HDFn conditioned media samples, perhaps suggesting that epithelial 
development is enhanced through conditioned media over controls levels regardless of 
the physiological context of the fibroblasts used, improving model sensitivity. Most 
interesting is the large increase in permeability when cultured with HIC conditioned 
media.  Small intestinal cells therefore can be seen to cause physiologically relevant 
changes to epithelial cells of colonic origin through the indirect effects of paracrine 
secretion, in isolation from any other factors.  
 
Analysis of the 3D model’s Atenolol transport is less easily reasoned in a physiological 
context. The beneficial increase on transport seen in paracrine cultures is lost in both 
CCD-18co and HIC 3D models with no significant changes in transport compared to 
controls. As mentioned previously it could be hypothesised that this decrease in 3D 
function is more to do with the absolute number of cells present within the 3D scaffold 
than a physiological effect of cells cultured in 3D. Whilst efforts were made to seed the 
same density of Caco-2 cells into 3D models as would exist in the same representative 
area of 2D cultures, the changing cellular metabolism and proliferative capacity of cells 
in 3D made this difficult to achieve over long culture periods.  3D HDFn models show a 
large increase compared to controls which doesn’t appear to be supported with literature 
evidence. Potentially, models were “leaky” as a consequence of model structure however 
HDFn models were routinely observed to form structurally capable models with little to 
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no Caco-2 invasion into the underlying stroma. Additionally, 3 independent 
measurements provide closely matching values with only a small amount of variability. 
One would expect if increased transport was due to the improper model structural 
characteristics then permeability values would be far larger and more variable. Indeed, if 
model structural consistency were an issue then 3D HIC models would be the more likely 
candidate for excessive permeability due to its inconsistent and poor structural 
morphology between models. To my knowledge, study of the effects of human dermal 
fibroblast cells on the morphology and function of Caco-2 cells has not been attempted 
before. Understanding the exact mechanisms and secretome of HDFn cells is beyond the 
scope of this work initially and will be revisited in the future direction of this project.  
 
The final passively transported compound utilised in this study is Propranolol. Generally, 
Propranolol is well known for being readily absorbed by the Caco-2 models and the 
human intestine. (358,359)Permeability of Propranolol was variable between culture 
conditions but generally high as expected and comparable for the most part to Caco-2 
control transport. Transwell paracrine models in each instance are relatively more 
permeable than their 3D culture counterparts, with some of the 3D cultures (CCD-18co 
and HIC) being lower than the Caco-2 Transwell controls. HDFn cultures, as seen in 
Atenolol transport quantification show the highest increase in membrane permeability 
compared to controls in Transwell paracrine models and comparatively higher between 
3D models. As such this could lend evidence that some unknown mechanism (unlikely to 
be simple tight junction dysfunction for reasons mentioned above) is inducing HDFn 
paracrine Caco-2 layers to increase passive permeability. Propranolol is known for being 
a highly lipophilic (360) compound and as such some levels of compound is likely move 
into and remain within cellular cytoplasmic spaces. As such, one explanation for the 
decreases seen in 3D cultures could simply be due to drug retention within the model 
itself rather than a physiologically relevant change in membrane integrity or function. 
Indeed, this is a known issue when measuring Propranolol transport in tissues whereby 
drug sequestration is markedly more pronounced than those seen here due to the sheer 
number and volume of cellular matter within an active tissue. (269) Considering that the 
comparative permeability pattern between Transwell models and their 3D counterparts is 
almost identical in each case albeit lower in 3D models, it is more likely that drug 
sequestration is responsible for the decrease observed. 
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6.5.4 Actively transported compound analysis 
Active transport of compounds was modelled in this study through the transport 
mechanisms of Rhodamine 123, Etoposide and Methotrexate. Nominally, these model 
compounds were chosen to study the active transport of MDR1/ P-gp, MRP1/2 and 
BCRP. However, as mentioned previously, analysis of the function of each drug 
transporter protein in isolation of the others is difficult, if not impossible, due to the 
significant levels of overlap which exist between the different transporter substrate 
specificities. For example, where Etoposide is used here to measure MRP family activity, 
it is also reasonably well known as a substrate of MDR1/ P-gp.  
 
Rhodamine 123 mediated functional analysis of MDR1/ P-gp and the subsequent use of 
Verapamil Hydrochloride, a competitive inhibitor of MDR1/ P-gp activity can tell a lot 
about MDR1/ P-gp activity in addition to the levels of overlapping transporter function 
seen within the models. (361) For example, Caco-2 control layers were shown to be  
significantly less permeable B-A to Rhodamine 123 after treatment with Verapamil 
Hydrochloride, as such suggesting that the primary transport mechanism of Rhodamine 
123 in control epithelial models is through MDR1/ P-gp. The same is true for CCD-18co 
and HDFn paracrine treated layers which show a similar pattern (Figure 6.12). 
Contrastingly, HIC paracrine model Papps are shown to be less effected by the addition 
of Verapamil Hydrochloride with no significant transport suppression in the case of HIC 
paracrine and 3D HDFn, as such suggesting Rhodamine 123 transport through some other 
mechanism, most probably, as mentioned previously, an overlapping ABC transporter 
protein such as BCRP or MRP1/2. Alternatively, evidence in the literature shows how 
Verapamil can have effects on the tight junction assembly within the Caco-2 epithelium, 
potentially increasing rates of paracellular permeability to hydrophilic compounds. 
(362,363) Sakai et al were able to show that the concentration dependant effects of 
Verapamil were able to increase the membrane permeability to FD-4 (a commonly 
utilised passive paracellular compound similar to lucifer yellow) approximately 4-6 fold. 
This could explain some of the anomalous instances in this study whereby application of 
Verapamil either increased or did no significantly change the membrane permeability to 
Rhodamine 123 B-A, such as in KGF treated Caco-2 Transwell layers and 3D 
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bioengineered models whereby permeability increased and stayed the same respectively 
in Verapamil treated assays.  Indeed, it is the models with the lowest measured TEER 
values which appear to be most affected by this potential mechanism further supporting 
evidence that, in some instances, Rhodamine 123 transport is primarily through a 
paracellular mechanism rather than MDR1/P-gp mediated.  
 
MDR1/ P-gp is thought to be underrepresented in some Caco-2 epithelial models with 
work in the past by Shirasaka et al focussed on increasing MDR1 mediated activity of 
Caco-2 membranes, They showed the MDR1/ P-gp expression can be induced by co-
culture of cells with the drug Vinblastine, normally used as a substrate for MDR1/ P-gp 
efflux measurements. (364). Additionally, other works have shown that MDR1/ P-gp 
expression rates can be effected by variables such as Caco-2 passage and culture time 
with increasing both correlating with increased MDR1/ P-gp expression. (365) Work 
undertaken in this study has highlighted that HDFn paracrine and all 3D conditions result 
in significant increase in Rhodamine 123 transport when compared to controls, 
suggesting, at least partially, an increase in MDR1/ P-gp activity.  
 
Etoposide and Methotrexate transport (MRP1/2 and BCRP respectively) both show 
improvements in transport capabilities when Caco-2 layers are cultured with paracrine 
media from CCD-18co, HDFn and HIC cells. These increases are significant compared 
to control Caco-2 layers yet small compared to the changes seen in 3D whereby, similar 
to other conditions, HDFn and HIC 3D models have the greatest increase in permeability. 
There is some evidence to  suggest that BCRP expression in untreated Caco-2 layers is 
expressed to a lesser level than found in human intestine. (28) Madden et al showed that 
the 3D culture of primary intestinal epithelial cells increased BCRP expression compared 
to Caco-2 controls, similar to that seen here. 
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Figure 6.43: Summary of the complete analysis of 2D Caco-2 Transwell models with the model compounds tested in this study  – Blank lines = No change from control, Thin 
green line = Small increase in permeability compared to control, Thick green line = Large increase in permeability compared to control, Thin red line = Small decrease in permeability 
compared to control, Thick red line = Large decrease in permeability compared to control. Generally, in the B-A direction all models tested show some degree of increased functional 
permeability compared to control layers. Only HIC treated models showed decreases in permeability with regards to both Lucifer yellow and Rhodamine 123. In the A-B (absorptive) 
direction less change was seen overall with only etoposide shown to consistently increase in permeability. A) B-A CCD-18co vs control, B) B-A HDFn vs Control, C) B-A HIC vs 
Control, D) A-B CCD-18co vs Control, E) A-B HDFn vs Control, F) A-B HIC vs Control. 
 
A) B) C) 










































































































































































































































































































































A) B) C) 
F) E) D) 
Chapter 6– Functional characterisation of advanced Transwell and Alvetex intestinal models 
 















































































































































































































































































































































Figure 6.44: Summary of the complete analysis of 3D bioengineered models with the model compounds tested in this study  – Blank lines = No change from control, 
Thin green line = Small increase in permeability compared to control, Thick green line = Large increase in permeability compared to control, Thin red line = Small decrease 
in permeability compared to control, Thick red line = Large decrease in permeability compared to control. Generally, in the B-A direction all models tested show some 
degree of increased functional permeability compared to control layers. Only HIC treated models showed decreases in permeability with regards to both Lucifer yellow 
and Rhodamine 123. A) 3D B-A CCD-18co vs control, B) 3D B-A HDFn vs Control, C) 3D B-A HIC vs Control, D) 3D A-B CCD-18co vs Control, E) 3D A-B HDFn vs 
Control, F) 3D A-B HIC vs Control 
 
F) E) D) 
A) B) C) 
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It is an important observation to note that in every single instance within this study, Caco-
2 transport has been observably lower than the average reported values from the literature. 
(68,90,313,320,333) In some instances the difference is small such as Lucifer Yellow and 
Atenolol which, whilst lower, fall within the assays range of error of the reported values. 
Others such as Etoposide, Rhodamine 123 and Propranolol fall well below reported 
control values. Encouragingly, often one or more of the co-culture conditions 
significantly improved the Caco-2 functional phenotype to be more akin to that seen in 
the literature. In this regard, both co-culture Caco-2 and 3D mucosal models result in a 
significantly more functionally representative epithelial equivalent compared to the 
controls in this study. When compared to average values gained from the literature the 
clear cut benefits to using advanced culture methods is significantly less obvious. The 





























































Figure 6.45: Reported human and animal tissue values compared to Caco-2 Transwell controls  
– Blank lines = No change from control, Thin green line = Small increase in permeability compared to 
control, Thick green line = Large increase in permeability compared to control, Thin red line = Small 
decrease in permeability compared to control, Thick red line = Large decrease in permeability 
compared to control. Comparisons of control models to values gained from the literature shows that 
Caco-2 Transwell systems generally underestimate B-A transfer of model compounds when compared 
to human and animal intestinal tissues. Decreased Propranolol transport in tissues compared to 
Transwell models is most likely due to its highly lipophilic nature resulting in high levels of drug 
acquiescence by cells and ECM. Methotrexate cannot be compared as no human tissue transport values 
can be found within the literature 
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variation seen in the literature reported values and here speaks volumes as to the 
suitability of Caco-2 cells as an appropriate tool for NCE development. The cells utilised 
in this study were obtained from a reputable source and maintained through 
manufacturers specifications throughout the culture process.  Even still, the phenotypic 
characteristics of these cells were significantly different from other reported values. This 
really highlights the non-homogenous nature of Caco-2 cells throughout the industry with 
often seemingly inconsequential details in the operation and maintenance of these cells 
having large effects on cellular phenotype both in individual experiments and in working 
culture stocks. 
 
Using the data available at the completion of this study, the “best” model with increased 
permeability phenotypes compared to both the mean of the internal controls and the mean 
of the literature reported values is the 3D Caco-2/ HDFn  model of the intestinal 
epithelium. This was simply calculated as the average of the percentage increase in 
permeability compared to control values, with average values over 100 indicating a 
general increase in permeability and under 100  generally less permeable. Obviously, this 
is a very rough technical analysis and doesn’t take into account data variability or even 
whether an increase in permeability is even a physiologically relevant change.  In reality, 
each model has its own strengths. For example,  the largest increase in Rhodamine 
permeability was seen in HDFn paracrine Transwell cultures whereas 3D HDFn models 
were most permeable to Atenolol. This data highlights in many respects how a singular 
test is often insufficient to provide a relevant answer in all conditions. A move to more 
tailored assays relying on each systems strengths could improve the in vivo reliability of 
NCE research.
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7. General discussion, project conclusions and future directions 
7.1 Introduction 
In their most general basis, the aims of this project were two-fold. First, to look at the 
effects of simple modifications to current Transwell models to achieve physiologically 
relevant changes in Caco-2 epithelial layers assessed by functional pharmacokinetic 
analysis of drug permeability. These simple modifications involved the paracrine co-
culture of Caco-2 Snapwell models with conditioned media from a number of fibroblast 
cell lines of varying origin, and in direct co-culture experiments with the “goblet cell like” 
epithelial cell line HT29-MTX. The purpose of these experiments were to understand the 
importance of a more complete, complex cellular environments on the development of 
epithelial layers, both in terms of understanding the processes within the models created 
in this study but more generally as a tool to understand epithelial-mucosal interactions in 
vivo.   
 
Second, to take the understanding formed from the simple co-culture experiments and 
apply the findings to the creation of a 3D tissue equivalent utilising Alvetex Scaffold ® 
and the cell lines studied in the previous aim, namely Caco-2, CCD-18co, HDFn and HIC. 
These 3D models allowed the study of the effects of direct epithelial-fibroblast co-culture 
on the pharmacologically relevant drug permeability functions of the resultant models. 
Additionally, 3D models allow for a study on the effects of substrate morphology and 
cellular microenvironment on the development of the structural elements of Caco-2 
epithelial cells through analysis of cell morphology and junctional marker composition.  
 
The hypothesis was that the Transwell paracrine and 3D co-culture of Caco-2 cells in a 
more in vivo “like” environment would result in a 3D construct more able to model the 
pharmacokinetic interactions of model drug compounds in vitro. This was done in an 
effort to improve the standard Caco-2 assay currently utilised in industry whilst 
maintaining as many of the beneficial characteristics of said model (mass producibility, 
ease of culture, low cost materials and in vivo relevancy). 
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7.2 Understanding the needs for an improved in vitro model of 
the intestinal epithelium 
Billions of  dollars per year are spent on the development of new drug compounds, many 
of which are optimised and tested on cellular models in vitro of in vivo tissues. (366–370)  
These simple models of intestinal tissues, whilst not perfect, are responsible for the 
validation of many of the commonly used drugs taken by many people on a daily basis. 
Through improved understanding of the epithelial interactions by examining the effects 
of cellular cross talk, either between the indirect effects of underlying, supportive 
fibroblast populations or through direct co-culture of epithelial cells with said fibroblasts 
or other components of the intestinal epithelium; this study was able to mimic and 
understand the function of the in vivo intestinal layer. Understanding of the principle 
biology behind the models being developed has powerful and wide-ranging consequences 
not only in the production, validation and the reduction of costs associated with NCE 
development but also as a tool for further research into areas such as; Intestinal disease 
modelling (371) and mechanism understanding, bacterial-epithelial interactions, (372) 
development biology, nutrition (373) etc. A sufficiently advanced model is 
indistinguishable from in vivo tissue  and as such could be utilised for all the same 
applications.  
 
7.3 Understanding the paracrine microenvironment is key to 
developing systems with improved in vivo mimicry. 
The first chapter of this thesis focussed on three main points. 1. The characterisation of 
the fibroblasts used within this study through histological and immunological staining 
techniques. 2. Creation of Caco-2 epithelial models in the paracrine media of each 
fibroblast cell type. Characteristics such as TEER along with immunological staining of 
key proteins . 3. Understanding the effects of KGF on the development of the Caco-2 
epithelial layer and comparison to the effects of conditioned media samples including 
quantification of KGF levels in conditioned media. 
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All fibroblast cell lines tested were observed in a classic spindle like formation. 
Additional analysis by immunological staining techniques showed cells to be Vimentin 
positive, αSMA positive (to a large extent with some mixed populations observed) and 
Desmin negative, together suggesting fibroblast cells of a myofibroblast origin. Similar 
in phenotype to intestinal sub-epithelial myofibroblast (ISEMF) populations. The 
discussion in section 3.5.2 highlighted the importance of good cellular characterisation 
before the commencement of work with many cell types often miss-identified or used on 
faith that past observation within the literature were correct. There are a number of 
phenotypically similar cell types within the sub-epithelial intestinal compartment with 
mostly overlapping but often distinct niche functions.(185) Pericytes are one such cell 
type which can be easily mixed with myofibroblast cells. Indeed, pericytes are thought to 
be potentially multipotent in the same way as MSC cells, and as such are potential parent 
cells to myofibroblast lineages.(374)  Pericytes absence was confirmed by the absence of 
Desmin staining. However, this in itself is a fairly poor way to confirm pericyte absence 
from a culture. More specific pericyte markers such as PDGF-B/PDGFRβ or Neural glial 
antigen 2 may be more suited for complete confirmation of absence from a culture. (183) 
 
Conditioned media gained from these fibroblast populations was applied to the standard 
Caco-2 model in an attempt to understand the physiological changes that could be induced 
by paracrine released small molecules. Significant changes could be observed with 
improvements in Caco-2 structure from a squamous to cuboidal cellular morphology.  
Analysis of TEER of the different model systems showed, as expected, a heightened 
TEER compared to reported intestinal tissue values gained from the literature. However, 
highly significant decreases of roughly 75% were observed in CCD-18co and HDFn 
paracrine medias with HIC models showing a more limited, but still significant, decrease. 
Decreases in TEER could be postulated to be due to changes in tight junction morphology 
with lower TEER values suggesting either a dysregulation of junction formation or 
polarity. However, immunostaining of the protein Occludin, a member of the tight 
junction complex, showed no significant changes in tight junction regularity between the 
models. 
 
qPCR analysis of the relative expression rates of Occludin mRNA between control, CCD-
18co and HDFn treated layers showed no significant differences between mRNA 
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expression, further confirming an unchanged tight junction phenotype between model 
conditions. Occludin mRNA levels however, were shown to decrease in HIC conditioned 
media models.  On the surface this would appear to be contradictory, with the two most 
significant decreases in TEER belonging to conditions which showed no deviation in 
relative Occludin expression whereas HIC models which do show a decrease in Occludin, 
only showed a small decrease in overall TEER.  Occludin however is only a single 
component of the tight junctional complex. Analysis of it in isolation of expression of 
other junctional components cannot be reliably used as a definitive test for tight junctional 
morphology. As was discussed in chapter 3, other proteins such as claudins are able to 
modulate the tight junction in terms of function without changing the overall expression 
rates of the junctional complex as a whole. Indeed, Claudin 2 expression is shown in the 
literature to be able to increase tight junctional permeability to ions and very small 
molecules without changing the overall integrity of the epithelial monolayer. (227) 
Analysis of Claudin 2 expression by qPCR showed a small increase in CCD-18co and 
HDFn conditions with a decrease in HIC models, similar to that seen in Occludin analysis. 
It is clear that there are at least two methods in which tight junctions are being modulated 
between the different conditions, which, if nothing else works to highlight the complex 
interactions between cells in the epithelium, with often simple looking processes on the 
surface becoming highly complex on closer analysis. This is a theme that is seen 
throughout this work, especially when discussing transporter mediated function.  
 
qPCR  analysis of functional transporter proteins such as OATP-B, BCRP and MDR1 
show a range of changes in treated CCD-18co, HDFn and HIC conditioned media 
samples. MDR1 or p-gp is a protein well known to be under expressed in Caco-2  
compared to intestinal tissues.  Interestingly, treatment of Caco-2 models with CCD-18co 
conditioned media resulted in a decrease in the levels of MDR1 compared to Caco-2 
controls. HDFn models on the other hand showed a significant increase, potentially to 
more physiological levels. Therefore, paracrine constituents of the HDFn conditioned 
media must be having physiological effects on the development of the Caco-2 model. 
mRNA qPCR relative expression however is not always the same as relative protein 
expression and can be influenced in a number of ways which will not affect he functional 
phenotype of the models. MDR1 expression is a good example of this when analysing the 
functional transport rates of Rhodamine 123, a specific MDR1/ P-gp substrate. Whilst 
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mRNA saw a significant decrease in relative expression, functionally, no changes could 
be seen in membrane transport function in CCD-18co treated conditions. Deregulation 
between mRNA levels and protein expression can be influenced by a number of factors 
such as; protein turnover rates, protein function (e.g. secreted proteins will only be 
translated when required, cell cycle proteins will only be used at certain points of cell 
cycle etc) and post-transcriptional regulation rates. This was shown in the study by 
Koussounadis et al in their study of mRNA- protein dysregulation, which, although their 
conclusion was that changes in mRNA generally are physiologically relevant, there are 
many exceptions which suggest protein quantification should be utilised to confirm 
mRNA findings. This study was not able to fully characterise protein expression between 
the different models so qPCR analysis should indicate physiologically deferent changes 
it cannot be relied upon entirely to explain changes in models functional phenotype.  
 
Initially it was hypothesised that KGF may be the potential paracrine agent responsible 
for the changes between 2D and 3D models. Indeed, initial investigations into the effects 
of KGF on the development of Caco-2 layers on Transwell showed promising results in 
regards to TEER values, with significant dose dependant decreases seen in models treated 
with 5 and 25 ng/ml of KGF. Interestingly, TEER levels after treatment were very similar 
to those seen in CCD-18co and HDFn treated cultures with an average TEER value of 
around 500 ohms, down from over 3000 ohms in control samples.  
 
Histological analysis of KGF treated models shows comparable promising changes, with 
improved Caco-2 organisation and structural morphology similar to those seen in 
conditioned media experiments.  Immunostaining of KGF treated layers showed no 
obvious differences between differences in protein expression between KGF 
concentrations albeit a seemingly dose dependant increase in Villin staining, perhaps 
suggesting enhanced differentiation over control models with increased development of 
apical brush border microvilli. 
 
Occludin staining, utilised as before as a marker of tight junction formation, showed no 
obvious changes in expression between treated samples. Again suggesting changes in 
TEER values were due to some other mechanism than simple tight junction non-
formation or disorganisation. A review of the literature suggests that KGF may also have 
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a role in the modulation of Claudin 2, another component of the tight junction complex, 
with upregulation seen in KGF treated cells. Claudin 2 is implicated, as discussed 
previously, in  a morphological change in tight junction structure, allowing an increase in 
the passive movement of ions and small compounds when compared to other tight 
junction formulations. This is achieved without significant effects in the rate of tight 
junction formation or organisation on a macro-cellular basis.  
 
ELISA analysis of conditioned media samples however showed that only CCD-18co cells 
secreted KGF at any significant rate, with both HDFn and HIC cells secreting 
significantly lower KGF levels, barely above the minimum assay detection range. HDFn 
conditioned media showed many of the same phenotypical effects on Caco-2 structure 
and function as was seen in CCD-18co conditioned media such as decreased TEER and 
changes to structural and functional morphology. The logical conclusion to this then is 
that HDFn conditioned media must therefore bring about these similar phenotypes 
through a different functional mechanism. This highlights the complexity of both 
epithelial differentiation and the likely composition of paracrine conditioned media. 
Another possibility is that the major structural and functional changes seen in both HDFn 
and CCD-18co conditioned medias occur thought the same mechanism, just that that 
mechanism is not mediated by KGF and that the effects of KGF on Caco-2 cells layers, 
whilst incurring similar structural changes to Caco-2 cells, is entirely co-incidental.  
Piecing together the exact composition of conditioned media is difficult without any 
reasonable ways to quickly screen a secretome that don’t involve multiple, expensive 
ELISA based kits. One potential route would be to look at the genome level expression 
analysis of each cell type in the hope to identify likely upregulated targets. Even then due 
to the multifaceted ways that secreted compounds interact with one another,  
understanding the significance of each secreted molecule on the development of the 
epithelial membrane is difficult, if not impossible, through analysis of each component in 
isolation of the others.  
 
It is clear that myofibroblasts have significant effects on both the development of Caco-
2 epithelial cells and in vivo. Placing work achieved here into context with the literature 
is more difficult than would appear on the surface with some evidence showing enhanced 
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cellular phenotypes  (375–377) in a range of tissues with others stating either no change 
or a negative effect on cellular phenotype (162) 
 
In terms of suitability for use in an industrial, pharmaceutical setting, it is extremely 
important that cellular models vary between experiments as little as reasonably possible.  
Future work in this area, specifically in that associated with myofibroblast effects on 
epithelial development, should focus on the effects of the paracrine secretome on 
epithelial differentiation. The use of paracrine media to induce physiologically relevant 
changes in Caco-2 function and morphology is both a powerful tool to demonstrate the 
effects of secreted factors, and a poor method for use in industry due to the major 
deviations in the secretome of cells dependant on origin, age and disease phenotypes. 
Research should work towards both higher level regulation of the Caco-2 cell model (e.g. 
validation and use of specific cell banks, reducing inter-lab variability) and in the 
development of defined medias for the enhanced differentiation of Caco-2 cells to create 
a more physiologically relevant model systems. There is a growing volume of work which 
is focussing more on the myofibroblast contribution to cellular phenotypes in models 
however there is still some distance to go before mastery of myofibroblast secretome. 
Work focussing on the exact composition of which would be most valuable. 
 
7.4 Stromal epithelial interactions result in loss of function of 
HT29-MTX cells when co-cultured in vitro. 
The second results chapter of this thesis focussed on the potential of adding HT29-MTX 
cells into the Caco-2 model epithelium. This method of modifying Caco-2 membranes is 
not novel by itself. However, through the addition of CCD-18co paracrine media the study 
examined the effects of myofibroblast influence on the goblet cell phenotype. This work 
was seen as a preliminary step towards addition of HT29-MTX cells into the 3D mucosal 
model, the optimisation of which was ongoing at the same time as this work.  
Preliminary investigations into the effects of CCD-18co conditioned media on HT29-
MTX cells showed an unfortunate change in the structural and functional phenotype to a 
significantly less morphologically “goblet-like” cell. This is potentially not unexpected 
given HT29-MTX parental cell line of HT29, an epithelial cell with some mucous 
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production capabilities. Unfortunately, work on the co-culture of both HT29-MTX and 
CCD-18co cells within the literature is sparse. Pereira et al to my knowledge are the only 
people to attempt creating a 3D model with Caco-2, HT29-MTX and CCD-18co. (162) 
They created their model by culturing CCD-18co cells within a matrigel matrix atop of a 
Transwell insert. Epithelial cells were then culture on the top of this CCD-18co/ Matrigel 
scaffold to create the mature model. Analysis of TEER values of the models and Caco-2 
Transwell controls did not show the same change membrane resistance as was observed 
in this study. However, careful review of the images provided within their paper it is clear 
to see how relatively few CCD-18co cells are present within the matrigel scaffold. Indeed, 
it was observed in this study that CCD-18co cells when grown in 3D significantly reduced 
the levels of KGF secretion overall. This suggest that whilst the observations do not match 
entirely, the differences could be more due to the system used. Conditioned media used 
by was created by a confluent layer of 2D CCD-18co cells and as such, concentrations of 
small molecules within the culture models, based on ELISA date gained in this study, are 
likely to be higher than sparsely 3D cultured CCD-18co cells and could explain the 
difference in overall phenotype.  
 
Models with HT29-MTX cells added were characterised through qPCR relative 
expression of key proteins of interest as well as being functionally assessed for 
Rhodamine 123 permeability. qPCR of MDR1 was essentially absent in HT29-MTX 
layers as would be expected from a cell with little enterocyte function. Whereas 
Rhodamine 123 transport in HT29-MTX cell layers was reduced compared to Caco-2 
controls, however, not to the extent that would be expected. It was hypothesised that the 
decreased epithelial resistance observed in HT29-MTX models compared to controls 
would naturally correlate with a “leaky” epithelium, as such accounting for higher than 
expected Rhodamine 123 permeability. Nevertheless, CCD-18co treatment of HT29-
MTX cell layer did not significantly decrease Rhodamine 123 permeability with 
increased TEER. However, in this instance Rhodamine 123 permeability could be 
influenced by the change in cellular phenotype to one more structurally reminiscent of 
enterocyte lineages. Indeed, if it is assumed that the parental HT29 lineage phenotype is 
restored upon co-culture with CCD-18co, some small level of MDR1/ P-gp activity was 
to be expected. (378)  Due to the uncertain changes in phenotype is was decided not to 
optimise HT29-MTX inclusion into the Alvetex 3D model and as such were omitted from 
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further study.  Further experimentation into the nature of the change in structural and 
functional phenotype of HT29-MTX cells would be required before they could be utilised 
in a regulated manner where model consistency is important.  qvv analysis of lineage 
specific markers such as ATOH1 (379,380), HES1 (379), KLF4(381) or SPDEF (380) 
could potentially shine some light onto the nature of the structural change. 
7.5 3D fibroblast culture allows for the development of a 
complex ECM microenvironment within cell substrates. 
Chapter three focussed on the optimisation of the technology of the 3D model, initially 
through the culture of the cells within the Alvetex scaffold and ultimately in the 
generation of further tools, developed to enable the higher throughput generation and 
analysis of intestinal models. To save time, full quantified optimisation of the models 
methodology was only done once (with 3 internal repeats)  with CCD-18co cells as these 
were shown to be both the slowest to grow and the most limited in the 3D proliferation 
capabilities compared to the HDFn cells. Both CCD-18co and HDFn models show good 
structural morphology and a high level of reproducibility when cultured in the multi-
seeded format as optimised in chapter 3.  
 
The HIC cells were first isolated after the model development of both the CCD-18co and 
HDFn 3D systems. Initially these HIC cells were for conditioned media experiments only 
as limited cells were available from the cultured explant. These primary cells would 
quickly lose proliferative capabilities in culture and as such were deemed not suitable for 
3D models which at the time first isolation were based on the 12 well format. With the 
development of the 96 well format, significantly less cells were required per model 
allowing for the creation of HIC 3D models. In order to keep the 3D models as close to 
one another as possible the optimised techniques applied to both CCD-18co and HDFn 
were also applied to HIC model development regardless of their growth phenotype in 
vitro. Unfortunately, HIC mucosal equivalents show significantly poorer structural 
morphology over both CCD-18co and HDFn models. With significant caco-2 invasion 
into the underlying stromal tissue. Analysis of their  functional properties was continued 
regardless in chapter 4 as, if nothing else, an example of the importance of model 
structural morphology on function. In a way, a negative control. Models within this 
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sections were analysed for their abilities to secrete ECM components into the Alvetex 
Scaffold structure, creating a cellular niche for differentiation and a support for epithelial 
cell culture. Differential secretion of ECM protein into the scaffold was highly cellular 
specific. CCD-18co cells were shown to secrete Collagen I, III and IV into the scaffold, 
chosen due to being major constituents of the small intestine ECM (Collagen I and III) 
and an important basement membrane protein (Collagen IV).  
 
7.6 Functional analysis of paracrine and 3D models shows 
significant changes in the function of Caco-2 epithelial layers. 
Results chapter four of this thesis focussed on the functional characterisation of both the 
advanced Transwell paracrine co-culture models and the 3D models of the intestine, 
bringing together the work achieved in results chapters one and three of this thesis. A 
range of compounds was analysed for their apparent permeability (Papp) through the test 
substrates with each model drug carefully chosen as a substrate for a specific protein 
under study. Rhodamine 123 for example is a well-known substrate for the efflux protein 
MDR1/ P-gp. This protein, often under expressed in the Caco-2 epithelium, is key in the 
development of NCE as P-gp is well known to efflux a range of drug compounds, 
reducing pharmacokinetic availability to the circulatory system in vivo. Verapamil 
Hydrochloride is a specific P-gp inhibitor and was utilised as such in this study as a 
mechanism to show substrate specificity.   
 
MDR1/ P-gp is possibly the most extensively studied ABC transporter protein being first 
isolated in the early 1970s and is important in the resistance of a large variety of 
compounds. Interestingly, MDR1 and other ABC transporter proteins are known to be 
inducible, with heightened levels of cellular expression in cells post exposure to MDR1 
substrates. In essence this makes for an effective anti-toxicity mechanism in vivo, but is 
an obstructive mechanism when considering drug bioavailability. (382) Other 
transporters focussed upon in this study which are known as clinically relevant transporter 
system are MRP1/2 and BCRP. It is important to note that the presence of these drug 
resistance proteins is not limited to the enterocytes of the intestine. Liver hepatocytes and 
endothelial cells of the blood brain barrier are also widely known to express high levels 
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of ABC transporters. Theoretically therefore were a drug to have clinical effects within 
the brain, there would be a minimum of two barriers through which the drug would have 
to pass whilst exposed at ABC proteins. In these situations it is imperative that drugs have 
low ABC substrate specificity in order to ensure bioavailability. (382) 
 
Rhodamine 123 modelling in the models showed a variable change dependant on both 
the cells utilised (control or paracrine influenced samples) and the dimensional format 
(Transwell vs Alvetex). Largely speaking, data values gained here were similar to those 
gained from the literature of other Caco-2 cells models. Generally, 3D models of the 
intestinal epithelium cultured in Alvetex® Scaffold displayed a higher permeability to 
Rhodamine 123 than their Transwell counterparts. This was true for both B-A and A-B 
directional travel. Whereas directional polarity was quite clear between Transwell 
conditioned media and control models, the same is sadly not true for 3D Alvetex® tissue 
equivalents. That is not to say that 3D models lack polarity in general, as that was 
demonstrated clearly through immunological staining of paraffin embedded sections and 
TEM imaging of surface Caco-2 layers and is also seen throughout the literature. 
(162,269,371) A-B directional travel tends to be lower in 3D models just to a far lesser 
extent than seen in 2D.  The loss of permeability polarity alongside increased transport in 
general would seem to suggest that 3D models passively allow the transfer of Rhodamine 
123. This explanation would seem logical until Lucifer yellow transport, a known 
passively transported compound is considered. Lucifer yellow permeability does not 
significantly change in 3D compared to 2D Transwell cultures, although in fairness, 
Lucifer Yellow transport is higher in general in each 3D cultured condition, just not to a 
significant level. There are of course, a number of ways in which this change in functional 
physiology could be explained. The first, as mentioned earlier, is the changes in barrier 
function incurred through modulation of tight junction structure within the epithelial 
membrane. 
 
Versantwoort et al conducted a similar study whereby the assessed the rate of Rhodamine 
123 permeability in both Caco-2 and IEC-18 cells. IEC-18 cells are a non-transformed 
epithelial cell line derived from rat small intestine. Interestingly, in their study similar to 
here, polarised Rhodamine 123 transport was only observed in Caco-2 cells, with 
permeability in either direction approximately equal in IEC-18 cells. (383)One could 
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make the argument that because IEC-18 cells are non-transformed and of a small 
intestinal origin they should theoretically be able to mimic in vivo physiology in vitro. 
IEC-18 cells are known to be able to create consistent tight junctions whilst differentiating 
to a lesser extent than Caco-2 cells.(266) Yet rhodamine 123 transport levels were similar 
in IEC-18 cells as Caco-2 cells in the B-A direction. How then is Rhodamine 123 being 
transported in IEC-18 cells and is this the same phenotype observe in the 3D intestinal 
models. P-gp inhibitors such as verapamil hydrochloride as utilised in this study are a 
good way of elucidating mechanisms of activity. In this study Verapamil hydrochloride 
addition did show a highly significant decreased in Rhodamine 123 permeability in 
Transwell samples (Control and CCD-18co). Lack of any change in B-A Rhodamine 123 
permeability in the presence of Verapamil Hydrochloride in 3D Alvetex® intestinal 
equivalent models again lends further evidence that Rhodamine 123 permeability in 
Alvetex® models is completely not MDR1/ P-gp mediated. The paracrine influences of 
fibroblasts have been used for decades in stem cell culture as feeder layers to maintain an 
undifferentiated phenotype.(384) Loss of directional bias in the models could conceivably 
be due to decreased differentiation compared to conventionally cultured Caco-2 
Transwell models As mentioned previously, there is a wide arrangement of highly 
overlapping functional proteins present in the intestinal epithelium. Upregulation of other 
transporter proteins within the Caco-2 epithelium could easily explain the change in 
functional phenotype. Further experimental testing into this phenomenon would be 
required before models could be utilised as replacements for Caco-2 models in industry. 
 
Regardless of the mechanism at work here, the more important question to ask in the first 
instance is whether the changes seen here are physiologically relevant. P-gp activity is 
thought to be underestimated by conventionally cultured Caco-2 models. Table 6.11 
shows the Papp summary of all the drugs tested in this study. In regards to Rhodamine 
123 all model systems except for Caco-2/ HIC (Transwell) demonstrated an increase in 
B-A permeability. Whilst Rhodamine 123 is a commonly used marker for Caco-2 
transport assays, it is reasonably rare to find comparable Papp values for intestinal tissues 
of this compound in the literature. However, Patient et al (269) utilised porcine intestinal 
tissues to measure Rhodamine 123 permeability in vitro. They found that intestinal tissues 
were far more permeable to Rhodamine 123 than permeability values seen in the 
conventionally cultured control Caco-2 layers (Papp; 0.82 (Controls) vs 1.8-3.6 (Porcine 
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tissues)). In each instance (barring Caco-2 HIC Transwell) each of the models was 
significantly closer to the in vitro tissue permeability values than the conventionally 
cultured Transwell models. Although, as mentioned earlier, the permeability values 
gained with the Caco-2 cells used in these systems were significantly lower than is 
generally seen in the literature (average of 0.82 (this study) vs 6.84 (literature), again 
highlighting the high degree of variability found within supposedly similar  Caco-2 cell 
populations. MDR1/P-gp is one of the most important considerations when assessing the 
pharmacokinetic of NCE’s. Increased MDR1/P-gp activity in cell culture models will 
allow for more sensitive assays in to NCE substrate specificity.  
 
As the name would suggest, BCRP was first isolated from breast carcinoma cells in 1997 
utilising the MCF-7 breast cancer cell line. (385) Methotrexate transport is facilitated by 
a number of overlapping protein functions, and as such cannot be utilised to test a single 
protein transporter in isolation from others with similar functions. Having said this, BCRP 
is a major clinically relevant efflux transporter of methotrexate and as such has been used 
in this study as a measurement of BCRP activity on the apical membrane. Unfortunately, 
BCRP is often co-expressed with MDR1/ P-gp and is highly similar in function, so 
unravelling the specific actions of both can be challenging as they are known to have a 
largely overlapping substrate specificity. BCRP is able to efflux a wide variety of 
xenobiotics from multiple different drug classifications; antibacterial, antivirals, protease 
inhibitors and statins to name just a few, highlighting the clinical importance of 
determining BCRP activity on NCE. (382) 
 
In this study Methotrexate was shown to be differentially transported in all conditions 
tested. In general, transport in the B-A direction was seen to increase with comparative 
T-test statistical analysis showed that 2D HDFn and 3D HIC models were both 
significantly higher than control levels with an increase in B-A Papp of 0.34 and 21.62 
respectively. 3D HIC transport was an order of magnitude greater than all other conditions 
tested, with no B-A/ A-B directional bias. This coupled with large levels of variation 
between tested models suggests that increases in HIC permeability were more due to a 
lack of epithelial development than a significant change in cellular phenotype. However, 
loss of B-A/ A-B directional bias is not necessarily an indicator of a loss of membrane 
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integrity in this instance as other conditions with far lower relative Papp, including 
controls, also show no significant directional bias.  
 
Methotrexate Papp values in this study are generally in line with those seen within the 
literature (with exception of 3D HIC/ Caco-2 models) with an average Papp value in the 
B-A direction of <1. General statistics of oral absorption in humans put methotrexate 
relatively low at 20%, suggesting that low absorption rates are to be expected for this 
compound.(386) The biggest question, as is the case for all of the drug transport analysis 
conducted in this study, is whether the changes seen in the models are physiologically 
relevant. It is clear that Papp values and % oral absorption rates cannot be directly 
compared making it difficult to say definitively without ex vivo tissue experimentation. 
Even then, transport assays with ex vivo tissues are unlikely to directly reflect the function 
within the body in vivo.  
 
Specifically, in regards to Methotrexate transport within this study, it could be argued that 
an increase in permeability is more physiologically relevant. A general observation made 
from the data with comparative analysis of values drawn from the literature (330,387) 
shows clearly that the Caco-2 in this study were significantly less “functional” in regards 
to relative permeability in every drug instance tested.  
 
Propranolol is a highly permeable compound in Caco-2 assays and in vivo with an average 
oral bioavailability of 90% and was one of the most consistent throughout all the 
conditions tested.. Using this knowledge, if data were to be compared and expressed as a 
percentage the permeability values of each of the drugs to Propranolol, and then compare 
that percentage to known in vivo absorption rates it could give a very basic understanding 
of how well the system designed is able to model intestinal absorption characteristics. 
Methotrexate control values result in a 1.24% absorption rate when compared to 
Propranolol. Taking into account the ~20% methotrexate oral absorption rate, it could be 
argued that any increase in methotrexate transport seen within the model systems is a 
physiologically relevant change. 
 
Etoposide is, like many other drugs and as described previously, transported by a range 
of protein transporters in the gut with overlapping functions such as the aforementioned 
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MDR1 and BCRP. (388) In this instance MRP family of transporters namely MRP2 
function is being assessed through the transport of Etoposide. Multi-drug resistance 
protein (MRP) transporters are a member of the ATP binding cassette (ABC) superfamily 
of drug efflux proteins which are well known to be efficient efflux transporters for a 
number of drug types, anti-viral, anti-bacterial and chemotherapeutic. (389,390) The 
Caco-2 cells utilised in this study when cultured using conventional Transwell culture 
techniques (Controls) demonstrated a very low Etoposide permeability of 0.05 x10-6, far 
below the Papp gained from the literature of 8.04x10-6 for similarly cultured Caco-2 cells. 
This follows an observed trend throughout this study when comparing Caco-2 cells used 
here (ECACC, PHE) to the literature. In each case, addition of paracrine factors or 
creation of a full mucosal intestinal model resulted in significant increase in the Papp of 
etoposide compared to conventionally cultured Caco-2 cells.  
 
Again, as with the other compounds described previously, finding human intestinal tissue 
Papp for this drug is challenging. Animal models for Etoposide transport are also highly 
variable depending on the system being studied. For example rabbit tissue transport 
equates to a Papp of roughly 1.13x10-6 whereas a similar experiment utilising rat tissue 
was an order of magnitude higher at 101x10-6.(67,69) In each instance the modified 
models created in this study fall within the large range seen within animal tissues. 
Generally, the conserved change seen in all test conditions in this study is an increase in 
permeability levels to a degree similar to those seen in the Caco-2 conventional literature 
(Papp values of approximately 8.04x10-6). As with other drugs tested here, Alvetex® HIC 
models showed a significantly increased average Papp over other conditions tested in this 
study, similar in scope to the Rat tissue Papp values seen in the literature. If nothing else 
this highlights the disadvantages of utilising animal tissues for drug discovery processes, 
with large variations observed between species. 
 
Takenaka et al showed a similar transport rate of Etoposide in their study on the 
application of primary intestinal cells as an alternative to Caco-2 use. (329)They showed 
that “primary” human enterocytes derived from intestinal stem (HIEC) cells were able to 
transport Etoposide at a significantly greater rate than their Caco-2 controls. Indeed, with 
a Papp of 1.9±0.2, HIEC cells showed remarkable similarity to values gained in this study 
when cultured in 3D or in paracrine media. Their conclusion in this study was that a 
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change in tight junction phenotype alongside junctional “looseness” was one of the main 
contributors to the increases in model permeability, ideas also explored and described 
earlier in this thesis as the methodology of action in these models. Etoposide has a 
fractional absorption rate in humans of approximately 50%. Obviously, intestinal models, 
even 3D cultured ones, are not expected to replicate this level of permeability due to the 
large difference in overall model surface area compared to human tissues. However, it 
was demonstrated here that co-culture of Etoposide in a Transwell system or in a 3D 
model has the effects of generally increasing model permeability, modelling intestinal 
tissues. 
 
Lucifer yellow, Atenolol and propranolol were all utilised as passive measurement of 
membrane integrity of different sized molecules. Lucifer yellow and atenolol were tested 
for their low Papp values in Caco-2 models whereas conversely Propranolol is known to 
be able to readily move through Caco-2 epithelial layers with subsequently high Papp 
values.(66) Passive transport of compounds is a well-known weakness of Caco-2 cell 
models which generally underestimate the rate at which passive permeability occurs. This 
is usually due attributes to an increase in tight junction integrity, resulting in a higher 
TEER values than seen in intestinal tissue, as such decreasing the capability of 
compounds to move through the membrane in Caco-2 models.  
 
Lucifer yellow permeability in humans has been shown by Rozehnal et al (345) to be 
around 4.02 x10-6 in human small intestinal samples. Conventionally cultured Caco-2 
controls had a permeability of roughly a quarter of that at 1.05 x10-6 which is low when 
compared to conventionally cultures Caco-2 values gained from the literature with an 
average Papp value of 2.58x10-6. Interestingly, paracrine cultured Transwell models in 
this study resulted in a decrease in apparent Lucifer yellow Papp in both HDFn and HIC 
conditions with CCD-18co paracrine cultures non-significantly different from controls. 
Whilst this is good in terms of suggesting that conditioned media does not influence caco-
2 ability to form a confluent monolayer in the Transwell system it is contrary to the 
expected increase in Papp hypothesised to be observed. This is in contrast to 3D cultured 
Alvetex intestinal equivalent models which do show a modest increase in Lucifer yellow 
permeability. When one considers the TEER values of 3D models compared to 
conventionally cultures Caco-2 models and even the significantly lower TEER values of 
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conditioned media models it becomes apparent that 3D models possess a less tightly 
joined epithelial layer. Alvetex® intestinal model TEER values are significantly closer to 
the observed TEER of human tissue, with physiologically relevant increases in lucifer 
yellow Papp potentially making them more accurate models for passive permeability 
studies.  
 
Atenolol transport in conventionally cultured (control) samples in this study was similar 
to that seen in the literature for Caco-2 intestinal models with some level of overlap when 
accounting for data deviation. Analysis of Atenolol permeability through intestinal tissue 
sections of both human and animals demonstrates a much higher Papp ex vivo than in 
conventionally cultured Caco-2 models. Conditioned media from CCD-18co and HDFn 
cells did not appreciatively change Atenolol permeability. HIC conditioned media 
however increased Atenolol Papp significantly to a level much more akin to human 
intestinal tissue (2.18 Caco-2/ HIC vs 2.82 Human tissue). Conversely, 3D cultured CCD-
18co and HIC models were not significantly different from Caco-2 Transwell controls 
whilst HDFn 3D models were significantly increase. Potentially highlighting the 
phenotypic effects that 3D culture can have on the secretome of fibroblast cells. Patient 
et al conducted a study similar to that seen here, gaining similar Papp values. The culture 
of Cao-2 cells on nano-fibre supports did not significantly increase Atenolol permeability 
over control conditions. Comparison with porcine tissue, Caco-2 models were 
significantly less permeable as is also suggested in studies of human fractional 
absorption.(269)  
 
Finally, Propranolol Papp was significantly higher in each case than similar experiments 
conducted in porcine tissue samples, albeit much lower than reported values seen for 
permeability in Caco-2 Transwell literature.(269) As mentioned previously however, 
propranolol is a highly lipophilic compounds and as such is easy uptake through the 
cellular membrane. As such, Papp values in tissue and 3D models are often artificially 
decreased due to propranolol sequestration throughout the transport assay into densely 
packed cells This explains why Transwell monolayer models have such a relatively high 
Papp value compared to tissue sections but doesn’t explain why Caco-2 controls in this 
study were low compared to literature values. Epithelial resistance was significantly 
higher in this study than the majority of Caco-2 systems however propranolol is generally 
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absorbed directly through the plasma membrane. There are some recent, controversial, 
studies which suggest that P-gp may be able to transport propranolol as such potentially 
changing permeability values. (391) Alternatively, pH has been shown to critically effects 
the rate or propranolol transport in an assay system. (320) The use of an Ussing chamber 
in this study allowed a carefully control the pH of the transport solution through the use 
of buffers (HBSS) and bubbling of low CO2 containing carbogen throughout the assay 
period. Generally however, Transwell based transport assays are conducted “in-well” in 
a standard culture plate, performed in normal cell culture conditions (high CO2). 
(269,320,392–394)As with most Caco-2 models, most variation seen between studies can 
be attributed to differences in assay technique. In this instance, no control of CO2 
concentration could have significant effects on buffer pH, changing transport dynamics 
in vivo. 
 
7.7 Future work 
Future work for the continued development of this model beyond the scope described in 
this thesis should focus on two parts. 1. Application of intestinal stem cell lines to the 
model and differentiation of said lines into a functional epithelium incorporating the 
cellular diversity found in vivo. 2. Engineering of the scaffold used to create 3D models 
to more accurately replicate the in vivo morphology of the intestine. For example, 
micropatterning of the scaffold surface could create villus-like structures for the culture 
epithelial cells. Application of both of these advances e.g. Addition of the stem cells into 
the villus structure, could potentially allow for the culture of a crypt niche and formation 
of an crypt-villus axis in vitro.  
 
Were this project to be extended further, additional work could be done to more clearly 
characterise the model created here to understand the paracrine secretome of the stromal 
cells utilised in this study. Cross talk between cells within paracrine and 3D models is of 
upmost importance to their development. For paracrine models specifically, an improved 
understanding on how co-cultured cells influence epithelial development would allow for 
the creation of, for example, advanced culture media with the same differentiative effects 
on Caco-2 cells as paracrine conditioned media without the added difficulty and 
variability of culturing stromal cell lines. These constituents could be identified in a 
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number of ways such as through genome sequencing (RNA seq) to identify upregulated 
genes of interest or through a series of knockdown studies, either genetically based or by 
incubating cells with target antibodies.  
 
Ultimately, personalised medicine is the future for the pharmacokinetic testing and use of 
drug compounds. The analysis of the literature throughout this study has demonstrated  
that in reality, the perfect model doesn’t exist, due to large variations in drug availability 
and overall effectiveness between people, so called perfect models. Bridging this inherent 
variation will require the development of an array of models able to mimic a large range 
of human interactions.  
7.8 Final remarks  
This project has highlighted how 3D models can be powerful tools for the modelling of 
critical cellular functions within the intestinal epithelium. As has been mentioned 
throughout this work one of the main difficulties in transferring 3D models into a 
regulated screening format is their lack of characterisation compared to Caco-2 Transwell 
models. Indeed, it will take a lot of additional data to get 3D models to the level of 
characterisation enjoyed by Transwell based systems due to the 30 year head start. 
Utilising Caco-2 cells within the models developed here is a good start as it allows for 
direct comparison with Transwell formats, highlighting both the strength and weaknesses 
of 2D tissue equivalents. Further experimentation with model drugs, is required to really 
understand the mechanisms of action for drug transport within this studies models. Work 
done in this thesis shows some good physiologically relevant changes. However, other 
questions have arisen  such as increased non-directional permeability of normally 
polarised drug compounds in 3D models which would require further work to validate.  
 
The model developed here could be an important first step to industrial acceptance of 3D 
models on a large scale. Work done in this study alongside the body of evidence described 
within will provide a basic foundation for the development of future intestinal models. 
Whose function, ultimately, is in the accurate predictability of NCE within humans and 
in the limitations of the need for animal models in the future of drug discovery and 
validation.
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9. Appendix and supplementary information. 
9.1 Negative control images 























Figure S1: Negative control images for 2D fibroblast cell lines – A-B) CCD-18co, 
mouse and rabbit respectively C-D) HDFn, mouse and rabbit respectively E-F) HIC, 
mouse and rabbit respectively. 2D fibroblast negative controls relate to Figure 3.3. 
Images representative of multiple observations 
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Figure S2: Negative control images for 2D Epithelial – A-B) Caco-2 mouse and 
rabbit negative control respectively. C-D) HT29-MTX mouse and rabbit negative 
control respectively. Images represent negative controls for Figures 3.4-7, 3.12 & 3.26. 
Staining and imaging seen in aforementioned figures was all done concurrently. 
A B 
C D 
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Figure S3: Negative control images for wholemount and transverse Caco-2 
Transwell models – A) Caco-2 control, relating to Figures 3.13. B) Caco-2/ CCD-18co 
treated, relating to figure 3.14, C) Caco-2/ KGF (25ng/ml) treated relating to figures 
3.20-23, D) Transverse Caco-2 Transwell section relating to Figure 3.13. E) Transverse 
Caco-2/ CCD-18co Transwell section relating to Figure 3.14. All staining in these figures 
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9.1.4 Caco-2 and HT29-MTX Transwell controls 
  
Figure S4: Negative control images for Sectioned Transwell models containing 
Caco-2 and HT29-MTX – A,B) Caco-2 Transwell models, Control and CCD-18co 
treated respectively C,D) HT29-MTX Transwell models, Control and CCD-18co 
treated respectively. Images representative of multiple observations. Controls relate 
to Figure 4.11. E-cadherin antibody was of mouse origin. 
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Figure S5: Negative control images for Sectioned 3D models – A,B) CCD-18co 
3D models, mouse and rabbit secondary antibody respectively C,D) HDFn 3D 
models, mouse and rabbit secondary antibody respectively E,F) HIC 3D models, 
mouse and rabbit secondary antibody respectively. Images representative of multiple 
observations 
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Figure S6: Negative control images for human tissues – A,B) Small intestine mouse 
and rabbit secondary antibody respectively, C,D) Colon mouse and rabbit secondary 
antibody respectively Relating to Figures 5.22-27. Images are representative of multiple 
observations. 
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9.3 PCR Primer optimisation 
 
All primers utilised in the quantitative RT-PCR seen in this study were taken from pre-
established, published peer-reviewed materials. Therefore, all primer utilised here should 
have high degrees of target specificity efficiency. In order to check the validity of the 
sources from which primers were gained a select number of primers were chosen for 
further analysis.  
  
Figure S7: Preliminary data for the intrinsic permeability of different Alvetex 
formats to Crystal Violet dye – Crystal Violet was added to the apical compartment 
of a permeability chamber. Samples were taken at 30 second intervals and 
absorbance was measured at 450nm. N=1, n=1 
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Figure S8: MDR1 primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. B) 
Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.9844, D) Product gel run, single band at correct weight suggests 
primer specificity for sequence of interest. 
A B 
C D 
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Figure S9: MRP2 primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. B) 
Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.985, D) Product gel run, single band at correct weight suggests 
primer specificity for sequence of interest. 
A B 
C D 
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Figure S10: OATP-B primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. 
B) Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.9966, D) Product gel run, single band at correct weight 
suggests primer specificity for sequence of interest. 
A B 
C D 
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Figure S11: Occludin primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of 
R2. B) Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.9581, D) Product gel run, single band at correct weight 
suggests primer specificity for sequence of interest. 
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Figure S12: Villin primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. B) 
Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.9676, D) Product gel run, single band at correct weight suggests 
primer specificity for sequence of interest. 
A B 
C D 
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Figure S13: BCRP primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. 
B) Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.971, D) Product gel run, single band at correct weight 
suggests primer specificity for sequence of interest. 
A B 
C D 
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Figure S14: GAPDH primer optimisation and efficiency check – A) Normal amplification curves utilised for calculation of R2. 
B) Melt peak to show primer specificity, C) R2 plotted diagram, R2 = 0.998, D) Product gel run, single band at correct weight 
suggests primer specificity for sequence of interest. 
A B 
C D 
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9.4 Project poster presentations 
  
Figure S15: Green channel for Figure 3.3 - Positive staining (Green channel) of 2D 
fibroblast cells. Mixed staining of Figure 3.3 
Figure S16: Green channel for Figure 3.4 - Positive staining (Green channel) of 2D 
Caco-2 cells. Mixed staining of Figure 3.4 
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Figure S17: Green channel for Figure 3.5  - Positive staining (Green channel) of 2D 
Caco-2 cells. Mixed staining of Figure 3.5 
Figure S18: Green channel for Figure 3.6 - Positive staining (Green channel) of 2D 
HT29-MTX cells. Mixed staining of Figure 3.6 
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Figure S19: Green channel for Figure 3.7  - Positive staining (Green channel) of 2D 
HT29-MTX cells. Mixed staining of Figure 3.7 
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Figure S20: Green channel for Figure 3.12 - Positive staining (Green channel) of 2D 
Caco-2 cells stained for Occludin, Figure 3.12 
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Figure S21: Green channel for Figure 3.26 - Positive staining (Green channel) of 2D 
Caco-2 cells stained for Occludin, Figure 3.26 
Chapter 9– Appendix and supplementary information 
 




Figure S22: Green channel for Figure 3.13 - Positive staining (Green channel) of 
Caco-2 cells grown on Transwell, Figure 3.13 
Figure S23: Green channel for Figure 3.14 - Positive staining (Green channel) of 
Caco-2 cells grown on Transwell, Figure 3.14 
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Figure S24: Green channel for Figure 3.20-23  - Positive staining (Green channel) 
of Caco-2 cells grown on Transwell in the presence of KGF, Figure 3.20-23 
respectivley. 
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Figure S25: Green channel for Figure 4.11 - Positive staining (Green channel) of E-
cadherin in Caco-2/ HT29-MTX co-cultures, Figure 4.11 
Figure S26: Green channel for Figure 5.22/23 - Positive staining (Green channel) of 
Colonic human tissues, Figures 5.22 and 5.23. 
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Figure S27: Green channel for Figure 5.25-27 - Positive staining (Green channel) of 
Small intestine human tissues, Figures 5.25, 5.26 and 5.27. 
Figure S28: Green channel for Figure 5.28 - Positive staining (Green channel) of 3D 
alvetex cultures created with CCD-18co fibroblast cells, Figure 5.28 
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Figure S29: Green channel for Figure 5.29 - Positive staining (Green channel) of 3D 
alvetex cultures created with HDFn fibroblast cells, Figure 5.29 
Figure S30: Green channel for Figure 5.30 -  Positive staining (Green channel) of 
3D alvetex cultures created with HIC fibroblast cells, Figure 5.30 
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9.5 Project poster presentations 
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